PATENTS AND DESIGNS JOURNAL · The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem. Fees to the Patent Office can be accepted only by payment to the Postal

November-א"ג בכסלו התשע"כ 30, 20101

6/2010ע"תש/'ט

רשומותISRAEL STATE RECORDS

November, 2010א"ג בכסלו התשע"כ 30

יומ הפטנטי והמדגמיPATENTS AND DESIGNS JOURNAL

Page/עמודPatentsפטנטי

4Applicationsבקשות שהוגשו filedApplications 67בקשות שקובלו acceptedPatents 295פטנטי שניתנו grantedPatents 295פטנטי שחודשו renewed

ot 295פטנטי שתוקפ פקע in forcePatents nPatents 297פטנטי שחודשו לעשרי שנה renewed for 20 years

ges 311שינויי בפרטי רשומי בפנקס in particulars entered inChanregister

Corrections 312תיקוניCountry 348קודי למדינות codes

Indices 339מפתחות לבקשות שהתקבלו of applications acceptedDesigns Designs registeredDesigns registeredDesigns Designs renewedrenewedDesigns Designs withdranDesigns cancelecanceled

withdranמדגמי שהוזנחו

335


ידיעות כלליות

אל בענייני' וכו, מסמכים, מכתבים :פטנטים ומדגמים יש לשלוח.ירושלים, מלחה5בנין, גנים טכנולוגיים ירושלים, רשם הפטנטים והמדגמים

' אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מסיש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה. 0-24145-2

.שולמה

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to:The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theAuthority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the officetogether with the application for the action for which the fee has been paid.

זכות היוצרים בתקצירים אלה שמורה למדינתאין להעתיק מתקצירים אלה אלא, ישראל

.ברשות לשכת הפטנטים

Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.


PATENTS פטנטי-ז"תשכ, לחוק הפטנטים16הודעה לפי סעיף

1967 NOTICE UNDER SECTION 16 OF THEPATENTS LAW, 5727-1967

להלן רשימת בקשות חדשות הממלאות אחרלתקנות)א(32הדרישות שנקבעו בתקנה

:1968-ח"תשכ, הפטנטים

In the following there are listed newapplications complying with the provisionsof rule 32(a) of the Patent Regulations, 5728-1968:

Particulars: פרטי הבקשות מובאים לפי סדר זה of the applications are given inthe following order:

ותאריך הגשתה וארבעה–מספר הבקשה הסמנים הראשונים של הסיווג הבינלאומי

Number and date of application and the firstfour symbols of the InternationalClassification.

ע(שם האמצאה Title)י המבקש"כפי שהוצע of invention (as proposed by applicant)Applicant המבקש

Convention–מדינת האיגוד: דין קדימה country-Priority right:Number תאריך ומספר and date ofForeign בקשת החוץ application

International מספר בקשה בינלאומית Application NumberInternational מספר פרסום בינלאומי Publication Number


)2010.01 (H01Q20430904/03/2010

מבנה תקשורת ובקרה למודול שידור קליטה למערך פעיל/

TRANSMIT/RECEIVE MODULECOMMUNICATION AND CONTROLARCHITECTURE FOR ACTIVEARRAYRAYTHEON COMPANY

17/03/200912/381867US

)2010.01 (H01Q20431004/03/2010

180/ מעלות0מסיט הניתנת להסטה מעלות בקו שידור פס מישורי גמיש

SWITCHABLE 0 DEGREE/180 DEGREEPHASE SHIFTER ON FLEXIBLECOPLANAR ON FLEXIBLECOPLANAR STRIP TRANSMISSIONLINERAYTHEON COMPANY

16/03/200912/405132US

)2010.01 (A47C20431104/03/2010

הרכבת משושת עדשת מערך משולב קלת משקל וניתנת לאחסון–

LIGHT WEIGHT STOWABLE PHASEDAPPAY LENS ANTENNA ASSEMBLY

RAYTHEON COMPANY16/03/200912/405135US

)2010.01 (F25B20431604/03/2010

אדום המקורר על ידי מצנן–חיישן תת סטירלינג

INFRARED SENSOR COOLED BYSTIRLING COOLER


SAGEM DEFENSE SECURITE06/03/20090951437FR

)2010.01 (G01S20432607/03/2010

גילוי ותיקון טעות במחזור של פזתב INSהמובסס עלGPS–המנשא

INS BASED GPS CARRIER PHASECYCLE SLIP DETECTION ANDREPAIRINGNORTHROP GRUMMAN GUIDANCEAND ELECTRONICS COMPANY, INC.

20/05/200912/454580US

)2010.01 (A62B20436509/03/2010

גז–מפוחון POWER)ך"אב(מפוח עזר למסכת ASSISTANT BLOWER FORGAS MASK

ILAN אילן יוגב YOGEV

)2010.01 (F41G20443911/03/2010

VEHICLE רכב בעל צריח מסתובב PROVIDED WITHREVOLVING TURRETOTO MELARA S.P.A.

)2010.01 (B65H20447614/03/2010


שלבית להשתלת–דיגיטלית דו מערכת תכנים

TWO-STAGE DIGITAL PROGRAMINSERTION SYSTEM

RGB NETWORKS, INC.01/04/200912/384278US

)2010.01 (B28B20448514/03/2010

A סגר עם יחידת מזיגה טלסקופית CLOSURE COOSURE DEVICE WITHTELESCOPIC POURING UNITTHE AFFILIATE IMAGE HOLDING OFTHE JSC IMAGE HOLDING APS

25/09/2009200909809UA

)2010.01 (H01L20450115/03/2010

GENERATOR גנרטור עבור מתמר פיאזואלקטרי FOR A PIEZOELECTRICTRANSDUCERTIP TOP TIPS SARL

16/03/200909155282.8EP27/08/200909168871.3EP

)2010.01 (A01K20451916/03/2010

WATERING שיטת השקייה ושיטה ליישומה SYSTEM AND METHODOF IMPLEMENTING IT

YITZHAK יצחק זינגר ZINGER


)2010.01 (F21V20455916/03/2010

MODULAR מחזירי אור מודולריים ומכלולים לתאורה LIGHT REFLECTORS ANDASSEMBLIES FOR LUMINAIRELSI INDUSTRIES, INC.

10/11/200912/615851US

)2010.01 (B08B20456016/03/2010

TURBINE מערכת לניקוי טורבינה CLEANING SYSTEMGAS TURBINE EFFICIENCY SWEDENAB

30/03/200961/164582US08/12/200912/633354US

)2010.01 (B26D20456817/03/2010

מערכת מסתגלת לספיגת אנרגיה עבור מושב של כלי טיס

ADAPTIVE ENERGY ABSORPTIONSYSTEM FOR A VEHICLE SEAT

TECHNO-SCIENCES, INC.17/03/200961/210326US

)2010.01 (F24J20461921/03/2010

HELIOSTAT מתקן למעקב אחר תנועת השמש FACETSENER, INGENIERIA Y SISTEMAS,S.A.

17/04/2009200901011ES


)2010.01 (H04B20464922/03/2010

מערכת ושיטה להעברת מידע מעל ערוץ הקול של מכשיר רדיו

SYSTEM AND METHOD FORTRANSFERRING DATA OVER AVOICE CHANNEL OF A RADIO SET

ATTOSENSEמ"אטוסנס בע LTD

)2010.01 (G01S20465422/03/2010

IMPROVED מערכת נחיתה משופרת LANDING SYSTEM

ISRAELמ"התעשיה האוירית לישראל בע AEROSPACE INDUSTRIESLTD.

)2010.01 (A61B20466422/03/2010

EPICARDIAL צנתר למיפוי עילית הלב ואבלציה MAPPING ANDABLATION CATHETERBIOSENSE WEBSTER, INC.

13/04/200912/384992US

)2010.01 (A62C20467823/03/2010

FIRE מערכת לכיבוי אש ושיטה SUPPRESSION SYSTEMMETHODKIDDE TECHNOLOGIES, INC.

23/03/200961/210842US


)2010.01 (G06F20468123/03/2010

SYSTEM מערכת ושיטה לניהול תור AND METHOD FOR QUEUEMANAGEMENTQ.NOMY

30/05/200912/413625US

)2010.01 (B01D20468423/03/2010

התקן ושיטה לאיסוף מי שפכים משטיפת מנועי טורבינות

DEVICE AND METHOD FORCOLLECTING WASTE WATER FROMTURBINE ENGINE WASHINGGAS TURBINE EFFICIENCY SWEDENAB

30/03/200961/164524US21/12/200912/643462US

)2010.01 (H01R20468823/03/2010

אופטי–ע האלקטרו התקן לאפיון הביצו של רכיב מוליך למחצה

DEVICE FOR CHARACTERIZING THEELECTRO - OPTICAL PERFORMANCEOF A SEMICONDUCTORCOMPONENTSOCIETE FRANCAISE DEDETECTEURS INFRAROUGES-SOFRADIR

08/04/20090952278FR

)2010.01 (H01P20469123/03/2010

TUNABLE מסנן העברת פס הניתן לכוונון BANDPASS FILTERRAYTHEON COMPANY

20/05/200912/469620US


)2010.01 (F16L20474825/03/2010

SCRIM ציפוי פנימי לצינור עם בד מוחזק -ENFORCED PIPE LINERPERMA-LINER INDUSTRIES, INC.

27/03/200961/164006US18/12/200912/642229US

)2010.01 (H04R20476525/03/2010

ELECTROACOUSTIC אקוסטית–ימית אלקטרו–אנטנה תת UNDERWATERANTENNAATLAS ELEKTRONIK GMBH

23/04/200910 2009018624.7

DE

)2010.01 (G11B20480228/03/2010

POINTER מכשיר גילוי פוינטר ושיטת גילוי פוינטר DETECTION APPARATUSAND POINTER DETECTION METHODWACOM CO., LTD.

18/06/20092009-145880

JP

)2010.01 (G06F20480628/03/2010



18/06/20092009-145880

JP

)2010.01 (G06F20480828/03/2010


18/06/20092009-145880

JP

)2010.01 (G11B20481328/03/2010


18/06/20092009-145880

JP

)2010.01 (H01L20482706/04/2010

התקן לחיבור כח הנוצר על ידי מודול וולטאי ליציאה–פוטו

APPARATUS FOR COUPLING POWERGENERATED BY A PHOTOVOLTAICMODULE TO AN OUTPUTENPHASE ENERGY, INC.

16/04/200961/212811US13/01/201012/657069US


)2010.01 (H04B20486506/04/2010

ACTIVE מערכת משושה משולבת מתועלת פעילה CHANNELIZEDINTEGRATED ANTENNA SYSTEMRAYTHEON COMPANY

06/04/200912/384490US

)2010.01 (G08G20487306/04/2010

מערכת ושיטה לעזרה בנחיתת מטוס בסיפון

SYSTEM AND METHOD FORASSISTING IN THE DECKING OF ANAIRCRAFTTHALES

03/04/20090901645FR

)2010.01 (A47L20489707/04/2010

חומר מוצק ריחני מסיס במים למכונת כביסה ושיטת ייצור

solid, fragrant, water-soluble substance foruse in washing machine. andmanufacturing method thereof

DROR דרור עטיה ATUYA

)2010.01 (A62C20492708/04/2010

מערכת למניעת אש משולבת אמצעים אקטיבי ופאסיבי

COMBINED PASSIVE AND ACTIVEVEHICLE FIRE PREVENTIONSYSTEMKIDDE TECHNOLOGIES, INC.

09/04/20090906268.8GB


)2010.01 (F24B20494308/04/2010

יציקת גשר מוליך למחצה הניתנת להטענה על פני שטח

SURFACE MOUNTABLESEMICONDUCTOR BRIDGE DIEENSIGN-BICKFORD AEROSPACE &DEFENSE COMPANY

13/04/200961/168650US

)2010.01 (G06F20507414/04/2010

SYSTEM מערכת ושיטה לניווט משותף AND METHOD FORCOLLABORATIVE NAVIGATIONHONEYWELL INTERNATIONAL INC.

22/04/200912/428358US

)2010.01 (B05B20508714/04/2010

DRIP טפטפת ושיטות להרכבה ולהתקנה EMITTER AND METHODS OFASSEMBLY AND MOUNTINGRAIN BIRD CORPORATION

06/05/200912/436394US

)2010.01 (A47C20508814/04/2010

ITEM פריט ריהוט לישיבה OF SEATING FURNITUREVOTTELER DESIGNPARTNER GMBH

14/04/200910 2009 016968.7

DE


)2010.01 (B05B20511915/04/2010

ROBOTIC יחידת השקייה רובוטית WATERING UNITDEERE & COMPANY

21/04/200912/427065US

)2010.01 (H04L20512015/04/2010

SYSTEM מערכת ושיטה לניהול שימוש במשאב AND METHOD FORMANAGING RESOURCE USEDEERE & COMPANY

21/04/200912/427043US

)2010.01 (G01J20513215/04/2010

רב–אורך גל אינפרא–גלאי תת פסי–אדום בעל חריצים בוררי תדר ושיטה להכנתו

MULTIBAND SUB - WAVELEGTH IRDETECTOR HAVING FREQUENCYSELECTIVE SLOTS AND METHOD OFMAKING THE SAMERAYTHEON COMPANY

30/04/200912/433631US

)2010.01 (B05D20518619/04/2010

Aת למריחה מותאמת לשפופרת קרםמברש SPREADING BRUSH SUITABLEFOR TUBE OF CREAM

ILANA אילנה מליחי MALIHI


)2010.01 (B01D20518717/10/2008

יחים שיטה והתקן לטיהור של זורמים מל וסילוק של חלקיקים מהם

METHOD AND APPARATUS FOR THEPURIFICATION OF SALTY STREAMSAND THE REMOVAL OFPARTICULATES THEREFROMPOROUS MEDIA CORPORATION

20/10/200760/981488US22/09/200812/234965US

PCT/US/2008/011842WO/2009/051773

)2010.01 (C02F20518828/11/2008

שיטה לטיפול במים בשימוש בכלור דיאוקסיד

METHOD FOR THE TREATMENT OFWATER USING CHLORINE DIOXIDE

INFRACOR GMBH19/12/2007102007061360.3DE07/08/2008102008041081.0DE29/09/2008102008042424.2DE

PCT/EP/2008/066428WO/2009/077309

)2010.01 (A61K20521714/10/2008

שימוש של נורגסטימט כמעכב סלקטיבי,3TRPCיוני של תעלות 6TRPC7–וTRPC

USE OF NORGESTIMATE AS ASELECTIVE INHIBITOR OF TRPC3,TRPC6 AND TRPC7 ION CHANNELSSANOFI AVENTIS

26/10/200707291301.5EPPCT/EP/2008/008671WO/2009/052972

)2010.01 (C07K20521814/10/2008


ואתריTRPCקומפלקסים של אתרי1SESTDושיטות ושימושים הקשורים

בהם

COMPLEXES OF TRPC DOMAINSAND SESTD1 DOMAINS ANDMETHODS AND USES INVOLVINGTHE SAMESANOFI AVENTIS

26/10/2007072913007EPPCT/EP/2008/008670WO/2009/052971

)2010.01 (A01J20523522/04/2010

A בטנה ושיטת חליבה MILKING TEATCUP AND METHODRAN רן סילביאנו SILVIANU

)2010.01 (F16C20523622/04/2010

SEIDING מיסב החלקה HEARINGLESHINSKIY ינסקי אלכסנדר'לשצ ALEXSNDER

)2010.01 (A61K20523706/11/2008

קומפלקס של חומצת גרעין ותכשיר לנתינת חומצת גרעין

NUCLEIC ACID COMPLEX ANDNUCLEIC ACID DELIVERYCOMPOSITIONOTSUKA PHARMACEUTICAL CO.,LTD.

08/11/20072007-291317

JP

PCT/JP/2008/070642WO/2009/061003


)2010.01 (C12N20523831/10/2008

התפתחות מכוונת באמצעות שימושבחלבונים המכילים חומצות אמינו שאינן

טבעיות

DIRECTED EVOLUTION USINGPROTEINS COMPRISINGUNNATURAL AMINO ACIDS

THE SCRIPPS RESEARCH INSTITUTE02/11/200761/001681US08/05/200861/127262US29/09/200861/194773US

PCT/US/2008/012363WO/2009/061369

)2010.01 (C12P20523919/12/2008

SMSM-PROTEIN–הנדסת הפרשה מבוססת על חלבון BASED SECRETIONENGINEERINGBOEHRINGER INGELHEIM PHARMAGMBH & CO. KG

20/12/200707150254.6EP17/03/200808152829.1EP

PCT/EP/2008/010882WO/2009/080299

)2010.01 (G02C20524012/12/2007

INTRACORNEAL עדשות תוך קרניות בעלות חור במרכז LENSES HAVING ACENTRAL HOLEBIOVISION AG

PCT/US/2007/087316WO/2009/075685

)2010.01 (H01L20557006/05/2010

MULTIPURPOSE תכליתי לכתיבה–גליון רב SCRIBABLEARTICLE

בע'החבר.ר.א .A.Rמ"ה הטובים שרותי פרסום THA GOOD GUYS ADVERTISINGSERVICES LTD


)2010.01 (H01M20557206/11/2007

TUBULAR תא אלקטרוכימי צינורי ELECTROCHEMICALCELLNANO CP. LLC

PCT/US/2007/023374WO/2009/061294

)2010.01 (H04L20557322/12/2008

שיטה ויחידת שידור עבור הפחתת סיכון של שיהוי שידור

METHOD AND TRANSMITTING UNITFOR REDUCING A RISK OFTRANSMISSION STALLINGTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

09/01/200861/019910USPCT/SE/2008/051552WO/2009/088348

)2010.01 (H01J20557406/11/2008

התקן רגיש לגילוי יונים ושיטת איבחון של תרכובות כאדים בגזים

SENSITIVE ION DETECTION DEVICEAND METHOD FOR ANALYSIS OFCOMPOUNDS AS VAPORS IN GASESTHE ARIZONA BOARD OF REGENTSON BEHALF OF THE UNIVERSITY OFARIZONA

06/11/200761/002121USPCT/US/2008/082589WO/2009/094059

)2010.01 (C07D20557506/11/2008


שיטות והרכובות ביניים לייצור אמינובנזאימידיזול

PROCESSES AND INTERMEDIATESFOR PRODUCINGAMINOBENZIMIDAZOLE UREASVERTEX PHARMACEUTICALSINCORPORATED

07/11/200760/986141USPCT/US/2008/082565WO/2009/061875

)2010.01 (C07K20557612/11/2008

ל–נוגדנים חד –שבטיים הנקשריםCSF–HGMותכשירים רפואיים

המכילים אותם

MONOCLONAL ANTIBODIES THAT BINDTO HGM-CSF AND MEDICALCOMPOSITIONS COMPRISING SAME

EVEC INC.13/11/20072007-294945JP14/02/2008PCT/JP2008/052471JP

PCT/US/2008/012680WO/2009/064399

)2010.01 (C07K20557706/11/2008

ANTI-FACTOR ושימושיהםBפקטור–נוגדנים אנטי B ANTIBODIES ANDTHEIR USESGENENTECH, INC.

08/11/200761/002648USPCT/US/2008/082621WO/2009/061910

)2010.01 (A61K20557806/11/2008

לטיפול בהפרעותALDH–2מעכבי פסיכיאטריות

ALDH-2 INHIBITORS IN THETREATMENT OF PSYCHIATRICDISORDERSCV THERAPEUTICS, INC.

06/11/200760/985911USPCT/US/2008/082643WO/2009/061924


)2010.01 (A61K20557920/11/2008

פוליפפטידים של אינסולין מתוקנים ושימושים בהם

MODIFIED INSULIN POLYPEPTIDESAND THEIR USES

AMBRX, INC.20/11/200760/989388US

PCT/US/2008/084252WO/2009/067636

)2010.01 (H01J20558014/11/2008

LIGHT מקור אור SOURCECERAVISION LIMITED

16/11/20070722548.5GB23/05/20080809471.6GB12/08/20080814699.5GB12/08/20080814701.9GB

PCT/GB/2008/003829WO/2009/063205

)2010.01 (C07D20558111/09/2008

מעכבי שכפול נגיף האיידסINHIBITORS OF HUMANIMMUNODEFICIENCY VIRUSREPLICATIONBOEHRINGER INGELHEIMINTERNATIONAL GMBH

16/11/200760/988686USPCT/CA/2008/001611WO/2009/062285

)2010.01 (C25D20558206/11/2008

שיטה לבורידציה של ציפויים המשתמשת בתהליך אלקטרוליטי במהירות גבוהה

METHOD FOR BORIDING OFCOATINGS USING HIGH SPEEDELECTROLYTIC PROCESSSERVET I. TIMUR OF


09/11/200707120419.2EPPCT/EP/2008/065065WO/2009/060033

)2010.01 (A61K20558307/11/2008

הגדלת תגובה חיסונית והכוונה באמצעותו קישור תרופתיאו/אנטיגנים

INCREASE OF IMMUNE RESPONSEAND TARGETING BY ANTIGENSAND/OR DRUG LINKAGEWITTYCELL

07/11/200707291336.1EP07/11/200760/996226US

PCT/EP/2008/065179WO/2009/060086

)2010.01 (G01S20558407/11/2008

ENERGY גילוי ארוע של פליטת אנרגיה EMISSION EVENTDETECTIONDOUBLESHOT, INC.

08/11/200760/986586USPCT/US/2008/012603WO/2009/102310

)2010.01 (A61F20558506/05/2010

IOL(INTRAOCULAR(התקן להזרקת עדשה תוך עינית LENS (IOL)INJECTOR APPARATUS

NULENSמ"ניולנס בע LTD.

)2009.01 (A61F20558621/08/2002

ACCOMMODATING עדשה מסתגלת LENSASSEMBLY


NULENSמ"ניולנס בע LTD.21/08/2001145015IL

PCT/IL/2002/000693WO/2003/015669

)2010.01 (H04J20558706/11/2008

מכשיר רדיו לביצוע תקשורת תוך שימושOFDMAבמערכת

RADIO COMMUNICATION DEVICEFOR PERFORMINGCOMMUNICATION USING THEOFDMA SYSTEMSUMITOMO ELECTRIC INDUSTRIES,LTD.

09/11/20072007-292114

JP

PCT/JP/2008/070200WO/2009/060894

)2010.01 (A61K20558819/11/2008

VAGINAL מערכת שחרור דרך הנרתיק DELIVERY SYSTEMBAYER SCHERING PHARMA OY

22/11/200707397042.8EP22/11/200707397043.6EP

PCT/FI/2008/050670WO/2009/066006

)2010.01 (G09B20558905/11/2008

MOTION כסא הדמיית תנועה SIMULATION CHAIRMONTECITO RESEARCH

07/11/200711/936579USPCT/US/2008/082493WO/2009/061828

)2010.01 (A01K20559019/11/2008


כלי משונן לטיפוח חיית מחמד הכולל מנגנון לסילוק פרווה

TOOTHED PET GROOMING TOOLWITH FUR EJECTING MECHANISM

FURMINATOR, INC.19/11/200711/942231US

PCT/US/2008/084065WO/2009/067537

)2010.01 (C09J20559107/11/2008

INSULATING חומר איטום לזכוכית מבודדת GLASS SEALANTTREMCO ILLBRUCKINTERNATIONAL GMBH

08/11/20070721958.7GBPCT/GB/2008/003747WO/2009/060199

)2010.01 (A01G20559205/11/2008

METHOD שיטה ומערכת לחימום וייבוש AND SYSTEM FORHEATING AND DEHUMIDIFYING

משרד החקלאות ופיתוח, מדינת ישראלמרכז, מינהל המחקר החקלאי, הכפר וולקני

THE STATE OF ISRAEL, MINISTRYOF AGRICULTURE AND RURALDEVELOPMENT, AGRICULTURALRESEARCH ORGANIZATION,VOLCANI CENTER

08/11/200760/996266USPCT/IL/2008/001449WO/2009/060436

)2010.01 (A61F20559305/11/2008

מכשיר מערכת ושיטה למניעת בריחת צואה

FECAL INCONTINENCE DEVICE,SYSTEM AND METHOD

RENEW MEDICAL INC08/11/200760/996275US29/02/200861/064374US

PCT/IL/2008/001450WO/2009/060437


)2010.01 (C12N20559403/11/2008

תכשירים להקניית עמידות למחלות והשימוש בהם, וירליות בחרקים חברתיים

COMPOSITIONS FOR CONFERRINGTOLERANCE TO VIRAL DISEASE INSOCIAL INSECTS, AND THE USETHEREOFBEEOLOGICS, LLC

07/11/200760/996244US20/08/200812/222949US

PCT/IL/2008/001440WO/2009/060429

)2010.01 (A61P20559507/11/2008

שימוש בדם טבורי בטיפול בסיבוכים הנגרמים עקב לידה מוקדמת

USE OF UMBILICAL CORD BLOOD INTHE TREATMENT OF PREMATUREBIRTH COMPLICATIONSANTHROGENESIS CORPORATION

07/11/200761/002375USPCT/US/2008/012540WO/2009/061447

)2010.01 (C07D20559604/02/2005

מוריפינונים מותמרים–O–3שיטות להכנתו מוריפינון דיאנול–O–3–בקבוצת הגנה

קרבוקסילטים מותמרים בקבוצת הגנה

METHODS FOR MAKING 3-O-PROTECTED MORPHINONES AND 3-O-PROTECTED MORPHINONEDIENOL CARBOXYLATESEURO-CELTIQUE S.A.

06/02/200460/542711USPCT/US/2005/003390WO/2005/077957

)2010.01 (H01R20559712/02/2009

IMPROVED מרוחקפיצוי משופר לערב דיבור בקצה FAR END CROSSTALKCOMPENSATION


ADC GMBH12/02/200861/028040US11/02/200912/369543US

PCT/US/2009/033892WO/2009/102851

)2010.01 (H01R20559812/02/2009

פיצוי אסימטרי לערב דיבור לקבלת ביצוע משופר לערב דיבור חיצוני

ASYMMETRIC CROSSTALKCOMPENSATION FOR IMPROVEDALIEN CROSSTALK PERFORMANCEADC GMBH

12/02/200861/028032US11/02/200912/369532US

PCT/US/2009/033890WO/2009/102849

)2010.01 (C07D20559920/08/2004

תרכובות בנזאימידאזולון בעלי פעילות4HT–5 רצפטור אגוניסט

BENZIMIDAZOLONE COMPOUNDSHAVING 5-HT4 RECEPTORAGONISTIC ACTIVITYPFIZER INC.

03/09/200360/500144USPCT/IB/2004/002741WO/2005/021539

)2010.01 (C07D20560020/08/2004

תרכובות בנזאימידאיזולון בעלי פעילות4HT–5 רצפטור אגוניסט

BENZIMIDAZOLONE COMPOUNDSHAVING 5-HT4 RECEPTORAGONISTIC ACTIVITYPFIZER INC.

03/09/200360/500144USPCT/IB/2004/002741WO/2005/021539


)2010.01 (C07D20560106/11/2008

METHOD שיטה להכנת תרכובות מורפין FOR THE PREPARATION OFMORPHINE COMPOUNDSSANOFI-AVENTIS

09/11/20070758923FR18/01/200861/021949US

PCT/FR/2008/001558WO/2009/092912

)2010.01 (C07D60220520/11/2008

LO–5 PYRAZOLEנגזרות פיראזול כמעכבי DERIVATIVES AS 5-LOINHIBITORSPFIZER INC.

26/11/200761/004261US26/11/200761/004236US23/05/200861/055497US

PCT/IB/2008/054873WO/2009/069044

)2010.01 (G06F20560307/11/2008

שיטה והתקן לייצור תכנית מבחן המשתמשת בגישת מבחן סטטיסטי

A METHOD AND APPARATUS FORGENERATING A TEST PLAN USING ASTATISTICAL TEST APPROACHRAYTHEON COMPANY

07/11/200760/986047USPCT/US/2008/082731WO/2009/061985

)2010.01 (C07D20560405/11/2008

ציקלופנטאנים מותמרים בעלי פעילות פרוסטגלנדינית

SUBSTITUTED CYCLOPENTANESHAVING PROSTAGLANDINGACTIVITYALLERGAN, INC.

09/11/200760/986849US05/11/200812/265062US

PCT/US/2008/082469


WO/2009/061811

)2010.01 (C07D20560510/12/2008

MEKהידאנטויינים מותמרים כמעכבי קינאז

SUBSTITUTED HYDANTOINS ASMEK KINASE INHIBITORS

F. HOFFMANN-LA ROCHE AG20/12/200761/015222US07/10/200861/103259US

PCT/EP/2008/067221WO/2009/080523

)2010.01 (C12N20560604/03/2005

תרביות פרפוזיה המכילות מדיום לתרבית תא ותאי חיה שעוברים אגרגציה

PERFUSION CULTURES COMPRISINGA CELL CULTURE MEDIUM ANDAGGREGATING ANIMAL CELLSDSM IP ASSETS B.V.

05/03/200404075703.1EP05/03/200404075702.3EP27/09/200404077656.9EP27/09/200404077657.7EP

PCT/EP/2005/002374WO/2005/095578

)2010.01 (C07K20560712/11/2008

AXLAXLנוגדני ANTIBODIESU3 PHARMA GMBH

12/11/200707021931.6EPPCT/EP/2008/009548WO/2009/062690

)2010.01 (C07D20560808/12/2008


טריאזול–תולדות ארילאמיד מותמרותושימושן כאנטגוניסטים של רצפטורים

2/3X2Pאו/ו3X2Pפורינרגיים

TRIAZOLE -SUBSTITUTEDARYLAMIDE DERIVATIVES ANDTHEIR USE AS P2X3 AND/ORP2X2/3PURINERGIC RECEPTORANTAGONISTSF. HOFFMANN-LA ROCHE AG

17/12/200761/007890USPCT/EP/2008/066987WO/2009/077366

)2010.01 (C07C20560914/11/2008

BIS-(SULFONYLAMINO) 066בטיפול)סולפונילאמינו(–תולדות ביסDERIVATIVES IN THERAPY 066ASTRAZENECA AB

15/11/200760/988164USPCT/SE/2008/051307WO/2009/064251

)2010.01 (G01N20561006/11/2008

שיטות למדידת חיות תא מבלי להשתמש בתאי ביקורת

METHODS OF MEASURING CELLVIABILITY WITHOUT USINGCONTROL CELLSGENZYME CORPORATION

09/11/200760/986751USPCT/US/2008/082612WO/2009/061905

)2010.01 (A01N20561114/11/2008

תרכובות מכילות קווינוקסאלין כמעכביCוירוס צהבת

QUINOXALINE-CONTAININGCOMPOUNDS AS HEPATITIS C VIRUSINHIBITORSENANTA PHARMACEUTICALS, INC.

14/11/200760/987958US01/02/200861/025458US

PCT/US/2008/083541WO/2009/064975


)2010.01 (A61B20561205/11/2008

מכשיר אימון להאזנה בסטטוסקופ ושיטות קשורות

AUSCULTATION TRAINING DEVICEAND RELATED METHODS

LECAT PAUL JACQUES06/11/200711/935468US

PCT/US/2008/082417WO/2009/061772

)2010.01 (A61K20561302/12/2008

פירימידין]D–5,4[תרכובות טריאזולו רצת עורקית של הבטןלטיפול במפ

TRIAZOLO [4,5-D]PYRIMIDINECOMPOUNDS FOR TREATMENT OFABDOMINAL AORTIC ANEURYSMSASTRAZENECA AB

03/12/200707301616.4EPPCT/SE/2008/051386WO/2009/072967

)2010.01 (A61B20561403/05/2010

DEVICE התקן ושיטה לבקרת פעילות כליה AND METHOD FORMONITORING RENAL FUNCTION

RENALSENSEמ"רנלסנס בע LTD08/05/200961/215580US

)2010.01 (B01D20561509/05/2010

FILTER סנן למים אפורים ללא צורך בבית סנן FOR GRAY WATERNEEDLESSLY STRUCTURE FILTER

PEL פל דויד DAVID


)2010.01 (A61K20561610/11/2008

תכשירים לשימוש בתיקון או התחדשות שריר הלב פגוע

COMPOSITIONS FOR USE IN THEREPAIR OR REGENERATION OFDAMAGED MYOCARDIUMNEW YORK MEDICAL COLLEGE

09/11/200760/986788USPCT/US/2008/082967WO/2009/062143

)2010.01 (A61K20561824/02/2004

6–אנטאגוניסטים לאינטרלוקיןINTERLEUKIN 6 ANTAGONISTS ASMODULATORS OF NEURAL CELLDIFFERENTIATIONKEIO UNIVERSITY

24/02/20032003-046214

JP

PCT/JP/2004/002111WO/2004/073741

)2010.01 (A61B20561930/10/2008

אדריכלות מידע ופנאומטית עבור התקן לטיפול בחולה

INFORMATION AND PNEUMATICARCHITECTURE FOR A PATIENTCARE AND TREATMENT DEVICEINTEGRATED MEDICAL SYSTEMS,INC.

09/11/200711/983567USPCT/US/2008/081845WO/2009/061665

)2010.01 (F02D20562009/05/2010

מערכת לעקיבה אתר השמש עבור תאים–תאים פוטו, וולטאים מבוססת–פוטו

חלטאים ומונעת על ידי בוכנה חשמלית

PHOTO-VOHAIC ELECTRIC PISTONSUN TRACKING SYTEM


MATALONמ"מטלון מקורות אנרגיה בע ENERGY SOURCES LTD

)2010.01 (C07C20562109/11/2008

אנלוגים סינתטיים חדשים של ספינגוליפידים

NOVEL SYNTHETIC ANALOGS OFSPHINGOLIPIDS

יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM

08/11/2007187247ILPCT/IL/2008/001472WO/2009/060457

)2010.01 (A01N20562210/11/2008

תערובות קוטלות מזיקים המכילות יותתרכובות ציאנוסולפוקסימינ

PESTICIDAL MIXTURESCOMPRISING CYANOSULFOXIMINECOMPOUNDSBASF SE

16/11/200760/988618USPCT/EP/2008/065213WO/2009/062905

)2010.01 (A61K20562307/11/2008

סדרים–רים ושיטות לטיפול באיתכשי מיקרוביאלים

COMPOSITIONS AND METHODS FORTREATMENT OF MICROBIALDISORDERSGENENTECH, INC.

07/11/200760/986170US13/12/200761/013620US20/12/200761/015620US

PCT/US/2008/082890WO/2009/062102


)2010.01(C07D20562417/11/2008

, תרכובות קרבוקסאמידיותסולפונאמידיות ואמיניות להפרעות

מטבוליות

CARBOXAMIDE, SULFONAMIDEAND AMINE COMPOUNDS FORMETABOLIC DISORDERS

RIGEL PHARMACEUTICALS, INC.16/11/200760/988721US27/11/200760/990554US27/11/200760/990558US29/11/200760/991189US14/12/200761/013924US

PCT/US/2008/083801WO/2009/065131

)2010.01 (C07H20562527/11/2008

ANTIVIRAL תרכובות נוקלאוזידיות אנטי וירליות NUCLEOSIDECOMPOUNDSLIGAND PHARMACEUTICALS, INC.

29/11/200760/991163US29/07/200861/084544US

PCT/IB/2008/054985WO/2009/069095

)2010.01 (C22C20562626/02/2008

חלד של ברזל אוסטניטי בעל–פלדת אל ריכוזים נמוכים של עפרות אחרות

LEAN AUSTENITIC STAINLESSSTEEL

ATI PROPERTIES, INC.29/11/200760/991016US

PCT/US/2008/054986WO/2009/070345

)2010.01 (G02B20562710/11/2008

LIGHT מבנים ממקדי אור ושיטות CONCENTRATORSTRUCTURES AND METHODS


SUNRGI08/11/200760/996272US

PCT/US/2008/012622WO/2009/061502

)2010.01 (F24J20562807/11/2008

מבנים ושיטות, תכשירים של חומר מרוכבבעלי התנהגות של מוליכות תרמית

משופרת

COMPOSITE MATERIALCOMPOSITIONS, ARRANGEMENTSAND METHODS HAVING ENHANCEDTHERMAL CONDUCTIVITYBEHAVIORSUNRGI

08/11/200760/996273US28/04/200861/071410US28/04/200861/071411US28/04/200861/071412US23/10/200812/257235US

PCT/US/2008/012611WO/2009/061492

)2010.01 (H01L20562907/11/2008

מבנים ושיטות, ריכוז סולרי והתקני קירורSOLAR CONCENTRATION ANDCOOLING DEVICES,ARRANGEMENTS AND METHODSSUNRGI

08/11/200760/996273US28/04/200861/071410US28/04/200861/071411US28/04/200861/071412US23/10/200812/257158US

PCT/US/2008/012612WO/2009/061493

)2010.01 (A01N20563010/11/2008


–Lשימוש בתמיסות של שמן מנטה או שלו של–או באי/קרוון לטיפול פטרייתי נביטה

פקעות

USE OF SOLUTIONS OF MINT OIL OROF L-CARVONE FOR THEFUNGICIDAL AND/OR ANTI-GERMINATING OF BULBS AND/ORTUBERSXEDA INTERNATIONAL

09/11/20070758919FRPCT/FR/2008/052022WO/2009/068803

)2010.01 (A62C20563107/11/2008

מערכות, מכשיר להגנה בפני שריפה ושיטות לטיפול בשריפה עם ערפל

FIRE PROTECTION APPARATUS,SYSTEMS AND METHODS FORADDRESSING A FIRE WITH A MISTTYCO FIRE PRODUCTS LP

09/11/200760/987021US19/11/200760/989083US03/03/20080803959.6GB

PCT/US/2008/012571WO/2009/061471

)2010.01 (H04W20563213/11/2008

שימוש באותות שידור להעביר מידע שיוך מוגבל

UTILIZING BROADCAST SIGNALS TOCONVEY RESTRICTEDASSOCIATION INFORMATIONQUALCOMM INCORPORATED

16/11/200760/988631US16/11/200760/988641US16/11/200760/988649US31/01/200861/025093US12/11/200812/269637US

PCT/US/2008/083467WO/2009/064932

)2010.01 (A61K20563312/11/2008


טיפול בסרטן הרחם וסרטן השחלות עםלבד או ביחד עם גורמים נגדPARPמעכב גידולים

TREATMENT OF UTERINE CANCERAND OVARIAN CANCER WITH APARP INHIBITOR ALONE OR INCOMBINATION WITH ANTI-TUMORAGENTSBIPAR SCIENCES, INC.

12/11/200760/987335US07/12/200761/012364US03/06/200861/058528US

PCT/US/2008/012757WO/2009/644444

)2010.01 (C12Q20563401/12/2005

שיטה למדידת התנגדות או רגישות לדוקטקסל

METHOD FOR MEASURINGRESISTANCE OR SENSITIVITY TODOCETAXELAVENTIS PHARMACEUTICALS INC.

08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20563501/12/2005

למדידת התנגדות או רגישות שיטה לדוקטקסל


08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20563601/12/2005



08/12/200460/634298USPCT/US/2005/043578


WO/2006/062811

)2010.01 (C12Q20563701/12/2005



08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20563801/12/2005



08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20563901/12/2005



08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20564001/12/2005


METHOD FOR MEASURINGRESISTANCE OR SENSITIVITY TODOCETAXEL


AVENTIS PHARMACEUTICALS INC.08/12/200460/634298US

PCT/US/2005/043578WO/2006/062811

)2010.01 (C12Q20564101/12/2005



08/12/200460/634298USPCT/US/2005/043578WO/2006/062811

)2010.01 (A45D20564212/11/2008

ג METEREDל בכמות מדודה'מנפק GEL DISPENSERANTARES PHARMA IPL AG

12/11/200760/987233USPCT/US/2008/083196WO/2009/064762

)2010.01 (A61K20564410/11/2008

שיטות למתן פורמולציות של קורטיקוסטרואידים

METHODS FOR ADMINISTERINGCORTICOSTEROID FORMULATIONS

MAP PHARMACEUTICALS, INC.09/11/200761/002645US14/03/200861/069498US

PCT/US/2008/083059WO/2009/062193

)2010.01 (H02B20564526/11/2008


מארז עם דופן כפול בעל קירות עםתאים בעלי יכולת משופרת לסילוק

חום

DOUBLE-WALL HOUSING HAVINGIMPROVED HEAT-REMOVINGFUNCTION CHAMBER WALLS

ADC GMBH04/12/2007102007058458.1DE

PCT/EP/2008/010010WO/2009/071226

)2010.01 (H02B20564603/03/2009

BASE ות בסיס עם בלוקים המאטמיםפלט PLATE WITH SEALING BLOCKS

BERTHOLD SICHERT GMBH04/03/2008102008012460.5DE

PCT/EP/2009/052492WO/2009/109568

)2010.01 (B65D20564810/05/2010

COMBINED מיכל מיחזור משולב RECYCLING CONTAINERSHERRY שרי גל GAL

)2010.01 (C07C20564913/11/2008

צורות גבישיות של אליסקירןט ותהליכים להכנתםהמיפומארא

POLYMORPHIC FORMS OFALISKIREN HEMIFUMARATE ANDPROCESS FOR PREPARATIONTHEREOF

TEVAמ"טבע תעשיות פרמצבטיות בע PHARMACEUTICALINDUSTRIES LTD.

13/11/200760/987679US26/11/200761/004382US26/12/200761/016650US14/01/200861/020845US19/02/200861/029752US25/02/200861/031069US


06/03/200861/034229US06/06/200861/059662US25/08/200861/091635US

PCT/US/2008/012816WO/2009/064479

)2010.01 (A61C20565010/05/2010

DENTAL שיטת חשתילת שיניים IMPLANT SYSTEMMIHA ROZENTAL

)2010.01 (C07C20565119/11/2008

של–תהליך להכנת סטראו סלקטיבית נגזרות חומצות אמינו

PROCESS FOR THESTEREOSELECTIVE PREPARATIONOF AMINO ACID DERIVATIESBCN PEPTIDES, S.A.

19/11/2007P200703112ESPCT/ES/2008/000724WO/2009/065987

)2010.01 (H04L20565210/11/2008

PREAMBLE הקדמה לאות אלחוטיעיצוב DESIGN FOR AWIRELESS SIGNALQUALCOMM INCORPORATED

16/11/200760/988720US29/10/200812/260826US

PCT/US/2008/083049WO/2009/064700

)2010.01 (H04W20565309/01/2009

SHARED הקצאת משאבים משותפים RESOURCE ALLOCATION


QUALCOMM INCORPORATED10/01/200861/020219US24/03/200861/039082US29/04/200861/048782US08/01/200912/350690US

PCT/US/2009/030658WO/2009/089490

)2010.01 (H04W20565414/11/2008

שמורת משבצות זמן לתרחיש הפרעהשולטת ברשת תקשורת אלחוטית על ידי תקשורת ישירה בין תחנת בסיס מופרעת

לתחנת בסיס מפריעה

TIME SLOT RESERVATION FOR ADOMINANT INTERFERENCESCENARIO IN A WIRELESSCOMMUNICATION NETWORKTHROUGH DIRECTCOMMUNICATION BETWEENINTERFERRED AND INTERFERINGBASE STATIONQUALCOMM INCORPORATED

16/11/200760/988662US12/11/200812/269696US

PCT/US/2008/083685WO/2009/065075

)2009.01 (H04L20565509/12/2003

הפקת אייגנווקטורים עבור עיבוד מרחביMIMOבמערכות תקשורת

DERIVATION OF EIGENVECTORSFOR SPATIAL PROCESSING IN MIMOCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED

11/12/200260/432760US04/12/200310/729070US

PCT/US/2003/039392WO/2004/054191

)2010.01 (C07K20565613/10/1999


לסנןG–השימוש בקולטן מזווג לחלבון מועמדות כגורם תרופתי–תרכובות

THE USE OF A G PROTEIN-COUPLEDRECEPTOR TO SCREEN CANDIDATECOMPOUNDS AS PHARMACEUTICALAGENTSARENA PHARMACEUTICALS, INC.

20/11/199860/109213US16/02/199960/120416US26/02/199960/121852US12/03/199960/123946US12/03/199960/123949US28/05/199960/136436US28/05/199960/137127US28/05/199960/137131US28/05/199960/136437US28/05/199960/136439US28/05/199960/136567US29/06/199960/141448US29/09/199960/157280US29/09/199960/156653US29/09/199960/156633US29/09/199960/156555US01/10/199960/157280US01/10/199960/157294US01/10/199960/157281US01/10/199960/157293US01/10/199960/157282US12/10/199909/417044US12/10/199909/416760US

PCT/US/1999/023687WO/2000/031258

)2010.01 (C07K20565713/10/1999

לסנןG–השימוש בקולטן מזווג לחלבון מועמדות כגורם תרופתי–תרכובות


20/11/199860/109213US16/02/199960/120416US26/02/199960/121852US12/03/199960/123946US12/03/199960/123949US28/05/199960/136436US28/05/199960/137127US


28/05/199960/137131US28/05/199960/136437US28/05/199960/136439US28/05/199960/136567US29/06/199960/141448US29/09/199960/157280US29/09/199960/156653US29/09/199960/156633US29/09/199960/156555US01/10/199960/157280US01/10/199960/157294US01/10/199960/157281US01/10/199960/157293US01/10/199960/157282US12/10/199909/417044US12/10/199909/416760US

PCT/US/1999/023687WO/2000/031258

)2010.01 (C07K20565813/10/1999

לסנןG–השימוש בקולטן מזווג לחלבון מועמדות כגורם תרופתי–תתרכובו


20/11/199860/109213US16/02/199960/120416US26/02/199960/121852US12/03/199960/123946US12/03/199960/123949US28/05/199960/136436US28/05/199960/137127US28/05/199960/137131US28/05/199960/136437US28/05/199960/136439US28/05/199960/136567US29/06/199960/141448US29/09/199960/157280US29/09/199960/156653US29/09/199960/156633US29/09/199960/156555US01/10/199960/157280US01/10/199960/157294US01/10/199960/157281US


01/10/199960/157293US01/10/199960/157282US12/10/199909/417044US12/10/199909/416760US

PCT/US/1999/023687WO/2000/031258

)2010.01 (H04W20565910/11/2008

שיכוך הפרעה נמשכת במערכת תקשורת אלחוטית

PERSISTENT INTERFERENCEMITIGATION IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

16/11/200760/988693US31/10/200812/262576US

PCT/US/2008/083047WO/2009/064699

)2010.01 (G01S20566011/11/2008

שיטה והתקן לגילוי מיקום שיגור של טילMETHOD AND APPARATUS FORDETECTING A LAUNCH POSITION OFA PROJECTILESELEX GALILEO LTD

12/11/20070722169.0GBPCT/EP/2008/065332WO/2009/062936

)2010.01 (C07C20566112/11/2008

–N–[4צורות פולימורפיות חדשות של–4–]בנזיל)טריפלואורומתיל(

מתוקסיבוטיראמיד

NEW POLYMORPHIC FORMS OF N-[4-(TRIFLUOROMETHYL)BENZYL]-4-METHOXYBUTYRAMIDE

LABORATORIO FARMACEUTICO C.T.S.R.L.

13/11/200707120551.2EPPCT/EP/2008/065367WO/2009/062949


)2010.01 (G01N20566213/11/2008

של מערך בזמן אמת לספקטרומטריהארוסול של ארוסולים אטמוספריים

MSושיטה בזמן אמת של ארוסול MALDI

MATRIX FOR REAL-TIME AEROSOLMASS SPECTROMETRY OFATMOSPHERIC AEROSOLS ANDREAL-TIME AEROSOL MALDI MSMETHODNEDERLANDSE ORGANISATIE VOORTOEGEPAST-NATUURWETENSCHAPPELIJKONDERZOEK TNO

13/11/200707120550.4EPPCT/NL/2008/050721WO/2009/064180

)2010.01 (C07D20566428/11/2008

BENZOMORPHAN תרכובות בנזומורפאן COMPOUNDSPURDUE PHARMA L.P.

30/11/200760/991369US02/07/200861/077616US

PCT/IB/2008/003311WO/2009/068989

)2010.01 (C07D52056611/12/2008

תולדות הטרואריל כאנטגוניסטים לרצפטור לאורקסין

HETEROARYL DERIVATIVES ASOREXIN RECEPTOR ANTAGONISTS

F. HOFFMANN-LA ROCHE AG21/12/200707150294.2EP

PCT/EP/2008/067273WO/2009/080533

)2010.01 (C07D20566620/11/2008

PYRIDINE תרכובות פירידין COMPOUNDSF. HOFFMANN-LA ROCHE AG


30/11/200707122017.2EPPCT/EP/2008/065911WO/2009/068468

)2010.01 (A61K20566728/11/2008

תכשיר רוקחי הכולל קוניוגאט פפטידאינסילינוטרופיק לטיפול במחלה קשור

להשמנה

A PHARMACEUTICAL COMPOSITIONFOR TREATING OBESITY-RELATEDDISEASE COMPRISINGINSULINOTROPIC PEPTIDECONJUGATEHANMI PHARMACEUTICAL CO.,LTD.

29/11/200711/947697US

26/08/2008 104200840083194 KR

PCT/KR/2008/007074WO/2009/069983

)2010.01 (A61K20566922/12/2008

ב–תרכובות רבי PPAR–יעד פעילות וקולטן קנאבינואיד

MULTITARGET COMPOUNDSACTIVE AT A PPAR ANDCANNABINOID RECEPTORGIULIANI INTERNATIONAL LIMITED

21/12/20072007/0928IEPCT/EP/2008/068205WO/2009/080821

)2010.01 (F16L20567011/11/2008

GRIP טבעת חיזוק מותאמת RING FOR FITTINGPLASSIMמ"פלסים אביזרים בע FITTINGS LTD.

11/11/200760/987067USPCT/IL/2008/001480WO/2009/060462


)2010.01 (C07C20567120/11/2008

תרכובות פחמימניות ציקליות חדשות לטיפול במחלות

NOVEL CYCLIC HYDROCARBONCOMPOUNDS FOR THE TREATMENTOF DISEASESLEO PHARMA A/S

23/11/200760/989856US28/08/200861/092553US

PCT/DK/2008/000410WO/2009/065406

)2010.01 (C02F20567214/11/2008

תהליך לטיפול במי שפכים ומפעל הכולל בקרת ריכוז החמצן המומס

WASTEWATER TREATMENTPROCESS AND PLANT COMPRISINGCONTROLLING THE DISSOLVEDOXYGEN CONCENTRATIONJAVEL LIMITED

16/11/20070722486.8GBPCT/EP/2008/065624WO/2009/063086

)2010.01 (H01P20567331/03/2008

FILTER הרכב מסנן ASSEMBLYTELEFONAKTIEBOLAGET L MERICSSON (PUBL)

31/01/20080800239-6SEPCT/SE/2008/050370WO/2009/096836

)2010.01 (H04N20567422/11/2007

שיטה ומכשיר להעברה מאובטחת של פקס

METHOD AND APPARATUS FORSECURED FACSIMILETRANSMISSIONPURELLA AG

PCT/EP/2007/010114WO/2009/065423


)2010.01 (A61K20567503/12/2008

ו של/אוקסאזולידינונים לטיפול או מניעה אי ספיקת לב

OXAZOLIDINONES FOR THETREATMENT AND/OR PROPHYLAXISOF HEART FAILUREJANSSEN PHARMACEUTICA, N.V.

11/12/200761/007406USPCT/EP/2008/010211WO/2009/074249

)2010.01 (A61M20567604/12/2008

SPIKE יתד בעל שתי סיכות HAVING TWO PINSBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

17/12/2007102007061346.8DEPCT/EP/2008/010278WO/2009/077084

)2010.01 (C01B20567812/11/2008

תהליך שריפה ליצור קלציום פוספאט וגרגרי קלציום פוספאט מרוכב

A COMBUSTION PROCESS FOR THEMANUFACTURE OF CALCIUMPHOSPHATE AND CALCIUMPHOSPHATE COMPOSITE PARTICLESHKPB SCIENTIFIC LIMITED

12/11/2007IE2007/0808IEPCT/EP/2008/065414WO/2009/062973

)2010.01 (C04B20567914/11/2008

שיטה לדבקוק באמצעות חום מים בתווךמימי של חומרים קרמיים ותוצרים

המתקבלים מכך

METHOD OF HYDROTHERMALLIQUID PHASE SINTERING OFCERAMIC MATERIALS ANDPRODUCTS DERIVED THEREFROM


RUTGERS, THE STATE UNIVERSITYOF NEW JERSEY

15/11/200761/003272USPCT/US/2008/083606WO/2009/102360

)2010.01 (A61K20568020/11/2008

וחומרים אנטי4PDEתצריפים של מעכבי פסיכוטיים לטיפול באי סדרים פסיכוטיים

COMBINATIONS OF PDE4INHIBITORS AND ANTIPSYCHOTICSFOR THE TREATMENT OFPSYCHOTIC DISORDERSMEMORY PHARMACEUTICALSCORPORATION

20/11/200760/989221USPCT/US/2008/084207WO/2009/067607

)2010.01 (C07K20568119/11/2008

ANTI-MESOTHELIN מזותלין ושימושים עבורם–נוגדנים אנטי ANTIBODIESAND USES THEREFORBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

26/11/200761/004378USPCT/EP/2008/009756WO/2009/068204

)2010.01 (C07D20568221/11/2008

K3PIAMINOאמינו טריאזולים כמעכבי TRIAZOLES AS PI3KINHIBITORSCELLZOME LIMITED

27/11/200707121607.1EP03/07/200861/078006US07/08/200861/086963US

PCT/EP/2008/066001WO/2009/068482


)2010.01 (E02D20568311/05/2010

מערכת פלטות לחיזוק קירות–מופנלסיסמבנים כנגד תזוזות קרקע ושאר כוחות

חיצוניים

PANEL SYSTEM FORSTRENGTHENING STRUCTURESWALLS AGAINST EARTHQUAKESAND OTHER OUTSIDE

RONEN רונן מעוז MAOZ

)2010.01 (A47G20568411/05/2010

MODULAR יחידה מודולארית לתצוגת תמונות PICTURES DISPLAY UNITELISHA אלישע שמאלי SMALY

)2010.01 (A61B20568503/12/2008

דחיסה ופענוח של נתוני טומוגרפיה ממוחשבת

COMPRESSION ANDDECOMPRESSION OF COMPUTEDTOMOGRAPHY DATASAMPLIFY SYSTEMS, INC.

03/12/200711/949670USPCT/US/2008/085417WO/2009/073730

)2010.01 (G06Q20568613/11/2008

מערכת ושיטה לניהול איכות המשתמשות באינדקטורים ברקודיים

A SYSTEM AND METHOD FOR QUALITYMANAGEMENT UTILIZING BARCODEINDICATORS

VARCODEמ"וארקוד בע LTD.14/11/2007PCT/IL2007/01411IL10/06/200861/131644US


PCT/IL/2008/001494WO/2009/063464

)2010.01 (G06Q20568713/11/2008

מערכת ושיטה לניהול איכותהמשתמשות באינדקטורים

ברקודיים

A SYSTEM AND METHOD FOR QUALITYMANAGEMENT UTILIZING BARCODEINDICATORS

VARCODEמ"וארקוד בע LTD.14/11/2007PCT/IL2007/001411IL10/06/200861/131644US

PCT/IL/2008/001495WO/2009/063465

)2010.01 (H04W20568814/11/2008

CLASSIFYINGמיון נקודות גישה המשתמש במזהי פיילוט ACCESS POINTSUSING PILOT IDENTIFIERSQUALCOMM INCORPORATED

16/11/200760/988631US16/11/200760/988641US16/11/200760/988649US31/01/200861/025093US12/11/200812/269642US

PCT/US/2008/083632WO/2009/065033

)2010.01 (A61K20568911/11/2008

לבדPARPטיפול בסרטן השד עם מעכב או ביחד עם גורמים נגד גידולים

TREATMENT OF BREAST CANCERWITH A PARP INHIBITOR ALONE ORIN COMBINATION WITH ANTI-TUMOR AGENTSBIPAR SCIENCES, INC.

12/11/200760/987333US07/12/200761/012364US03/06/200861/058528US

PCT/US/2008/083147WO/2009/064738


)2010.01 (F41A20569017/07/2008

DIRECT שיפור הנעה ישירה לרובים DRIVE RETROFIT FORRIFLESJASON ADAMS

12/11/200711/938678US17/07/2008US

PCT/US/2008/008768WO/2009/064327

)2010.01 (H04W20569105/11/2008

PREAMBLE עיצוב הקדמה לאות אלחוטי DESIGN FOR AWIRELESS SIGNALQUALCOMM INCORPORATED

16/11/200760/988665US16/11/200760/988720US01/02/200861/025670US13/02/200861/028497US22/04/200861/047021US29/10/200812/260856US

PCT/US/2008/082521WO/2009/064647

)2010.01 (H04W20569214/11/2008

זיהוי סקטור המשתמש בחתימות פרמטרי סקטור

SECTOR IDENTIFICATION USINGSECTOR PARAMETERS SIGNATURES

QUALCOMM INCORPORATED16/11/200760/988631US16/11/200760/988641US16/11/200760/988649US12/11/200812/269654US

PCT/US/2008/083643WO/2009/065041


)2010.01 (C07D20569312/11/2003

–פיפרידיניל–6–אמינו–4תרכובותפירימידין כאנטגוניסטים של קולטן

שיטה להפקתן שימושן, הויטרונקטיןבהכנת תרופות ותכשירים רוקחיים

המכילים אותן

4-AMINO-6-PIPERIDINYL-PYRIMIDINE COMPOUNDS ASANTAGONISTS OF THEVITRONECTIN RECEPTOR, METHODFOR THEIR PREPARATION, THEIRUSE IN THE PREPARATION OFMEDICINES AND PHARMACEUTICALCOPOSITIONS CONTAINING THESAMEGALAPAGOS SAS

19/11/200202/14429FRPCT/FR/2003/003349WO/2004/048375

)2010.01 (H04N20569412/11/2008

תהליך והתקן להערכה ולפיצוי תנועהMOTION ESTIMATION ANDCOMPENSATION PROCESS ANDDEVICEVRIJE UNIVERSITEIT BRUSSEL

13/11/200707120604.9EPPCT/EP/2008/065422WO/2009/062979

)2009.01 (C12N20569531/10/2002

לטיפול1אלפאDSPAתכשירם המכילים בשבץ

COMPOSITIONS CONTAINING DSPAALPHA 1 FOR THE TREATMENT OFSTROKEPAION DEUTSCHLAND GMBH

02/11/2001101/53/601.1DE17/12/200101/130/006.8EP

PCT/EP/2002/012204WO/2003/037363

)2010.01 (C07D20569612/11/2008


נגזרות הטרוציקלויות תכשירים המכילים אותן ושימושים בהן

HETEROCYCLIC DERIVATIVES,COMPOSITIONS COMPRISING THESAME AND USES THEREOFVERTEX PHARMACEUTICALSINCORPORATED

13/11/200760/987490USPCT/US/2008/083173WO/2009/064752

)2010.01 (C07D20569712/11/2008

–2–)מורפולינו)פניל(–2–(–3–(4נגזרות אוקסופירולידין

–בנזינסולפון)יל–2–טיאזול(–N–)יל–1– תכשירים, אמיד

המכילים אותם ושימושים בהם

4(-3-(-2-(PHENYL)MORPHOLINO)-2-OXOPYRROLIDIN-1-YL)-N-(THIAZOLE-2-YL)BENZENESULFON-AMIDE DERIVATIVES,COMPOSITIONS COMPRISING THESAME AND USES THEREOFVERTEX PHARMACEUTICALSINCORPORATED

13/11/200760/987485US12/08/200861/088141US

PCT/US/2008/083165WO/2009/064747

)2010.01 (C07K20569816/12/1999

בון היתוך מכשיר תרבית תאים המכיל חלואימונוגלוביולין? של קולטן לימפוטוקסין

))LT–?–R–Igבצורות פעילות ובלתי פעילות

METHODS FOR THE EXPRESSION OFACTIVE PROTEIN-IMMUNOGLOBULIN FUSIONS,ACTIVE PROTEIN-IMMUNOGLOBULIN FUSIONSOBTAINED TBIOGEN IDEC MA INC.

17/12/199860/112752USPCT/US/1999/029873WO/2000/036092

)2010.01 (B01L20569913/11/2008

PROTEASE גילוי פרוטאז DETECTION


MOLOGIC LTD13/11/20070722287.0GB

PCT/GB/2008/003833WO/2009/063208

)2009.01 (C07D20570603/09/2004

חומרי ביניים להכנת היבריד של אוקסאזולידינון וקווינולין

INTERMEDIATE PRODUCTS FORPRODUCING OXAZOLIDINONE-QUINOLONE HYBRIDSMORPHOCHEMAKTIENGESELLSCHAFT FURKOMBINATORISCHE CHEMIE

03/09/200310340485.6DEPCT/EP/2004/009858WO/2005/023801

)2010.01 (G06F20570712/05/2010

FEED-BACKובקופסת מש BOXSHACHAR שחר גלוברזון GLOBERSON

)2010.01 (G08B20570812/05/2010

CAPTURED נוסע הלכוד ברכב/מערכת התראה לילד CHILD/PASSENGERWARNING SYSTEM FOR VEHICLES

MENASHE מנשה גנן GANAN

)2010.01 (H04B20572413/05/2010


טכנולוגיה לשחזור תחבורה ברשתות תקשורת רב שכבתיות

TECHNIQUE FOR TRAFFICRECOVERY IN MULTILAYERCOMMUNICATION NETWORKS

בע. איי.סי. אי ECIמ"טלקום TELECOM LTD.

)2010.01 (G08B20572713/05/2010

DISTRIBUTED רשתות–בעלת תתי רשת חיישנים מבוזרת SENSOR NETWORKHAVING SUBNETWORKS

PEARLSמ"פניני חכמה מחקר ופיתוח בע OF WISDOM RESEARCH &DEVELOPMENT LTD,

)2009.01 (H04B20572918/10/2002

SYSTEM מערכת ושיטה לסיגנל קישור דינמי מהיר AND METHOD FOR FASTDYNAMIC LINK ADAPTATIONINTERDIGITAL TECHNOLOGYCORPORATION

19/10/200160/344693USPCT/US/2002/033587WO/2003/041317

)2010.01 (G01D20573810/06/2004

מונה רושם עם מקודד למדידת זרימה שלחומר ואלגוריתם לחסימה סלקטיבית של

שידור אותות

METER REGISTER HAVING ANENCODER FOR MEASURINGMATERIAL FLOW AND ANALGORITHM TO SELECTIVELYBLOCK SIGNAL TRANSMISSION

ARADמ"ארד טכנולוגיות מדידה בע MEASURING TECHNOLOGIESLTD.

13/06/200360/478522US13/06/200360/478310US

PCT/IL/2004/000498


WO/2004/111576

)2010.01 (A61K20575713/05/2010

מזון מעובד על ידי חימום כנשא תרופהושיטה למתן דרך הפה של תרופות תוך שימוש במזון מעובד על ידי חום כנשא

HEAT-PROCESSED FOOD AS A DRUGCARRIER AND A METHOD OFORALLY DELIVERING DRUGS USINGHEAT-PROCESSED FOOD AS ACARRIER

ז YOCHAI ורע פריאלכרמית ZOREA PRIEL

)2010.01 (A45D20576013/05/2010

HAIR מגהץ שיער עם פילטר לאדים רעילים STRAIGHTENING IRON WITHTOXIC FUMES FILTER

מדנ בע&די DANDEמ"מ M&M LTD

)2010.01 (H04B20577213/05/2010

TELEPHONE מערכת מיתוג טלפונית SWITCWING SYSTEMYITZCHAK יצחק כהן COHEN

)2010.01 (H01L20577906/08/2004

התקן לייצר חריטה בעלת יחס רוחב גובהבתדריםRFעל ידי מודולציה של כוחות

שונים

APPARATUS FOR PRODUCING HIGHASPECT RATIO ETCH USINGMODULATION OF RF POWERS OFVARIOUS FREQUENCIES


LAM RESEARCH CORPORATION22/08/200310/645665US15/12/200310/737022US

PCT/US/2004/025406WO/2005/022623

)2010.01 (D06F20578816/05/2010

MOTOR חבל כביסה ממונע לייבוש כביסה DRIVEN CLOTHESLINE FORDRYING CLOTHES

ISRAEL ישראל קריטנברג KRITENBERG

)2010.01 (B43L20579016/05/2010

על מכשיר DEVICE דיסקיםCDגבי–להדפסה FOR SUPERSCRIBING OFCOMPACT DISCUSES

SERGEY סרגיי פופוב POPOV

)2010.01 (C07C20579209/07/2002

תרכובות חדשות המשמשות כנוגדימאפנני חיסון ונוגדי התרבות, דלקת

השימושים בהן ושיטות להכנתן

NOVEL COMPOUNDS AS ANTI-INFLAMMATORY,IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS USESTHEREOF AND PROCESS FO THEIRPREPARATION4SC AG

10/07/2001PCT/EP01/07948EPPCT/EP/2002/007655WO/2003/006425


)2010.01 (C12N20579302/04/1999

VERTEBRATE של בעלי חוליות2–חלבון מטולא PATCHED -2 PROTEINGENENTECH, INC.

15/04/199809/060939USPCT/US/1999/007417WO/1999/053058

)2009.01 (H04L20579918/02/2004

COMMUNICATION מקלט תקשורת עם משווה מסתגל RECEIVER WITHAN ADAPTIVE EQUALIZERQUALCOMM INCORPORATED

18/02/200310/368920USPCT/US/2004/004706WO/2004/075498

)2009.01 (C12N20580206/05/2004

תצמידים אימוניים המכילים איזור קבועשל אימונוגלוביולין ומולקולה בעלת

פעילות ביולוגית

IMMUNOCONJUGATES COMPRISINGAN IMMUNOGLOBULIN CONSTANTREGION AND A BIOLOGICALLYACTIVE MOLECULESYNTONIX PHARMACEUTICALS, INC

06/05/200360/469600US17/07/200360/487964US26/01/200460/539207US

PCT/US/2004/014064WO/2005/001025

)2010.01 (B23C20581117/05/2010

MILLING כלי כרסום ושימת כרסום עבורו TOOL AND CUTTINGINSERT THEREFOR

ISCARמ"ישקר בע LTD.


)2010.01 (B23K20581317/05/2010

בעל יכולת עקיבה מלווה רובוטי קומפקטי אוטונומית

COMPACT COMPANION ROBOTICPLATFORM WITH AUTONOMOUSTRACING CAPABILITIES

בע-חברת רובו ROBO-TEAMמ"טים LTD

)2010.01 (A47C20581417/05/2010

A מתקן ושיטה לשיזוף SUN-TANNING DEVICE ANDMETHOD

EZRA עזרא עמרני AMRANI

)2010.01 (G09C20581517/05/2010

סט כללי אבטחה שיטה ומערכת לניהולMETHOD AND SYSTEM FORMANAGEMENT OF SECURITY RULESET

TUFINמ"תופין טכנולוגיות תוכנה בע SOFTWARE TECHNOLOGIESLTD

18/05/200961/179089US

)2009.01 (H04W20582717/01/2002

הקצאת רוחב פס דינמית עבור תקשורת רבת כניסות

DYNAMIC BANDWIDTHALLOCATION FOR MULTIPLEACCESS COMMUNICATION USINGSESSION QUEUESTANTIVY COMMUNICATIONS, INC.


31/01/200109/773252USPCT/US/2002/001512WO/2002/061993

)2009.01 (A61M20582819/04/2005

תוצרת התקן רפואי המבוסס על הכרה של מידע מזוהה

MEDICAL DEVICE CONFIGURATIONBASED ON RECOGNITION OFIDENTIFICATION INFORMATIONBAXTER INTERNATIONAL INC.

27/05/200410/855855USPCT/US/2005/013350WO/2005/118054

)2010.01 (C07K20584015/09/2006

שיטה להגברת ההשפעה של גורמיםהמועילים לחומר המורכב ממספר פרטים

נפרדים

METHOD FOR ENHANCING THEEFFECT OF PARTICULATE BENEFITAGENTS

E.I. DU PONT DE NEMOURS ANDCOMPANY

16/09/200560/718035USPCT/US/2006/036108WO/2007/035531

)2010.01 (C07K20584115/09/2006


נפרדים



16/09/200560/718035USPCT/US/2006/036108WO/2007/035531


)2010.01 (C07K20584215/09/2006


נפרדים



16/09/200560/718035USPCT/US/2006/036108WO/2007/035531

)2010.01 (F16M20584517/05/2010

AIR זרוע בטיחות למדחס מזגן CONDITIONER COMPRESSORSAFETY ARM

SHECHAKIMמ"שחקים טכנולוגיות רב חבל בע TECHNOLOGIES RAVHEVEL LTD.

)2010.01 (B23Q20584617/05/2010

סגר אוטם מגנטי ושיטה ליצורוA MAGNETIC SEALING CLOSUREAND A METHOD OFMANUFACTURING THE SAME

GOOPERמ"גופר הרמטיק בע HERMETIC LTD

)2010.01 (F24D20584717/05/2010

HYBRID היברידיתמערכת חימום HEATING SYSTEMPHOEBUSמ"פבוס אנרגיה בע ENERGY LTD


)2010.01 (C07K20585025/11/2003

טיפול במחלות ומצבים רפואיים המטופלים בפוספורילציה מוגברת

TREATMENT OF DISEASES ANDCONDITIONS MEDIATED BYINCREASED PHOSPHORYLATIONDMI BIOSCIENCES, INC.

27/11/200260/429,924USPCT/US/2003/037901WO/2004/050023

)2010.01 (C07K20585125/11/2003



27/11/200260/429,924USPCT/US/2003/037901WO/2004/050023

)2010.01 (C07K20585225/11/2003



27/11/200260/429,924USPCT/US/2003/037901WO/2004/050023

)2010.01 (G09B20585320/05/2010

שיטה מערכת ותוכנה ייעודיתלטיפול עצמי בדיכאון באמצעות

שימוש באינטרנט

A METHOD, SYSTEM AND PROGRAM FORDELIVERING SELF INTERVENTIONS FORDEPRESSION BY USING THE INTERNT

JOSEPH יוסף אנשל בומפלד ANSHEL BOMFELD21/09/200760/994638US


18/09/2008PCT/IL2008/001251WO

)2010.01 (B65D20585420/05/2010

BAG תיק לתפילין וטלית יחד OF TFILIN AND TALITTOGETHER

BENYAMIN בנימין ישראל ISRAEL

)2010.01 (C07D20587122/09/2003

PROCESS תהליך לייצור ולסרטן FOR THE MANUFACTUREOF VALSARTANNOVARTIS AG

23/09/20020222056.4GBPCT/EP/2003/010543WO/2004/026847

)2010.01 (C07K20587917/10/1997

מעכבי פרוטאיזי סירין במיוחד פרוטאיזתכשירי רוקחות,Cשל צהבתNS3ויראלי

המכילים אותם ושימוש בהם

INHIBITORS OF SERINE PROTEASESPARTICULARLY HEPATITIS C VIRUSNS3 PROTEASE, PHARMACEUTICAL

COMPOSITIONS CONTAININGTHE SAME AND THE USE THEREOFVERTEX PHARMACEUTICALSINCORPORATED

18/10/199660/028290USPCT/US/1997/018968WO/1998/017679

)2010.01 (G06F20588920/05/2010


OBJECT מערכת ושיטה לניהול אובייקטים MANAGEMENT SYSTEMAND METHOD

THEמ"דה סטנלי וורקס ישראל בע STANLEY WORKS ISRAEL LTD22/05/200961/180778US

)2009.01 (G01N20589021/03/2002

שיטות וקיטים לקביעת סיכון לחלותשל, בסרטן להערכת היעילות והמינון תרופות

METHODS AND KITS FORDETERMINING A RISK TO DEVELOPCANCER, FOR EVALUATING ANEFFECTIVENESS AND DOSAGE OFCANCER THERAPY

YEDAמ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD.

23/03/200109/815015US09/07/200160/303338US

PCT/IL/2002/000231WO/2002/076280

)2010.01 (A61K20589209/12/2005

רת תערובות דרונבינול יציבות בטמפרטו החדר

ROOM-TEMPERATURE STABLEDRONABINOL FORMULATIONS

INSYS THERAPEUTICS, INC.09/12/200460/634474US

PCT/US/2005/044375WO/2006/063109

)2010.01 (E05D20589723/05/2010

METHOD שיטה למניעת נזק לכלונסאות בטון FOR DAMAGEPREVENTION TO CONCRETE PILES

DRר באסם חזאן"ד BASSEM HAZZAN


)2010.01 (E05B20589823/05/2010

A מצביע של הפעלת מנעול ושיטה עבורו LOCK OPERATION INDICATORAND METHOD THEREFOR

YIFTACH יפתח אורי URI

)2010.01 (E05B20589923/05/2010

A מערכת ושיטת נעילה LOCKING SYSTEM AND METHODYIFTACH יפתח אורי URI

)2010.01 (A61B20590006/05/2010

HAND עדשה לבקרת לחץ שמוחזק ביד HELD PRESSURE CONTROLLENS

NULENSמ"ניולנס בע LTD.


-ז"לחוק הפטנטים תשכ26הודעה לפי סעיף1976

NOTICE UNDER SECTION 26 OF THEPATENTS LAW, 5727-1967

הבקשות שפרטיהן מתפרסמים להלן קובלוכל המעונין. לחוק הפטנטים17לפי סעיף

פטנט על פי בקשה מהבקשות להתנגד למתן תוך שלושה חדשים, המתפרסמות רשאי

להגיש לרשם הפטנטים, מתאריך יומן זהלחוק הפטנטים30הודעת התנגדות לפי סעיף

ואילך לתקנות57בדרך הקבועה בתקנה .1968–ח"תשכ, הפטנטים

The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968

פרטי הבקשות במידה ויישימים מובאים לפי:סדר זה

Particulars of the applications, whereapplicable, are given in the following order:

[11] מספר הבקשה [21] Number of application[54] שם האמצאה Title of invention

[22] תאריך הבקשה Application dateמדינת–יך של בקשות החוץ מספר ותאר

האגוד[31] [32] [33] Number and date of foreignapplication – convention country.

[51]* סיווג בינלאומי* Int.Cl.[61] בקשה לפטנט מוסף Application for patent of addition

[62] בקשת חלוקה Divisional application[71] המבקש Applicant[72] הממציא Inventor

[87] פרסום של בקשה הבינלאומית' מס International Publication Number[74] מען למסירת מסמכים Address for service

[57])בשפה בה ערוך הפירוט(תקציר האמצאה Abridgement of invention (in thelanguage in which the specification is drawnup)

בקשות הפטנטים שפורסמו ביומן: הערה**זה סווגו בהתאם לגרסת הסיווג הבינלאומי

.שהייתה בתוקף בעת הכנת הבקשות לפרסום

*Note:, patent applications published in thisjournal were classified according to theInternational Classification version that wasin force when this journal was prepared.


103992]21][11[

תרכובות אנטיוירליות של אימידזול המכילות קובלט

ANTIVIRAL COBALTCONTAINING IMIDAZOLECOMPOUNDS

]54[

06.12.1992]22[US]33[05.12.1991]32[07/803259]31[

Int. Cl.(2010.01) C07F 15//06]51[CHAI-TECH CORPORATION, U.S.A.]71[

,שמעון לביא21הרצוג

ירושלים

SIMON LAVIE,21 HERZOG ST.,JERUSALEM

]74[

A compound of formula II as set forth in the specificationwherein eachA may be the same or different and is an alkyl group, a phenyl group or a substitutedderivative of a phenyl group;Y may be the same or different and is hydrogen, an unbranched alkyl group, a

halide or group having the formulaR-COwherein R is hydrogen, an alkoxide group, an alkyl group or OH;B may be the same or different and each is hydrogen or an alkyl group;Z- is a soluble, pharmaceutically acceptable negative ion, andX may be the same or different and is an axial ligand selected from the groupconsisting of moieties having the formula IIa as set forth in the specificationwherein R1, R2, R3 and R4 may be same or different and may be hydrogen or loweralkyl having from 1 to 4 carbon atoms: with the proviso that R1, R2, R3 and R4 are of asuitably small size so as not to prohibit the attachment of the axial ligand to the Coatom due to steric hindrance.

]57[

לתקנות35פירוט זה נבח5 בהתא לתקנה 1968–ח"תשכ, הפטנטי

This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________________

116114]21][11[

TRANSGENICצמחי טרנסגני המבטאי קונסטרוקציות PLANTS EXPRESSING]54[


DNAהמכילי ריבוי גני להקניית עמידות מפני וירוסי

DNA CONSTRUCTS CONTAINING APLURALITY OF GENES TO IMPARTVIRUS RESISTANCE

23.11.1995]22[US]33[30.12.1994]32[08/366991]31[WO07.06.1995 PCT/US95/06261

Int. Cl.(2010.01) A01H 05//00, C07K 14//08, C12N 07//00, 15//10, 15//29, 15//40,15//62, 15//82, 15//84

]51[

SEMINIS VEGETABLE SEEDS, INC.,U.S.A.

]71[

',ר שלמה כהן ושות"ד 124גבירול אבן

תל אביב11490.ד.ת,

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,P.O.B. 11490,TEL AVIV 62038

]74[

A chimeric recombinant DNA molecule comprising: at least three tandemly linkedDNA sequences, each of which comprises a promoter operably linked to a DNAsequence which encodes a viral protein, wherein said DNA sequences are expressed invirus-susceptible plant cells transformed with said recombinant DNA sequences toimpart resistance to infection of said cells by each of said viruses, with the proviso thatthe DNA sequences encoding viral proteins do not encode potyvirus protease;and wherein expression of said DNA sequences imparts substantially equal levels ofresistance to infection.

]57[

בקשות חלוקה מבקשה זו.שטר פורסמו

195591,The applications for divisionfrom this application have notyet been published

__________________

125432]21][11[

PERSONALIZED אינטרקציות אינטרנט אישיות INTERNETINTERACTION

]54[

20.07.1998]22[IL]33[30.01.1998]32[123129]31[

Int. Cl.(2009.01) G06F 17/30]51[EASYNET ACCESS INC., U.S.A.]71[

,מ"בע) 1995(ארליך.אי.י'גב,15קומה, מגדל איילון 11גין רחוב מנחם

רמת גן

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,

]74[


RAMAT GAN 52521A method of a user interacting with an Internet, comprising:tracking interactions of the user with an Internet;analyzing said tracked interactions to determine at least a part of a user profile; andmodifying a plurality of future interactions of said user with computers on said Internetresponsive to said user profile, by modifying at least one of a presentation ofinformation to said user or a functional response of a computer to input from user,wherein said plurality of modified interactions comprise interactions with the sitecontent of a plurality of unrelated sites.

]57[


206271,The applications for divisionfrom this application havenot yet been published

__________________

131245]21][11[

שיטה ומכשיר משופרי לאיבחו מצב הל או הל–טרו

METHOD AND APPARATUSFOR THE DIAGNOSIS OFACTUAL OR PRE-SHOCKSTATE

]54[

04.08.1999]22[Int. Cl.(2009.01) A61B 05/046, 05/103, A61N 01/38]51[

CARDIOSENSE,מ"קרדיוסנס בע LTD.]71[ITTAI שני חיים, איתי שביט SHAVIT, HAIM SHANI]72[

,ריינהולד כהן ושותפיו'א26רחוב הברזל רמת החייל

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

A method for the diagnosis of pre-shock state in a patient and of recovery of a patientfrom actual state of shock by measuring the filling time of blood vessels subjacent toan area of the skin of said patient, comprising acquiring an image of an area to begauged for color, acquiring said image to obtain a base-line color measurement, anddetermining the filling time of blood vessels in said area by comparison with the colorof one or more additional images of the gauged area with said baseline measurement.

]57[


__________________

132669]21][11[

MULTIVALENT ערכי המכיל חומר נושא מעורב–תכשיר חיסו רב VACCINECOMPOSITION WITH MIXEDCARRIER

]54[

14.05.1998]22[FR]33[14.05.1997]32[97/06210]31[

Int. Cl.(2009.01) A61K 39/09, 39/385, 47/42, 47/48, A61P 31/10, C07K 14/315]51[SANOFI PASTEUR, FRANCE]71[WO/1998/051339]87[

,לוצאטו את לוצאטו עומר, גן תעשייה

באר שבע5352.ד.ת,

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,P.O.B. 5352,BEER-SHEVA 84152

]74[

The invention concerns a pharmaceutical composition for treating or preventing acertain number of infections caused by pathogenic agents such as bacteria, comprisingas immunogen, one or several polyosides derived from one or several pathogenicagents. The polyosides are in the form of conjugates, coupled with a carrier protein.The composition contains at least two types of conjugates, each being at leastcharacterised by a different protein carrier.

]57[



__________________

134068]21][11[

30B–אינטרלאוקי: ציטוקי של יונק ופולינוקליאוטידי מבודדי המקדדי אות

MAMMALIAN CYTOKINE:INTERLEUKIN - B 30 ANDISOLATED POLUNUCLEOTIDESENCODING THE SAME

]54[

24.07.1998]22[US]33[25.07.1997]32[08/900905]31[

Int. Cl.(2009.01) A61K 38/19, C07K 14/54, 16/24, C12N 01/15, 01/19, 01/21, 05/10,15/10, 15/19, 15/24, 15/63, C12P 21/02, 21/08, C12Q 01/68, G01N 33/68

]51[


SCHERING CORPORATION, U.S.A.]71[WO/1999/005280]87[

',ר שלמה כהן ושות"ד 124אבן גבירול



]74[

Purified genes encoding cytokine from a mammal, reagents related thereto includingpurified proteins, specific antibodies, and nucleic acids encoding this molecule areprovided. Methods of using said reagents and diagnostic kits are also provided.

]57[



__________________

136252]21][11[

או קטעABתכשירי רוקחות ואבחנה המכילי הימנו

PHARMACEUTICAL ANDDIAGNOSTIC COMPOSITIONSCONTAINING AB ORFRAGMENTS THEREOF

]54[

30.11.1998]22[US]33[02.12.1997]32[60/067740]31[US07.04.1998 60/080970

Int. Cl.(2009.01) A61K 09/26, 33/06, 38/19, 39/00]51[ELAN PHARMA INTERNATIONALLTD., IRELAND

]71[

WO/1999/027944]87[,ברגמן וגולר, וולף

ירושלים1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

The invention provides compositions and methods for treatment of amyloidogenicdiseases. Such methods entail administering an agent that induces a beneficial immuneresponse against an amyloid deposit in the patient. The methods are particularly usefulfor prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, asuitable agent is Abeta peptide or an antibody thereto.

]57[

The,205298,193245,191904בקשות חלוקה מבקשה זו applications for division


from.שטר פורסמו this application havenot yet been published

__________________

858513]21][11[

VERTEBRATE של בעלי חוליות2–חלבו מטולא PATCHED -2PROTEIN

]54[

02.04.1999]22[US]33[15.04.1998]32[09/060939]31[

Int. Cl.(2010.01) C07K 14//705, 19//00, C12N 01//19, 01//21, 05//10, 15//11, 15//12,15//62, G01N 33//68

]51[

GENENTECH, INC., U.S.A.]71[WO/1999/053058]87[


REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

The present invention relates to nucleotide sequences, including expressed sequencetags (ESTs), oligonucleotide probes, polypeptides, antibodies, vectors and host cellsexpressing, immunoadhesins, agonists and antagonists topatched-2.

]57[



__________________

140621]21][11[

בחירת והכנת צמחי מצליבי בעלי יחס קבועמראש בי אלקיל גלוקוזאינאולט ואינדול

ולטגלוקוזאינא

SELECTING AND PREPARINGCRUCIFEROUS PLANTS HAVINGA PREDETERMINED RATIO OFALKYLGLUCOSINOLATE TOINDOLE GLUCOSINOLATE

]54[

01.07.1999]22[US]33[01.07.1998]32[60/091471]31[

Int. Cl.(2009.01) A01H 01/04, 01/06]51[JOHNS HOPKINS SCHOOL OF]71[


MEDICINE, U.S.A.WO/2000/001222]87[

,ברגמן וגולר, וולף ירושלים1352.ד.ת,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

A method for producing crucifer germplasm, in particular broccoli and cauliflowergermplasm, with high levels of cancer chemoprotectant agents which comprisesscreening a population of plants for glucosinolate profiles and selecting an individualplant with an enhanced alkyl/indole glucosinolate ratio. Subsequent breeding with aselected plant results in varieties, lines, and plants with desirable glucosinolateprofiles. A method of growing crucifer sprouts to enhance chemoprotectant activity ofthe sprouts by germinating the seeds in a limited water volume. A method forproducing crucifer germplasm which produces seeds with reduced leakage of seedmaterial which comprises screening a population of plants for production of seeds withreduced leakage and selecting an individual plant which produces such seeds.

]57[

__________________

141800]21][11[

מכשיר ושיטה להתאמת קצב תקשורת למערכת תקשורת נתוני

RATE MATCHING DEVICE ANDMETHOD FOR A DATACOMMUNICATION SYSTEM

]54[

06.07.2000]22[KR]33[06.07.1999]32[26978/1999]31[KR10.07.1999 27865/1999

Int. Cl.(2009.01) H03M 13/29, H04J 13/00, H04L 01/00]51[SAMSUNG ELECTRONICS CO.,LTD., REPUBLIC OF KOREA

]71[

WO/2001/003369]87[ט ',קולב ושות. סנפורד מרמורק,4שער הגיא

רחובות2273.ד.ת,

SANFORD T.COLB & CO.,P.O.B. 2273,REHOVOT 76122

]74[

A device and method for matching a rate of channel-encoded symbols in a datacommunication system. The rate matching device and method can be applied to a datacommunication system which uses one or both of a non-systematic code (such as aconvolution code or a linear block code) and a systematic code (such as a turbo code).The rate matching device includes a plurality of rate matching blocks, the number ofthe rate matching blocks being equal to a reciprocal of a coding rate of a channelencoder. The rate matching device can rate match the symbols encoded with a non-

]57[


systematic code or the symbols encoded with a systematic code, by changing initialparameters including the number of input symbols, the number of output symbols, andthe puncturing/repetition pattern determining parameter.

__________________

142207]21][11[

ALZHEIMER'S סקריטאז השיי למחלת אלצהיימר DISEASESECRETASE

]54[

23.09.1999]22[US]33[24.09.1998]32[60/101594]31[

Int. Cl.(2009.01) C07K 14/47, C12N 09/64, 15/57, C12Q 01/37, G01N 33/68]51[PHARMACIA & UPJOHNCOMPANY LLC, U.S.A.

]71[

WO/2000/017369]87[,לצר וכהן צדק, פרל, איתן

7רחוב שנקר הרצליה12688.ד.ת,

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,HERZLIYA 46733

]74[

The present invention provides the enzyme and enzymatic procedures for cleaving thebeta- secretase cleavage site of the APP protein and associated nucleic acids, peptides,vectors, cells and cell isolates and assays.

]57[

__________________

142824]21][11[

נגזרות של חומצה ליפואיק ושמוש כתכשירי אנטי מטבוליי

LIPOIC ACID DERIVATIVES ANDTHEIR USE AS ANTI METABOLIC

]54[


AGENTS

26.10.1999]22[US]33[26.10.1998]32[60/105628]31[

Int. Cl.(2009.01) A61K 31/385, A61P 35/00, C07C 321/04, 323/52, 327/20, 327/58,391/00, C07D 339/02, C07F 19/00

]51[

THE RESEARCH FOUNDATION OFTHE STATE UNIVERSITY OF NEWYORK, U.S.A.

]71[

PAUL M. BINGHAM, ZUZANAZACHAR

]72[

WO/2000/024734]87[,שמעון לביא

21הרצוג ירושלים

SIMON LAVIE,21 HERZOG ST.,JERUSALEM

]74[

This invention relates to the identification of a novel class of therapeutic agents whichselectively target and kill tumor cells and certain other types of diseased cells, and tocompositions comprising lipoic acid derivatives which poison the pyruvatedehydrogenase complex specifically in such cells. This invention also provides formethods of using therapeutically effective amounts of the lipoic acid derivatives forthe treatment of cancer and other diseases. The lipoic acid derivatives described hereinhave a wide range of preventive and therapeutic applications.

]57[

__________________

145134]21][11[

ל אנושיLI–21–נוגדני אנושיי המתחברי ות לייצורושיט

HUMAN ANTIBODIES THAT BINDHUMAN IL-12 AND METHODSFOR PRODUCING THEM

]54[

24.03.2000]22[


US]33[25.03.1999]32[60/126603]31[Int. Cl.(2009.01) A61K 39/395, A61P 01/04, 37/02, 43/00, C07K 16/24, C12N 15/13]51[ABBOTT GMBH & CO. KG,GERMANY

]71[

WO/2000/056772]87[,ריינהולד כהן ושותפיו

'א26רחוב הברזל רמת החייל


]74[

Human antibodies, preferably recombinant human antibodies, that specifically bind tohuman interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinityfor hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of theinvention can be a full-length antibody or an antigen-binding portion thereof. Theantibodies, or antibody portions, of the inveniton are useful for detecting hIL-12 andfor inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder inwhich hIL-12 activity is detrimental. Nucleic acids, vectors and host cells forexpressing the recombinant human antibodies of the invention, and methods ofsynthesizing the recombinant human antibodies, are also encompassed by theinvention.

]57[


207029,203845,The applications for divisionfrom this application havenot yet been published

__________________

145288]21][11[

פוליפפטידי של ליגנדה חדשה לציטוקי11ZALPHAושימושי שלו

ISOLATED CYTOKINEZALPHA11 LIGANDPOLYPEPTIDE AND USESTHEREOF

]54[

09.03.2000]22[US]33[09.03.1999]32[264908]31[US11.03.1999 265992 US01.07.199960/142013

Int. Cl.(2009.01) A61K 38/19, C07K 14/52, 16/24, 19/00, C12N 15/19, 15/62, 15/85]51[ZYMOGENETICS INC., U.S.A.]71[WO/2000/053761]87[



]74[


The present invention relates to zalpha11 Ligand polynucleotide and polypeptidemolecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be usedwithin methods for stimulating the proliferation and/or development of hematopoieticcellsin vitro andin vivo. The present invention also includes methods for producingthe protein, uses therefor and antibodies thereto.

]57[



__________________

145526]21][11[

HDLשיטה לאבחנה מוקדמת של כולסטרולושיטה לקביעת עיכובAIנמו ואפוליפופרוטאי

אוHDL–וLIPGשל תגובה אינזימתית בי VLDLאוLDL

METHOD FOR DIAGNOSINGPREDISPOSITIONS TO LOW HDLCHOLESTEROL ANDAPOLIPOPROTEIN AI ANDMETHOD FOR DETERMININGINHIBITION OF ENZYMOTICREACTION BETWEEN LIPG ANDHDL OR VLDL OR LDL

]54[

24.03.2000]22[US]33[26.03.1999]32[09/277401]31[

Int. Cl.(2009.01) C12N 09/20, G01N 33/53]51[THE TRUSTEES OF THEUNIVERSITY OF PENNSYLVANIA,U.S.A.AVENTIS PHARMACEUTICALSINC., U.S.A.

]71[




]74[

Compositions and methods for raising the level of HDL cholesterol and apolipoproteinAI in a patient and for lowering the levels of VLDL cholesterol and LDL cholesterol ina patient, including compositions and methods which effect the expression of a gene,LIPG, which encodes a lipase enzyme that is a member of the tryacylglycerol lipasefamily or which effect the enzymatic activity of the enzyme.

]57[


__________________

146482]21][11[

ל TEKTEK–אנטגוניסטי ANTAGONISTS]54[

07.06.2000]22[US]33[07.06.1999]32[60/137889]31[

Int. Cl.(2009.01) A61K 38/17, A61P 35/00, C07K 14/71, 19/00, C12N 15/12, G01N33/68

]51[

IMMUNEX CORPORATION, U.S.A.]71[WO/2000/075323]87[

,ד כהן ושותפיוריינהול'א26רחוב הברזל רמת החייל


]74[

The present invention provides Tek antagonists and methods of inhibiting angiogenesisin a mammal by administering Tek antagonists. The methods are particularly useful intreating diseases or conditions mediated by angiogenesis, such as solid tumors anddiseases or conditions characterized by ocular neovascularization.

]57[

__________________

146625]21][11[

METHOD שיטה ומערכת לניהול חיובי AND SYSTEM FORBILL MANAGEMENT

]54[

24.05.2000]22[Int. Cl.(2009.01) G06K 11/00]51[KIA SILVERBROOK, AUSTRALIA]71[WO/2000/072245]87[



]74[


Methods and systems are disclosed which relate to online bill management viainterface surfaces printed with information and coded data. The coded data, encodedvisibly or invisibly, may be queried by an appropriate sensing device. The sensingdevice communicates with a computer system. Together, the interface surfaces,sensing device and computer system are capable of effecting online bill management,including bill payment, over a network.

]57[


171146,The applications fordivision from thisapplication have not yetbeen published

__________________

146937]21][11[

שיטה ליצירת ספריית צאצאי הכוללת רצפי פולינוקליוטיד

METHOD FOR PRODUCING APROGENY LIBRARY COMPRISEDOF POLYNUCLEOTIDESEQUENCES

]54[

14.06.2000]22[US]33[14.06.1999]32[332835]31[

Int. Cl.(2010.01) C12N 15//10, C12Q 01//68, C40B 10//00, 30//00, 50//00]51[VERENIUM CORPORATION, U.S.A.]71[WO/2000/077262]87[



]74[

The invention is directed to a process of preparing nucleic acid and poly nucleotidelibraries by cloning non-randomly generated nucleotide fragments having ligatableends into an expression vector. The expression of the polynucleotide provides an

]57[


indirect means by which to screen the polynucleotide library.

__________________

147102]21][11[

DETONATOR התק הפעלה של בפ" בעזרת חוט WIRE ACTUATORAPPARATUS

]54[

13.12.2001]22[Int. Cl.(2010.01) F42C 15//42]51[

ARIE אשקלון, אריה סנסולו SANSOLO]71[,מ"דקל פטנט בע27חדר,18מנוחה ונחלה

רחובות

DEKEL PATENT LTD.,18 MENUHA VENAHALA ST.,REHOVOT 76209

]74[

Detonator wire actuator apparatus comprising:an actuator comprising an at least partially hollow housing;a cap element removably mountable on said actuator;a coil of electrical wire disposed inside said at least partially hollow housing, a portionof said coil of electrical wire being arranged for electrical connection with said capelement, said coil of electrical wire being unwindable outwards from said at leastpartially hollow housing; anda control device adapted to be electrically connected to said actuator, wherein saidcontrol device and said actuator comprise mating electrical connectors adapted tobring said control device and said actuator into electrical communication with oneanother, and wherein at least one of the mating electrical connectors is electricallyshorted until the mating electrical connectors are mated.

]57[

__________________

147889]21][11[


HUMAN ממקור אנושיGקולט צמוד לחלבו G-PROTEIN COUPLEDRECEPTOR

]54[

25.09.2000]22[EP]33[24.09.1999]32[99203140.1]31[NL24.09.1999 1013140 EP28.07.200000202683.9US31.07.200060/222047

Int. Cl.(2009.01) A01K 67/00, A61K 38/17, C07K 14/705, 14/72, 16/28, C12N 15/12,C12Q 01/68

]51[

SOLVAY PHARMACEUTICALSB.V., THE NETHERLANDS

]71[




]74[

The polynucleotides and polypeptides of the present invention relate to the G-proteincoupled receptor family, referred to as IGS4-family. The invention also relates toinhibiting or activating the action of such polynucleotides and polypeptides, to a vectorcontaining said polynucleotides, a host cell containing such vector and transgenicanimals where the IGS4-gene is either overexpressed, misexpressed, underexpressedor suppressed (knock-out animals). The invention further relates to a method forscreening compounds capable to act as an agonist or an antagonist of IGS4-family andthe use of such IGS4 polypeptides, polynucleotides, agonists or antagonists. Preferreduses of the invention relate to disorders of the nervous system, disorders of thegastrointestinal system and/or of the cardiovascular system and/or of skeletal muscleand/or of the thyroid, and/or also to lung diseases, immunological diseases anddisorders of the genitourinary system. The invention also relates to the identification ofthe cognate ligand of the IGS4 polypeptides the neuropeptides known as neuromedinU.

]57[



__________________

148417]21][11[

) מאפנני קולט פרוגסטרו(מזופרוגסטיני כמרכיב בתכשירי לטיפול של תחליפי הורמו

MESOPROGESTINS(PROGESTERONE RECEPTORMODULATORS) AS A

]54[


COMPONENT OFCOMPOSITIONS FOR HORMONEREPLACEMENT THERAPY (HRT)

31.08.2000]22[US]33[31.08.1999]32[386140]31[

Int. Cl.(2009.01) A61K 45/00]51[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The present invention refers to the use of mesoprogestins as pharmaceuticalcomponents for the manufacture of a medicament for hormone replacement therapy(HRT) and as component for the combined use together with an estrogen for themanufacture of a medicament for HRT as well as in respective HRT-methods andmethods of treating hormone deficiency and hormone irregularity symptoms.Mesoprogestins are defined as compounds possessing both agonistic and antagonisticactivities at the progesterone receptor (PR) in vivo. They stabilize the function of PR atan intermediate level of agonistic and antagonistic. Corresponding functional statescannot be achieved with progestins or antiprogestins. J867, J912, J956 and J1042 arethe mesoprogestins preferred according to the invention.

]57[

__________________

149147]21][11[

ביצור תרופות לטיפול שימוש באוקסקרבזפי בהתקפי

USE OF OXCARBAZEPINE FORTHE PREPARATION OFMEDICAMENTS FOR THETREATMENT OF SEIZURES

]54[

31.10.2000]22[GB]33[02.11.1999]32[9925962.4]31[

Int. Cl.(2010.01) A61K 45//06, C07D 22/3/00, 22/3/18]51[NOVARTIS AG, SWITZERLAND]71[WO/2001/032183]87[


LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

]74[


.P.O.B באר שבע5352.ד.ת, 5352,BEER-SHEVA 84152

Oral dosage forms comprising oxcarbazepine which when administered to a patientdisplay no food effect.

]57[



__________________

149459]21][11[

RECOMBINANT גלטיני רקומביננטי GELATINS]54[

10.11.2000]22[US]33[12.11.1999]32[60/165114]31[US15.05.2000 60/204437

Int. Cl.(2010.01) A61K 08//65, 09//08, 09//14, 09//16, 09//48, 38//17, 47//42, C07K14//78, C12N 15//12

]51[

FIBROGEN, INC., U.S.A.]71[WO/2001/034646]87[



]74[

The present invention relates to recombinant gelatins and composiitions thereof, andmethods of producing and using the same.

]57[

__________________


149959]21][11[

AUDIO מערכת שמע ע חייש להצפנה PLAYER WITH CODESENSOR

]54[

27.11.2000]22[AU]33[01.12.1999]32[PQ4392]31[

Int. Cl.(2010.01) G06F 17//00]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

An audio player (10) is provided with an image sensor (16) capable of imaginginvisible infrared tags (78) on a substrate (70). The tags (78) encode identity datawhich is directly or indirectly associated in a computer system with one or more audioclips.The audio player (10) can be used to select and play audio clips. It acquires tagidentity data via the image sensor (16), transmits it to the computer system, anddownloads associated clip(s) for playback via a speaker (22).

]57[

__________________

150151]21][11[

SYSTEM מערכת להרמת חזה FOR BREAST LIFTING]54[

11.06.2002]22[Int. Cl.(2009.01) A61B 17/00]51[


מינימלי אינוסיב מסטופקסי-אם איי אם קרית שמונה,מ"בע

MIM - MINIMALLY INVASIVEMASTOPEXY LTD.

]71[



]74[

A system for minimally invasive breast lifting and imparting a breast with natural andlifted shape, the system comprising:one or more anchors adapted to be fixed to a posture tissue above a desired nipplelevel;two or more readily adjustable suspension members suspended from the one or moreanchors each readily adjustable suspension member having a free end; anda cradling portion having a first end and a second end and being configured to cradlethe breast from below, the first end and the second end of the cradling portion beingintegral with and/or movably attached to the free end of a respective suspensionmember, and the cradling portion having a width greater than the width of each of thetwo or more readily adjustable suspension members,wherein the system is configured to lift and thereby impart the breast with a naturalshape.

]57[

__________________

150194]21][11[

IgYתהלי של הפרדה סלקטיבית של נוגדניANSERIFORMמחלמו ביצה של ציפור

שהתקבלו מכ IgYונוגדני

PROCESS FOR SELECTIVELYISOLATING IGY ANTIBODIESFROM EGG YOLK OF ANANSERIFORM BIRD AND IGYANTIBODIES OBTAINEDTHEREBY

]54[

12.06.2002]22[Int. Cl.(2010.01) A61K 39//395, C07K 01//14, 01//16, 16//02]51[GOOD BIOTECH CORPORATION,TAIWAN R.O.C.

]71[

,מ"בע) 1995(ארליך.אי.י'ג11רחוב מנחם בגין,15קומה, מגדל איילון

רמת גן

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A process for selectively isolating lgY antibodies antibodies from egg yolk of ananseriform bird, which is characherized in(a) absorbing yolk antibodies in a water-miscible fraction obtained from the egg yolk

]57[


of an anseriform bird with a water insoluble non-charged absorbent selected from thegroup consisting of silicate, silicon compounds, carbonate, sulfate, phosphate, carbon,cellulose and synthetic fiber, ceramics, and metal oxide, and wherein the waterinsoluble non-charged absorbent is at an amount effective for separating the yolkantibodies from the water-miscible fraction; and(b) flowing the water isoluble non-charged absorbent with a buffer to obtain anaqueous fraction containing the yolk antibodies.

__________________

150518]21][11[

FEED מערבל מזו למקנה MIXER FOR LIVESTOCK]54[

02.07.2002]22[Int. Cl.(2010.01) A01K 05//00, A23N 17//00]51[

DAN דן יוסף YOSEF]71[,ריינהולד כהן ושותפיו



]74[

A vertical feed mixer for livetock, comprising a hopper and multiple augers, each ofwhich adjoins at least two other augers and wherein each of said multiple augerscomprises:a central shaft vertically extending within the hopper;a spiral mixing blade which spirals up and out from the central shaft such that each ofsaid augers has an external profile that lies on a substantially conical surface;multiple cutters disposed on an edge of the blade; andwherein at a top elevation, peripheral most edges of adjoining augers are substantiallytangent.

]57[

__________________

151004]21][11[

SYSTEM מערכת עבור לסריקה אוטומטית במצלמות AND METHOD FORAUTOMATED SCREENING OFSECURITY

]54[


05.02.2001]22[US]33[04.02.2000]32[60/180323]31[US02.02.2001 773475

Int. Cl.(2010.01) H04N 07//18]51[CERNIUM CORPORATION, U.S.A.]71[WO/2001/057787]87[



]74[

A system (10) for automatically screening closed circuit television (CCTV) cameras(14) for large and small scale security systems, as used for example in parking garages.The system includes six primary software elements (30, 32, 34, 36, 38, 40), eachperforming a unique function within the operation of the security system to provideintelligent camera selection for operators, resulting in a marked decrease of operatorfatigue in a CCTV system.

]57[

__________________

151016]21][11[

שיטה והתק לבקרת עוצמה של מספר ערוצי במערכת תקשורת אלחוטית

METHOD AND APPARATUS FORPOWER CONTROL OFMULTIPLE CHANNELS IN AWIRELESS COMMUNICATIONSYSTEM

]54[

13.02.2001]22[US]33[14.02.2000]32[60/182322]31[US05.01.2001 09/755659

Int. Cl.(2009.01) H04B 07/005]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2001/061884]87[


ט ',קולב ושות. סנפורד מרמורק,4שער הגיא



]74[

Techniques to control the transmit power of multiple transmissions in wirelesscommunication system. A transmitting source (e.g., a base station) receives from areceiving device (e.g., a remote terminal) a number of feedbacks of one or more(coded or uncoded) bit streams and possibly one or more messages. The bit streammay include one or more power control sub-channels used to send one or more metrics(e.g., power control commands, erasure indicator bits, or quality indicator bits) for oneor more sets of channels. The bits allocated for each sub-channel may be aggregated toform one or more lower rate feedback sub-streams having improved reliability. Thetransmit power of two or more channels can be (1) independently adjusted based onthe feedbacks from respective sub-channels, or (2) adjusted together based on feedbackfrom one sub-channel, with the power difference being adjacent based on feedbackfrom another sub-channel.

]57[

__________________

151886]21][11[

פרומוטורי של וירוס הגור להסתלסלות של עלה צהוב של צסטרו

CESTRUM YELLOW LEAFCURLING VIRUS PROMOTERS

]54[

26.03.2001]22[GB]33[27.03.2000]32[0007427.8]31[GB28.04.2000 0010486.9 EP26.01.200101101802.5US28.02.200160/272076

Int. Cl.(2010.01) A01H 05//00, C07K 14//005, C12N 05//10, 05//14, 15//11, 15//33,15//82

]51[

SYNGENTA PARTICIPATIONS AG,SWITZERLAND

]71[

WO/2001/073087]87[





]74[

This invention describes novel DNA sequences that function as promoters oftranscription of associated nucleotide sequences. More specifically, this inventiondescribes DNA sequences conferring constitutive expression to an associatednucleotide sequence. The invention also describes recombinant sequences containingsuch promoter sequences. The said recombinant DNA sequences may be used to createtransgenic plants, but especially plants expressing a nucleotide sequence of interest atall times and in most tissues and organs.

]57[

__________________

152128]21][11[

בוחייש תמונה ואנדוסקופ המש IMAGE תמש SENSOR AND ANENDOSCOPE USING THE SAME

]54[

04.04.2001]22[IL]33[10.04.2000]32[135571]31[

Int. Cl.(2010.01) A61B 01//00]51[בע'גיוון אימג GIVEN יקנעם,מ"ינג IMAGING LTD.

C2CURE INC., U.S.A.]71[

WO/2001/076452]87[בעקליגל.ד ,מ"ר שירותי קניין רוחני תל אביב33111.ד.ת,

D. KLIGLER I.P. SERVICES LTD,P.O.BOX 33111TEL AVIV 61330

]74[

An endoscope (fig. 2, item 40) having restricted dimensions and comprising at leastone image gatherer (48), at least one image distorter and at least one image sensor (46)shaped to fit the limited dimensions, and wherein said image distorter (fig. 13, itel 115)is operable to distort an image receiver (fig. 2, item 40) from the image gatherer so thatthe image is sensible at said shaped image sensor (fig. 2, item 46).

]57[

__________________


152288]21][11[

, תולדות של חומצת גרעי פוליאמידית תכשירי ושיטות להכנת

POLYAMIDE NUCLEIC ACIDDERIVATIVES, AGENTS ANDMETHODS FOR PRODUCINGTHEM

]54[

07.04.2001]22[DE]33[18.04.2000]32[10019135.5]31[

Int. Cl.(2010.01) A61K 31//10, 38//04, 48//00, A61P 09//00, 31//04, 35//00, C07F09//09, 09//24, 09//40, 09//547, C07H 21//00, C07K 01//16, 14//00, C12N 15//12,C12Q 01//68, G01N 33//53

]51[

SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention relates to PNA derivatives that carry one or more phosphoryl groups atthe C terminus or at the C and N terminus of the PNA backbone, said phosphorylgroups optionally carrying one or more marker groups, or groups for cross-linking, orgroups that promote the intracellular uptake, or groups that improve the bindingaffinity of the PNA derivative to nucleic acids. The invention further relates to amethod for producing the above PNA derivatives and to the use thereof as amedicament or diagnostic agent.

]57[

__________________

152332]21][11[

נוגדני לגילוי ספציפי של פריוני פתוגנייממקור אנושי ושיטות גילוי הנערכות תו שמוש

בנוגדני אלו

ANTIBODIES FORSPECIFICALLY DETECTINGPATHOGENIC PRIONS OFHUMAN ORIGIN ANDDETECTION METHODS CARRIEDOUT USING THESE ANTIBODIES

]54[

16.10.2002]22[DE]33[19.10.2001]32[10152677.6]31[

Int. Cl.(2010.01) C07K 16//18, G01N 33//68]51[CSL BEHRING GMBH, GERMANY]71[


MARTIN VEY, WIEGAND LANG,ALBRECHT GROENER

]72[

,פרל כהן צדק לצר5שנקר'רח,1ים-מרכז גב

הרצליה12704.ד.ת,

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,P.O.B. 12704,HERZLIYA 46733

]74[

Conformational epitope specific for human prion protein and only present in prionprotein under oxidizing conditions, characterized in that it is recognized by at least oneof the antibodies formed by one of the hybridoma cell lines DSM ACC 2522, DSMACC 2523 or DSM ACC 2524.

]57[

__________________

152630]21][11[

IMPLANTABLE התק מושתל DEVICE]54[

04.11.2002]22[Int. Cl.(2009.01) A61F 02/02, A61M 29/00]51[

INNOVENTIONS קיסריה, פארק תעשיה,מ"אינובנשינס בע LTD.]71[,ריינהולד כהן ושותפיו



]74[

An implantable medical device for insertion into a body cavity, comprising anexpandable balloon having a wall and a lumen and having a steroidal shape defining ahole, and an insert configured to be received and secured in the hole.

]57[

__________________

152717]21][11[

מערכת להעברת תרופה לרכוש מרוחק מבוזר וניהול רפויי

DISTRIBUTED REMOTE ASSETAND MEDICATIONMANAGEMENT DRUGDELIVERY SYSTEM

]54[

18.05.2001]22[


US]33[18.05.2000]32[60/205125]31[Int. Cl.(2009.01) G06F 19/00]51[CAREFUSION 303, INC., U.S.A.MCKESSON AUTOMATION, INC.,U.S.A.

]71[



]74[

A system and method for communicating and validating patient information includingmedication delivery information in a care-giving facility is provided. A medicaltransaction carrier is used to communicate information regarding medication deliveryand other patient information between a control system in communication with thecare-giving facility's other information systems and a patient specific asset such as aninfusion pump. All information carried by the medical transaction carrier is validatedboth at the patient specific asset and at the control system. This validation allows forpositive control of all transactions even if a medical transaction carrier is lost. Themedical transaction carrier may be a smartcard, a PDA such as a Palm?TM¿ Pilot,laptop computer, pager, mobile phone, or other device capable of storing andcommunicating information. The system may use either wired or wireless connectionsto communicate information between the components of the system.

]57[



__________________

152860]21][11[

על"טיהור דנ ע–א ידי היווצרות סליל משולש אוליגונוקלאוטיד מקובע

PURIFICATION OF DNA BY ATRIPLE HELIX FORMATIONWITH AN IMMOBILIZEDOLIGONUCLEOTIDE

]54[


25.05.2001]22[US]33[26.05.2000]32[09/580923]31[

Int. Cl.(2009.01) C12N 15/10, C12Q 01/68]51[CENTELION, FRANCE]71[WO/2001/092511]87[




]74[

Method for double-stranded DNA purification, by which a solution containing saidDNA in a mixture with other components is passed over a support on which iscovalently coupled in oligonucleotide capable of hybridizing with a specific sequencepresent on said DNA to form a triple helix.

]57[

בקשות חלוקה מבקשה זו.ר פורסמושט


__________________

153438]21][11[

IMPLANTABLE להשתלה או להחדרהתגי פסיביי הניתני ANDINSERTABLE PASSIVE TAGS

]54[

13.12.2002]22[US]33[21.12.2001]32[029595]31[

Int. Cl.(2010.01) A61B 05//00]51[BIOSENSE WEBSTER INC., U.S.A.]71[

בע.ד ,מ"קליגלר שירותי קניין רוחני תל אביב33111.ד.ת,


]74[

Apparatus (20) for determining the position of an object (22) within a body of asubject, comprising:at least one acoustic wave generator (11, 13, 15), adapted to direct a first acoustic wavetoward the body at a first frequency; an acoustic tag (12) adapted to be fixed to theobject, the tag being wireless and comprising a shell defining a cavity therein and amedium contained within the shell, such that responsive to incidence thereon of thefirst acoustic wave, the tag emits a second acoustic wave at a second frequency,different from the first frequency; one or more detectors, adapted to detect the secondacoustic wave and to generate signals responsive thereto; anda signal processor, coupled to process the signals so as to determine six-dimensional

]57[


position and orientation coordinates of the object in the body.

__________________

154421]21][11[

METHOD שיטה לבקרת תיזמו FOR TIMINGCONTROL

]54[

26.03.2002]22[US]33[29.03.2001]32[60/279406]31[

Int. Cl.(2009.01) H04N 03/14, 07/18, 09/64]51[בע'גיוון אימג GIVEN יקנעם,מ"ינג IMAGING LTD.]71[

ARKADY דב אבני, ארקדי גלוקחובסקי GLUKHOVSKY, DOVAVNI

]72[

WO/2002/080376]87[,פרל כהן צדק לצר

5שנקר'רח,1ים-מרכז גב הרצליה12704.ד.ת,


]74[

An imaging device (30) having an in vivo CMOS image sensor (34), at least oneillumination source (33) and a controller (36). The controller controls the illuminationsource to illuminate for a first period and to be shut off for a subsequent period.

]57[


__________________

154465]21][11[

BETA1מולקולות קושרות IL–ושימוש בהכנת תכשירי רוקחיי ותרופות

IL-1BETA BINDING MOLECULESAND USE THEREOF IN THEPREPARATION OFPHARMACEUTICALCOMPOSITIONS ANDMEDICAMENTS

]54[

20.08.2001]22[GB]33[22.08.2000]32[0020685.4]31[

Int. Cl.(2009.01) C07K 16/24, C12N 15/13]51[NOVARTIS AG, SWITZERLAND]71[WO/2002/016436]87[




]74[

An IL-1β binding molecule, in particular an antibody to human IL-1β, especially ahuman antibody to human IL-1βis provided, wherein the CDRs of the heavy and lightchains having amino acid sequences as defined, for use in the treatment of an IL-1mediated disease or disorder, e.g. osteoarthritis, osteoporosis and other inflammatoryarthritides.

]57[

__________________

154700]21][11[

, מטרות מסומנות, מגיבי מסומנימסומני תהליכי להכנת מגיבי

ותהליכי המשתמשי בה

LABELING REAGENTS, LABELEDTARGETS, PROCESSES FOR PREPARINGLABELING REAGENTS AND PROCESSESUSING THE SAME

]54[

02.03.2003]22[US]33[12.03.2002]32[10/096075]31[

Int. Cl.(2009.01) C12P 17/06, C12Q 01/68]51[


ENZO LIFE SCIENCES, INC., U.S.A.]71[,לוצאטו את לוצאטו

עומר, גן תעשייה באר שבע5352.ד.ת,


]74[

A labeling reagent for labeling a target, said labeling reagent comprising a marker moietyM and a reactive group R

M-R wherein said marker moiety M and said reactive group R are covalently linked togetherby a linker arm comprising a backbone which comprises one or more carbon atoms,wherein said backbone further comprises one or more peptide bonds, said M comprisingat least one moiety that comprises a ligand, a dye, or both a ligand and a dye; andwherein said target is labeled by forming a carbon-carbon bond between a carbon atom insaid target and a carbon atom in said labeling reagent by means of said reactive group R.

]57[

בקשותחלוקה

מבקשה זו שטר .פורסמו

207068,206078,195439,195438,195308,195307,195306,195305,195304,195303,

The applications fordivision from thisapplication have not yetbeen published

__________________

154838]21][11[

מתק להעברה חשמלית דר העור ושיטה ליצורו

TRANSDERMALELECTROTRANSPORT DEVICEAND METHOD FORMANUFACTURING SAME

]54[

10.09.2001]22[US]33[11.09.2000]32[60/231898]31[

Int. Cl.(2010.01) A61N 01//30]51[ALZA CORPORATION, U.S.A.]71[WO/2002/022204]87[



]74[

An electrotransport device for delivering or sampling an agent through a body surfaceby electrotransport, the device having a housing including an upper, exterior housingportion and a lower housing portion, the housing enclosing electronic components, andat least one hydratable or hydrated reservoir containing water or an at least partiallyaqueous solution of the agent. At least a portion of the housing is composed of an

]57[


ethylene-octene copolymer

__________________

154846]21][11[

DRINKING כלי לשתיה VESSEL]54[

25.07.2001]22[GB]33[12.09.2000]32[0022345.3]31[

Int. Cl.(2009.01) A61J 11/00]51[JACKEL INTERNATIONALLIMITED, UNITED KINGDOM

]71[




]74[

An infant cup includes a cup body (12), a cover (16), a flexible mouthpiece (24) and avalve element (26). The valve element (26) includes a sealing face (70) which closesan orifice (44) in the mouthpiece in a relaxed position. The valve element includes anangled face cooperating with an internal angled face of the mouthpiece such that whenpressure is applied to the valve element moves downwardly, opening the mouthpieceorifice (44). The valve element is resiliently biased upwards such that when relaxed itsprings back to close the mouthpiece orifice (44) once again, and is biased upwards inthe closed position.

]57[


__________________

155300]21][11[

SYSTEM מערכת לניטור לח" ד FOR MONITORINGBLOOD PRESSURE

]54[

17.05.2001]22[SG]33[09.10.2000]32[200005776-0 ]31[

Int. Cl.(2010.01) A61B 05//022, 05//04]51[HEALTHSTATS INTERNATIONALPTE LTD., SINGAPORE

]71[

CHOON MENG TING, NGAK HWEECHUA

]72[

WO/2002/030277]87[בי'ג בע, יי אמ ,מ"פקטור אנד קו

הר חוצבים, רחוב המרפאיםירושל45087.ד.ת,

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,P.O.B. 45087,JERUSALEM 91450

]74[

A device for continuously monitoring a user's arterial blood pressure has a sensoradapted to continuoulsy detect the blood pressuer and to generate signalsrepresentative thereof by contact with an external surface of the user's body at alocation adjacent an artery. The sensor is securely held in operable contact with theuser's body at the location. A microprocessor interprets the signals generated by thesensor to determine the actual arterial blood pressure. The sensor includes a projectingportion for detecting and transmitting changes in blood pressure, wherein theprojecting portion is adapted to effect at least partial occlusion of the artery at thelocation.

]57[


__________________

155783]21][11[

תאיות של תאי גזע אנושיי עובריי–מערכות רב פוטנציאל ותאי סרט והשימוש בה–רבי

MULTICELLULAR SYSTEMS OFPLURIPOTENT HUMANEMBRYONIC STEM CELLS ANDCANCER CELLS AND USESTHEREOF

]54[

05.05.2003]22[Int. Cl.(2009.01) A61K 35/12, C12N 05/08, C12Q 01/00]51[

TECHNION חיפה,מ"מוסד הטכניון למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT FOUNDATIONLTD.

]71[

MATY קרל סקורסקי, רמןמתי צוק TZUKERMAN, KARLSKORECKI

]72[

',ר וב ושות"ד2פקריס' רח


WEBB & CO.,2 PEKERIS ST., P.O.B. 2189,REHOVOT 76121

]74[

A method of producing a multicellular system of cancer cells of human origin within amicroenvironment of a normal human tissue derived from human embryonic stemcells, comprising culturing hESC in conditions sutitable for the formation of embryoidbodies or teratomas, and injecting cancer cells into at least one embryoid body orteratoma, wherein the cancer cells within the multicellular system maintain theirahnormal phenotype.

]57[

__________________


156597]21][11[

RANDOM מערכת הגרלה אקראית מונפשת ANIMATED LOTTERYSYSTEM

]54[

23.06.2003]22[US]33[12.08.2002]32[10/218155]31[

Int. Cl.(2009.01) A63F 13/00, G07F 17/32]51[SCIENTIFIC GAMES HOLDINGSLIMITED, IRELAND

]71[




]74[

A lottery system graphically portraying a lottery result in animation, comprising:a plurality of lottery terminals configured to provide lottery game parameters to aplurality of players for selection; anda game generator incluiding a random number generator and an animation drawingsubsystem, said animation drawing subsystem including a storage device,wherein a video sequence is generated for each candidate game event, said videosequence built of a plurality of animation segments generated for each candidate gameevent and stored in said storage device of said animation drawing subsystem, whereinat least one of said animation segments is randomly selected from a plurality ofpossible appropriate segments, and after selection of the game parameters is ended at apredetermined time, the random number generator randomly selects a plurality ofrandomly selected numbers, and the animation drawing subsystem randomly selectsfor at least one of the randomly selected numbers one of the appropriate storedanimation segments corresponding to the randomly selected number, and all of theselected animation segments corresponding to the respective randomly selectednumbers into the video sequence;wherein the animated lottery game video is made available to the plurality of players.

]57[

__________________

157152]21][11[

ל לפצע ושיטה להכנתה'תחבושת הידרוג ולשימוש בה

HYDROGEL WOUND DRESSINGAND METHOD OF MAKING ANDUSING THE SAME

]54[

30.01.2002]22[US]33[30.01.2001]32[09/772801]31[

Int. Cl.(2009.01) A61L 15/00, 15/26]51[


SHERWOOD SERVICES AG,SWITZERLAND

]71[

WO/2002/060501]87[',ר שלמה כהן ושות"ד

124אבן גבירול תל אביב11490.ד.ת,


]74[

A hydrogel wound dressing which is highly absorptive, contours to a wound site, andmaintains the wound in a moist state to promote healing thereof. The hydrogel wounddressing may also contain additives to prevent bacterial and fungal infections and tocontrol wound odor.

]57[

__________________

157159]21][11[

צמצו מגנטי ואלקטרוסטטי של פלסמה בתצורה הפוכה

MAGNETIC ANDELECTROSTATICCONFINEMENT OF PLASMA IN AFIELD REVERSEDCONFIGURATION

]54[

01.02.2002]22[US]33[01.02.2001]32[60/266074]31[US08.06.2001 60/297086 US31.01.200210/066424

Int. Cl.(2010.01) H05H 01//12]51[THE REGENTS OF THEUNIVERSITY OF CALIFORNIA,U.S.A.

]71[

NORMAN ROSTOKER, MICHLBINDERBAUER, ARTAN QERUSHI,HOSSANG TAHSIRI, EUSEBIOGARATE, VITALY BYSTRITSKII

]72[

WO/2002/062112]87[בע"ד ,מ"ר מרק פרידמן

ז,54.ק, אביבמגדל משה 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

A system and method for containing plasma and forming a Field ReversedConfiguration (FRC) magnetic topology are described in which plasma ions are

]57[


contained magnetically in stable, non-adiabatic orbits in the FRC. Further, theelectrons are contained electrostatically in a deep energy well, created by tuning anexternally applied magnetic field. The simultaneous electrostatic confinement ofelectrons and magnetic confinement of ions avoids anomalous transport and facilitatesclassical containment of both electrons and ions. In this configuration, ions andelectrons may have adequate density and temperature so that upon collisions they arefused together by nuclear force, thus releasing fusion energy. Moreover, the fusion fuelplasmas that can be used with the present confinement system and method are notlimited to neutronic fuels only, but also advantageously include advanced fuels.



__________________

157177]21][11[

REFRACTIVE עדשה–שתל תו עיני רפרקטבי INTRAOCULARIMPLANT LENS

]54[

29.01.2002]22[US]33[30.01.2001]32[09/774127]31[

Int. Cl.(2009.01) A61F 02/14]51[TIMOTHY R. WILLIS, U.S.A.]71[TIMOTHY R. WILLIS, LYLE E.PAUL, JOSEPH COLLIN

]72[

WO/2002/060342]87[,מ"בע) 1995(ארליך.אי.י'ג

11רחוב מנחם בגין,15קומה, מגדל איילון רמת גן


]74[

A refractive intraocular lens (104) and method of locating the lens within the eye andattaching the lens to the iris. The refractive intraocular lens (104) may be attached via astaple (230), a fastener (312), anchor (412) or by the tip of the haptic (118).

]57[


__________________

157341]21][11[

תרכובות המשמשות לטיפול במחלות או מצבי דהמיאלניזציה ותכשירי המכילי אות

COMPOUNDS FOR USE INTREATING DEMYELINATINGDISEASES OR CONDITIONS ANDCOMPOSITIONS COMPRISINGSAME

]54[

14.02.2002]22[US]33[15.02.2001]32[60/268846]31[GB09.08.2001 0119435.6

Int. Cl.(2010.01) A61K 31//4439, A61P 13//00, 25//28, C07D 40/1/12, 40/1/14]51[AVENTIS PHARMACEUTICALSINC., U.S.A.

]71[




]74[

N-(Pyridinyl)-1H-indol-1-amines of formula I provide a unique combination ofblocking properties for both the potassium and sodium channels. These compounds areuseful for the treatment of Demyelinating Diseases and Conditions such as MultipleSclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compounds arealso useful for Stroke Rehabilitation, the treatment of Bladder Irritation andDysfunction, and the treatment of Neuropathic Pain and Chemokine-Induced Pain.

]57[



__________________


157419]21][11[

APPARATUS מתק ללכידת מזיקי FOR TRAPPINGPESTS

]54[

14.08.2003]22[Int. Cl.(2009.01) A01M 23/00, 23/02]51[

באר שבע, עמרם אוחיון עומר, מישל כהן

AMRAM OHAYONMICHEL COHEN

]71[




]74[

An apparatus for trapping pests comprising:(a) a housing defining an internal chamber with a floor in which an entrapped pestremains until being released from said chamber;(b) at least one tubular passageway spaced above the floor of said chamber, each ofsaid passageways being closed at a first end and open at a second end, and beinginclined so the said first end is higher than said second end;(c) a space for receiving bait placed underneath said at least one tubular passageway;(d) an aperture formed in the wall of each passageway and in communication with saidinternal chamber, wherein the ratio of the distance between the closed end of apassageway and the corresponding aperture to the distance between the aperture andthe open end of the passageway ranges from 25 to 60 percent; and(e) an occluding element which is insertable and displaceable within each of saidpassageways,wherein each occluding element is upwardly displaceable upon ingress of a pestwithin the corresponding passageway by pressure exerted by said pest anddownwardly displaceable by gravity upon passage of said pest through said apertureformed in the wall of said passageway, said pest being trapped within said chamberfollowing displacement of said element below said aperture.

]57[

__________________

157669]21][11[

NITROGEN-BASED פטוטקי מבוסס חנקתולדות של קמCAMPTOTHECIN DERIVATIVES

]54[

06.02.2002]22[US]33[01.03.2001]32[797765]31[


Int. Cl.(2009.01) A61K 31/437, A61P 35/00, C07D 471/04, 487/04, 491/147]51[CATHOLIC HEALTHCARE WEST,U.S.A.CALIFORNIA PACIFIC MEDICALCENTER, U.S.A.

]71[




]74[

(20S) esters of camptothecin analogs are provided. The compounds are (20S) esters ofan aminoalkanoic acid or an imidoalkanoic acid and camptothecin, which is optionallysubstituted at the 7, 9, 10, 11, and 12 positions of the camptothecin ring. Thecompounds are useful for treating cancer.

]57[

__________________

157694]21][11[

שיטה לקביעת ביטוי גני של דהידרוגנז דהידרופירימידיני

METHOD OF DETERMININGDIHYDROPYRIMIDINEDEHYDROGENASE GENEEXPRESSION

]54[

22.02.2002]22[US]33[02.03.2001]32[09/796807]31[US26.04.2001 09/842111 US13.06.200109/879217

Int. Cl.(2009.01) C12Q 01/68]51[RESPONSE GENETICS, INC., U.S.A.]71[KATHLEEN D. DANENBERG]72[WO/2002/070750]87[

עורכי דין ועורכי, קבוצת איתן מהולל,פטנטים

10שדרות אבא אבן הרצליה2081.ד.ת,

EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,P.O. B. 2081,HERZLIYA 46120

]74[

The present invention relates to prognostic methods which are useful in medicine,particularly cancer chemotherapy. The object of the invention to provide a method forassessing Dihydropyrimidine dehydrogenase()DPD expression levels in tissues andprognosticate the probable resistance of a patient's tumor to treatment with 5-FU basedtherapies by examination of the amount ofDPD mRNA in a patient's tumor cells and

]57[


comparing it to a predetermined threshold expression level. More specifically, theinvention provides to oligonucleotide primer pairs DPD3A and DPD3B and methodscomprising their use for detecting levels of Dihydropyrimidine dehydrogenase (DPD)mRNA.



__________________

157768]21][11[

TISSUE התק הפרדת ריקמה DISTRACTION DEVICE]54[

08.03.2002]22[US]33[08.03.2001]32[60/274372]31[US01.06.2001 09/872905

Int. Cl.(2009.01) A61B 17/00]51[SPINE WAVE, INC., U.S.A.]71[WO/2002/071921]87[




]74[

An apparatus and method for distracting, in a given direction, and supporting twotissue surfaces. A plurality of wafers (198, 200, 202) are consecutively insertedbetween the two tissue surfaces to create a column (192) of wafers. The column ofwafers (192) is oriented between the tissue surfaces so as to expand in the givendirection as the wafers (198, 200, 202) are consecutively added to the column (192).The apparatus is particularly suited for vertebral (60) compression fractures.

]57[


__________________

157770]21][11[

שימוש באנטגוניסטי לקולטניגלוקוקורטיקליי ביצור תרופות לטיפול

בסימפטומי של הפרעת לח"

USE OF A GLUCOCORTICOIDRECEPTOR ANTAGONIST IN THEMANUFACTURE OF AMEDICAMENT FORAMELIORATING THESYMPTOMS OF A STRESSDISORDER

]54[

19.03.2002]22[US]33[23.03.2001]32[60/278523]31[

Int. Cl.(2009.01) A61K 31/56, 31/57, 31/59]51[CORCEPT THERAPEUTICS, INC.,U.S.A.

]71[




]74[

This invention generally pertains to the field of psychiatry. In particular, this inventionpertains to the discovery that agents which inhibit the binding of cortisol to itsreceptors can be used in methods for treating stress disorders. Mifepristone, a potentspecific glucocorticoid receptor antagonist, can be used in these methods. Theinvention also provides a kit for treating stress disorders in a human including aglucocorticoid receptor antagonist and instructional material teaching the indications,dosage and schedule of administration of the glucocorticoid receptor antagonist.

]57[

__________________


157786]21][11[

PERSONALIZED קוסמטיקה אישית COSMETICS]54[

07.09.2003]22[Int. Cl.(2009.01) A61B 05/00, C12Q 01/68]51[

בע-אהבה -AHAVAמ"מעבדות ים המלח DEAD SEALABORATORIES LTD.

]71[

פרנסוא מנחם, יורם מילנר, זאבי מאורר'ז'ברז

ZEEVI MAOR, YORAM MILNER,FRANCOIS MENAHEMBREGEGERE

]72[

עו' דר ,פ"אייל ברסלר11תובלגן-רמת

DR. EYAL BRESSLER,11 TUVAL ST.,RAMAT GAN 52522

]74[

A method for designing specific dermo-cosmetic compositions that correspond to aspecific individual's skin condition comprising:(a) sampling the skin to be treated, so as to allow the analysis of defined sets ofbiomarkers relevant to at least one condition under treatment;(b) measuring quantitatively at least one biomarker in said sampled skin, so as todetermine an individual profile of selected biomarkers that defines the individual skincondition;(c) analyzing said biomarker profile and designing a skin care protocol especiallyadapted to the condition of said individual's skin, said skin care protocol comprising atleast one dermo-cosmetic composition corresponding to said condition of saidindividual's skin;(d) applying at least one dermo-cosmetic composition, in accordance with said skincare protocol;whereby a correspondence between said specific individual's skin condition and saidapplied dermo-cosmetic composition is obtained.

]57[

__________________

158003]21][11[

, שיטות וקיטי לקביעת סיכו לחלות בסרטלהערכת היעילות והמינו של תרופות לריפוי

סרט

METHODS AND KITS FORDETERMINING A RISK TODEVELOP CANCER, FOREVALUATING ANEFFECTIVENESS AND DOSAGEOF CANCER THERAPY AND FORCORRELATING BETWEEN ANACTIVITY OF A DNA REPAIRENZYME AND A CANCER

]54[


21.03.2002]22[US]33[23.03.2001]32[09/815015]31[US09.07.2001 60/303338

Int. Cl.(2009.01) C12Q 01/68, G01N 33/574]51[DIVISION FROM 158003]62[

YEDA רחובות,מ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD.

]71[

פז, צבי לבנה שרה, אליצור- תמר בלומנשטיין

ZVI LIVNEH, TAMAR PAZ-ELIZUR,SARA BLUMENSTEIN

]72[

WO/2002/076280]87[,מ"בע) 1995(ארליך.אי.י'ג



]74[

Methods and kits for (i) determining a risk of a subject to develop cancer; (ii)evaluating an effectiveness and dosage of cancer therapy administered to a cancerpatient; and (iii) determining a presence of correlation or non-correlation between anactivity of at least one DNA repair enzyme and at least one cancer, are disclosed.

]57[



__________________

158165]21][11[

DETECTION זיהוי והגברה של ליגנדי ANDAMPLIFICATION OF LIGANDS

]54[

29.03.2002]22[US]33[29.03.2001]32[09/821396]31[

Int. Cl.(2009.01) G01N 33/53, 33/545]51[KENT STATE UNIVERSITY, U.S.A.]71[WO/2002/079755]87[




]74[

Devices and systems for the detection of ligands comprising at least one receptor andan amplification mechanism comprising a liquid crystalline, where an amplified signalis produced as a result of receptor binding to a ligand are provided. Also provided are

]57[


methods for the automatic detection of ligands.

__________________

158559]21][11[

ליפוקסיגנאז להכנת תכשיר–5שימוש במעכבי רוקחי לטיפול באקנה

USE OF 5-LIPOXYGENASEINHIBITORS FOR THEPREPARATION OF APHARMACEUTICALCOMPOSITION FOR TREATINGACNE

]54[

29.04.2002]22[DE]33[30.04.2001]32[10121252.6]31[

Int. Cl.(2010.01) A61K 31//00, 31//381]51[CHRISTOS C. ZOUBOULIS,GERMANY

]71[




]74[

The invention relates to the use of lipoxygenase inhibitors for treating acne,particularly inflammatory acne. The inventive lipoxygenase inhibitor can be usedalone or in combination with other lipoxygenase inhibitors or anti-acne active agentsin a pharmaceutically suitable composition, particularly through oral and/or local-topicapplication.

]57[


__________________

158589]21][11[

נגזרות של אוקסאזול מותמרות בחומצההרכבי רוקחיי, תהלי להכנת, קרבוקסילית

המכילי אות ושימושיה בהכנת תרופות לטיפול ולטיפול מונע במחלות המווסתות על ידי

ו–PPARמפעילי של גמא–אלפא

CARBOXYLIC ACIDSUBSTITUTED OXAZOLEDERIVATIVES, PROCESS FORTHEIR MANUFACTURE,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF INTHE PREPARATION OFMEDICAMENTS FOR THETREATMENT ANDPROPHYLAXIS OF DISEASESWHICH ARE MODULATED BYPPAR-ALPHA AND -GAMMAACTIVATORS

]54[

06.05.2002]22[EP]33[15.05.2001]32[01111745.4]31[

Int. Cl.(2009.01) A61K 31/421, A61P 03/10, C07D 263/32, 413/12]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[

WO/2002/092084]87[,לוצאטו את לוצאטו



]74[

The present invention relates to compounds of formula (I) wherein R1 to R7 are asdefined in the description and claims, and pharmaceutically acceptable salts and estersthereof. The compounds are useful for the treatment of diseases such as diabetes.

]57[

__________________


158969]21][11[

נוגדני לאנטיג ספציפי של קרו תאי הערמונית והשימוש בה

MODIFIED ANTIBODIES TOPROSTATE-SPECIFICMEMBRANE ANTIGEN AND USESTHEREOF

]54[

30.05.2002]22[US]33[01.06.2001]32[60/295214]31[US20.09.2001 60/323585 US08.03.200260/362810

Int. Cl.(2010.01) A61K 39//395, C07K 16//30]51[CORNELL RESEARCHFOUNDATION, INC., U.S.A.

]71[

WO/2002/098897]87[,גרבר ולוין, סילבר

'ב29קרן היסוד ירושלים

SILBER, GERBER AND LEWIN,29B KEREN HAYESOD STREETJERUSALEM

]74[

Modified antibodies, or antigen-binding fragments thereof, to the extracellular domainof human prostate specific membrane antigen (PSMA) are provided. The modifiedanti-PSMA antibodies, or antigen-binding fragments thereof, have been rendered lessimmunogenic compared to their unmodified counterparts to a given species, e.g., ahuman. Pharmaceutical compositions including the aforesaid antibodies, nucleic acids,recombinant expression vectors and host cells for making such antibodies andfragments are also disclosed. Methods of using the antibodies of the invention to detecthuman PSMA, or to ablate or kill a PSMA-expressing cell, e.g., a PSMA-expressingcancer or prostatic cell, either in vitro or in vivo, are also provided.

]57[



__________________

159065]21][11[

ELECTRONIC מער אלקטרוני ושיטות לייצורו ARRAY ANDMETHODS FOR FABRICATINGSAME

]54[

26.11.2003]22[US]33[06.12.2002]32[313078]31[

Int. Cl.(2009.01) H01L 23/02]51[


GENERAL ELECTRIC COMPANY,U.S.A.

]71[

',זליגסון גבריאלי ושות31יבנה' רח


SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,P.O.B. 1426,TEL AVIV 61013

]74[

A tileable sensor array comprising:a substrate (14) including a front side and a back side;a plurality of transducers (10) fabricated on said front side of said substrate,said transducers arranged in a continuous two-dimensional array such that eachtransducer is butted against at least two adjacent transducers;a plurality of input/output connections (34) positioned on said back side of saidsubstrate, said input/output connections electrically coupled to said transducers;at least one electronic device (18) comprising at least one signal processor circuit; anda flexible metal-on-polyimide interposer (16) positioned between and against saidsubstrate and said electronic device, said flexible interposer comprising a multilayerinterconnect system configured to electrically connect said transducers and saidinput/output connections to said electronic device.

]57[

__________________

159578]21][11[

אוכלוסיית תאי לייצור של תאי מקור לעצ או אוסטיאובלסטי

DIFFERENTIATED CELLPOPULATION FOR GENERATINGOSTEOPROGENITORS OROSTEOBLASTS

]54[

03.07.2002]22[US]33[06.07.2001]32[60/303732]31[

Int. Cl.(2010.01) A61K 35//12, A61L 27//38, C12N 05//071, 05//095, 05//10, C12Q]51[


01//02GERON CORPORATION, U.S.A.]71[WO/2003/004605]87[




]74[

This invention provides populations of mesenchymal cells obtained from pluripotentstem cells by differentiating them ex vivo. Multipotent mesenchymal cells can in turnbe differentiated into more specialized cell types such as osteoblasts, with propertiesthat make them suitable for reconstituting musculoskeletal cell function in anindividual. The compositions, methods, and techniques described in this disclosure canbe used for a variety of commercially important diagnostic, drug screening, andtherapeutic applications.

]57[

__________________

160047]21][11[

דימתיל– 2,2–) כלורופניל–4(–6שיטה ליצוראיל–5– פירוליזי–דיהידרו– 3,2פניל–7–1Hחומצה אצטית

METHOD FOR THEPRODUCTION OF 6-(4-CHLOROPHENYL)- 2,2-DIMETHYL- 7- PHENYL- 2,3-DIHYDRO-1H -PYRROLIZIN- 5-YLACETIC ACID

]54[

21.08.2002]22[DE]33[23.08.2001]32[10141285.1]31[

Int. Cl.(2009.01) C07D 207/20, 487/04]51[MERCKLE GMBH, GERMANY]71[WO/2003/018583]87[



]74[

The invention relates to a method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid, in which 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole is reacted withΩ-bromo-4-chloroacetophenone togive 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-lH-pyrrolizine withintroduction of the acetic acid group in the 5 position, whereby 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole is obtained by hydrogenation of 2,2-dimethyl-4-oxo-5-phenylvaleronitrile or a ketal. The invention further relates to methods for the

]57[


production intermediates occurring in the above method.

__________________

160157]21][11[

אוליגונוקליאוטידי מעוררי חיסוניות משולבי מוטיב בעלי פעילות משופרת

COMBINATION MOTIF IMMUNESTIMULATORY

OLIGONUCLEOTIDES WITHIMPROVED ACTIVITY

]54[

19.08.2002]22[US]33[17.08.2001]32[60/313273]31[US03.07.2002 60/393952

Int. Cl.(2009.01) A61K 31/7088, A61P 31/00, 35/00, 37/04, 37/08, C12N 15/11]51[UNIVERSITY OF IOWA RESEARCHFOUNDATION, U.S.A.COLEY PHARMACEUTICALGMBH, GERMANY

]71[




]74[

A class of immunostimulatory nucleic acids having at least two functionally andstructurally defined domains is provided. This class of combination motifimmunostimulatory nucleic acids activates an immune response and is useful fortreating a variety of immune realted disorders such as cancer, infectious disease, andallergic disorders. The nucleic acids also stimulate activation of natural killer cells andproduction of type 1 interferon.

]57[

__________________

160555]21][11[

תהלי לזיהוי זיקה להפרעה גנטית הגורמתאנורקסיה, עוד, משקל, להשמנה פנוטיפית

תת, נרבוזה משקל–בלומיה או

PROCESS FOR IDENTIFICATIONOF A DISPOSITION FOR AGENETIC DISORDER RESULTING

]54[


IN PHENOTYPIC OBESITY, BODYOVERWEIGHT, ANOREXIANERVOSA, BULIMIA OR BODYUNDERWEIGHT

21.08.2002]22[EP]33[31.08.2001]32[01120943.4]31[

Int. Cl.(2009.01) C12Q 01/68]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

A process for identification of a human individual's disposition for a genetic disorderin maintaining this individual's body weight by detecting single nucleotidepolymorphisms (SNPs) of the melanin-concentrating hormone receptor (MCH-R).

]57[

__________________

160762]21][11[

תערובות אנלוגי של צקלוספורי ושימוש כמווסתי מערכת החיסו

CYCLOSPORIN ANALOGUEMIXTURES AND THEIR USE ASIMMUNOMODULATING AGENTS

]54[

17.10.2002]22[US]33[19.10.2001]32[60/346201]31[

Int. Cl.(2009.01) A61K 09/08, 09/107, 09/48, 38/13, 47/10, 47/14, 47/34, 47/42, A61P01/00, 03/00, 07/00, 09/00, 11/00, 17/00, 19/00, 21/00, 25/00, 27/00, 29/00, 31/00,37/00, C07K 07/64

]51[

ISOTECHNIKA INC., CANADA]71[WO/2003/033527]87[




]74[

The invention is directed to isomeric mixtures of cyclosporine analogues that arestructurally similar to cyclosporine A . The mixtures possess enhanced efficacy andreduced toxicity over the individual isomers and over naturally occurring and otherpresently known cyclosporines and cyclosporine derivatives. Embodiments of the

]57[


present invention are directed towardcis andtrans-isomers of cyclosporin A analogsreferred to as ISATX247, and derivatives thereof. Mixtures of ISATX247 isomersexhibit a combination of enhanced potency and reduced toxicity over the naturallyoccurring and presently known cyclosporins. ISATX247 isomers and alkylated,arylated, and deuterated derivatives are synthesized by stereoselective pathways wherethe particular conditions of a reaction determine the degree of stereoselectivity.Stereoselective pathways may utilize a Wittig reaction, or an organometallic reagentcomprising inorganic elements such as boron, silicon, titanium, and lithium. The ratioof isomers in a mixture may range from about 10 to 90 percent by weight of the (E)-isomer to about 90 to 10 percent by weight of the (Z)-isomer, based on the total weightof the mixture.

__________________

160795]21][11[

תכשיר גלני למת דר הפה והמכיל מיקרוחלקיקי לשיחרור מושהה ומבוקר של חומרי

בעלי פעילות רוקחית

GALENIC MICROPARTICULATEORAL FORMULATION FORDELAYED AND CONTROLLEDRELEASE OFPHARMACEUTICAL ACTIVEPRINCIPLES

]54[

09.10.2002]22[FR]33[09.10.2001]32[01/12999]31[

Int. Cl.(2010.01) A61K 09//00, 09//14, 09//22, 09//50, 09//52, 09//56]51[FLAMEL TECHNOLOGIES,FRANCE

]71[




]74[


The invention concerns a microparticulate system for delayed and controlled release ofactive principles whereof the in vivo absorption window is essentially limited to thehigh parts of the gastrointestinal tract, said system being designed for oraladministration. The invention aims at providing a system for reliably releasing activeprinciples through a double time-dependent and pH-dependent mechanism. Therefor,the invention proposes a multiple microcapsule galenic oral formulation designed so asto guarantee its therapeutic efficacy, and wherein the release of active principles iscontrolled by a double release-triggering mechanism: time-triggering and pH-triggering. Said system consists of microcapsules (200 to 600 $g(m)m) comprising acore of active principles coated with a coating film (not more than 40 wt. %) includinga hydrophilic polymer A (Eudradigit$m(3)L) and a hydrophobic compound B(vegetable wax with melting point between 40 to 90°C), B/A ranging between 0.2 and1.5. Said microcapsules have a dissolving behaviour in vitro such that at constant pH1.4, a latent period ranging between 1 and 5 hours is observed followed by a release ofactive principles and such that the shift from pH 1.4 to of pH 6.8 results in a release ofactive principles without latent time in vitro.

]57[

__________________

160909]21][11[

תרכובות ללא הלוג המונעות בעירה ושיטות להכנת

HALOGEN-FREE FLAMERETARDANT COMPOUNDS ANDMETHODS FOR THEIRPREPARATION

]54[

01.10.2002]22[NL]33[09.10.2001]32[1019144]31[

Int. Cl.(2010.01) C07D 25/1/66, C08K 05//3492]51[CIBA SPECIALTY CHEMICALSHOLDING INC., SWITZERLAND

]71[




]74[

The invention relates to a compound of the general formula: Z1-O-[m(R1PO3),n(R2HPO3]-Z2, in which [m(R1PO3)] represent a copolyphosphate, withm (R1PO3) units and n (R2HPO3) units; R3 represents an ammonium building block;R2 represents a 1,3,5-triazine building block; Z1 and Z2 represent ammonium or 1,3,5-triazine building blocks, to be chosen independently of each other; m and n represent

]57[


whole numbers greater than or equal to 1; and m+n numbers greater than 3. Theinvention further relates to a method for the preparation of the above compound and toflame-retardant polymer compositions in which compounds with the above formula areapplied as flame retardant, the use of the halogen-free compound in a coatingcomposition and a substrate containing a coating formed from the coating compositionthat has been cured.

__________________

160938]21][11[

תהלי להכנת, קוניוסולפידי ותולדותיה והשמוש בה כתכשירי רוקחות

CONIOSULPHIDES AND THEIRDERIVATIVES, PROCESSES FORPREPARING THEM AND THEIRUSE AS PHARMACEUTICALS

]54[

06.09.2002]22[DE]33[22.09.2000]32[10146737.0]31[

Int. Cl.(2009.01) A61K 38/05, 38/06, A61P 25/28, C07C 323/00, C07K 05/04, 07/06]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention relates to compounds of formula (I), which are formed from the micro-organismConiochaeta ellipsoidea Udagawa, DSM 13856, or from one of its mutationsand/or variants during fermentation and which optionally are chemically convertedinto derivatives. The invention also relates to a method for producing compounds offormula (I) and to the use of the same as medicaments. In addition, the inventionrelates to the use of a compound of formula (VI) for producing a medicament for thetreatment and prophylaxis of degenerative neuropathies or Alzheimer's disease.

]57[


__________________

160939]21][11[

ENERGY מנגנו בלימה למשוב ברכב ABSORBING DEVICEFOR A VECHICLE SEAT

]54[

18.03.2004]22[Int. Cl.(2009.01) B60N 02/427, 02/54, F16F 03/10]51[

PLASAN קבוץ סאסא-פלסאן -KIBBUTZ SASA]71[,ריינהולד כהן ושותפיו



]74[

An energy absorbing device (1) for reducing acceleration transmitted to a seatedoccupant in a vehicle as a result of a force of a high energy impact acting thereon in animpact direction, the device comprising a first energy absorbing mechanism (8) havinga first dimension in the impact direction and capable of undergoing elasticdeformation of a predetermined amount in the impact direction; and a second energyabsorbing mechanism (10) having a second dimension in the impact direction, whichis smaller than the first dimension to a distance corresponding to said amount ofelastic deformation, thereby allowing the second mechanism to be loaded with saidforce after the first mechanism has undergone said elastic deformation, said secondmechanism comprising a material capable of progressive deformation.

]57[


__________________

160988]21][11[

PEPTIDES פפטידי שימושיי לאימונומודולציה USEFUL INIMMUNOMODULATION

]54[

15.10.2002]22[IL]33[15.10.2001]32[145926]31[

Int. Cl.(2010.01) A61K 38//08, 38//10, A61P 35//00, 37//00, C07K 07//06, 07//08,16//28, C12N 15//12, 15//63

]51[

יבנה,מ"בע קיורטק תקווה-פתח,מ"מור ישום מחקרים בע

CURETECH LTD.MOR RESEARCH APPLICATIONSLTD.

]71[

BRITTA לאה קלפר, ענת רייטר, בריטה הרדי HARDY, ANNAT RAITER,LEAH KLAPPER

]72[

WO/2003/033644]87[',ר וב ושות"ד

2פקריס' רח רחובות2189.ד.ת,


]74[

The present invention provides peptides and polynucleotides, and their use forimmunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy,and for diagnosis purposes. The immunomodulatory effect includes induction ofproliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects sufferingfrom cancer.

]57[

__________________


161114]21][11[

שימוש במינו ספציפי של סודיו פונדפרינוקסב ACS–להכנת תכשיר לטיפול

USE OF SPECIFIC DOSE OFFONDAPARINUX SODIUM IN THEPREPARATION OF AMEDICAMENT FOR THETREATMENT OF ACS

]54[

07.11.2002]22[EP]33[13.11.2001]32[01204323.8]31[

Int. Cl.(2009.01) A61K 31/7024, A61P 09/10]51[GLAXO GROUP LIMITED, UNITEDKINGDOM

]71[


ובותרח2273.ד.ת,


]74[

The invention relates to the use of a dose of 2.5 mg of the pentasaccharide methyl O-(2-deoxy-2-sulfoamino-6-O-sulfo-α-D-glucopyranosyl)-(1-4)-O-(β-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfoamino-3,6-di-O-sulfo-α-D-glucopyranosyl)-(1-4)-O-(2-O-sulfo-α-L-idopyranosyl uronic acid)-(1-4)-2-deoxy-2-sulfoamino-6-O-sulfo-α-D-glucopyranoside or a pharmaceutically acceptable salt thereof for thepreparation of a medicament for the treatment of Acute Coronary Syndromes (ACS).

]57[

__________________

161145]21][11[

תהלי להכנת גרגרי או אבקה לייצור חומריאבקה ציפוי וקישור עבור תרופות וגרגירי או

המתקבלי בשיטה האמורה

PROCESS FOR PREPARATION OFGRANULATE OR POWDER FORPRODUCING COATING ORBINDING AGENTS FORMEDICAMENTS ANDGRANULATE OR POWDEROBTAINED BY SAID PROCESS

]54[

08.07.2003]22[DE]33[27.08.2002]32[10239999.9]31[

Int. Cl.(2009.01) A61K 09/00, 09/14, 09/16, 09/28, 47/10, 47/12]51[


EVONIK ROHM GMBH, GERMANY]71[WO/2004/019918]87[



]74[

The invention relates to a method for producing a granulate or powder which issuitable as a coating and binding agent for oral and dermal medicaments, cosmeticproducts or food supplements and substantially consists of (a) a copolymer containingradically polymerized C1 to C4 esters of acrylic acid or methacrylic acid andadditional (meth)acrylate monomers that comprise functional tertiary amino groups,(b) 3 to 25 percent by weight relative to (a) of an emulsifier having an HLB value of atleast 14, and (c) 5 to 50 percent by weight relative to (a) of C12 to C18 monocarboxylicacid or a C12 to C18 hydroxyl compound. Components (a), (b), and (c) aresimultaneously or successively blended or mixed by optionally adding apharmaceutical agent and/or other common loading agents, melted and mixed in aheatable mixer, whereupon the melted product is cooled and comminuted into agranulate or powder.

]57[

__________________

447161]21][11[

הכנת חלקיקי זעירי: עיבוד נוזלי קריטי של חלבוני ויצוב

SUPERCRITICAL FLUIDSPROCESSING: PREPARATION OFPROTEIN MICROPARTICLESAND THEIR STABILISATION

]54[

21.10.2002]22[EP]33[22.10.2001]32[01125048.7]31[

Int. Cl.(2009.01) C07K 01/30, 01/32, C12N 09/96]51[DOMPE S.P.A., ITALY]71[WO/2003/035673]87[



]74[

A process for the co-precipitation of a substance with a stabiliser therefor, by a gas antisolvent process comprising introducing into a particle formation vessel a supercriticalfluid pure or mixed with a modifier; and a solution comprising said substance and saidstabiliser dissolved in a solvent; so as said solvent is extracted from the solution bysaid supercritical fluid and co-precipitation of the substance and stabiliser occurs. The

]57[


process may be carried out using an apparatus comprising a particle formation vessel(22) and a nozzle (27) having a central orifice (39) serving to introduce a solution ofthe substance and a plurality of outer orifices (41) serving to carry a flow ofsupercritical fluid into the particle formation vessel (22), such that the solvent isextracted from the solution by the supercritical fluid and precipitation of micron sizedparticles of the substance/stabilizer occurs. The substance is preferably a protein ofpharmaceutical interest, which is highly stabilized for storage by this process.

__________________

161545]21][11[

תכשירי רוקחות וקוסמטיקה המכילי אלדהידי ארומטי הנושאי קבוצת אוקסי

PHARMACEUTICAL ANDCOSMETIC COMPOSITIONSCONTAINING OXY GROUP-BEARING AROMATICALDEHYDES

]54[

16.08.2002]22[US]33[16.11.2001]32[60/332277]31[US04.01.2002 60/346049 US01.04.200260/368518US01.04.200260/368565US30.05.200260/384589US30.05.200260/384690

Int. Cl.(2009.01) A61K 09/52, 31/11, C07C 47/00, 47/54]51[BIOFORM MEDICAL, INC., U.S.A.]71[WO/2003/043621]87[



]74[

Disclosed are pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehyde compounds or acetal derivatives thereof. Some of the

]57[


disclosed compositions are useful as topical therapeutics for treating inflammatorydermatologic conditions. Some of the compositions are useful in transdermal and othersystemic dose forms for treating other inflammatory conditions in mammals.

__________________

161562]21][11[

PSYCHOSOMATIC מערכת אבחנה פסיכוסומטית DIAGNOSISSYSTEM

]54[

11.11.2002]22[Int. Cl.(2010.01) A61B 05//00, G10L 17//00]51[ELECTRONIC NAVIGATIONRESEARCH INSTITUTE, JAPANMITSUBISHI SPACE SOFTWARECO., LTD., JAPANKAKUICHI SHIOMI, JAPANMICHIKO TAKAOKA, JAPAN

]71[

WO/2004/043259]87[,ר יצחק הס ושותפיו"ד

279רחוב הירקון תל אביב6451.ד.ת,

DR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,P.O.B. 6451,TEL AVIV 61063

]74[

Psychosomatic diagnosis system capable of automatically and objectively evaluatingthe psychosomatic conditions of a person subjected to the diagnosis according toreplies to inquiries made to the person. The psychosomatic diagnosis systemdiagnoses the psychosomatic conditions by the voice replied to the inquiries andcomprises an index database, a voice processing unit for acquiring the voice as a voicesignal, an analog−digital conversion unit for converting the voice signal into a digitalvoice signal, a data processing unit for calculating a human strange attractor by usingthe chaos theory and storing it in the index database, an attractor evaluation unit forperforming quantitative evaluation by using the calculated human strange attractor,and a display unit for displaying the result of evaluation.

]57[

__________________


161680]21][11[

מערי פרמטרי המעוצב להבחי בי שיאי לאונות צד של פונקציות מתא

PARAMETER ESTIMATORCONFIGURED TO DISTINGUISHBETWEEN PEAKS ANDSIDELOBES OF CORRELATIONFUNCTION

]54[

01.11.2002]22[US]33[01.11.2001]32[60/340100]31[US29.01.2002 10/060885

Int. Cl.(2009.01) G01S 01/00, 05/14, H04B 01/707, H04J 13/04]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A parameter estimator for estimating one or more parameter(s) from a signal isdescribed. A correlation function is derived from the signal, and the correlationfunction analyzed to determine if one or more first peak(s) (312) are present, and, if so,distinguishable from the sidelobe(s) (318) of a second peak. If the one or more firstpeak(s) (312) are present and distinguishable from the sidelobe(s) (318) of the secondpeak, the one or more parameter(s) are estimated from the one or more first peak(s). Ifthe one or more first peak(s) are not present, or, if present, are not distinguishable fromthe sidelobe(s) of the second peak, the one or more parameter(s) are estimated from thesecond peak. The parameter estimator may be employed in a subscriber station toestimate a parameter such as the time of arrival of one or more base station or sectorpilot signals in a wireless communication system. This information may be utilized inan overall advanced forward link trilateration process for estimating the location of thesubscriber station.

]57[

__________________

161830]21][11[

תיאדיאזוליו כמודולטורי–1,2,4נגזרות לרצפטור הקושר מלנוקורטי

1,2,4-THIADIAZOLIUMDERIVATIVES ASMELANOCORTIN RECEPTORMODULATORS

]54[


05.11.2002]22[US]33[08.11.2001]32[60/337762]31[

Int. Cl.(2009.01) A61K 31/433, A61P 03/00, C07D 285/08]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.

]71[

WO/2003/040118]87[,לד כהן ושותפיוריינהו



]74[

The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives of theformula (I); wherein R1, R2 and R4 are ring containing radicals, R3 is H, alkyl,alkenyl or alkynyl, useful as agonists or antagonists of the melanocortin receptor. Moreparticularly, the compounds of the present invention are useful for the treatement ofmetabolic, CNS and dermatological disorders.

]57[

__________________

161883]21][11[

בחירת צירופי תצורת העברה עבור מצב דחוס CDMA–Wבמערכת

TRANSPORT FORMATCOMBINATION SELECTION FORCOMPRESSED MODE IN A W-CDMA SYSTEM

]54[

12.11.2002]22[US]33[13.11.2001]32[09/993381]31[

Int. Cl.(2009.01) H04B 07/005, H04J 13/00]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Techniques for determining valid (i.e., supported) TFCs from among all configuredTFCs for normal and compressed modes. These techniques maintain sufficienthistorical information such that 'TFC qualification' may be accurately performed. In afirst scheme, Tx_power_requirement states are maintained for different combinationsof each TFC. One combination is applicable for each TFC at each TFC interval, and

]57[


valid TFCs are determined from applicable combinations in the proper state(s). In asecond scheme, two Tx_power_requirement states are maintained for each TFC for thenormal and compressed modes. In a third scheme, a single Tx_power_requirementstate is maintained for each TFC for both modes based on a particular relative powerrequirement. In a fourth scheme, Tx_power_requirement states are maintained for a setof relative 'bins' that cover the total range of required transmit power for all TFCs. Andin a fifth scheme, a set of relative power requirement thresholds are maintained.

__________________

161926]21][11[

ניתוחית חוזרת בעלת–אלקטרודה אלקטרו הגבלה עצמית

SELF-LIMITINGELECTROSURGICAL RETURNELECTRODE

]54[

29.04.2003]22[US]33[09.05.2002]32[10/142253]31[

Int. Cl.(2010.01) A61B 18//08, 18//16, A61G 13//00]51[

רחובות, וריס גלינרבMEGADYNE MEDICAL PRODUCTS,INC., U.S.A.BORIS GLINER

]71[



]74[

A removable semi-insulating sheet for use in self-limiting electrosurgical returnelectrode for electrosurgery. Through the selection of impedance characteristics for theelectrode materials of the principal body of the semi-insulating sheet, and throughtailoring of semi-insulating sheet geometries, the return electrode of the presentinvention is self-regulating and self-limiting as to current density and temperature riseso as to prevent patient trauma. The semi-insulating sheet has an effective bulkimpedance equal to or greater than about 4,000 ohm-cm. The effective bulk impedance

]57[


of the sheet may rise from resistive components, capacitive components, inductivecomponents, or combinations thereof. The configuration of the presently describedreturn electrode allows the electrode to self-limit the electrode's current densities,thereby preventing burning of a patient during surgery.

__________________

162003]21][11[

IMAGE מערכת זיהוי דמות IDENTIFICATIONSYSTEM

]54[

15.11.2002]22[US]33[16.11.2001]32[09/991589]31[

Int. Cl.(2010.01) G06K 09//62]51[BIO-KEY INTERNATIONAL, INC.,U.S.A.

]71[



]74[

Methods and procedures for improving the performance and reliability of imageanalysis within an image identification system (10) include a series of imagequalification functions designed to quickly process a fraction of available image dataand to provide feedback to a system user pertaining to image quality and authenticity.Functions designed to produce image models based on original image data and tocatalogue such image models into a searchable database (16) are included in thepresent invention. The present invention also includes functions for comparing oneimage model to another. Finally, the present invention provides functions for making aquick determination as to which, if any, of a potential thousands (or more, i.e.,millions) of image models within a searchable database (16) exhibit a desired level ofsimilarity, as compared to a target image model.

]57[


__________________

162012]21][11[

INFANT תמיכה לתינוק SUPPORT]54[

16.05.2004]22[Int. Cl.(2010.01) A47D 07//03, 15//00]51[

,מ"עמינח תעשית רהיטים ומזרונים בע רמלה

AMINACH BEDDING &FURNITURE MANUFACTURINGLTD.

]71[

,לד כהן ושותפיוריינהו'א26רחוב הברזל רמת החייל


]74[

A support system for an infant or child comprising:a mattress having a movable part that is pivotable with respect to a stationary part; anda harness adapted for holding said infant or child, and configured to be releasablysecured to said movable portion, said system having at least one operativeconfiguration, wherein said harness is selectively secured to said movable part, andsaid movable part is selectively pivoted with respect to said fixed part to provide adesired inclined position to an infant or child that may be selectively secured to saidharness.

]57[

__________________

162272]21][11[

METHOD שיטה להכנת תרכובת גלוקוזאמי FOR PREPARING AGLUCOSAMINE COMPOUND

]54[

02.12.2002]22[IT]33[28.12.2001]32[MI2001A002818]31[

Int. Cl.(2009.01) C07H 05/06]51[AZIENDE CHIMICHE RIUNITEANGELINI FRANCESCO A.C.R.A.F.S.P.A., ITALY

]71[

WO/2003/055897]87[




]74[

Method for preparing a compound comprising protonated glucosamine and Cl-, Na+and SO42- ions, in which (a) glucosamine hydrochloride and a stoichiometric excess ofsodium sulphate are placed in water, (b) the mixture obtained from the preceding step(a) is heated, (c) the mixture is cooled, and (d) the solid present in the said cooledmixture is recovered by filtration. Compound comprising protonated glucosamine andCl-, Na+ and SO42- ions and having the X-ray diffraction diagram of Fig. 1.

]57[

__________________

162409]21][11[

שיטה ומתק להעברת מידע על עצ מטרה ביCTקד סורק לבי סורק

METHOD AND APPARATUS FORTRANSMITTING INFORMATIONABOUT A TARGET OBJECTBETWEEN A PRESCANNER ANDA CT SCANNER

]54[

06.02.2003]22[US]33[06.02.2002]32[10/068459]31[

Int. Cl.(2009.01) G01N 23/04]51[L-3 COMMUNICATIONS SECURITY& DETECTION SYSTEMS, U.S.A.

]71[




]74[

A method or apparatus for analyzing an object includes an X-ray prescanner (1) thatperforms a prescan of the object to determine prescan information about the object.Then, a computer tomography (CT) scanner (3) performs a CT scan on at least oneplane of the object based on the prescan information to determine CT information. Inone embodiment, if the CT scan of the object includes or is in the vicinity of metal,then metal artifact correction of a reconstructed image from the CT scan is performedbased on the prescan information. In another embodiment, a processor (5) analyzes theCT information and the prescan information to determine whether to update theprescan information based on the CT information.

]57[


__________________

162670]21][11[

תוכנית למימוש, שיטה ומערכת חלוקת מידע השיטה ואמצעי מידע הקשור לתוכנית

INFORMATION DISTRIBUTIONSYSTEM AND METHOD,PROGRAM REALIZING THEMETHOD AND INFORMATIONMEDIUM CONCERNING THEPROGRAM

]54[

25.12.2002]22[JP]33[25.12.2001]32[2001-392930]31[

Int. Cl.(2010.01) G06F 15//173, G06Q 30//00, H04N 07//16, 07//173]51[DENTSU INC., JAPAN]71[WO/2003/056829]87[



]74[

The information transmission medium has become broadband and informationdistribution on demand has become possible. Accordingly, there is a need for anautonomous information distribution system satisfying a variety of client needs andpromptness of processing. An information distribution system includes number-of-distributions management means, distribution list creation means for creating adistribution list for selection in which the selection probability of each informationmaterial when random selection is performed is equal to a ratio of the remainingnumber (to be distributed) of each information material with respect to the total of theremaining numbers (to be distributed) of the information materials at a moment, handyassigning means for assigning a handy to the remaining number (to be distributed) ofeach information material contained in the distribution list, and random selectionmeans for performing random selection of the distribution list and selecting oneinformation material. The information material selected is distributed from an

]57[


information distribution server via an information network to a distribution demandterminal and the content of the distribution list is updated.

__________________

162680]21][11[

א של–שימוש של מעכבי נוקלאוזידטרנסקריפטז הפכי להכנת תכשריי

ו או מניעה של פתלוגיות/רפואיי לטיפולהמאופיינות באובד דיפרנציאציה של תאי

וגדילה בלתי נשלטת של תאי

USE OF NON-NUCLEOSIDICINHIBITORS OF REVERSETRANSCRIPTASE FOR THEPREPARATION OFPHARMACEUTICALCOMPOSITIONS FOR THERAPHYAND / OR PREVENTION OFPATHOLOGIES CHARACTERIZEDBY LOSS OF CELLULARDIFFERENTIATION ANDUNCONTROLLED CELL GROWTH

]54[

23.12.2002]22[IT]33[24.12.2001]32[RM2001A000767]31[IT19.08.2002 MI2002A001833

Int. Cl.(2009.01) A61K 31/495, 31/536, 31/551, 38/00]51[ISTITUTO SUPERIORE DI SANITA,ITALY

]71[

CORRADO SPADAFORA, PATRIZIALAVIA, ELISABETTA MATTEI,GUGLIELMO PALOMBINI, RODOLFONELLO LORENZINI, CLARA NERVI

]72[



EITAN, PEARL, LATZER AND COHENZEDEK,P.O.B. 12688,HERZLIYA 46733

]74[


The invention refers to the use of Reverse Transcriptase (RT) inhibitor compounds forthe preparation of pharmaceutical compositions to counteract the loss of cellulardifferentiation in tumour and non tumour pathologies, said compound being able tobind the hydrophobic pocket on the RT subunit p66. Particularly preferred for suchuses are the following compounds: nevirapine, efavirenz, delavirdine, correspondingsalts and/or pharmaceutically acceptable derivatives thereof.

]57[

__________________

162966]21][11[

חוטי מובילי בדרגת קבל בעלי חוזק פיתול וקשיות מוגברי

CAPACITOR-GRADE LEADWIRES WITH INCREASEDTENSILE STRENGTH ANDHARDNESS

]54[

21.01.2003]22[US]33[24.01.2002]32[60/351554]31[

Int. Cl.(2009.01) H01G 09/042]51[H.C. STARCK INC., U.S.A.]71[WO/2004/003949]87[



]74[

A capacitor-grade wire made from powder metallurgy containing at least niobium andsilicon, wherein the niobium is the highest weight percent metal present in the niobiumwire. The wire having a controlled tensile strength at finish diameter exceeds thestrength of capacitor-grade wire formed by ingot metallurgy. Also, the powdermetallurgy wire hardness exceeds capacitor-grade wire formed from ingot metallurgywith electrical leakage meeting the specifications normally applied to capacitor gradetantalum, niobium or niobium-zirconium lead wire at sinter temperatures of about

]57[


1150°C and above.

__________________

163187]21][11[

מערכת ושיטה לאספקת הודעות בהתק אלחוטי המתחבר לשרת יישומי

SYSTEM AND METHOD FORPROVIDING MESSAGES ON AWIRELESS DEVICECONNECTING TO ANAPPLICATION SERVER

]54[

31.01.2003]22[US]33[31.01.2002]32[10/061642]31[

Int. Cl.(2009.01) G06F 13/00, H04B 07/26, H04L 12/56, H04M 01/725]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A system and method for providing a message on the graphic display of a wirelessdevice (12) while the wireless device (12) is connecting to an application downloadserver (16) across a wireless network (14). When the wireless device (12) attempts tocommunicate with an application download server (16) or changes files whilenavigating an application download server (16), a message is transmitted across thewireless network (14) to the computer platform of the wireless device (12) anddisplayed to the user of the wireless device (12). The message can be transmitted to thewireless device (12) from the same application download server (16) that the wirelessdevice (12) is attempting to connect to or navigate, or alternately, the message can betransmitted from another server on the wireless network (14).

]57[




__________________

163263]21][11[

HEAT מנוע חו ENGINE]54[

29.07.2004]22[Int. Cl.(2010.01) F02C 01//00]51[

בעמ מערכות אנר"אג AGAM הוד השרון,מ"גיה ENERGY SYSTEMS LTD.]71[GAD גד אסף ASSAF]72[



]74[

A heat engine (2), comprising:at least one Liquid Ring Rotating Casing Compressor (LRRCC) (4) having a jacketadapted to rotate eccentrically around a rotor core, a fluid inlet and a fluid outlet (12);a combustion chamber (20) in fluid communication with the output of said LRRCC,andat least one expander (6) having a fluid inlet (24) and a fluid outlet (26), said fluidinlet communicating with said combustion chamber;characterized in that:the jacket of the LRRCC is articulated to the expander so that rotation of the expanderinduces rotation of the LRRCC,the jacket is articulated to the rotor core via a mechanical transmission (10) so thatrotation of the jacket of the LRRCC by the expander induces rotation of the rotor coreof the LRRCC, anda first heat exchanger mechanically coupled by bearings to said jacket so as to rotatetherewith and allow fluid communication between an output of the LRRCC and thefirst heat exchanger for receiving water heated by the LRRCC and returning cooledwater for injection into the LRRCC so as to maintain the LRRCC isothermal.

]57[


__________________

163413]21][11[

השימוש בה להכנת, ותיאדיאזולי–אוקסא תרופה ותהלי להכנת

OXA-AND THIADIAZOLES,THEIR USE FOR THEPREPARATION OF AMEDICAMENT AND PROCESSFOR THEIR PREPARATION

]54[

20.02.2003]22[GB]33[22.02.2002]32[0204159.8]31[

Int. Cl.(2009.01) A61K 31/4245, 31/433, A61P 01/16, 19/00, 25/00, 29/00, 35/00,43/00, C07D 271/06, 285/08, 413/04, 413/06, 417/04

]51[

VERNALIS (R&D) LIMITED,UNITED KINGDOMMERCK SERONO S.A.,SWITZERLAND

]71[




]74[

Compounds of the formula (IA) or (IB), wherein W represents HO(C=O−(,HONH(C=O−(or H(C=O)N(OH −(; X represents− O −or− S −; and R 1, R 2, and R3are as defined in the description and claims, are inhibitors of matrixmetalloproteinases, in particular MMP9 and/or MMP12.

]57[

__________________

163637]21][11[


קודאי פוספט, צירופי רוקחות של מלוקסיק ופאראצטמול

PHARMACEUTICALCOMBINATIONS OFMELOXICAM, CODEINEPHOSPHATE ANDPARACETAMOL

]54[

14.02.2003]22[ZA]33[19.02.2002]32[2002/1395]31[

Int. Cl.(2010.01) A61K 31//167, 31//485, 31//5415, 45//00, 45//06, A61P 29//00]51[ADCOCK INGRAM LIMITED,SOUTH AFRICA

]71[

MICHAEL CHRISTIAN NORRIS]72[WO/2003/070251]87[

בי'ג בע, יי אמ ,מ"פקטור אנד קו הר חוצבים, רחוב המרפא

ירושלים45087.ד.ת,


]74[

A pharmaceutical composition comprises a combination of a selective or specific COX2 inhibitor or a pharmaceutically acceptable salt or derivative thereof and an opiate ora pharmaceutically acceptable salt or derivative thereof, for example a combination ofmeloxicam and codeine, as active ingredients, and a pharmaceutically acceptablecarrier. It may include a centrally-acting cyclo-oxygenase inhibitor such asparacetamol or its pharmaceutically acceptable salts or derivatives. The pharmaceuticalcompositions are used in methods of providing symptomatic relief or treatment ofpain, in an algesic and/or hyperalgesic state, with or without fever, in particular thatassociated with inflammation such as that associated with trauma, osteoarthritis,rheumatoid arthritis, non-inflammatory myalgia or dysmenorrhoea.

]57[

__________________

163698]21][11[

( ברומוהקסילאוקסי4–)6–שיטה לייצור של בוטל בנז

METHOD FOR THEPRODUCTION OF 4-(6-BROMOHEXYLOXY)BUTYLBENZENE

]54[

28.02.2003]22[DE]33[05.03.2002]32[10209583.3]31[

Int. Cl.(2009.01) C07C 43/00, 51/02, 51/41, C07F 09/141]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,

]71[


GERMANYWO/2003/074458]87[



]74[

The invention relates to an improved method for producing 4-(6-bromohexyloxy)butylbenzene by reacting 4-phenylbutanol with 1,6-dibromohexane in the presence ofa base and a phase transfer catalyst. 4-phenylbutanol is metered in a diluent to amixture consisting of 1,6-dibromohexane, a base, a phase transfer catalyst, and adiluent. Also disclosed is the use of the resulting 4-(6-bromohexyloxy) butylbenzenefor producing salmeterol in a previously known manner.

]57[

__________________

163851]21][11[

CD–74הפנמה של נוגדני נוגדי ושיטותלשימוש בה

INTERNALIZING ANTI-CD74ANTIBODIES AND METHODS OFUSE

]54[

03.03.2003]22[US]33[01.03.2002]32[60/360259]31[

Int. Cl.(2010.01) A61K 39//395, A61P 35//02, C07K 16//28, G01N 33//574]51[IMMUNOMEDICS, INC., U.S.A.]71[WO/2003/074567]87[



]74[

The present invention provides humanized, chimeric and human anti-CD74 antibodies,CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bindto CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii,which is useful for the treatment and diagnosis of B-cell disorders, such as B-cellmalignancies, other malignancies in which the cells are reactive with CD74, andautoimmune diseases, and methods of treatment and diagnosis.

]57[


205985,The applications for divisionfrom this application have


not yet been published

__________________

164314]21][11[

שיטה לדכא גידול של תאי המשתמשת באוליגונוקליאטידי

METHOD TO INHIBIT CELLGROWTH USINGOLIGONUCLEOTIDES

]54[

11.04.2003]22[US]33[12.04.2002]32[10/122,630]31[

Int. Cl.(2010.01) A61K 31//70, C07H 21//00]51[TRUSTEES OF BOSTONUNIVERSITY, U.S.A.

]71[




]74[

Described are methods for treating hyperproliferative disorders, including cancers, byadministering to the affected mammal (e.g.,human) an effective amount of acomposition comprising pTT or a composition comprising one or moreoligonucleotides which share at least 50% nucleotide sequence identity with the humantelomere overhang repeat. Methods of treatment or prevention of hyperproliferativediseases or pre-cancerous conditions affecting epithelial cells, such as psoriasis, atopicdermatitis, or hyperproliferative diseases of other epithelia and methods for reducingphotoaging, or oxidative stress or for prophylaxis against or reduction in the likelihoodof the development of skin cancer, are also disclosed.

]57[



__________________

164356]21][11[

–ברומו או אלפא–שימוש בתולדות אלפאדיסטמיצי להכנת תרופות–אקרילוליל–כלורו

לטיפול בסרט

USE OF ALPHA- BROMO ORALPHA-CHLORO ACRYLOYLDISTAMYCIN DERIVATIVES INTHE PREPARATION OFMEDICAMENTS FOR TREATING

]54[


CANCER

17.03.2003]22[EP]33[02.04.2002]32[02076240.7]31[

Int. Cl.(2009.01) A61K 31/40, 31/4025, 41/00, A61P 35/00, C07D 207/34, 403/12]51[NERVIANO MEDICAL SCIENCESS.R.L., ITALY

]71[




]74[

The present invention provides the use of acryloyl distamycin derivatives, in particularalpha-bromo- or alpha-chloro-acryloyl distamycin derivatives, in combination withradiotherapy, for the treatment of tumors.

]57[

__________________

164383]21][11[

PAYMENT מסו, תשלו להמרת מידע לתשלו TERMINAL DEVICEFOR PAYMENT DATAEXCHANGE

]54[

16.04.2002]22[Int. Cl.(2010.01) G06Q 20//00, G07F 19//00]51[ULTRA PROIZVODNJAELEKTRONSKIH NAPRAV D.O.O.,REPUBLIC OF SLOVENIA

]71[




]74[

Disclosed is a terminal device (10) for payment data exchange comprising interfacesfor coupling to a point of sale devices (26), to a mobile phone (14), and to a paymentcentre (1). The payment data exchange is performed on two different ways. In a firstway from the payment terminal device (10) via the mobile phone (14) and the mobilevoice network (5) to the authorisation centre (1) or, vice versa, from the paymentcentre (1) via the mobile voice network (5) and the mobile phone (14) to the payment

]57[


terminal device (10), wherein the payment data are transferred between the paymentterminal device (10) and the mobile phone (14) on voice information. On the secondway the data are transferred directly from the terminal device (10) via e.g. the network(5) to the authorisation centre (1) and, vice versa, from the payment centre (1) via thenetwork (5) to the payment terminal device (10).

__________________

164400]21][11[

] מתיל) איל–2–פיפרידי(פניל[–Nנגזרות של שיטת הכנת יישומ הרפואי, בנגאמיד

DERIVATIVES OF N -[PHENYL(PIPERIDIN-2 -YL)METHYL]BENZAMIDE, THEPREPARATION METHODTHEREOF AND APPLICATION OFSAME IN THERAPEUTICS

]54[

17.04.2003]22[FR]33[19.04.2002]32[02/04916]31[

Int. Cl.(2009.01) A61K 31/445, 31/5375, A61P 25/00, C07D 211/26, 211/28, 401/12,413/12

]51[

SANOFI-AVENTIS, FRANCE]71[WO/2003/089411]87[




]74[

The invention relates to compounds having general formula (I), wherein - A denotes: agroup with formula N-R1 in which R1 denotes a hydrogen atom, an alkyl group, acycloalkyl group, a phenylalkyl group, an alkenyl group or an alkynyl group; or agroup with formula N+ (O-) R1 in which R1 is as defined above; or a group withformula N+ (R ) R1 in which R denotes an alkyl group and R1 is as defined above. Xdenotes a hydrogen atom or one or more substituents selected from the halogen atomsand the trifluoromethyl, alkyl and alcoxy groups. - R2 denotes a hydrogen atom, one or

]57[


more substituents selected from the halogen atoms and the trifluoromethyl, alkyl,alkoxy, amino groups with formula NR3R4 in which R3 and R4 each denote a hydrogenatom or an alkyl group or, together with the nitrogen atom bearing same, form apyrrolidine, piperidine or morpholine ring, or an optionally substituted phenyl group.The invention is suitable for use in therapeutics.

__________________

164499]21][11[

ENDOSCOPE סגול–אנדוסקופ בעל תאורת אולטרה WITHULTRAVIOLET ILLUMINATION

]54[

11.10.2004]22[FR]33[16.10.2003]32[0312063]31[

Int. Cl.(2009.01) A61B 01/00, G02B 23/24]51[SNECMA, FRANCE]71[ISABELLE BONNINGUE, JOHN LEQUELLEC, JEAN ROVEGNO

]72[

,לצר וכהן צדק, פרל, איתן7רחוב שנקר



]74[

The borescope has lighting and observation units with deviating prisms (48, 30)mounted at a distal end of a rigid tube (10). A light guiding unit (44) extends from thetube to the prism (48) and a lens (32) extends from the prism (30) to the tube. Theprisms are placed transversally side by side in the tube and deviate a light beam fromthe guiding unit, in a direction parallel to a visual axis of the prism (30).

]57[


__________________

164569]21][11[

שימוש בתרכובות שמעכבותCETP

באופ סלקטיבי להכנת תכשירי רוקחיי לטיפול בהיפרליפידמיה וטרשת עורקי

USE OF COMPOUNDS THATSELECTIVELY INHIBIT CETPACTIVITY FOR PREPARINGCOMPOSITIONS FOR TREATINGHYPERLIPIDEMIA ORATHEROSCLEROSIS

]54[

10.02.1998]22[JP]33[12.02.1997]32[9/44836]31[JP05.06.1997 9/165085 JP23.01.199810/26688

Int. Cl.(2010.01) A61K 31//167, 31//255, A61P 03//06, 09//10, C07C 32/3/40,32/7/06, 32/7/22

]51[

DIVISION FROM 131250]62[JAPAN TOBACCO INC., JAPAN]71[WO/1998/035937]87[



]74[

CETP activity inhitors containing as the active ingredient compounds represented bygeneral formula (I), prodrug compounds thereof, pharmaceutically acceptable salts

]57[


thereof, or hydrates or solvates of these, (wherein R represents linear or branchedalkyl, linear or branched alkenyl, lower haloalkyl, optionally substitued cycloalkyl,optionally substituted cycloalkenyl, optionally substituted cycloalkylalkyl, optionallysubstitued aryl or optionally substituted heterocycle; X1, X2, X3 and X4 may be thesame or different from each other and each represents hydrogen, halogeno, loweralkyl, lower haloalkyl, lower alkoxy, cyano, nitro, acyl or aryl; Y represents -CO- or -SO¿2?-; and Z represents hydrogen or a mercapto-protective group). The compoundsrepresented by general formula (I) are expected to be useful as preventives or remediesof a novel type for arteriosclerosis or hyperlipemia, since they can selectively inhibitthe CETP activity to thereby increase HDL and, at the same time, decrease LDL.

__________________

164572]21][11[

HIGH מערכת רוחב פס תדר גבוה להעברת נתוני BANDWIDTH DATATRANSPORT SYSTEM

]54[

30.04.2003]22[US]33[30.04.2002]32[60/376952]31[US20.01.2003 09/698793

Int. Cl.(2009.01) H04B 01/69, H04L 25/03, 27/00]51[LIGHTWAVES SYSTEMS, INC.,U.S.A.

]71[



]74[

The present invention provides for a methods, system, and apparatus relating (1500) todata transmission. One method of the present invention includes representing datausing at least one pulse based on a Gaussian wave form, sending the at least one pulseover an electrically conductive guided media, and recovering the data from the at leastone pulse. The present invention can be used in conjunction with telephonyapplications, cable TV applications, and data bus applications.

]57[


__________________

164645]21][11[

–2(–1[–4[–2[–4פולימורפ של1–] איל–2–בנזימאדוזול–H1–) אתוקסיאתיל

דימיתיל בנז חומצה–αα–] אתיל] פיפרדיניל–תכשירי פארמצבטיי, שיטה להכנתו, אצטית

הכוללי אותו ושימוש להכנת תרופות

POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIDIMAZOLE-2-YL]-1- PIPERIDINYL] ETHYL]- ALPHA,ALPHA- DIMETHYL -BENZENOACETIC ACID,METHOD OF PREPARING THESAME AND USE OF THE SAMEIN THE PREPARATION OFMEDICAMENTS

]54[

19.04.2002]22[Int. Cl.(2009.01) A61K 31/454, A61P 37/08, C07D 401/04]51[FAES FARMA ,S.A., SPAIN]71[WO/2003/089425]87[




]74[

The invention relates to polymorph 1 of acid 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-il] -1-piperidinyl]ethyl [- α ,α-dimethyl-benzeneacetic having formula(I), preparation methods thereof, pharmaceutical formulations containing polymorph 1and the use of polymorph 1 for the treatment of allergic reactions and pathologicalprocesses mediated by histamine in mammals such as humans.

]57[


__________________

164731]21][11[

שיטה משולבת לטפל בתקשורת וציודטלפוניה על גבי העברת מידע וקול ברשת

LAN

METHOD OF HANDLING PHONECOMMUNICATIONS ANDRELATED EQUIPMENTS ON LANSSUPPORTING VOICE AND DATATRANSMISSION IN ANINTEGRATED WAY

]54[

16.10.2002]22[IT]33[30.04.2002]32[PI2002A000026]31[

Int. Cl.(2009.01) H04L 12/56, 29/06, H04M 11/00]51[GEFA S.R.L., ITALY]71[WO/2003/094480]87[



]74[

On a LAN which supports the transmission of data, including multimedial, anddigitalized telephone communications, in an integrated way, a method of handlingtelephone communications and related equipments provides for the exclusiveinstallation in the central processing unit, or network server, specific softwarededicated to controling, monitoring and handling of telephone communications andrelated equipments. The method provides for the activation of said specific softwareusing a standard Internet browser for sending commands and for the exchange of dataon the network, through immediate interaction on bar type graphs (21) on thevisualization means of the LAN peripheral computers. Said software enables thecontinuous visual monitoring of the status of the telephone communication in progressor other communications on arrival or on hold.

]57[


__________________

164827]21][11[

שיטה והתק לשדרור יעיל זמ המשתמש בצברת סימני

METHOD AND APPARATUS FORTIME EFFICIENTRETRANSMISSION USINGSYMBOL ACCUMULATION

]54[

12.11.1998]22[US]33[17.11.1997]32[08/969319]31[

Int. Cl.(2009.01) H04J 13/00, H04L 01/18]51[DIVISION FROM 136065]62[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

An efficient retransmission of data using symbol accumulation wherein the packetreceived in error is retransmitted at a lower energy-per-bit level concurrently in thesame frame with the new packet. The destination device receives the data transmissionand retransmission, demodulate the signal, and separates the received data into the newand retransmitted packet. The destination device then accumulates the energy of theretransmitted packet with the energy already accumulated for the packet received inerror and decodes the accumulated packet. The accumulation of the additional energyprovided by the subsequent retransmissions improves the probability of a correctdecoding. The throughput rate can be improved since the packet received in error isretransmitted concurrently with the transmission of the new data packet. The capacityis maximized since the retransmission of the packet received in error is at a lowerenergy level than that of the new packet.

]57[


__________________

165065]21][11[

תכשיר רוקחות המכילי רופלומילסט לטיפול במחלות עיניי

PHARMACEUTICALCOMPOSITIONS CONTAININGROFLUMILAST FORTREATMENT OF EYE DISEASE

]54[

27.05.2003]22[EP]33[28.05.2002]32[02011830.3]31[DK28.05.2002 10223828.6 DK14.03.200310311613.3

Int. Cl.(2009.01) A61K 31/44, A61P 29/00, C07D 213/00]51[NYCOMED GMBH, GERMANY]71[WO/2003/099278]87[



]74[

A pharmaceutical preparation comprising roflumilast for treatment of a disease of theeye is described.

]57[

__________________

165105]21][11[

DIGITAL וטי דיגיטליחייש מיקו אלח WIRELESS POSITIONSENSOR

]54[


09.11.2004]22[US]33[11.11.2003]32[10/706298]31[

Int. Cl.(2010.01) A61B 05//00, 05//06]51[BIOSENSE WEBSTER, INC., U.S.A.]71[

בע.ד ,מ"קליגלר שירותי קניין רוחני תל אביב33111.ד.ת,


]74[

A method is provided for tracking an object, including positioning a radio frequency(RF) driver to radiate an RF driving field toward the object, and fixing to the object awireless transponder that includes a power coil and at least one sensor coil. Themethod also includes receiving the RF driving field using the power coil and storingelectrical energy derived therefrom. A plurality of field generators are driven togenerate electromagnetic field at respective frequencies in a vicinity of the object thatinduce a voltage drop across the at least one sensor coil. A digital output signal isgenerated at the wireless transponder indicative of the voltage drop across the sensorcoil, and the generation of the digital output signal is powered using the storedelectrical energy. The digital output signal is transmitted from the wireless transponderusing the power coil, and the transmission of the digital output signal is powered usingthe stored electrical energy. The digital output signal is received and processed todetermine coordinates of the object.

]57[

__________________

165573]21][11[

טה והתק לביצוע העברה פסיבית במערכת שי תקשורת מכפלי

METHOD AND APPARATUS FORPERFORMING IDLE HANDOFF INA MULTIPLE ACCESSCOMMUNICATION SYSTEM

]54[

06.06.1997]22[US]33[07.06.1996]32[660436]31[

Int. Cl.(2010.01) H04B 07//26, H04W 48//20]51[DIVISION FROM 127385]62[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A method and apparatus which permits handoffs while the mobile station (2) is in the]57[


system access state. This is achieved by providing for channel assignment messages tobe sent over the paging channel of a plurality of base stations (26), which increases theprobability of one of the messages getting through. In addition, this assures the mobilestation (2) will be able to handoff to a different base station (26) and have a trafficchannel allocated to it on the new base station (26) without delay. In addition, amethod and apparatus which permits the mobile station (2) to be directly assigned intoa soft handoff state upon traffic channel assignment.


201702,201701,201700,The applications for divisionfrom this application havenot yet been published

__________________

165600]21][11[

כיווני–בדי ובדי מרוכבי בעלי מימד רב ודו שזורי או סרוגי

BI-DIRECTIONAL WOVEN ORKNITTED MULTI-AXIALFABRICS AND FABRICCOMPOSITES

]54[

05.06.2003]22[US]33[07.06.2002]32[60/387201]31[US25.06.2002 10/179715

Int. Cl.(2010.01) D03D 11//00, 15//00, 15//08]51[HONEYWELL INTERNATIONALINC., U.S.A.

]71[




]74[

Bi-directional and multi-axial woven or knitted fabrics, fabric composites, ballisticallyresistant assemblies thereof, and the methods by which they are made. The fabrics are

]57[


comprised of sets of strong, substantially parallel, unidirectional yarns lying in parallelplanes, one above the other, with the direction of the yarns (11) in a given planerotated at an angle to the direction of the yarns (12) in adjacent planes; and one ormore sets of yarns (13, 14) having lower strength and higher elongation interleavedwith the strong yarns. The fabrics of the invention provide superior ballisticeffectiveness compared to ordinary woven and knitted fabrics but retain the ease ofmanufacture on conventional looms and knitting machines.

__________________

165832]21][11[

מערכת ושיטה לאימות אוטומטית של מחזיקה ויסוד אוטומטי של אמיתותח השרא"של דו

ותוק, של דוח ההשראה

SYSTEM AND METHOD FORAUTOMATIC VERIFICATION OFTHE HOLDER OF ANAUTHORISATION DOCUMENT

]54[

19.06.2003]22[NL]33[19.06.2002]32[1020903]31[

Int. Cl.(2009.01) B42D 15/10, G07C 09/00]51[ENSCHEDE/SDU B.V., THENETHERLANDS

]71[




]74[

System for reading a document provided with machine-readable holder details andestablishing whether a person presenting the document has a predetermined right,which document at least contains a chip containing biometric data on a holder as wellas data with a predetermined relationship to the holder details, and wherein the systemcomprises: • a reader for reading the chip and the machine-readable holder details; • a

]57[


memory containing details with regard to the right of the holder; • a biometric featurescanner; • a processing unit connected to reader, memory and scanner and equipped to:• establish the authenticity of chip and data using public key encryption technology; •receive the biometric data on the holder from the chip; • receive the biometric data onthe person presenting the document from the scanner and to compare these with thedata on the holder to determine whether the person presenting the document is theholder; • receive the holder details via the reader, check the relationship between theholder details and the data and read the right of the holder from the memory; provide asignal to indicate the right for the person presenting the document if the chip and thedata are authentic, the relationship has been established and the person presenting thedocument is the same as the holder.

__________________

165879]21][11[

COMPOSITION תכשיר להסרת שאריות ממשטחי צדדיי FOR REMOVINGSIDEWALL RESIDUES

]54[

27.05.2003]22[DE]33[22.06.2002]32[10227867.9]31[

Int. Cl.(2009.01) H01L 21/302]51[BASF SE, GERMANY]71[WO/2004/001834]87[

ועורכי עורכי דין, קבוצת איתן מהולל,פטנטים

10שדרות אבא אבן הרצליה2081.ד.ת,


]74[

The invention relates to a composition for removing sidewall residues from metalsurfaces, particularly aluminum or aluminum-containing surfaces, especiallyaluminum or aluminum-containing surfaces during the production of semiconductorelements.

]57[

__________________


716595]21][11[

שיטה לזיהוי קול טבעי המבוססת על דקדוק מתרבה, צירו, מילי/מיבנה שנוי צורה

METHOD FOR NATURAL VOICERECOGNITION BASED ON AGENERATIVETRANSFORMATION/PHRASESTRUCTURE GRAMMAR

]54[

26.06.2003]22[DE]33[28.06.2002]32[10229207.8]31[

Int. Cl.(2010.01) G10L 15//00]51[T-MOBILE DEUTSCHLAND GMBH,GERMANY

]71[



]74[

The invention relates to a method for natural voice recognition based on a generativetransformation/phrase structure grammar known as GT /PS grammar. According to theinvention, a spoken phrase is analyzed for triphones contained therein, wordscontained in the spoken phrase are formed from the recognized triphones with the aiddictionaries and the spoken phrase is syntactically reconstructed from the recognizedwords using a grammar. The GT /PS grammar is a novel method enabling targetsentences to be placed in said grammar. It uses traditional Grammar SpecificationLanguage (GSL), structures said sentences however in an innovative manner. It isoriented towards the rules of phrase structure grammar and Noam Chomsky's conceptof generative transformation grammar.

]57[

__________________

166030]21][11[

ע CORRELATIONי קורלציות מעקב"גילוי שבירת נעילה TRACKERBREAK LOCK DETECTION

]54[

28.07.2003]22[US]33[01.08.2002]32[10/210241]31[

Int. Cl.(2010.01) G01S 03//786]51[RAYTHEON COMPANY, U.S.A.]71[WO/2004/013650]87[

ט SANFORD,'קולב ושות. סנפורד T.COLB & CO.,]74[


מרמורק,4שער הגיא רחובות2273.ד.ת,

P.O.B. 2273,REHOVOT 76122

System and method for detecting breaklock for correlation trackers. The inventivesystem includes a first circuit (50) for computing energyEL in a residual image, asecond circuit (52) for computing energyE1 in an input image, and a third circuit (54)for computing a residual metricRL based on the residual image energyEL scaled by theinput image energyE1. In the illustrative embodiment, the system further includes afourth circuit (56) for comparing the residual metricRL to a thresholdTR, and a fifthcircuit (58) for setting a breaklock signal based on the output of the fourth circuit (56).

]57[

__________________

166038]21][11[

PEGYLATED מותמר בפוליאתיל גליקולT20פוליפפטיד T20 POLYPEPTIDE]54[

16.07.2003]22[US]33[24.07.2002]32[60/398195]31[

Int. Cl.(2010.01) A61K 38//16, 38//18, 47//48, A61P 31//18, C07K 14//16, 17//08]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

Pegylated T20 polypeptide compounds are provided. Also provided are pharmaceuticalcompositions containing pegylated T20 polypeptide compounds, and processes ofmaking and using such compounds and compositions.

]57[

__________________


166438]21][11[

METHOD פרואינסולי–שיטה לניקוי פרה FOR PURIFYINGPREPROINSULIN

]54[

18.07.2003]22[DE]33[01.08.2002]32[10235168.6]31[

Int. Cl.(2010.01) C07K 01//14, 01//16, 14//62]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2004/013176]87[,לצר וכהן צדק, פרל,תןאי



]74[

The invention relates to a method for the chromatographic purification ofpreproinsulins, according to which higher-molecular substances are separated from anaqueous solution of the preproinsulin by means of a first chromatography on an anionexchanger in through-flow mode and a subsequent second chromatography on a cationexchanger in adsorption mode, and a method for the production of insulins, whichcomprises the method for producing preproinsulins.

]57[

__________________

166496]21][11[

FLUID משאבה מופעלת בנוזל OPERATED PUMP]54[

29.07.2003]22[AU]33[29.07.2002]32[2002950421]31[

Int. Cl.(2010.01) F04B 43//10, 43//113]51[WEIR MINERALS NETHERLANDSB.V., THE NETHERLANDS

]71[

GORDON LEITH MORRISS,ROBERT LESLIE WEST

]72[

WO/2004/001180]87[,ר דוד אגרנוב"ד אבא-אלוני15.ד.ת,

DR. DAVID AGRANOV,P.O.B. 15,ALONEY-ABA36005

]74[


A pumping system comprising a pump (21) for conveying a pumped fluid using anactuating fluid. The pump comprising a rigid outer casing (25) defining an interiorspace (26), a tube structure (27) accommodated in the interior space (26), the tubestructure (27) being flexible and substantially inelastic. The interior of the tubestructure (27) defines a pumping chamber (28) for receiving pumped fluid. The tubestructure (27) is movable between laterally expanded and collapsed conditions forvarying the volume of the pumping chamber (28) thereby to provide discharge andintake strokes. The region of the interior space (26) surrounding the tube structure (27)defines an actuating region for receiving and accommodating actuating fluid. Thepumping chamber (28) is adapted to receive pumped fluid to cause the tube structure(27) to move towards the expanded condition and the pumping chamber (28) therebyundergoing an intake stroke. The pumping chamber (28) undergoes a discharge strokeupon collapsing of the tube structure (27) in response to the action of actuating fluid inthe actuating region. The pumping system also comprises a delivery means (50) fordelivering pumped fluid to the pumping chamber (28) in timed sequence for causingthe pumping chamber (28) to undergo an intake stroke, and means (70) for supplyingactuating fluid to the actuating region in timed sequence to cause the tube structure(27) to laterally collapse whereby the pumping chamber (28) undergoes a dischargestroke.

]57[

__________________

166681]21][11[

FIRE חומר מעכב בעירה ושיטה לייצורו RETARDANT ANDMETHOD FOR PRODUCTIONTHEREOF

]54[

05.08.2003]22[AU]33[07.08.2002]32[2002950614]31[

Int. Cl.(2010.01) C09K 03//00]51[JENS BIRGER NILSSON,AUSTRALIA

]71[

WO/2004/015026]87[


,ן ושותפיוריינהולד כה'א26רחוב הברזל רמת החייל


]74[

A fire retardant composition and a method of producing it.The compositioncomprising water, a highly concentrated alkali, at least one of or a combinationthereof, of anhydrous citric acid,citric acid, acetic acid or a related salt thereto. Thecomposition also includes phosphate as well as an alkali metal salt or compound fromat least one of lithium, sodium and/or potassium cation in combination with at leastone of an acetate, bicarbonate, carbonate and/or hydroxide anion. The composition isthen adjusted to a pH value around 6.5 % to 7.5 % by adjusting the amounts of highlyconcentrated alkali and/or the citric acid/acetic acid respectively.

]57[

__________________

166747]21][11[

–קומפלכסי מסיסי במי של ברזלהייצור שלה ותרופות המכילות, קרבוהידראט

אות

WATER-SOLUBLE IRON-CARBOHYDRATE COMPLEXES,PRODUCTION THEREOF ANDMEDICAMENTS CONTAININGSAID COMPLEXES

]54[

20.10.2003]22[DE]33[23.10.2002]32[10249552.1]31[

Int. Cl.(2010.01) A61K 33//26, A61P 03//02, C08B 01//00, 31//18]51[VIFOR (INTERNATIONAL) AG.,SWITZERLAND

]71[




]74[

Disclosed is a water-soluble iron-carbohydrate complex obtained from an aqueousiron(III)-salt solution and an aqueous solution of the product obtained by oxidizing oneor several maltodextrins with an aqueous hypochlorite solution at an alkaline pH value.The dextrose equivalent of the maltodextrin ranges from 5 to 20 if a singlemaltodextrin is used while the dextrose equivalent of the mixture of severalmaltodextrins ranges from 5 to 20 and the dextrose equivalent of each individualmaltodextrin contained in the mixture ranges from 2 to 40 if a mixture of severalmaltodextrins is used. Also disclosed are a method for the production of said complex

]57[


and medicaments for the treatment and prophylaxis of iron deficiencies.

__________________

166795]21][11[

בביפנילקרבוקסאמידי המותמרי –N–ארילתכשירי רוקחיי המכילי אות, פיפרידי

ושיטה להכנת

N - ARYL PIPERIDINESUBSTITUTEDBIPHENYLCARBOXAMIDES,PHARMACEUTICALCOMPOSIITONS COMPRISINGTHEM AND METHOD FOR THEIRPREPARATION

]54[

05.08.2003]22[EP]33[12.08.2002]32[02078309.8]31[

Int. Cl.(2010.01) A61K 31//445, A61P 09//10, C07D 21/1/34, 21/1/62, 40/1/04]51[JANSSEN PHARMACEUTICA N.V.,BELGIUM

]71[




]74[

N-aryl piperidine substituted biphenylcarboxamides compounds of formula (I)methods for preparing such compounds, pharmaceutical compositions comprising saidcompounds as well as the use of said compounds as a medicine for the treatment ofhyperlipidemia, obesity and type II diabetes. The compounds act as inhibitors ofapolipoprotein B.

]57[

__________________

166819]21][11[

APPARATUS מתק לזיהוי נסיו התערבות במד FOR DETECTINGTAMPERING WITH A UTILITY

]54[


METER

04.08.2003]22[GB]33[15.08.2002]32[0219035.3]31[

Int. Cl.(2010.01) G01R 11//24]51[POLYMETERS RESPONSEINTERNATIONAL LTD., UNITEDKINGDOM

]71[




]74[

An electronic utility meter to monitor magnetic fields in utility meters and to indicatethe presence of abnormally large magnetic fields. The meter comprises means fordetecting consumption of a utility, means for indicating the result of the detection andmeans for detecting the presence of a magnetic field originating outside the meter.Preferably, the magnetic field detection means includes a detection circuit, whichincludes an inductance in the form of a coil wound around a ferrite core.

]57[

__________________

697816]21][11[

VEHICLE מערכת איתור ומניעה, אמצעי לזיהוי רכב IDENTIFICATIONMEANS DETECTION ANDEVASION SYSTEM

]54[

13.08.2003]22[US]33[19.08.2002]32[60/404450]31[

Int. Cl.(2009.01) B60R 13/10, G08G 01/017]51[RON זכרון יעקב, רון יעקב דוידסון YAACOV DAVIDSON]71[רון יעקב, נתנאל דוידסון, נחום לאואנבורג

דוידסוןNAUM LAUENBURG, NATHANIELDAVIDSON, RON YAACOVDAVIDSON

]72[

WO/2004/017276]87[.G.E,מ"בע) 1995(ארליך.אי.י'ג EHRLICH (1995) LTD.,]74[



AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,RAMAT GAN 52521

A system for detecting and evading vehicle identification means (VIM), comprising:locating means, control means having a plurality of I/O channels, each adapted toreceive or transmit serial or parallel data, processing means, electronic storage meanscomprising at least one database of known VIM coordinates and identificationprevention device (IPD) adapted to automatically prevent identification of the vehicle'slicense plate number, owner or driver.

]57[

__________________

167038]21][11[

תכשירי רוקחות המכילי, תולדות פיראזולשימוש בה להכנת תרופות וחומרי ביניי, אות

להכנת

PYRAZOLE DERIVATIVES,PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME, USE THEREOF INTHE MANUFACTURE OFMEDICAMENTS ANDINTERMEDIATE FORPRODUCTION THEREOF

]54[

21.08.2003]22[JP]33[23.08.2002]32[2002-244381]31[JP07.11.2002 2002-324076

Int. Cl.(2009.01) A61K 31/7056, A61P 03/04, 03/06, 03/10, 09/12, 19/06, 43/00,C07H 17/02

]51[

KISSEI PHARMACEUTICAL CO.,LTD., JAPAN

]71[




]74[


A pyrazole derivative represented by the general formula (I) [wherein R1 is H,optionally substituted C1-6 alkyl, etc.; either of Q and T is the group of the formula (II)or the formula (III) and the other is optionally substituted C1-6 alkyl, etc.; R2 is H,halogeno, OH, optionally substituted C1-6 alkyl, etc.; X is a single bond, O, or S; Y isoptionally substituted C1-6 alkylene, etc.; Z is-RB, -CORC, etc. (RB is optionallysubstituted C1-6 alkyl, etc.; and RC is optionally substituted C1-6 alkyl, etc.); R4 is H,optionally substituted C1-6 alkyl, etc.; and R3, R5, and R6 each is H, halogeno, etc.], apharmacologically acceptable salt of the derivative, or a prodrug of either. They haveexcellent human SGLT1 inhibitory activity and are useful as a preventive ortherapeutic agent for diseases attributable to hyperglycemia such as diabetes, impairedglucose tolerance, fasting blood sugar abnormality, complications of diabetes, andobesity and for diseases attributable to an increased blood galactose level such asgalactosemia.

]57[

__________________

167079]21][11[

מערכת מצלמת וידיאו לרכב בעלת אפשרות360°צילו של

360 DEGREE AUTOMOBILEVIDEO CAMERA SYSTEM

]54[

21.08.2003]22[US]33[26.08.2002]32[227270]31[US30.09.2002 261606

Int. Cl.(2009.01) B60R 01/04, H04N 07/171]51[JOSEPH J. MAZZILLI, U.S.A.]71[WO/2004/019601]87[



]74[

The present invention relates to a video camera system which has a 360o range for]57[


digital video recording inside and outside of an automotive vehicle.

__________________

167168]21][11[

לשימוש בתרופה תרכובת אינדולי במופע גבישימוצקה פומית ותרופה מוצקה פומית כזו לטיפול

בכאב במת שת

INDOLINE COMPOUND INCRYSTALLINE FORM FOR USEIN ORAL SOLID MEDICAMENTAND SUCH ORAL SOLIDMEDICAMENT FOR TREATINGDYSURIA

]54[

05.09.2003]22[JP]33[06.09.2002]32[2002-262157]31[

Int. Cl.(2009.01) A61K 09/20, 09/48, 31/404, 45/00, 47/02, A61P 13/02, C07D209/08

]51[

KISSEI PHARMACEUTICAL CO.,LTD., JAPAN

]71[




]74[

A crystal for oral solid drug comprised of indoline compound (KMD-3213) whichexerts alpha1-adrenaline receptor shielding activity, is useful as a therapeutic agent fordysuria and is represented by the formula: (I) wherein in the powder X-ray diffractionpattern, the compound is characterized by main peaks of 5.5°± 0.2°, 6.1°± 0.2°, 9.8°±0.2°, 11.1°± 0.2°, 12.2°± 0.2°, 16.4°± 0.2°, 19.7°± 0.2° and 20.0°± 0.2° as 2thetas;.There is further provided an oral solid drug for dysuria treatment containing the crystalas an active ingredient.

]57[

__________________


167306]21][11[

דיסק רב שיכבתי בעל אינדיקטור המותא להקלטה בשכבות

MULTILAYER OPTICAL DISCHAVING A RECORDING STACKTYPE INDICATOR

]54[

28.08.2003]22[EP]33[11.09.2002]32[02078718.0]31[EP24.03.2003 03100750.3

Int. Cl.(2010.01) G11B 07//24]51[KONINKLIJKE PHILIPSELECTRONICS N.V., THENETHERLANDS

]71[




]74[

A multilayer record carrier of a writable type has a first recording layer (40) having afirst recording stack (50,51) of a first type and a second recording layer (41) having asecond recording stack (54,55) of a second type. The first and second recording stackshave different writing parameters. Each recording layer has a pre-formed recordingcontrol pattern that is readable via a laser beam for indicating the track. At least onerecording control pattern comprises a recording stack type indicator for indicating thewriting parameters of the second recording stack. A recording device has a control unit(20) for adjusting recording parameters in the device in dependence of the recordingstack type indicator retrieved from the recording control pattern.

]57[

__________________

167378]21][11[


WLANמערכת MIMOMIMO WLAN SYSTEM]54[

24.10.2003]22[US]33[25.10.2002]32[60/421309]31[US23.10.2003 10/693419

Int. Cl.(2010.01) H04L 12//28]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A multiple-access MIMO WLAN system that employs MIMO, OFDM, and TDD. Thesystem (1) uses a channel structure with a number of configurable transport channels,(2) supports multiple rates and transmission modes, which are configurable based onchannel conditions and user terminal capabilities, (3) employs a pilot structure withseveral types of pilot (e.g., beacon, MIMO, steered reference, and carrier pilots) fordifferent functions, (4) implements rate, timing, and power control loops for propersystem operation, and (5) employs random access for system access by the userterminals, fast acknowledgment, and quick resource assignments. Calibration may beperformed to account for differences in the frequency responses of transmit/receivechains at the access point and user terminals. The spatial processing may then besimplified by taking advantage of the reciprocal nature of the downlink and uplink andthe calibration.

]57[



__________________

167426]21][11[

PROCESS תהלי לייצור ולסרט FOR THEMANUFACTURE OF VALSARTAN

]54[


22.09.2003]22[GB]33[23.09.2002]32[0222056.4]31[

Int. Cl.(2010.01) C07D 25/7/00, 25/7/04]51[NOVARTIS AG, SWITZERLAND]71[WO/2004/026847]87[




]74[

The present invention relates to a process for the manufacture of Valsartan, anangiotensin receptor blocker (ARB; also called angiotension II receptor antagonist orAT1 receptor antagonist) and salts thereof, to novel intermediates and process steps.

]57[



__________________

167829]21][11[

-1,2,4 תיאדיאזול והשימוש מכ –4,2,1תרכובות THIADIAZOLECOMPOUND, COMPOSITIONFOR CONTROLLING HARMFULARTHROPOD CONTAINING THESAME, METHOD FORCONTROLLING HARMFULARTHROPOD USING THE SAMEAND USE OF THE SAME IN THEPREPARATION OF THECOMPOSITION

]54[

08.11.2002]22[Int. Cl.(2010.01) A01N 43//836, A01P 07//00, C07D 28/5/08]51[SUMITOMO CHEMICALCOMPANY, LIMITED, JAPAN

]71[




]74[

1,2,4−Thiadiazole compounds represented by the general formula (1) have excellent]57[


control activities against injurious arthropods: (1) wherein R1 is C3−7 alkynyl whichmay be halogenated; R2 is halogeno, C1−4 alkyl, C1−4 haloalkyl, C1−4 alkoxy, C1−4haloalkoxy, C1−4 alkylthio, cyano, or nitro, and n is an integer of 0 to 5, with theproviso that when n is an integer of 2 or above, R2s may be the same or different fromeach other; A is oxygen, sulfur, a single bond, CR3R4, or NR5; R3 and R4 are eachindependently hydrogen or C1−4 alkyl and R5 is hydrogen or the like.

__________________

167832]21][11[

SESQUITERPENE סטקוויטרפ סינטאזות ושיטות לשימוש בה SYNTHASES ANDMETHODS OF USE

]54[

02.10.2003]22[US]33[04.10.2002]32[60/415765]31[WO02.12.2002 PCT/IB02/05070

Int. Cl.(2010.01) C12N 09//88, 15//29, 15//60, C12P 05//00, 21//02]51[FIRMENICH SA, SWITZERLAND]71[MICHEL SCHALK, ANTHONY CLARK]72[WO/2004/031376]87[




]74[

The invention relates to sesquiterpene synthases and methods of their production anduse. In one embodiment, the invention provides nucleic acids comprising a nucleotidesequence as described herein that encodes for at least one sesquiterpene synthases. In afurther embodiment, the invention also provides for sesquiterpene synthases andmethods of making and using these enzymes. For example, sesquiterpene synthases ofthe invention may be used to convert famesyl-pyrophosphate to various oxygenatedand aliphatic sesquiterpenes including valencene, bicyclo-germacrene, cubebol anddelta- cadinene.

]57[

__________________


167835]21][11[

תכשיר מוצק הכולל פיוגליטאזו וביגואניד ושיטה להכנתו

SOLID PREPARATIONCOMPRISING PIOGLITAZONEAND BIGUANIDE AND PROCESSFOR PRODUCING THE SAME

]54[

06.10.2003]22[JP]33[07.10.2002]32[294045/2002]31[

Int. Cl.(2009.01) A61K 45/00, A61P 03/10, C07D 417/00, 417/12]51[TAKEDA PHARMACEUTICALCOMPANY LIMITED, JAPAN

]71[




]74[

It is intended to provide a solid preparation containing an insulin resistance improvingdrug and an active ingredient (other than the insulin resistance improving drug) whichis useful as a remedy for diabetes, etc. and excellent in the uniformity in the contentsof the insulin resistance improving drug and the active ingredient (other than theinsulin resistance improving drug) and the preparation characteristics such as elutionproperties and preparation hardness.

]57[

__________________

168053]21][11[

FOLDING אנטנה כיוונית מתקפלת DIRECTIONALANTENNA

]54[

04.11.2003]22[US]33[04.11.2002]32[10/288256]31[

Int. Cl.(2010.01) H01Q 01//08, 01//24, 01//38, 03//26, 19//00]51[IPR LICENSING, INC., U.S.A.]71[WO/2004/042938]87[



]74[

An antenna array formed an a deformable dielectric material or substrate includes acenter element and plurality of radial elements extending from a center hub. In theoperative mode, the radial elements are folded upwardly into an approximately vertical

]57[


position, with the Center element at the center of the hub and the radial elementscircumferentially surrounding the center element. In one embodiment the centerelement serves an active element of the antenna array and the radial elements arecontrollable in a directive or reflective state to effect a directive beam pattern from theantenna array. When not in use, the antenna elements are deformed into a plane andcan therefore be integrated into a housing for compact storage. In a phased arrayembodiment, the center element is absent and the plurality of radial elements, arecontrollable to steer the antenna beam.

__________________

168149]21][11[

SYSTEM שיטה ומערכת לעיבוד של נתוני תקשורת לווי AND METHOD FORPROCESSING SATELLITECOMMUNICATION DATA

]54[

20.04.2005]22[Int. Cl.(2009.01) H04B 07/185, H04M 03/22]51[

ELTA אשדוד,מ"אלתא מערכות בע SYSTEMS LTD.]71[BENJAMIN בנימין גילה GILOH]72[



]74[

An apparatus for intercepting and monitoring communications between target mobilesand a main station of communication system, wherein communication between themobiles and the satellite is achieved by using L-band spot beams, chosen by themobiles and wherein communication between the satellite and the main station isachieved by using a wideband C-band link, and wherein the network changes themapping scheme of the L-band frequencies to the C-band frequencies, said apparatuscomprises:at least one RF C-band and at least one RF L-band receive antenna which transmits thereceived signals to at least one RF C-band and at least one L-band receiver

]57[


respectively; an intermediate frequency RF distributor which receivers signals fromsaid RF C-band and RF L-band receivers and splits the transmission into groups offrequencies;a plurality of demodulators which are tuned to cover sequentially the L-bandfrequency spectrum, for extracting identification codes of target mobiles anddecryption messages;wide angle mapping unit which receives the C-band signals from said intermediatefrequency distributor, analyses and maps the received frequencies according to theirtime occurrence, and correlates said frequencies with said L-band frequencies; meansfor recording and monitoring said communications.

__________________

168266]21][11[

, תהליכי להכנת, תולדות נוקלויאוזידשימוש, תכשירי רוקחיי המכילי אות

בה ליצור תרופות

NUCLEOSIDE DERIVATIVES,PROCESSES FOR THEIRPREPARATION.PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USES THEREOF FORTHE MANUFACTURE OFMEDICAMENTS

]54[

14.11.2003]22[US]33[19.11.2002]32[60/427447]31[US01.07.2003 60/483970

Int. Cl.(2010.01) A61K 31//70, A61P 31//14, C07H 19//167]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[


'א26רחוב הברזלה חיילרמת


]74[

The present invention relates to nucleoside derivatives for the treatment of Hepatitis Cviral infections including compounds of formula I (I), to pharmaceutical compositionscomprising these compounds and methods for treatment or prophylaxis of Hepatitis CVirus mediated diseases employing said compounds in monotherapy or in combinationtherapy. The present invention further provides a process for preparing 1',3',4'-triacylpyrimidine nucleoside from a N,1',3',4'-tetraacylpyrimidine nucleoside.

]57[


__________________

168350]21][11[

PROCESS תהלי ליצירת קבלי אלקטרוליטי FOR PRODUCTION OFELECTROLYTIC CAPACITORS

]54[

03.05.2005]22[DE]33[05.05.2004]32[1020040221103]31[

Int. Cl.(2010.01) H01G 09//028]51[H.C. STARCK GMBH, GERMANY]71[



]74[

Process for production of an electrolytic capacitor comprising at least the followingprocess steps:(A) for the formation of a solid electrolyte a mixture containing precursors for theproduction of conducting polymers, one or more oxidizing agents and optionallycounter-ions is introduced into a porous electrode body of an electrode material coatedwith a dielectric and optionally further layers,(B) the electrode body impregnated with the mixture containing precursors for theproduction of conducting polymers, one or more oxidizing agents and optionallycounter-ions is exposed to a relative atmospheric humidity of greater than or equal to70%, and the precursors are polymerized to form a solid electrolyte, and(C) for the formation of a conducting outer layer a solution or dispersion containing atleast one conducting polymer and at least one binder is applied to the porous electrodebody covered with a dielectric as well as wholly or partially with a solid electrolyteand optionally further layers, and then is dried.

]57[

__________________


168477]21][11[

תולדות איזואינדולי ותרכובות של רוקחות המכילה אות

ISOINDOLINE DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

25.11.2003]22[JP]33[26.11.2002]32[2002-342399]31[

Int. Cl.(2010.01) A61K 31//4035, 31//427, 31//44, 31//4439, 31//4545, 31//496, A61P23//00, 25//20, C07D 20/9/46, 20/9/70, 40/1/04, 40/1/12, 40/1/14, 40/3/06, 40/3/14,40/5/14, 41/7/12, 49/1/048, 49/1/056

]51[

MARUISHI PHARMACEUTICALCO., LTD., JAPAN

]71[




]74[

A novel isoindoline compound represented by the formula (I). (I) The compound hassedative activity. The compound leads mammals to sedation and is hence useful as anarcotic drug.

]57[

__________________

168512]21][11[

הקטנת מורכבות של אומד ערו" עבור מערכות תקשורת אלחוטית

REDUCED COMPLEXITYCHANNEL ESTIMATION FORWIRELESS COMMUNICATIONSYSTEMS

]54[


12.11.2003]22[US]33[19.11.2002]32[60/427896]31[US22.10.2003 10/691826

Int. Cl.(2009.01) H04L 25/02, 27/26, H04W 40/12]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2004/047311]87[טסנ ',קולב ושות. פורד



]74[

Techniques to derive a channel estimate using substantially fewer number of complexmultiplications than with a brute-force method to derive the same channel estimate. Inone method, an intermediate vector B(418) is initially derived based on K sub-vectorsof a vector Hfor a channel frequency response estimate and at least two DFT sub-matrices for a DFT matrix W, where K > 1. An intermediate matrix A(420) for theDFT matrix Wis also obtained. A least square channel impulse response estimate isthen derived based on the intermediate vector Band the intermediate matrix A(422).In one implementation, the intermediate vector Bis obtained by first computing DFTsof a matrix HTXL , which is formed based on the vector H, to provide a matrix GLXL.Inner products between the columns of a base DFT sub-matrix W1 and the rows of thematrix GLXL are then computed to obtain the entries of the intermediate vector B.

]57[

__________________

168538]21][11[

הולוגרמה והתק וידאו ליצירה מחדש של הולוגרמות וידאו

VIDEO HOLOGRAM AND DEVICEFOR RECONSTRUCTING VIDEOHOLOGRAMS

]54[

11.11.2003]22[DE]33[13.11.2002]32[10253292.3]31[

Int. Cl.(2010.01) G03H 01//22]51[SEEREAL TECHNOLOGIES GMBH,]71[


GERMANYWO/2004/044659]87[



]74[

The invention relates to video holograms and devices for reconstructing videoholograms, comprising an optical system that consists of a light source (1), lens (2) andthe video hologram (3) that is composed of cells arranged in a matrix or a regularpattern with at least one opening per cell, the phase or amplitude of said opening beingcontrollable. The video holograms and devices for reconstructing the same arecharacterised in that holographic video representations of expanded spatial objects (6)can be achieved in a wide viewing area in real time using controllable displays,whereby the objects are either computer-generated or created by different means. Thespace-bandwidth product (SBP) of the hologram is thus reduced to a minimum and theperiodicity interval of the Fourier spectrum is used as a viewing window (5) on theinverse transformation plane, through which the object is visible in the precedingspace. The mobility of the viewer(s) is achieved by tracking the viewing window. Theinvention can be advantageously used in the television, multimedia, games andconstruction fields, in military and medical technology, in addition to other economicand social areas.

]57[

__________________

168620]21][11[

מערכת והתק לחשיפת תחומי חוברות, שיטה מידעעבודה כמקורות

METHOD, SYSTEM ANDAPPARATUS FOR EXPOSINGWORKBOOK RANGES AS DATASOURCES

]54[

17.05.2005]22[US]33[01.06.2004]32[10/858175]31[

Int. Cl.(2010.01) G06F 12//06, 17//30]51[MICROSOFT CORPORATION,U.S.A.

]71[

,ריינהולד כהן ושותפיוה 'א26ברזל רחוב

רמת החייל


]74[

A method for exposing data objects of a workbook as a server data source, comprising:generating metadata for the data objects by automatically identifying the metadata inthe workbook and setting properties for the identified metadata, wherein the metadata

]57[


is utilized by a first server computer in responding to requests for the data objectsstored in the workbook as a server data source, the server data source comprising amultidimensional database, wherein identifying the metadata comprises analyzing thedata objects to identify the following:data types, measures, hierarchy, and default aggregations, and wherein setting theproperties comprises indicating a first default aggregation as a count for a string datafield in the metadata and setting a second aggregation as a sum for a numeric datafield in the metadata;publishing the workbook and the metadata to the first server computer, whereinpublishing comprises programmatically generating a spreadsheet and sending thespreadsheet to the first server computer through a server application program interface,wherein the workbook is parsed for ranges including the data objects by a spreadsheetserver application executing on the first server computer, and wherein user-specifieddata objects from among the data objects are exposed at the first server computer asserver data sources; andconnecting to the data object exposed at the first server computer as server datasources in a manner identical to connecting to a dedicated OLAP data source providedby a second server computer.

__________________

168816]21][11[

REWINDER מכונת גלילה מחודשת ליצור גלילי חומר ארוג MACHINE FOR THEPRODUCTION OF ROLLS OF WEBMATERIAL

]54[

22.11.2000]22[IT]33[03.12.2002]32[FI2002A000236]31[IT30.05.2003 FI2003A000157

Int. Cl.(2010.01) B65H 19//22, 67//04]51[FABIO PERINI S.P.A., ITALY]71[WO/2004/050520]87[




]74[

The rewinder machine comprises: a first winding roller (3); a second winding roller(5), defining with said first winding roller (3) a winding cradle; a feeder (33) forsequentially introducing winding cores to said winding cradle; an optional glue

]57[


applicator (21) for applying glue to said cores. The feeder (33) may include an element(39) for applying glue to the winding cores while they are being fed to said windingcradle. In a special embodiment, the feeder is mechanically linked to a system forunloading the roll from the winding cradle.

__________________

168851]21][11[

הרכבה המורכבת מסודואפדרי ודומפרידו למניעת נחירה

COMPOSITION COMPRISINGPSEUDOEPHEDRINE ANDDOMPERIDONE FORPREVENTING SNORING

]54[

01.12.2003]22[US]33[02.12.2002]32[2760/2002]31[

Int. Cl.(2009.01) A61K 31/135, 31/445, C07D 401/00]51[AUGUSTO LARRAIN ORREGO,CHILE

]71[




]74[

The invention relates to the novel use of a pharmaceutical product which combinesdomperidone and pseudoephedrine sulphate substances and which can be used toreduce or stop moderate or severe snoring.

]57[

__________________


168896]21][11[

איתור אמינותו של אינדיקטור לאיכותו של ערו" וישו לבקרת כוח של לולאה חיצונית

RELIABILITY DETECTION OFCHANNEL QUALITY INDICATOR(CQI) AND APPLICATION TOOUTER LOOP POWER CONTROL

]54[

02.12.2003]22[US]33[04.12.2002]32[60/430854]31[US06.01.2003 60/438560

Int. Cl.(2009.01) H04B 07/005, H04L 01/20]51[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[




]74[

A method for improving the reliability of a channel quality indicator (CQI) (102, 106Fig. 3) message in a wireless communications network begins with receipt of the CQImessage. The CQI message is then decoded, and a decision metric value for eachsymbol in the CQI message is computed. A largest decision metric value and a secondlargest decision metric value for the CQI message are determined. The reliability of theCQI message can be determined by comparing the two largest decision metric values.This method may be applicable to high-speed downlink packet access in time divisionduplex, frequency division duplex, or other modes of transmission.

]57[



__________________

168932]21][11[


הפקת אייגנווקטורי עבור עיבוד מרחביMIMOבמערכות תקשורת

DERIVATION OFEIGENVECTORS FOR SPATIALPROCESSING IN MIMOCOMMUNICATION SYSTEMS

]54[

09.12.2003]22[US]33[11.12.2002]32[60/432760]31[US04.12.2003 10/729070

Int. Cl.(2009.01) H04B 07/04, H04L 01/02, 01/14]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2004/054191]87[טסנפו ',קולב ושות. רד



]74[

Techniques for deriving eigenvectors based on steered reference and used for spatialprocessing. A steered reference is a pilot transmission on one eigenmode of a MIMOchannel per symbol period using a steering vector for that eigenmode. The steeredreference is used to estimate both a matrixΣ of singular values and a matrix Uof lefteigenvectors of a channel response matrix H . A matrix Uwith orthogonalizedcolumns may be derived based on the estimates ofΣ and U, e.g., using QRfactorization, minimum square error computation, or polar decomposition. Theestimates ofΣ and U(or the estimate ofΣ and the matrix U) may be used for matchedfiltering of data transmission received via a first link. The estimate Uof or the matrixU may also be used for spatial processing of data transmission on a second link (forreciprocal first and second links).

]57[



__________________

169149]21][11[


תירגו אוטומטי מגיאומטריה מורכב בסדר) תכנו הנעזר במחשב(CADגבוהה ממודל

משטח של גיאומטריה משולבת–לפורמט מבוסס

AUTOMATED TRANSLATION OFHIGH ORDER COMPLEXGEOMETRY FROM A CADMODEL INTO A SURFACE BASEDCOMBINATORIAL GEOMETRYFORMAT

]54[

11.05.2004]22[US]33[19.05.2003]32[60/471580]31[

Int. Cl.(2009.01) G06T 17/00]51[RAYTHEON COMPANY, U.S.A.]71[WO/2004/104870]87[




]74[

A computer implemented process translates the high order complex geometryembodied in CAD software to the surface based combinatorial geometry (SBCG)format. The translation process is comprised of a set of lower-level algorithms thatoperate on two data sets which are commonly available from commercial CADsoftware systems. The process writes a list of trimmed surfaces (step 36) which makeup a given part. These data are typically available from one of the standard geometryrepresentations such as IGES, STEP, or ACIS. The process also writes a list of nodaldata (step 38) : an appropriately dense grouping of point coordinates, designated aseither inside or outside the part. These data may be obtained by discretizing solidgeometry both within and external to the part of interest using standard FE tools (e.g.ProMechanica). The process translates these two data sets into a list of analyticsurfaces and a well-posed zoning statement (step 40) and then optimizes that statement(step 50).

]57[

__________________

169190]21][11[

METHODשיטה ומערכת לתאו תרחיש רפואי המקושר AND SYSTEM FOR]54[


ע מערכת, למערכת קואורדינטות אחתבאמצעות מערכת מיקו, קואורדינטות שניה

רפואית

REGISTERING A MEDICALSITUATION ASSOCIATED WITHA FIRST COORDINATE SYSTEM,IN A SECOND COORDINATESYSTEM USING AN MPS SYSTEM

18.12.2003]22[US]33[13.01.2003]32[10/341535]31[US09.06.2003 10/458332

Int. Cl.(2009.01) A61B 05/05]51[MEDIGUIDE חיפה,מ"מדיגייד בע LTD.]71[

WO/2004/062497]87[',בורוכוב קורח ושות מגדל כלל עתידים

אביב-תל58100.ד.ת,

BOROCHOV, KORAKH & CO.,15TH FLOOR, ATIDIM TOWER,KIRYAT ATIDIM,P.O.B. 58100,TEL AVIV 61580

]74[

System for registering a first image with a second image, the system including a firstmedical positioning system (226) for detecting a first position and orientation of thebody of a patient, a second medical positioning system (236) for detecting a secondposition and orientation of the body, and a registering module (232) coupled with asecond imager and second medical positioning system, the first medical positioningsystem associated with and coupled with a first imager (224), the first imager acquiringthe first image from the body, the first imager producing the first image by associatingthe first image with the first position and orientation, the second medical positioningsystem associated with and coupled with the second imager (234), the second imageracquiring the second image and associating the second image with the second positionand orientation, the registering module registering the first image with the secondimage, according to the first position and orientation and the second position andorientation.

]57[

__________________

169197]21][11[


EGG תרכיז של תחלי, ביצה ותחלי, ביצה נוזלי REPLACER CONCENTRATEAND LIQUID EGG REPLACER

]54[

05.02.2004]22[EP]33[21.02.2003]32[03075500.3]31[

Int. Cl.(2009.01) A23L 01/052, 01/32]51[UNILEVER PLC, UNITEDKINGDOM

]71[




]74[

An egg replacer concentrate is provided that has a low cholesterol content. It includes40-85% protein, 10-50% vegetable oil and 0.5-15% carbohydrate. The cholesterolcontent is less than 0.5%. The protein includes soy protein, milk protein and optionallyegg white protein, at least half of the protein being soy protein. The PDI is at least60%. The concentrate is dispersed in water, and optionally egg whites, to provide aliquid egg replacer. The liquid egg replacer includes egg white protein and has amoisture content of 75-84%. It contains 16-28% of the egg replacer concentrate, 45-82% water and optionally egg white.

]57[

__________________

169200]21][11[

מער של חלבו הכולל פוליפפטיד המחוברכנלת ל"מיכה מוצקת ושיטה לחיבור פולפפטיד

ל"לתמיכה כנ

PROTEIN ARRAYS COMPRISINGA POLYPEPTIDE ATTACHED TOA SOLID SUPPORT AND METHODFOR ATTACHING SUCHPOLYPEPTIDE TO SUCH SOLIDSUPPORT

]54[

22.12.2003]22[US]33[22.12.2002]32[60/435821]31[

Int. Cl.(2010.01) C07K 01//00, 17//00, C40B 40//10]51[THE SCRIPPS RESEARCHINSTITUTE, U.S.A.

]71[




]74[


The invention provides proteins attached to solid supports, and methods of preparingsuch solid support-bound proteins are provided. The proteins are attached to solidsupports by means of an unnatural amino acid incorporated into the protein, whichunnatural amino acid includes a reactive group that can react with a second reactivegroup that is attached to a solid support.

]57[

__________________

169425]21][11[

צורות מינו מקומיות מיוצבות של תרכובותEפרוסטגלנדי

TOPICAL STABILIZEDPROSTAGLANDIN E COMPOUNDDOSAGE FORMS

]54[

31.12.2003]22[US]33[03.01.2003]32[10/336481]31[

Int. Cl.(2009.01) A61K 09/00]51[NEXMED HOLDINGS, INC., U.S.A.]71[WO/2004/062632]87[




]74[

Compounds of prostaglandin E group (PGE compounds) are stabilized as non-aqueouscompositions that include the compound together with a bulking agent that can be anon-aqueous liquid or a solid in a sheet, film or powder form. The composition canoptionally include a skin penetration enhancer. A non-aqueous, solid dosage formcomprises a PGE compound substantially uniformly distributed in a carrier sheet orfilm.

]57[

__________________

169589]21][11[

MOUNTING/ADJUSTING מנגנו כונו והתאמה למערכת הגברת ראיהMECHANISM FOR VISIONENHANCEMENT SYSTEM

]54[

07.07.2005]22[US]33[12.07.2004]32[10/889478]31[

Int. Cl.(2009.01) G02B 27/01]51[


ITT MANUFACTURINGENTERPRISES, INC., U.S.A.

]71[

CHARLES D. WILLEY, STEVEN A.BRILLHART, BLAIR R. DOBBIE

]72[

,יורם צביון פארק התעשיה,2הטוחן' רח

קיסריה3148.ד.ת,

YORAM TSIVION,2 HATOCHEN ST.P.O.B. 3148,CAESAREA 38900

]74[

A mounting assembly (10) for a vision enhancement device and associated visionenhancement display, the assembly comprising:(a) a display mount (80) for holding the vision enhancement display (82);(b) an arm (70) extending from a fixed end to a free end positionable in front of an eyeof a user in a first position, which corresponds to an in use position;(c) on said arm the display mount is mounted; and(d) at least one intermediate member (20, 40, 50) for connecting the arm (70) to amounting platform (12) for wearing on the user's head;characterized in that the arm (70) is invertable between the first position and a secondposition, which corresponds to a non-use position, in such a manner that when thedisplay mount is pulled away from the first position in direction to the second position,the arm snaps into an inverted configuration.

]57[

__________________

169600]21][11[

–ביס– 5,3(–2צורה גבישית של–N–)פניל–טריפלואורומתיל

–4–תיאומורפולינ–16–דיאוקסו– 1,1(–6[–) פניל–מתיל–2–פלואורו–4(4–) יל

איזובוטיראמיד–מתיל–N–]יל–3–פירידינ

CRYSTALLINE MODIFICATIONOF 2-(3,5-BIS-TRIFLUOROMETHYL- PHENYL)-N- [6 -(1,1-DIOXO- 1 LAMBDA 6 -THIOMORPHOLIN-4-YL)-4-(4-FLUORO-2 METHYL- PHENYL)-PYRIDINE- 3- YL]- N- METHYL-ISOBUTYRAMIDE

]54[

23.01.2004]22[EP]33[31.01.2003]32[03002134.9]31[

Int. Cl.(2009.01) A61K 09/14, 09/48, 31/541, A61P 25/00, C07D 417/04]51[


F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The present invention relates to a new crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1lambda6- thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl] -N-methyl-isobutyramide characterized by the followingX-ray diffraction pattern obtained with a CUK&agr ;radiation at2 thetas; (2Theta)= 4.5,6.4, 7.5, 7.7, 8.0, 8.2, 10.0, 10.2, 10.9, 11.1, 12.9, 13.4, 14.0, 14.5, 15.1, 15.6, 16.2,16.5, 17.3, 17.5, 18.0, 18.9, 19.3, 19.5, 19.9, 20.1, 20.6, 21.0, 21.4, 22.7, 23.1 and 23.6and an infrared spectrum having sharp bands at 2925, 2845, 1637, 1604, 1484, 1395,1375, 1285, 1230, 1172, 1125, 1082, 999, 943, 893, 863, 860, 782, 705, 684 cm-1, andwherein the extrapolated melting point (DSC) is 137.2°C.

]57[

__________________

169689]21][11[

עלמצומד ידי חיזור ע אמיני–י המתקבלישל פוליסכריד מעטפתי של פנומוקוקוס מסוג

5סרוטיפ

CONJUGATES OBTAINED BYREDUCTIVE AMINATION OFSEROTYPE 5 PNEUMOCOCCUSCAPSULAR POLYSACCHARIDE

]54[

16.01.2004]22[FR]33[17.01.2003]32[03/00488]31[

Int. Cl.(2010.01) A61K 39//395, C08B 37//00]51[SANOFI PASTEUR, FRANCE]71[WO/2004/067574]87[




]74[

The invention relates to conjugates obtained by reductive amination of serotype 5pneumococcus capsular polysaccharide. The reductive amination conditions differfrom conventional conditions in that they avoid the creation of an undesired compoundwhich is harmful to the immunogenicity of the conjugates. In carbon NMRspectrometry, the undesired compound is characterized by a resonance signal of 13 -14ppm. The aminated polysaccharides involved in the production of the conjugates havea carbon NMR spectrum devoid of a resonance signal of 13 -14 ppm. The reductive

]57[


amination conditions according to the invention are twofold. According to a firstmethod, the reductive amination is performed at a pH which is slightly acidic (4-6, 5)for a maximum of 4 hours. According to a second method, the polysaccharide isinitially reduced, then fragmented and finally undergoes the reductive amination per sein conventional or unconventional conditions. According to the method used, thestructure of the aminated polysaccharide can vary (conversion or not of the Sugresidue of the repeater unit into N-acetyl quinovosamine and N-acetyl fucosamine) butsaid variations, as recorded in carbon NMR spectrometry, have no effect onimmunogenicity.

__________________

169836]21][11[

SYSTEM מערכת ושיטה לזיהוי ואיתור אירוע אקוסטי AND METHOD FORIDENTIFYING AND LOCATINGAN ACOUSTIC EVENT

]54[

22.01.2004]22[US]33[24.01.2003]32[10/248511]31[

Int. Cl.(2010.01) G01S 05//30]51[SHOTSPOTTER, INC., U.S.A.]71[WO/2004/068162]87[

',זליגסון גבריאלי ושות31יבנה' רח



]74[

A system and method for detecting, identifying, and fixing the location of the source ofan acoustic event. The inventive system includes: a plurality of sensors dispersed atsomewhat regular intervals throughout a monitored area; a communication networkadapted to deliver information from the sensors to a host processor; and a processwithin the host processor for determining, from the absolute times of arrival of anevent at two or more sensors, a position of the source of the event. Acoustic events aredetected and analyzed at each sensor so that the sensor transmits over the network: anidentifier for the sensor; an identifier for the type of event; and a precise absolute timeof arrival of the event at the sensor. In a preferred embodiment, the system alsoidentifies the type of weapon firing a gunshot.

]57[

__________________


169842]21][11[

ELECTRONIC התק אלקטרוני לשיתוק DISABLINGDEVICE

]54[

11.02.2004]22[US]33[11.02.2003]32[10/364164]31[US29.05.2003 10/447447

Int. Cl.(2009.01) H01G 02/00]51[TASER INTERNATIONAL, INC.,U.S.A.

]71[

WO/2004/073361]87[,לצרפרל כהן צדק



]74[

An electronic disabling device (200) includes first and second electrodes (E1, E2) forcontact with a target animal or person. The device disables the target by providing acurrent through the electrodes and consequently through the target. To assure suitablecurrent flow, the device imposes across the electrodes a relatively high voltage for arelatively short time to ionize an air gap that may exist due to electrode placement.After a short time period, a lower voltage is used to sustain disabling current flowthrough the electrodes.

]57[



__________________

169884]21][11[

ASSAY ערכת בדיקה DEVICE]54[

26.07.2005]22[


US]33[29.07.2004]32[60/591964]31[Int. Cl.(2009.01) G01N 21/00]51[

SAVYON אשדוד,מ"סביון דיאגנוסטיקה בע DIAGNOSTICS LTD.]71[,ריינהולד כהן ושותפיו



]74[

A device for carrying out a lateral flow assay on a sample comprising:(a) a sample containing unit (4) comprising a sample container (8) said samplecontainer being closed off at one end by a bottom wall (9) said bottom wall having ahole (10) sealed by a plug (11); and(b) a housing (6) located under said sample container and adapted for holding a lateralflow assay test strip, said sample containing unit and said housing being coupled so asto allow rotation one relative to the other, said housing comprising a cuttingarrangement (58) capable of cutting said plug;wherein rotation of said sample containing unit and said housing one relative to theother results in said cutting arrangement cutting said plug, thereby unplugging the holein said bottom wall.

]57[

__________________

169885]21][11[

ADAPTIVE מערכת לסינו דואר זבל JUNK MESSAGEFILTERING SYSTEM

]54[

31.12.2003]22[US]33[25.02.2003]32[10/374005]31[

Int. Cl.(2010.01) G06Q 10//00, H04L 12//58]51[


MICROSOFT CORPORATION,U.S.A.

]71[

WO/2004/079501]87[,וריינהולד כהן ושותפי



]74[

The invention relates to a system for filtering messages (102) - the system includes aseed filter (106) having associated therewith a false positive rate and a false negativerate. A new filter (108) is also provided for filtering the messages (102), the new filter(108) is evaluated according to the false positive rate and the false negative rate of theseed filter, the data used to determine the false positive rate and the false negative rateof the seed filter (106) are utilized to determine a new false positive rate and a newfalse negative rate of the new filter (108) as a function of threshold. The new filter(108) is employed in lieu of the seed filter (106) if a threshold exists for the new filter(108) such that the new false positive rate and new false negative rate are togetherconsidered better than the false positive and the false negative rate of the seed filter(106).

]57[

__________________

169890]21][11[

SAFETY כיסויי בטיחות של שקעי חשמליי ודומיה COVERS FOR ELECTRICSOCKETS AND THE LIKE

]54[

27.01.2004]22[GB]33[27.01.2003]32[0302411.4]31[GB27.01.2003 0302412.2 GB28.01.20030301903.1GB23.10.20030325676.5GB23.10.20030325677.3

Int. Cl.(2009.01) H01R 13/62]51[DORMINA UK LIMITED, UNITEDKINGDOM

]71[

WO/2004/068647]87[REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[



26A HABARZEL ST.,RAMAT HACHAYAL 69710

An electrical socket comprises a wall mounted faceplate (17) with pin receivingapertures for a plug and an integral (built-in) cover having a cover panel (22) movablebetween an open position allowing access to the apertures and a closed positionconcealing the apertures. The cover panel (22) is secured in the closed position byengagement of latch pins (64) with latching means within the faceplate (17). The latchpins (64) are released by a key inserted into keyholes (66) in the side of the faceplate(17) and opens automatically under the biasing of a spring.

]57[

__________________

170056]21][11[

PYRAZOLE תרכובות פיראזול COMPOUNDS]54[

03.02.2004]22[JP]33[25.03.2003]32[2003-082385]31[

Int. Cl.(2010.01) A01N 43//56, A61K 31//4468, C07D 23/1/20]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN

]71[




]74[

A pyrazole compound represented by the formula (a): (a) wherein R1 represents C1-4 alkyl or trifluoromethyl, R2 represents C1-4 alkyl, and R3 represents hydrogen or C1-6 alkyl; R4 represents halogeno, etc. and m is an integer of 0 to 4; R5 representshalogeno, etc. and n is an integer of 0 to 4; R6 and R7 are the same or different andeach represents hydrogen, halogeno, or methyl; and X represents oxygen or a grouprepresented by R8O-N, wherein R8 represents hydrogen, C1-6 alkyl, etc. The compoundis highly active in controlling harmful arthropods.

]57[

__________________


170145]21][11[

COMMUNICATION משווה מסתגל מקלט תקשורת ע של RECEIVERWITH AN ADAPTIVE EQUALIZER

]54[

18.02.2004]22[US]33[18.02.2003]32[10/368920]31[

Int. Cl.(2009.01) H04L 25/03]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

In a wireless communication system, a method for estimating a transmitted signal isdisclosed. A wireless signal is received that includes a pilot channel and at least oneother channel. A transmitted signal is estimated using an equalizer and the receivedwireless signal. The equalizer includes a filter with a plurality of taps that are adaptedthrough use of an adaptive algorithm that uses an estimated pilot estimated from thereceived wireless signal. The pilot channel is transmitted in the wireless signal thatincluded the at least one other channel. The estimated pilot is extracted and provided tothe adaptive algorithm.

]57[



__________________

170191]21][11[

MACHINE מכונה להזרקת נוזלי FOR INJECTINGLIQUIDS

]54[

06.02.2004]22[US]33[10.02.2003]32[10/361459]31[

Int. Cl.(2009.01) A23B 04/00, B67D 01/00]51[EDWARD D. WATTS, U.S.A.CONLY L. HANSEN, U.S.A.

]71[

WO/2004/071936]87[REINHOLD,ן ושותפיוריינהולד כה COHN AND PARTNERS,]74[




A machine for injecting liquids is disclosed including use of at least one air pump (32)in fluid communication with at least one injection head (34) having apertures (48) fornozzles (42). High-pressure injectate flows from the air pump into the head, preferablythrough a threadlessly mounted filter (72) located within the injection head. To furtherminimize contamination, fluid that enters the injection head will not contact anythreading present in either the head or the nozzles. An air pressure regulator isincluded to ensure a steady stream of injectate of a desired pressure is delivered to aninjection subject via each injection head and also helping to eliminate hesitation indelivery of the fluid by the air pump. Cleaning of the machine is simplified by movingsensitive components into a sealed enclosure, removing them from a wet workingenvironment.

]57[

בקשות חלוקה מבקשה זו.ושטר פורסמ


__________________

170231]21][11[

ש ידור בטלפו שיטה ומתק לספור מקבלי תוכ אלחוטי

METHOD AND APPARATUS TOCOUNT BROADCAST CONTENTRECIPIENTS IN A WIRELESSTELEPHONE NETWORK

]54[

18.02.2004]22[US]33[18.02.2003]32[10/368876]31[

Int. Cl.(2009.01) H04L 12/18, H04W 04/06]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2004/075516]87[ט SANFORD',קולב ושות. סנפורד T.COLB & CO.,]74[



P.O.B. 2273,REHOVOT 76122

A base station (110) in a wireless communications network (100) counts mobilestations (114) receiving broadcast content via multi-user channel. The base stationbroadcasts (608) a repeating message identifying at least one broadcast content streamand, for each stream, a REGISTER (R) or DO NOT REGISTER (DNR) indicator.Mobile stations periodically re-examine (722) contents of this message. When theindicator is R for a broadcast content stream, mobile stations whose users have electedto receive it send (714) the base station a registration message for that stream. Whenthe number of registered mobile stations reaches (612) a prescribed number, the basestation changes (614) the indicator to DNR. When the indicator is DNR for a broadcastcontent stream, mobile stations refrain (712/716) from sending any registrationmessage for that broadcast content stream. The base station may institute a recount(618) by resetting the indicator to R.

]57[



__________________

170271]21][11[

TEMPERATURE שסתו המגיב לטמפרטורה RESPONSIVEVALVE

]54[

14.08.2005]22[Int. Cl.(2010.01) F16K 31//64, F25B 09//02, G05D 23//00]51[

,מ"רפאל רשות פתוח אמצעי לחימה בע חיפה

RAFAEL - ARMAMENTDEVELOPMENT AUTHORITY LTD

]71[

, דוד גורני,ןמרדכי שמחו, יוסף פלומנבליט אילון פארן, ליאוניד רובינסון

JOSEF FLOMENBLIT, MORDEHAISHIMHON, DAVID GORNI,LEONID RUBINSON, EILONFARAN

]72[

,יורם צביון פארק התעשיה,2הטוחן' רח

קיסריה3148.ד.ת,

YORAM TSIVION,2 HATOCHEN ST.P.O.B. 3148,CAESAREA 38900

]74[

A temperature responsive valve for controlling a gas flow, said valve comprising:a hollow body (10) having an inlet (12), an outlet and an inner surface;a nozzle (14) disposed at said outlet;a shape memory alloy wire (18) having a first end (16) and a second end, said first endattached to the inner surface of the hollow body and having an austenitic andmartensitic phase;

]57[


a stopper (20) attached to the second end of the shape memory alloy wire, said stopperdesigned to be fittable into said nozzle;wherein when the gas flows it impacts the stopper providing a stress on the wire andtending to cool the wire to a temperature below the martensitic transition temperaturethereby allowing the wire to elongate and thus the stopper engages the nozzle andslows or blocks flow, resulting in a temperature increase of the wire to a temperaturegreater than the austenitic transition temperature thereby resulting in a contraction ofthe wire retracting the stopper from the nozzle to allow gas to flow again.

__________________

170283]21][11[

ב IMCREQUEST–טיפול בבקשת הכוונה REDIRECTIONHANDLING IN IMC

]54[

23.03.2004]22[EP]33[24.03.2003]32[03006573.4]31[US05.08.2003 10/633692

Int. Cl.(2010.01) H04L 29//06]51[NOKIA CORPORATION, FINLAND]71[WO/2004/086723]87[



]74[

According to an aspect of the invention a method of processing a service request in an]57[


IP multimedia core network is disclosed. The method comprises the steps of receivinga service request initiated by a first user, for a second user, forwarding the receivedservice request to a unit for processing the service, receiving a processing result fromthe processing unit, and determining, on the basis of the received processing result,whether service request processing for the second user is to be stopped.

__________________

170313]21][11[

נגזרות דיארילציקלואלקיל ותכשירי רפואיי המכילי אות

DIARYLCYCLOALKYLDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

19.02.2004]22[DE]33[27.02.2003]32[10308353.7]31[

Int. Cl.(2009.01) A61K 31/421, A61P 03/08, 03/10, C07D 263/32, 413/04]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention relates to diarylcycloalkyl derivatives, their physiologically compatiblesalts, racemates and physiologically functional derivatives. The invention relates tocompounds of formula (I), in which the groups are defined as cited in the description,in addition to their physiologically compatible salts and to a method for theirproduction. The compounds are suitable for treating and/or preventing disorders of thefatty acid metabolism and disorders of glucose utilisation in addition to disorders, inwhich insulin resistance plays a part.

]57[


__________________

170314]21][11[

–4–אוקאזול–פניל–2(–3(–4נגזרות חומצהבוט–) קיצלוהקסילאוקסי–) אילמתוקסי

תכשירי רפואיי, ותרכובות משויכות ושימוש שלה, המכילי אות

4 - (3 -(2 - PHENYL - OXAZOL - 4 -YLMETHOXY) -CYCLOHEXYLOXY) - BUTANEACID DERIVATIVES ANDRELATED COMPOUNDS,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF

]54[

19.02.2004]22[DE]33[27.02.2003]32[10308355.3]31[

Int. Cl.(2009.01) A61K 31/421, A61P 03/08, 03/10, C07D 263/32, 413/04]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention relates to aryl-cycloalkyl substituted alkane acid derivatives and thephysiologically compatible salts and physiologically functional derivatives thereof.The invention also relates to compounds of formula (I), wherein the radicals have theabove-mentioned meanings, in addition to the physiologically compatible salts thereofand a method for the production thereof. Said compounds can be used for example, inthe treatment and/or prevention of disorders in the metabolism of fatty acids anddisorders related to the use of glucose, in addition to insulin-related disorders.

]57[

__________________

170316]21][11[

–נגזרות חומצה אצטית מותמרות במתוקסי ציקלואלקיל ותכשירי רפואיי המכילי אות

CYCLOALKYL-METHOXYSUBSTITUTED ACETIC ACIDDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS COMPRISING

]54[


THEM

19.02.2004]22[DE]33[27.02.2003]32[10308355.3]31[

Int. Cl.(2009.01) A61K 31/421, A61P 03/00, C07D 263/32, 413/04]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention relates to cycloalkyl methoxy substituted acetic acid derivatives, inaddition to their physiologically compatible salts and physiologically functionalderivatives. The invention relates to compounds of formula (I), in which the groups aredefined as cited in the description, in addition to their physiologically compatible saltsand to a method for their production. The compounds are suitable e.g. for treatingand/or preventing disorders of the fatty acid metabolism and disorders of glucoseutilisation in addition to disorders, in which insulin resistance plays a part.

]57[

__________________

170518]21][11[

–5תכשירי אוראליי נוזליי המכילי חומצה) פלואורואנילינו–6'–כלורו–2'(–2–מתיל

שיטות להכנת ושימוש בהכנת, פנילאצטית תרופות

LIQUID ORAL DOSAGEFORMULATIONS COMPRISING5-METHYL-2-(2'-CHLORO-6'-FLUOROANILINO)PHENYLACETIC ACID,METHODS FOR PREPARINGTHEM AND USE THEREOF FORTHE MANUFACTURE OFMEDICAMENTS

]54[

11.03.2004]22[US]33[12.03.2003]32[60/454145]31[

Int. Cl.(2009.01) A61K 09/08, 31/195]51[NOVARTIS AG, SWITZERLAND]71[WO/2004/080451]87[




]74[


Provided are compositions comprising aqueous suspensions of 5-methyl-2-(2’-chloro-6’-fluoroanilino)phenylacetic acid suitable for oral administration. Methods formaking such compositions and methods for their stabilization are provided.

]57[

__________________

170913]21[]11[

שימוש במעכב של מעביר חומצת מרה של המעיאו)IBAT( העקו להכנת תכשיר לטיפול

למניעת עצירות

USE OF AN ILEAL BILE ACIDTRANSPORT (IBAT) INHIBITORIN THE PREPARATION OF AMEDICAMENT FOR THETREATMENT OR PROPHYLAXISOF CONSTIPATION

]54[

01.04.2004]22[GB ]33[05.04.2003]32[0307918.3]31[

Int. Cl.(2009.01) A61K 31/00]51[ALBIREO AB, SWEDEN]71[HASSE ROLAND ABRAHAMSSON,PER-GORAN GILLBERG

]72[

WO/2004/089350]87[',הורוביץ ושות.ש

31רחוב אחד העם תל אביב2499.ד.ת,

S. HOROWITZ & CO.,31 AHAD HAAM STREETP.O. BOX 2499TEL AVIV 65202

]74[

The use of an IBAT inhibitor in the treatment and/or prophylaxis of constipation, in awarm-blooded animal, such as man is described.

]57[

__________________

170974]21][11[

מערכת לקריאה ללא מגע עבור כרטיסי שבבי הממוקמי על גבי פריטי

CONTACTLESS READINGSYSTEM FOR CHIP CARDSPLACED ON OBJECTS

]54[

01.04.2004]22[FR]33[02.04.2003]32[03/04092]31[


Int. Cl.(2010.01) G06K 07//08]51[ASK S.A., FRANCE]71[WO/2004/090793]87[



]74[

A contactless reading system, wherein a chip card is fixed on a planar support of anobject such as a book (11) for identification by means of the data contained in the chipcard, and a mobile reader (16) provided with an antenna in order to read the data of thecard. The antenna of the reader (16) consists of a small-sized convolution disposed in aseries with a large-sized convolution, which are concentric and which have the samewinding direction. A maximum value is obtained for the component (H) of theelectromagnetic field produced by the antenna parallel to the antenna at a givendistance from the antenna. Maximum reception by the chip card of electromagneticsignals emitted by the antenna is obtained when the antenna is disposed in aperpendicular position in relation to the support of the card and at the given distancefrom the card.

]57[

__________________

171027]21][11[

מערכת ושיטה לטיפול בהפרעות בצינור שלפוחית השת

SYSTEM AND METHOD FORTREATING URINARY TRACTDISORDERS

]54[

16.03.2004]22[US]33[18.03.2003]32[10/389948]31[

Int. Cl.(2010.01) A61F 07//12, A61M 25//14]51[ELMEDICAL הרצליה,מ"אלמדיקל בע LTD.]71[

UZI עוזי אשל ESHEL]72[WO/2004/082734]87[

]SOROKER-AGMON,]74,אגמון-סורוקר


14רחוב שנקר, בית נולטון הרצליה פיתוח

14 SHENKAR ST.,HERZLIYA PITUAH 46725

A method, device, and system for treatment of urinary tract disorders is provided. Thedevice includes a catheter having multiple lumens for insertion into a urinary bladderand for providing fluid flow within the bladder and within the fluid reservoir within theurethra. The device further includes an anchor to be placed within the bladder. A porthub having multiple ports is connected at a proximal end of the catheter. A method oftreatment includes providing heated fluid to a urinary bladder and to a fluid reservoirfor insertion into an adjacent organ such as the urethra. Simultaneous treatment orseparate treatment may be done. Optionally, a medicated solution may be added to theheated fluid. Additionally, pressure may be adjusted so as to optimize the therapeuticeffect

]57[

__________________

171040]21][11[

CONVERTED כלי רכב מומר בעל מוביליות גבוהה ושיטת המרה HIGH MOBILITYVEHICLE AND CONVERSIONMETHOD THEREFOR

]54[

22.09.2005]22[Int. Cl.(2010.01) B60P 03//42, B62D 65//00]51[

PLASANמ"פלסן סאסא אגודה שיתופית חקלאית בע SASA AGRICULTURALCOOPERATIVE SOCIETY LTED.

]71[

בן, טל דאי TAL ארי-יעקב DAI, JAKOB BEN-ARY]72[,ריינהולד כהן ושותפיו



]74[

Method for manufacturing an armored high mobility vehicle (10) from an after market4x4 produced by a manufacturer, having a chassis (12) with a frame, front axle andrear axle (20), said chassis having a standard wheelbase, the high mobility vehiclehaving increased maneuverability and on-road and/or off-road capability, relative tothe 4x4, including:dismounting at least one of the front axle or rear axle from said frame;shortening said frame;mounting the dismounted axle to the shortened frame so as to obtain a shortenedchassis having a shortened wheelbase which is shorter than any standard wheelbase ofthe line of models produced by said manufacturer; and protecting at least a portion ofthe high mobility vehicle by armor.

]57[



This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968



__________________

171255]21][11[

חומר להקשיה תרמופלסטית לשימוש בייצור ושיטה לייצורו, נעליי

THERMOPLASTIC STIFFENINGMATERIAL FOR USE FORMANUFACTURING SHOES AND AMETHOD FOR THEPRODUCTION THEREOF

]54[

27.03.2004]22[DE]33[11.04.2003]32[10316617.3]31[

Int. Cl.(2010.01) C08K 03//00, C09J 12/3/08, 16/7/04]51[BK GIULINI GMBH, GERMANY]71[WO/2004/090061]87[

',דניאל פריימן ושות10בית כלל קומה5דרויאנוב תל אביב

DANIEL FREIMANN & CO.,5 DROYANOV ST., 10TH FLOOR ,TEL AVIV 63143

]74[

The invention relates to a novel thermoplastic stiffening material used formanufacturing shoes or shoe parts, and to an environmentally friendly method for theproduction thereof. The inventive material is provided in the form of a hot-meltadhesive/filler compound and is characterized in that it is comprised of one or morehot-melt adhesives and of one or more fillers, which are provided in quantities rangingfrom 50 to 15 % by weight and which do not dissolve in the hot-melt adhesive. Thehot-melt adhesive/filler compound simultaneously fulfills the following parameters: 1.

]57[


MVR value between 2 and 6, preferably between 3 and 5 cm3/10min; 2. Surface tack,when measured according to DIN EN 14610 at 65 °C, ranging from at least 10 N/2 cm,preferably 15 N/2 cm, particularly 20 N/2 cm; 3. Bonding value/peel resistance withregard to upper materials and linings of at least 30 N/5 cm when measured accordingto DIN 53357; 4. Longitudinal extension of no greater than 25 %, preferably less than20 %, when measured at a temperature of 90 °C.

__________________

171356]21][11[

חלת נוגד נגד קולט של אינטרפרו לטיפול במ מעיי דלקתית

ANTI-INTERFERON RECEPTORANTIBODY FOR TREATMENT OFINFLAMMATORY BOWELDISEASE

]54[

23.04.2004]22[US]33[23.04.2003]32[60/465155]31[

Int. Cl.(2009.01) A61K 39/395, C07K 16/18, 16/28]51[BRISTOL-MYERS SQUIBBCOMPANY, U.S.A.

]71[




]74[

Compositions and methods for the therapy of Inflammatory Bowel Disease (IBD),including Celiac Disease, Crohn’s Disease, and Ulcerative Colitis, are disclosed.Illustrative compositions comprise one or more anti-type 1 interferon antagonists, suchas anti-type 1 interferon receptor antibody antagonists and fragments thereof, as wellas polypeptides and small molecules that inhibit the interaction of type 1 interferonwith its receptor (IFNAR).

]57[


__________________

171542]21][11[

קולטי שמש ע מקלט מרוק ומחזירי חיצוניי שאינ משתקפי

SOLAR COLLECTORS WITHEVACUATED RECEIVER ANDNONIMAGING EXTERNALREFLECTORS

]54[

22.04.2004]22[US]33[22.04.2003]32[60/464429]31[

Int. Cl.(2009.01) F24J 02/10]51[SOLARGENIX ENERGY LLC, U.S.A.]71[WO/2004/094924]87[



]74[

A solar collector with external reflector. A solar collector includes a glass housinghaving a heat pipe disposed within the housing and a light reflector disposed externalto the housing.

]57[

__________________

171671]21][11[

METHOD שיטה והתק להברגה בסלעי AND DEVICE FORROCK BOLTING

]54[

12.05.2004]22[SE]33[12.05.2003]32[0301376-0 ]31[

Int. Cl.(2010.01) E21D 20//00]51[ATLAS COPCO ROCK DRILLS AB,SWEDEN

]71[


WO/2004/099569]87[',זליגסון גבריאלי ושות

31יבנה' רח תל אביב1426.ד.ת,


]74[

Method and device for rock bolting, wherein a tubular bolt (2) with closed cross-section is inserted and expanded for anchoring inside a bore hole (12), wherein thetubular bolt is expanded to contact in the inner portion of the bore hole, a tensionelement (3, 7, 8, 9) which is arranged in the outer portion of the bore hole with aninner part (7) attached to the tubular bolt (2) is pre-stressed and a settable medium isinjected into the outer portion of the bore hole (14) between (27) the tension elementand the wall of the bore hole and is allowed to set.

]57[

__________________

171733]21[]11[

APO2Lפפטידי הנקשרי לקולטTRAIL(( ושימושיה

APO2L (TRAIL) RECEPTORBINDING PEPTIDES AND USESTHEREOF

]54[

29.04.2004]22[US]33[09.05.2003]32[60/469436]31[

Int. Cl.(2010.01) A61K 38//04, A61P 35//00, C07K 07//04, 07//08, 14//47, 14//525,14//705, C12N 01//21, 05//07, 15//19, 15//63

]51[

GENENTECH, INC., U.S.A.]71[WO/2004/101608]87[



]74[

Peptides are provided that bind Apo-2L receptor molecules. These peptides can beused for example in methods where a modulation of the biological activities of Apo-2Land/or Apo-2L receptor molecules such as DR5 is desired.

]57[


__________________

171779]21][11[

תצמידי אימוניי המכילי איזור קבוע של אימונוגלוביולי ומולקולה בעלת פעילות ביולוגית

IMMUNOCONJUGATESCOMPRISING ANIMMUNOGLOBULIN CONSTANTREGION AND A BIOLOGICALLYACTIVE MOLECULE

]54[

06.05.2004]22[US]33[06.05.2003]32[60/469600]31[US17.07.2003 60/487964 US26.01.200460/539207

Int. Cl.(2009.01) C07K 19/00, C12N 15/13, 15/62]51[SYNTONIX PHARMACEUTICALS,INC, U.S.A.

]71[




]74[

The invention relates to a chimeric monomer-dimer hybrid protein wherein saidprotein comprises a first and a second polypeptide chain, said first polypeptide chaincomprising at least a portion of an immunoglobulin constant region and a biologicallyactive molecule, and said second polypeptide chain comprising at least a portion of animmunoglobulin constant region without the biologically active molecule of the firstchain. The invention also relates to methods of using and methods of making thechimeric monomer-dimer hybrid protein of the invention.

]57[



__________________

171802]21][11[

מבקר אלקטרוני עבור פליטת גז של מנורה בעצמה גבוהה

ELECTRONIC CONTROLLER FORHIGH POWER GAS DISCHARGELAMP

]54[

14.04.2004]22[CN]33[17.02.2004]32[200410016366.4]31[


Int. Cl.(2010.01) H05B 41//00]51[FANGLU LOU, CHINA]71[WO/2005/081588]87[



]74[

A electronic controller for high power gas discharge lamp, which is comprised of thecircuit of filtering, rectifying, power factor switch, driving transform power control,startup trigger protection, output matching and auxiliary power supply, and. thesecircuit are coupled to each other in this order. The filtering circuit adopts inultipleelectrode common mode and difference mode filter, which is fully according withEMC standard, the interfere of outer track is decreased at controller, and adopts threeintegrated block circuit, which has high integration degree, low element deviceutilized, simple circuit, and low cost, whereas the auxiliary power supply circuit, whichsupplies the integrated block working, is obtained by commercial power after voltagetransformer and voltage stabilizing tube voltage-stabilizing, and has working stabilityand high reliability. In the drive circuit, straight driving switching tube Q3 byintegrated block IC2, this circuit is simple, and has little distortion, can work underconstant voltage, constant current and constant power, and has the function of workstable in a state of short cij,,-cuit, open circuit and ordinary guide, in particular adaptsfor its fix and use on high power gas discharge lamp, and has high power factor, longperformance life and high quality of lighting.

]57[

__________________

171933]21][11[

DEVICE התק ושיטה לקידוד ופענוח גוש נתוני AND METHOD FORENCRYPTING AND DECRYPTINGA BLOCK OF DATA

]54[

19.05.2004]22[EP]33[23.05.2003]32[03011696.6]31[

Int. Cl.(2010.01) H04L 09//06, 09//28]51[NAGRAVISION S.A.,SWITZERLAND

]71[



]74[

Method to encrypt or decrypt blocks of data X to Y, based on a main key R, thismethod using several serially connected modules, each module using a sub-key RA

]57[


derived from the main key R and comprising the steps of: - inputting at least two initialvalues XOL and XOR, and mixing these values to form a mixed value X1, - obtaininga value X2 by mixing a first part RAH of the sub-key RA with the value X1, -obtaining a value X3 by applying the value X2 to a substitution layer, comprising atleast one substitution box (sbox), - obtaining a value X4 by using a diffusion box ofmulti-permutation type based on the value X3, - obtaining a value X5 by mixing asecond part RAL of the sub-key RA with the value X4, - obtaining the value X6 byapplying to the value X5 a substitution layer, - obtaining a value X7 by mixing a firstpart RAH of the sub-key RA with the value X6, - mixing the value X7 with the initialat least two values XOL and XOR to obtain the at least two values X8L and X81R,X8L and X8R representing the output value X8 of the module. This method using atleast two modules, and applies to at least one of the value X8L or X8R anorthomorphism function before feeding them to the next module.

__________________

171934]21][11[

METHOD אקראי–שיטה לייצור רצ, דמוי FOR GENERATINGPSEUDO-RANDOM SEQUENCE

]54[

02.09.2004]22[EP]33[05.09.2003]32[03103307.9]31[

Int. Cl.(2010.01) H04L 09//06]51[NAGRAVISION S.A.,SWITZERLAND

]71[



]74[

The aim of this invention is to propose a method to generate sequences or sub-keysbased on a main key, in which each sub-key gives no information to recover the mainkey or any other sub-keys. The aim is achieved with a method to generate sub-keysbased on a main key (MKEY), comprising the following steps: - obtaining a first value

]57[


(A1) by applying to the main key (MKEY) a linear diversification layer by mixing themain key (MKEY) with a constant, - applying to the first value (A1) a non-lineartransformation, this transformation comprising the steps of: - obtaining a second value(A2) by applying the first value (A1) to a substitution layer, the substitution layercomprising at least one substitution box (sbox), each substitution box containing atleast one table of constants for which the input serves as the pointer and the pointedconstant serves as the output, - obtaining a third value (A3) by using a diffusion box ofmulti-permutation type based on the second value (A2), - dividing the third value (A3)in N blocks of same size, obtaining the output fourth value (A4) formed by N blocks,each block of the fourth value (A4) being the result of the combination of N-1 blocksof the third value (A3), the missing block being the block of the same index, -obtaining the fifth value (A5) by applying to the fourth value (A4) a substitution layer,- obtaining the sub-key (RKEY) by applying to the fifth value (A5) a symmetricalencryption module, the first value (A1) serving as the key input for this module.

__________________

172034]21][11[

PVCPROCESSלהכנת תמיסתPVCתהלי להמרת שר, FOR DISSOLVINGPOLYVINYL CHLORIDE RESINFOR THE MANUFACTURE OFPVC SOLUTION

]54[

19.05.2004]22[KR]33[19.05.2003]32[10-2003-

0031515]31[

Int. Cl.(2010.01) C08J 03//02]51[בע.טי.איי.אמ. אי E.M.A.T חיפה,מ"טכנולוגיות TECHNOLOGIES LTD]71[

MOSHE ויליאם גיא יוז גאמס, משה ליפר LIPPER, WILLIAM GAYHUGHES GAMES

]72[

WO/2004/101654]87[REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[




The present invention relates to a process for the preparation of a PVC homopolymersolution containing PVC in concentration greater than 5 wt %, comprising adding solidPVC to an organic solvent containing a dissolving agent selected from phthalates,adipates, phosphates, sebacates and azelates, and stirring the same until a clear solutionis obtained, a process for the manufacturing of the PVC sheet, comprising applying thePVC homopolymer solution, and a PVC film, whenever manufactured by the processof the PVC sheet. The present invention provides a process for the preparation of thePVC homopolymer solution, the transparent solution which is stable and in which noprecipitation or gel formation occurs for long periods of time, the PVC dissolvingsolution without applying any external heat, and the PVC sheet by efficient andinexpensive method.

]57[

__________________

172078]21][11[

DUAL זחלי לתנועה בתנאי שטח קשי–רובוט נייד דו TRACKED MOBILEROBOT FOR MOTION INROUGH TERRAIN

]54[

21.11.2005]22[Int. Cl.(2009.01) B62D 55/065, 59/04]51[

חברה אוניברסיטאית למחקר-אריאל אריאל,מ"ופיתוח בע

ARIEL-UNIVERSITY RESEARCHAND DEVELOPMENT COMPANYLTD

]71[

SHRAGA שפירו אמיר, שרגא שובל SHOVAL, AMIRSHAPIRO

]72[




]74[

An autonomous dual tracked mobile robot system comprising two or more trackeddriving units configured to travel in tandem and a separate mechanical linkage joiningeach of said mobile units to the unit immediately preceding and following it;wherein, each of said mechanical linkages comprises:one connecting bar and three revolute joints on each of said units; anda connecting beam that connects said connecting bar on one of said units with saidconnecting bar on the second of said units.said mechanical linkage enabling efficient force transmission between said twodriving units.

]57[


__________________

172083]21][11[

זרז להקטנת פחמ חד חמצני וחנק חמצני מזר עש המרכזי של סיגריה

CATALYST TO REDUCE CARBONMONOXIDE AND NITRIC OXIDEFROM THE MAINSTREAMSMOKE OF CIGARETTE

]54[

10.06.2004]22[US]33[13.06.2003]32[10/460303]31[

Int. Cl.(2010.01) A24B 15//00, 15//18, 15//28, A24D 03//00, 03//06]51[PHILIP MORRIS PRODUCTS S.A.,SWITZERLAND

]71[




]74[

Cut filler compositions, cigarettes, methods for making cigarettes and methods forsmoking cigarettes are provided, which involve the use of a catalyst capableconverting carbon monoxide to carbon dioxide and/or nitric oxide to nitrogen. Cutfiller compositions comprise tobacco and at least one catalyst. Cigarettes are provided,which comprise a cut filler having at least one catalyst. The catalyst comprisesnanoscale metal and/or metal oxide particles supported on a fibrous support. Thecatalyst can be prepared by combining a dispersion of nanoscale particles with afibrous support, or by combining a metal precursor solution with a fibrous support andthen heat treating the fibrous support.

]57[

__________________


172262]21][11[

ל GSMSYSTEM–מערכת ושיטה עבור מסירה AND METHOD FOR GSMHARD HANDOFF

]54[

18.06.2004]22[US]33[18.06.2003]32[60/479777]31[US18.12.2003 60/531583

Int. Cl.(2009.01) H04W 36/14, 52/42]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A GSM1x (206)-to-GSM (208) handoff feature allows a GSM1x subscriber with adual-mode (GSM1x and GSM modes) handset (204) to seamlessly roam from GSM1xcoverage areas to GSM coverage areas. This functionality is facilitated by the GSM1xsystem design which integrates a CDMA RAN with a standard GSM core network.The GSM1x system is built using standard CDMA as its air interface and anunmodified CDMA RAN with a standard IOS interface to the MSN (304). The onlymodifications are done at the MSN (304) and the MS.

]57[

__________________

172308]21][11[

POOL התק ושיטה לחימו בריכה HEATING SYSTEM ANDMETHOD

]54[

01.12.2005]22[Int. Cl.(2009.01) F25B 13/00, 27/02, F25D 29/00]51[


DAVID קרית שמואל, דוד פרץ PERETZ]71[,מ"בע) 1992(גולד פטנטים וייעוץ כלכלי

15יוחנן הסנדלר חיפה25267.ד.ת,

GOLD PATENTS LTD.,15 YOHANAN HA'SANDLAR ST.P.O.B 25267HAIFA 31251

]74[

A pool heating system (10) comprising:an immersed condenser coil (132), immersed in pool of water (136) receiving hotrefrigerant gas (141) at high pressure from an outdoor unit (12), transferring heat towater in said pool, condensing said gas and transmitting condensed refrigerant to saidoutdoors unit; andan outdoors unit comprising:a compressor (110) for compressing low-pressure refrigerant gas producing hotrefrigerant gas at high pressure;an expansion valve (120) receiving and expanding condensed refrigerant from saidimmersed coil for producing low-pressure cold mixture of gaseous and liquidrefrigerant;an evaporator (142) for evaporating said low-pressure cold mixture of gaseous andliquid refrigerant producing low-pressure refrigerant gas and transmitting said low-pressure refrigerant gas to said compressor; anda fan (148) for blowing outside air over said evaporator for transferring heat to, andevaporatinga low-pressure cold mixture of gaseous and liquid refrigerant.

]57[

__________________

172470]21][11[

שיטה למעקב היווצרות נזק מבני והתקדמותוב אמצעות גלאי במבנה מרוכב מונוליטי וזאת

סבכת סיב ברג

METHOD TO MONITORSTRUCTURAL DAMAGEOCCURRENCE ANDPROGRESSION IN MONOLITHICCOMPOSITE STRUCTURESUSING FIBRE BRAGG GRATING

]54[


SENSORS

08.12.2005]22[EP]33[28.12.2004]32[04107032.7]31[

Int. Cl.(2009.01) G02B 06/34]51[AIRBUS ESPANA, S.L., SPAIN]71[



]74[

A method of monitoring structural damage in a composite structure manufactured byco-curing, co-bonding or secondary bonding of several sub-components, using fibreoptic Bragg grating sensors attached or embedded to or between (in the bonding line)said sub-components, characterized by comprising the steps of:(a) measuring the wavelength spectra of said Bragg grating sensors at the end of themanufacturing of the part, and in a known load condition, considered as reference;(b) identifying the occurrence of a failure of the structure and the progress of saidfailure detecting the release of the residual stresses/strains stored during the curingprocess by measuring changes with respect to said reference wavelength spectra.

]57[

__________________

725681]21][11[

שיטה ומערכת ליצירה ולהפעלה של מתקני תכליתיות ביומטריי–ניהול תעודות רב

METHOD AND SYSTEM FORCREATING AND OPERATINGBIOMETRICALLY ENABLEDMULTI-PURPOSE CREDENTIALMANAGEMENT DEVICES

]54[

15.06.2004]22[US]33[16.06.2003]32[60/478363]31[

Int. Cl.(2010.01) G06F 21//00, G06Q 30//00, G07C 09//00]51[URU TECHNOLOGY,INCORPORATED, U.S.A.

]71[

JOHN ROBERT COYNE,CHRISTOPHER ANDREW COYNE,WILLIAM MARK ADAMS,RAYMOND MUNSEN WALLACE

]72[


ז,54.ק, מגדל משה אביב 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,

]74[


RAMAT GAN 52520

A method and system used to integrate and control multiple secure credentialingapproaches including magnetic stripes, bar codes, contact and contactless SmartCardchips (12), Short Message Systems (SMS), Global Positioning Systems (GPS), vicinitytype Radio Frequency Identification Devices (RFID) (14), and proximity-type RFID(22), into compact, self-powered, biometrically-protected devices.

]57[

__________________

172644]21][11[

METHOD שיטה להתגברות על עיכובי בניהול מערכות FOR OVERCOMINGSYSTEM ADMINISTRATIONBLOCKAGE

]54[

18.12.2005]22[SG]33[20.12.2004]32[200407554-5 ]31[

Int. Cl.(2009.01) G06F 09/445]51[TREK 2000 INTERNATIONAL LTD.,SINGAPORE

]71[

ט ',ולב ושותק. סנפורד מרמורק,4שער הגיא



]74[

A method for overcoming system administrator blockage of a non-volatile memorydevice newly-connected to a host computer operatively connected to a networkcontrollable by a system administrator, the non-volatile memory device comprising apublic memory and a private memory, the private memory being of a category forwhich communication by a host computer application is able to be blocked in anadministrative privilege environment, the method comprising:enumerating the device with the host computer application as a composite deviceincluding a human interface device for enabling communication between the hostcomputer application and the private memory in a non-adminstrative privilegeenvironment.

]57[


__________________

172703]21][11[

, ואלסרט, תולדות ניטרואוקסיות של לוסטררט ואולמסרט אפרוס, תלמיסרט, קנדסרט

לטיפולII–כבלוקרי של קולט אנגיוטנסי במחלות של הלב וכלי הד

NITROOXY DERIVATIVES OFLOSARTAN, VALSARTAN,CANDESARTAN, TELMISARTAN,EPROSARTAN ANDOLMESARTAN AS ANGIOTENSIN- II RECEPTOR BLOCKERS FORTHE TREATMENT OFCARDIOVASCULAR DISEASES

]54[

20.07.2004]22[EP]33[31.07.2003]32[03102379.9]31[

Int. Cl.(2010.01) A61K 31//4178, C07D 25/7/04, 40/3/10, 40/9/06]51[NICOX S.A., FRANCE]71[WO/2005/011646]87[



]74[

Nitrooxy derivatives of the angiotensin-II receptor blockers Iosartan vaalsartan,candesartan, telmisartan, eprosartan and olmesartan and related compounds of formula(I): R-(Y-ONO2)swherein R is of formula (II) or (III): R0 is e.g: and R1 is: (IIa), (IIb),(IIc), (IId) or (IIe).

]57[

__________________

172753]21][11[

התק ושיטות לקביעת גורמי הגברת מתח עבור עוצמת העברה בתקשורת אלחוטית

APPARATUS AND METHODS FORDETERMINATION OF GAINFACTORS FOR WIRELESSCOMMUNICATIONTRANSMISSION POWER

]54[

13.09.2004]22[US]33[26.09.2003]32[60/506522]31[

Int. Cl.(2010.01) H04B 07//185, H04W 52//06, 52//16]51[


INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[




]74[

Apparatus and methods for wireless communication transmission power control areprovided. Determination of gain factors and adjustments for physical channelreconfiguration in the context of transmission power control are addressed. Preferably,implementation is in con unction with communication systems in which wirelesscommunications are conducted between wireless transmit receive units (WTRUs)using multiple channels that are concurrently transmitted.

]57[

__________________

172945]21][11[

,THIN שכבת לוח דקה מחוזקת ושיטה לייצורה STRATIFIED, REINFORCEDSLAB AND METHOD FOR THEMANUFACTURE THEREOF

]54[

23.07.2004]22[IT]33[29.07.2003]32[TV03A000108]31[

Int. Cl.(2009.01) B29C 67/24, 70/02, B32B 09/04]51[LUCA TONCELLI, ITALY]71[WO/2005/014952]87[




]74[

Between two layers (10, 12) of BretonstoneTM mix - formed by inert materials (11), ahardening resin and a filler (13) - at least one fibrous middle layer (14) is arrangedwhich consists of linear elements or inorganic filaments (15), preferably made of glassand in the form of continuous non-woven elements, pre-impregnated with a resin of

]57[


the same kind as, or compatible with that forming the said mix. The assembly issubjected to vacuum vibro-compression before a final hardening step in a catalysisoven. USE/ADVANTAGES : a stratified and reinforced slab is obtained whichcombines a reduced thickness (even as small as 3.5 mm) to a very high impact strengthand improved mechanical properties.

__________________

172973]21][11[

תהלי להכנתACID CARBOXYLIC – 5 –

OXAZOLIDINE – 1 – ISOBUTYL – 4 –(DIMETHOXYPHENYL – 4, 2) – 2 –

BOC – N – (R5, S4(

PROCESS FOR THEPREPARATION OF (4S, 5R) - N -BOC - 2 - (2' 4 -DIMETHOXYPHENYL) - 4 -ISOBUTYL - 1 - OXAZOLIDINE - 5- CARBOXYLIC ACID

]54[

03.07.2000]22[IT]33[06.07.1999]32[MI99A001483]31[

Int. Cl.(2010.01) A61K 31//357, A61P 35//00, C07D 49/3/04]51[DIVISION FROM 147445]62[INDENA S.P.A., ITALY]71[WO/2001/002407]87[

,ריינהולד כהן ושותפיו'א26רחוב הברזל

החייל רמת


]74[

A process for the preparation of (4S, 5R)-N-Boc-2-(2,4-dimethoxyphenyl)-4-isobutyl-1-oxazolidine-5-carboxylic acid, which comprises the following steps:(a) protection of the amino group of leucinol with Boc;(b) transformation of N-R-Boc-L-leucinol into N-Boc-L-leucinal;(c) preparation of the cyanhydrine of the product of step (b);(d) transformation of the cyanhydrine nitrile into the corresponding carboxylic acid;(e) formation of the carboxylic acid methyl ester;(f) purification of the (2B, 3S)-3-(N-Boc)amino-2-hydroxy-5-methylhexanoic acid

]57[


methyl ester;(g) condensation of the product of step (f) with 2,4-dimethoxybenzaldehyde dimethylacetal, to yield (4S, 5R)-N-Boc-2-(2,4-dimethoxyphenyl)-4-isobutyl-1-oxazolidine-5-carboxylic acid methyl ester;(h) transformation of the product of step (g) into the corresponding carboxylic acid.

__________________

172996]21][11[

שיטה ומתק ליצירת צורות גל שרירותיות חד מחזוריות

METHOD AND APPARATUS FORGENERATION OF ARBITRARYMONO-CYCLE WAVEFORMS

]54[

09.07.2004]22[US]33[10.07.2003]32[10/616672]31[

Int. Cl.(2010.01) G06F 01//02, H03B 28//00]51[RAYTHEON COMPANY, U.S.A.]71[WO/2005/008882]87[




]74[

A waveform generator digitally synthesizes a waveform having a plurality ofsuccessive portions that can each be as short as one mono-cycle of the waveform, or apart of one mono-cycle. The waveform generator changes at least one of a frequency, aphase and an amplitude of the waveform between each successive pair of the portionsthereof. A method includes digitally synthesizing a waveform having a plurality ofsuccessive portions that can each be as short as one mono-cycle of the waveform, or apart of one mono-cycle, including changing at least one of a frequency, a phase and anamplitude of the waveform between each successive pair of the portions thereof.

]57[


__________________

173055]21][11[

ABRASION-RESISTANT יריעת חומר עמידה בפני שפשו, SHEETMATERIAL

]54[

07.07.2004]22[US]33[10.07.2003]32[10/616790]31[

Int. Cl.(2009.01) B60V 01/16]51[HONEYWELL INTERNATIONALINC., U.S.A.JHRG, LLC, U.S.A.

]71[


'א26רחוב הברזללרמת החיי


]74[

An abrasion-resistant skirt material (15) for use with air cushion vehicles having atleast one air chamber. The sheet material comprises a fabric base (12a) comprisingyarns of an ultra-high molecular weight polyethylene. A bonding layer (12b),comprising a thermoplastic material is bonded to the fabric base, and an outer layer(14), comprising a rubber compound is bonded to the bonding layer.

]57[

__________________

173154]21][11[

של"שיטה לבקרת הספק שידור עפ י שערו סיבית פעילות בערו" החוזר ופונקציות עליה

וכ מסו,, וירידה הספציפיות לזרימת המידע אלחוטי מתאי

METHOD FOR TRANSMISSIONPOWER CONTROL BASED ONEVALUATION OF A REVERSEACTIVITY BIT AND DATA FLOWSPECIFIC UPWARD/DOWNWARD

]54[


RAMPING FUNCTIONS, ANDCORRESPONDING WIRELESSACCESS TERMINAL

15.07.2004]22[US]33[15.07.2003]32[60/487648]31[US06.08.2003 60/493782 US03.12.200360/527081US13.07.200410/890719

Int. Cl.(2009.01) H04B 07/005, H04W 52/00, 52/34, 52/50, 72/08]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

An access terminal (206) is configured for wireless communication with an accessnetwork (204) within a sector (1032). The access terminal (206) includes a transmitter(2608) for transmitting a reverse traffic channel to the access network (204), anantenna (2614) for receiving signals from the access network (204), a processor (2602)and memory (2604) in electronic communication with the processor (2602).Instructions are stored in the memory (2604). The instructions are arranged to estimatea current value of a reverse activity bit (1444) transmitted by the access network (204).Per flow power allocation may be decreased on increased based on an estimatedcurrent value of the reverse activity bit.

]57[



__________________

173166]21][11[

FLAMEמעכבי בעירה ע תכולת הלוג גבוהה וצמיגות RETARDANTS WITH]54[


HIGH נמוכה HALOGEN CONTENT ANDLOW VISCOSITY

19.08.2004]22[US]33[29.08.2003]32[10/651823]31[US20.05.2004 10/849680

Int. Cl.(2010.01) C08K 05//12]51[ALBEMARLE CORPORATION,U.S.A.

]71[




]74[

A flame retardant formulation which is the combination of at least (1) at least onebromine-containing polyol flame retardant formed from the reaction of (a)tetrabromophthalic anhydride, (b) an aliphatic polyol, and (c) an epoxide, and (2) atleast one aliphatic diester of an alkane dicarboxylic acid, with the proviso that theformulation has a viscosity at 25°C of about 20,000 cps or less, and a bromine contentof at least about 40 wt%. A flame retardant compound formed from A)tetrabromophthalic anhydride; B) diethylene glycol; C) at least one alpha-omegaalkane diol, or at least one alpha-omega alkane diol and at least one aliphatic monool;and D) at least one alkylene oxide; with the proviso that the compound has a viscosityat 25°C of about 60,000 cps or less, and a bromine content of at least about 43 wt%.Polymer compositions formed from (a) a polyurethane or a polyisocyanurate and (b) aformulation of the invention. One process to make a formulation involves heating amixture of (a), (b), and at least one liquid aliphatic diester of a alkane dicarboxylic acidto form an intermediate composition; and then the intermediate is contacted one ormore times with (c) thereby producing the formulation. Optionally, excess (c) isremoved.

]57[

__________________

173266]21][11[

METHODשיטה והתק לחלוקת הספק לערוצי שליטה AND APPARATUS FOR]54[


POWER במערכת תקשורת ALLOCATION TOCONTROL CHANNELS IN ACOMMUNICATION SYSTEM

23.07.2004]22[US]33[25.07.2003]32[60/490338]31[US18.08.2003 10/643603

Int. Cl.(2010.01) H04B 07//005]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

An apparatus and a method for a control channel power allocation in a communicationsystem are disclosed. The method of control channel power allocation in anembodiment includes sorting a plurality of access terminals in an order of increasingrequired medium access control (MAC) channel power into a plurality of bins, sortingthe access terminals with equal required MAC channel power in an order of decreasingforward link signal to interference and noise ratio (FL SINR) if two or more accessterminals have equal required MAC channel power, and determining total availableARQ power based upon total MAC channel power, total power allocated to reversepower control (RPC) channels, and total power allocated to reverse activity bit (RAB)channels.

]57[

__________________

173279]21][11[

OTOSCOPIC אלמנט קצה אוטוסקופי ושיטה לשימוש בו TIP ELEMENT ANDRELATED METHOD OF USE

]54[

26.07.2004]22[US]33[28.07.2003]32[60/490566]31[


US30.09.2003 60/507473 US11.02.200460/543858US23.07.200410/897455

Int. Cl.(2009.01) A61B 01/227, 01/267]51[WELCH ALLYN, INC., U.S.A.]71[JOHN R. STROM, CYNTHIA A.KUIPER, CHRIS R. ROBERTS,MICHAEL E. BAUSCH, ALLAN I.KRAUTER, ERIC M. ANDREASSEN,DAVID WOODS

]72[


חוצביםהר, רחוב המרפא ירושלים45087.ד.ת,


]74[

A tip element for an otoscopic apparatus includes engagement features that permitselective attachment to two different tip attachment mechanisms. The tip elementincludes both interior and exterior engagement features that provide interchangeabilitywith otoscopes having different tip attachment schemes. The tip element includes anincreased distal aperture formed from a decreased slope that enables a larger field ofview, permitting the entire tympanic membrane to be viewed at once. Externalengagement features permit ejection of the tip from the otoscope, as well asstackability of a plurality of tip elements.

]57[

__________________

173327]21][11[

הפקת נתיב טיסה באמצעות תכנות מעורבלינארי ושל מספר של עבור טיסה אוטומטית

באיזור סכנה

MIXED INTEGER LINEARPROGRAMMING TRAJECTORYGENERATION FORAUTONOMOUS FLIGHT IN ATHREAT ENVIRONMENT

]54[


24.01.2006]22[US]33[17.02.2005]32[11/060347]31[

Int. Cl.(2010.01) G06F 01//00]51[NORTHROP GRUMMANCORPORATION, U.S.A.

]71[



]74[

A method of planning a path of a vehicle, the method comprising the steps:defining a first plurality of constraints reprinting dynamics of the vehicle;defining a second plurality of constraints reprinting collisions with obstacles;defining a third plurality of constraints reprinting visibility to threats; andusing the first, second and third plurality of constraints with mixed integer linearprogramming to generate a trajectory for the vehicle from a starting point to adestination point in an environment containing the obstacles and the threats.

]57[

__________________

173331]21][11[

SYNCHRONIZATION כרו תוכניות תעופה רבות המוכנות לפעולהסינ OFMULTIPLE OPERATIONALFLIGHT PROGRAMS

]54[

24.01.2006]22[US]33[10.02.2005]32[11/055753]31[

Int. Cl.(2010.01) G06F 01//04, 01//12, 15//16, G11C 07//10, H04L 07//00]51[NORTHROP GRUMMANCORPORATION, U.S.A.

]71[



]74[

A method for synchronizing frame clocks in a plurality of processors, the methodcomprising the steps of:(a) sending data packets from each of the processors to each of the other processors;(b) each of the processors receiving the data packets and identifying two of the datapackets having the largest phase difference;(c) using the largest phase difference to determine a target synchronization phaseangle;(d) adjusting a period of a frame clock so that the frame clock approaches the targetsynchronization phase angle; and

]57[


(e) repeating steps (a), (b), (c) and (d).

__________________

173372]21][11[

בנזתיאזול ובנזוקסאזול, נגזרות של בנזאימידזולLTA4Hושימושיה כמודולטורי של

BENZIMIDAZOLE,BENZTHIAZOLE ANDBENZOXAZOLE DERIVATIVESAND THEIR USE AS LTA4HMODULATORS

]54[

27.07.2004]22[US]33[28.07.2003]32[60/490710]31[

Int. Cl.(2009.01) A61P 29/00, C07D 235/26, 263/58, 417/12]51[JANSSEN PHARMACEUTICA, N.V.,BELGIUM

]71[


'א26רחוב הברזלת החיילרמ


]74[

Leukotriene A4 hydrolase (LTA4H) inhibitors of Formula (I), compositions containingthem, and their use for the inhibition of LTA4H enzyme activity and the treatment,prevention or inhibition of inflammation and/or conditions associated withinflammation. Wherein X is selected from the group consisting of NR5, O, and S, withR5 being on of H and CH3; Y is selected from the group consisting; W is selected fromthe group consisting Of CH2 and CHR1-CH2, with R1 being one H and OH, wherein R1-attached carbon member in said CHR1-CH2 is not directly attached; R4 is selected fromthe group consisting of H, OCH3, CI, F Br, OH, NH2, CN, CF3 and CH3; R6 is H or F;and R2 and R3 are each independently selected from various groups.

]57[

__________________


173417]21][11[

שיטה לתקשורת ספרתית במוד מנות על גבי קו תקשורת משות, למשתמשי רבי

METHOD OF PACKET MODEDIGITAL COMMUNICATIONOVER A TRANSMISSIONCHANNEL SHARED BY APLURALITY OF USERS

]54[

29.01.2006]22[FR]33[31.01.2005]32[0500934]31[

Int. Cl.(2009.01) H04L 12/56]51[AGENCE SPATIALE EUROPEENNE(ESA), FRANCE

]71[

ENRICO CASINI, OSCAR DEL RIOHERRERO, RICCARDO DEGAUDENZI, DANIEL MAURICEELIANE DELARUELLE, JEAN-PIERRE GEORGES JOSEPHGHISLAIN CHOFFRAY

]72[




]74[

A method of transmitting data packets over a transmission channel shared by aplurality of users (RU1,RU2), the method comprising steps of:generating (511) at least two replicas of each packet to be transmitted; andsending (515) said replicas over said transmission channel, separated by random timeand/or frequency shifts, the method beingcharacterized in that it further comprises astep (512) of inserting signaling information into each replica for enabling the otherreplica(s) of the same packet to be located in the time and/or frequency domain.

]57[


__________________

173443]21][11[

CALCIUM גירעו של סיד קרבונאט CARBONATEGRANULATION

]54[

14.07.2004]22[US]33[31.07.2003]32[10/631923]31[

Int. Cl.(2009.01) C01F 11/18]51[DELAVAU L.L.C., U.S.A.]71[WO/2005/011570]87[




]74[

Highly compactable granulations and methods for preparing highly compactablegranulations are disclosed. More particularly, highly compactable calcium carbonategranulations are disclosed. The granulations comprise powdered materials such ascalcium carbonate that have small median particle sizes. The disclosed granulations areuseful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizeupon compression than previously available.

]57[

מבקשה זו בקשות חלוקה.שטר פורסמו


__________________

173495]21][11[

עמשאבת קור STIRLINGCOOLINGי מנוע"המופעלת MACHINE WHICHFUNCTIONS ACCORDING TOTHE STIRLING CYCLE

]54[

02.02.2006]22[FR]33[03.02.2005]32[0501100]31[

Int. Cl.(2010.01) F25B 09//14]51[SAGEM DEFENSE SECURITE,FRANCE

]71[

REINHOLD,ריינהולד כהן ושותפיו COHN AND]74[


'א26הברזל רחוב רמת החייל

PARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

A cooler machine using the Stirling cycle and comprising: at least one compressor (5)with a compressor piston (6) movable in a compression cylinder (7); a regenerator (8)with a regenerator piston (9) movable in a regeneration cylinder (10) placed at a givenangle relative to the compression cylinder (7); a rotary drive crank (11); a compressorconnecting rod (12) possessing a first end pivotally coupled to the compressor pistonand a second end pivotally coupled to the crank; a regenerator connecting rod (13)possessing a first end pivotally coupled to the regenerator piston and a second endpivotally coupled to the crank; wherein at least one of the compressor and regeneratorconnecting rods (a) is pivotally connected to a first end of an auxiliary link that has asecond end pivotally coupled to a structural element of the machine, and (b) iscomprised of at least two connecting rod segments pivotally connected to one another;and where the connecting rod segments and connected auxiliary link are arranged tomove together with crank rotation so that the movement of the corresponding piston isslowed down on passing through its top or bottom dead center.

]57[

__________________

173664]21][11[

–משחות לקילו, וניקוי חלקי מיקרו אלקטרוניקה

STRIPPING AND CLEANINGCOMPOSITIONS FORMICROELECTRONICS

]54[

26.07.2004]22[US]33[19.08.2003]32[60/496110]31[US01.03.2004 60/548976

Int. Cl.(2009.01) G03F 07/42]51[


MALLINCKRODT BAKER, INC.,U.S.A.

]71[

WO/2005/019939]87[עורכי דין ועורכי, קבוצת איתן מהולל

,פטנטים10שדרות אבא אבן



]74[

Aqueous cleaning compositions and method of using the cleaning compositions forcleaning microelectronic substrates, which compositions are able to essentiallycompletely clean such substrates and produce essentially no metal corrosion of themetal elements of such substrates. The aqueous cleaning compositions of thisinvention have (a) water, (b) at least one of ammonium and quaternary ammoniumions and (c) at least one of hypophosphite (H2PO2

-) and/or phosphite (HPO32-) ions.

The cleaning compositions also may contain fluoride ions. Optionally, the compositionmay contain other components such as organic solvents, oxidizing agent, surfactants,corrosion inhibitors and metal complexing agents.

]57[

__________________

173695]21][11[

METHOD שיטה לניטור רמת גלוקוז OF MONITORINGGLUCOSE LEVEL

]54[

09.08.2004]22[US]33[19.08.2003]32[10/643804]31[

Int. Cl.(2009.01) A61B 05/00]51[A.D. INTEGRITY APPLICATIONS,LTD.

]71[

ALEXANDER M. RAYKHMAN,AVNER GAL, DAVID FREGER

]72[


הר חוצבים, רחוב המרפאםירושלי45087.ד.ת,


]74[

The method of monitoring or measuring the concentration of glucose level in humanand animal blood uses a non-invasive technique and includes measurements of thespeed of sound through the blood, the conductivity of the blood, and the heat capacityof the blood, or by non-invasive measurement of any other parameters that can be usedto calculate the glucose level. Thereafter, the glucose level for each of the threemeasurements is calculated (102,108,114) and the final glucose value is determined by

]57[


a weighted average of the three calculated glucose values (126).

__________________

173718]21][11[

מוט אסיפה לכותנה בעל צפיפות גבוהה והרכב צירי עבורו

HIGH DENSITY COTTON PICKERBAR AND SPINDLE ASSEMBLYTHEREFOR

]54[

14.02.2006]22[US]33[15.02.2005]32[11/058150]31[

Int. Cl.(2009.01) A01D 46/16]51[DEERE & COMPANY, U.S.A.]71[



]74[

A cotton picker spindle bar assembly including an upright single spindle bar having anarm for orienting the bar about an upright bar axis, the spindle bar mounting a pluralityof vertically spaced spindles having picking ends and gear ends, a drive shaft structureincluding an upright drive shaft supported for rotation by the bar in drivingrelationship with the gear ends, wherein the plurality of vertically spaced spindles onthe spindle bar include at least two sets of spindles vertically spaced on the singlespindle bar and nonaligned in the vertical direction, the arm orienting the two sets ofspindles in cotton plants during picking with the spindle ends extending generallyhorizontally from one side of the spindle bar.

]57[

__________________

173731]21][11[

של, שיטה ומוצר תוכנה, מערכת ,SYSTEMלניהול מרכזי METHOD AND]54[


COMPUTER מערכת רשת מבוזרת מסוג אינפיניבאנד PROGRAMPRODUCT FOR CENTRALIZEDMANAGEMENT DISTRIBUTEDSYSTEM AREA NETWORK

04.08.2004]22[US]33[14.08.2003]32[10/640821]31[

Int. Cl.(2010.01) H04L 12//24]51[IBM CORPORATION, U.S.A.]71[WO/2005/018149]87[

,מעבדות יבמ מחלקת קנין רוחני אוניברסיטת חיפה הר הכרמל

חיפה

IBM LABORATORIES,HAIFA UNIVERSITY,HAIFA 31905

]74[

A method, system, and product in a data processing system are disclosed for providingcentralized management of an InfiniBand distributed system-area network thatincludes multiple end nodes. A manager application is established in one of the endnodes. An agent application is established in one or more end nodes. Each agentapplication is independent from the manager application. The manager applicationmaintains a current list of active agent applications and uses the list to manage theagent applications in the end nodes.

]57[

__________________

173865]21][11[

SYSTEM מערכת וערכה להעברת חומרי שחזור AND KIT FORDELIVERY OF RESTORATIVEMATERIALS

]54[

02.09.2004]22[US]33[02.09.2003]32[10/654543]31[

Int. Cl.(2009.01) A61B 17/16, 17/88, A61M 05/00]51[ORTHOVITA, INC., U.S.A.]71[





]74[

Novel kits are provided for the delivery of restorative or injectable compositions intoan intraosseous space or surgical defect comprising cannulae for accessing anintraosseous space, mandarins insertable into the cannulae and movable therein, one ormore catheters and a system for the delivery of aliquots of restorative compositionsinto the space via catheters. Independant claims relate to the catheter having a highporosity tip (10) and to a microreamer having an expandable section comprising leavesthat flex (13).

]57[

ת חלוקה מבקשה זו בקשו.שטר פורסמו


__________________

173906]21][11[

APPARATUS ק ושיטה להסרת פיגמנטי מהעורמת AND METHOD FORREMOVING PIGMENTS FROM APIGMENTED SECTION OF SKIN

]54[

30.08.2004]22[IL]33[01.09.2003]32[157696]31[

Int. Cl.(2009.01) A61B 17/20]51[בע'הוק מדיקל טכנולוג HAWK ראשון לציון,מ"יס MEDICAL TECHNOLOGIES

LTD]71[




]74[

An apparatus for removing a pigmented section of skin, comprises a) a skin puncturingdevice; b) an array of one or more needles connected to said device for puncturing theskin at said pigmented section; and c) a mediating member attached to said device and

]57[


to suction means, for allowing said suction means to collect the mixture of thepigments with the cellular fluids at said punctured section of the skin.

__________________

174145]21][11[

ושימושו ע זיקה מוגברתA–קישור לנגו הרוקחי

NOGO-A BINDING WITHENHANCED AFFINITY ANDPHARMACEUTICAL USETHEREOF

]54[

17.09.2004]22[GB]33[19.09.2003]32[0321997.9]31[

Int. Cl.(2010.01) A61K 39//395, C07K 16//18, C12N 15//13]51[NOVARTIS AG, SWITZERLANDUNIVERSITY OF ZURICH,SWITZERLAND

]71[




]74[

The present invention provides a binding molecule which is capable of binding to thehuman NogoA polypeptide or human NiG or human NiG-D20 or human NogoA_342-357 with a dissociation constant < 1000nM, a polynucleotide encoding such bindingmolecule; an expression vector comprising said polynucleotide; an expression systemcomprising a polynucleotide capable of producing a binding molecule; an isolated hostcell which comprises an expression system as defined above; the use of such bindingmolecule as a pharmaceutical, especially in the treatment of nerve repair; apharmaceutical composition comprising said binding molecule; and a method oftreatment of diseases associated with nerve repair.

]57[




__________________

174194]21][11[

METHOD מורפולינו–3–)אמינופניל–4(–4שיטה ליצור FOR THEPRODUCTION OF 4-(4-AMINOPHENYL)-3-MORPHOLINON

]54[

09.09.2004]22[DE ]33[15.09.2003]32[10342570.5]31[

Int. Cl.(2009.01) C07D 265/32, 413/14]51[BAYER SCHERING PHARMA AG,GERMANY

]71[




]74[

The invention relates to a method for the production of 4-(4-aminophenyl)-3-morpholinon by reacting 4-(4-nitrophenyl)-3-morpholinon with hydrogen in thepresence of a hydrogenation catalyst. The invention is characterised in that the reactionis carried out in an aliphatic alcohol.

]57[

__________________

174280]21][11[

אלמנט סופג אנרגיה להתקנת חלונות לפתח משקו, ושיטה לשימוש בו

ENERGY ABSORBINGELEMENT FOR WALLOPENINGS AND METHOD OFUSE THEREFOR

]54[

13.03.2006]22[Int. Cl.(2010.01) E06B 05//12]51[

ARPAL לוד,מ''ארפל אלומיניום בע ALUMINUM LTD.]71[,ריינהולד כהן ושותפיו

'א26רחוב הברזלREINHOLD COHN ANDPARTNERS,

]74[


26A רמת החייל HABARZEL ST.,RAMAT HACHAYAL 69710

An energy absorber (10) for use in an opening of a wall of a building, the openingdefined by a perimeter surface, the wall supporting a closure (20) substantially fillingthe opening, said closure having respective edges which are substantially parallel tosaid perimeter surface of the opening; the energy absorber having a planar wallconnecting portion having a first mounting aperture (12a), and a planar closureconnecting portion having a second mounting aperture (12a), said connecting portionsbeing connected by at least one plastically deformable deforming surface, saidmounting apertures being formed at a distance from each other along an axis, theabsorber further comprising at least one slot (14) transferring said axis and having alength exceeding said distance, said deforming surface adapted to absorb, by plasticdeformation, a force applied to the closure.

]57[

__________________

174318]21][11[

DEVICE התק ושיטה לעיבוד לפחות שני ערכי קלט AND METHOD FORPROCESSING AT LEAST TWOINPUT VALUES

]54[

28.09.2004]22[DE]33[02.10.2003]32[10345996.0]31[

Int. Cl.(2010.01) G06F 17//14, G06T 09//00, G10L 19//00, 19//02, H04N 07//30]51[FRAUNHOFER-GESELLSCHAFTZUR FORDERUNG DERANGEWANDTEN FORSCHUNGE.V., GERMANY

]71[





]74[

In order to reduce a rounding error, a first and second non integral input value isprovided (260,262) and in a non integral state is combined (268) by addition,forexample, so that a non integral result value can be obtained, rounded and added to athird input value (269). The rounding error can thus be reduced at an interface betweentwo rotations broken down into lifting steps or between a first rotation broken downinto lifting steps and a first lifting step of a subsequent multidimensional liftingsequence.

]57[

__________________

174320]21][11[

OLIVE חומ" ב גפת זיתי POMACE VINEGAR]54[

15.03.2006]22[Int. Cl.(2009.01) C12J 01/00]51[

CAPERקצרין,מ"תצפית כפר נחום שוק שמן זית בע NAUM VISTA OLIVE OILMARKET LTD

]71[

GREGORY גרגורי פיפקו PIPKO]72[עו' דר ,פ"אייל ברסלר

11תובלגן-רמת

DR. EYAL BRESSLER,11 TUVAL ST.,RAMAT GAN 52522

]74[

Vinegar derived from olive pomace, comprising olive pomace, water, a carbohydratesource and fermenting microorganisms.

]57[



__________________


174453]21][11[

תהלי להכנת כמוסות של פוליאקרילאמיד המכילות תאי

PROCESS FOR THEPREPARATION OFPOLYACRYLAMIDE BEADSCONTAINING ENCAPSULATEDCELLS

]54[

26.10.2004]22[EP]33[27.10.2003]32[03024648.2]31[

Int. Cl.(2009.01) B01J 13/02, C12N 11/04]51[LONZA AG, SWITZERLAND]71[WO/2005/040373]87[




]74[

Polyacrylamide beads containing encapsulated cells were prepared by a processcomprising the steps of (i) providing an aqueous solution of a mixture of acrylicmonomers, (ii) providing a suspension of cells in an aqueous solution of a persulfate(iii) providing an emulsion of an aqueous solution of a tertiary amine in a water-immiscible liquid, which liquid optionally contains a surfactant, (iv) mixing thesolution provided in step (i) and the suspension provided in step (ii) (v) adding themixture obtained in step (iv) to the stirred emulsion provided in step (iii) (vi)polymerizing the mixture of acrylic monomers and simultaneously encapsulating thecells to form polyacrylamide beads containing encapsulated cells.

]57[

__________________

174545]21][11[

רכיבית להכנת תכשיר–שימוש במערכת דו עיכוב גידול שיער

USE OF A TWO-COMPONENTSYSTEM FOR THEPREPARATION OF A HAIRGROWTH INHIBITINGCOMPOSITION

]54[

11.10.2004]22[DK]33[10.10.2003]32[PA200301500]31[US01.12.2003 60/525967

Int. Cl.(2009.01) A61K 06/00, 08/02, 08/66, A61Q 07/02]51[


COSMEDICAL APS, DENMARK]71[WO/2005/034892]87[

כ ,הן ושותפיוריינהולד'א26רחוב הברזל רמת החייל


]74[

The invention relates to the use of a composition for the preparation of a hair growthinhibitor and furthermore to the use of a system for the preparation of a hair growthinhibitor. The invention also relates to a composition comprising at least one enzyme,a solvent, and a water activity reducing agent. Moreover, the invention concerns asystem for hair growth inhibition comprising a first component and a secondcomponent, wherein the first composition of the first component comprises at least oneenzyme, a solvent and a water activity reducing agent, and wherein the secondcomposition of the second component comprises an enzyme-activating agent and/or aanti-inflammatory, penetration-promoting agent and/or a preservative agent. Theinvention in addition relates to a method for inhibiting hair growth and a method forthe preparation of hair growth inhibitor.

]57[

__________________

174583]21][11[

CAKE בלילה לעוגה MIXTURE]54[

01.04.2004]22[EP]33[13.10.2003]32[03023035.3]31[

Int. Cl.(2010.01) A21D 08//00, 10//02]51[NESTEC S.A., SWITZERLAND]71[WO/2005/034636]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

The invention relates to a fluid cake mixture that is sufficiently refrigerated for making]57[


cakes such as chocolate fondant. The inventive cake mixture is characterised by theuse of butterfat in the form of small particles of butterfat that are solid at roomtemperature and dispersed in the continuous cake mixture phase. Said mixture thuskeeps its fluidity, even at the usual refrigeration temperatures at which the product canbe stored for several weeks.

__________________

174613]21][11[

התק ושיטה לבקרת קישור הפו של שיעור שידור נתוני

APPARATUS AND METHOD FORCONTROLLING REVERSE-LINKDATA TRANSMISSION RATE

]54[

05.03.2004]22[KR]33[06.03.2003]32[10-2003-

0014036]31[

KR29.04.2003 10-2003-0027199

US24.10.200360/514383US29.10.200360/515897US30.10.200360/516232KR31.10.200310-2003-

0076562US05.03.200410/794744

Int. Cl.(2010.01) H04L 12//56]51[LG ELECTRONICS INC., REPUBLICOF KOREA

]71[



]74[

Apparatus and method for controlling data transmission rate in a wirelesscommunication system during handoff comprises a terminal recognizing an active setcomprising a serving base station and at least one non-serving base station with respectto the terminal communicating with the network at a first data transmission rate,receiving a first rate control parameter from the serving base station (S402) and asecond rate control parameter from the at least one non-serving base station (S400),wherein the first and second rate control parameters are associated with determinationof a second data transmission rate of the terminal during the handoff and determiningthe second data transmission rate in response to the first and the second rate controlparameters, wherein the second data transmission rate is one of increased rate (S403),decreased rate (S401, S405) and same rate (S404) from the first data transmission rate.

]57[


__________________

174777]21][11[

מערכות ושיטות העושות שימוש בקליע טעו מטע חשמלי

SYSTEMS AND METHODS USINGAN ELECTRIFIED PROJECTILE

]54[

07.10.2004]22[US]33[07.10.2003]32[60/509577]31[US13.11.2003 10/714572

Int. Cl.(2010.01) H01T 23//00]51[TASER INTERNATIONAL, INC.,U.S.A.

]71[




]74[

An apparatus (100) for immobilizing a target includes electrodes (514, 504) deployedafter contact is made between the apparatus and the target. Spacing of deployedelectrodes (514, 504) may be more accurate and/or more repeatable for more effectivedelivery of an immobilizing stimulus signal.

]57[

__________________


174909]21][11[

תכשירי רוקחות המכילי אנטגוניסט6–לאינטרליוקי

PHARMACEUTICALCOMPOSITIONS CONTAININGAN INTERLEUKIN-6ANTAGONIST

]54[

15.10.2004]22[JP]33[17.10.2003]32[2003-358152]31[

Int. Cl.(2010.01) A61K 39//395, 45//00, 45//06, C07K 16//18, 16//24, 16//28]51[CHUGAI SEIYAKU KABUSHIKIKAISHA, JAPAN

]71[



]74[

A therapeutic agent for mesothelioma, comprising an interleukin-6 (IL-6) antagonist,for example, an antibody against IL-6 receptor (IL-6R); and a mesothelioma cytostaticagent comprising an IL-6 antagonist, for example, an antibody against IL-6R.

]57[

__________________

175505]21][11[

תא, אלקטרוליט מוצק במיוחד עבור אלקטרוכימי בעל שכבה דקה ושיטה לייצור

SOLID ELECTROLYTE, INPARTICULAR FOR A THINLAYER ELECTROCHEMICALCELL AND PRODUCTIONMETHOD

]54[

09.11.2004]22[FR]33[14.11.2003]32[0313378]31[


Int. Cl.(2010.01) C03C 03//19, C23C 14//00, H01M 06//18]51[H.E.F., FRANCE]71[WO/2005/050764]87[



]74[

The invention relates to a vitreous solid electrolyte for a thin layer electrochemical cellcomprising B whose atomic content ranges from 0.001 to 0.20, P whose atomiccontent ranges from 0.05 to 0.15, N whose atomic content ranges from 0.02 to 0.18, Liwhose atomic content ranges from 0.20 to 0.50 and O whose atomic content rangesfrom 0.35 to 0.50, the total content being substentially equal to 100.

]57[

__________________

175720]21][11[

תרכובת ניתריל והשימוש בה בבקרת פרוקי רגליי

NITRILE COMPOUND AND ITSUSE IN ARTHROPOD CONTROL

]54[

22.12.2004]22[JP]33[26.12.2003]32[2003-431908]31[JP13.02.2004 2004-036230 JP29.09.20042004-283540

Int. Cl.(2010.01) A01N 37//34, C07C 25/5/10, 25/5/31]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN

]71[




]74[

The present invention provides a nitrile compound represented by the formula (I):wherein R represents C1-C4 fluoroalkyl, Q represents halogen, C1-C11 alkyloptionally substituted with halogen, C2-C6 alkenyl group optionally substituted withhalogen, C2-C6 alkynyl optionally substituted with halogen, C3-C7 cycloalkyloptionally substituted with halogen or (C3-C7 cycloalkyl optionally substituted withhalogen)C1-C4 alkyl, which has excellent control effect against pests.

]57[

__________________


175754]21][11[

AMINOPYRROLIDONE-3 אמינופירולידוניות–3תולדותDERIVATIVES

]54[

16.11.2004]22[EP]33[21.11.2003]32[03026779.3]31[

Int. Cl.(2010.01) A61K 31//4015, 31//45, 31//55, A61P 01//00, 03//04, 13//00, 15//00,25//00, 27//02, 29//00, C07D 20/7/273, 21/1/76, 22/3/12

]51[

NEWRON PHARMACEUTICALSS.P.A., ITALY

]71[


'א26 רחוב הברזל רמת החייל


]74[

This invention is related to compounds and use of 3-aminopyrrolidone derivatives andanalogues of the following general formula (I), wherein m is an integer from 1 to 3; Xis methylene, oxygen, sulphur or a NR6 group; R1 is a straight or branched C1-C8 alkylor C3-C8 alkenylene or C3-C8 alkynylene chain, optionally substituted with CF3,phenyl, phenoxy or naphthyl, or phenyl the aromatic rings optionally substituted byone or more C1-C4 alkyl, halogens, trifluoromethyl, hydroxy or C1-C4 alkoxy groups;R2, R3 are independently hydrogen, a C1-C3 alkyl chain, halogen, trifluoromethyl,hydroxy or C1-C4 alkoxy groups; R4, R5, R6 are independently hydrogen or C1-C6

alkyl; and the pharmaceutically acceptable salts thereof that are active as sodiumand/or calcium channel modulators and therefore useful in preventing, alleviating andcuring a wide range of pathologies, including, but not limited to cardiovascular,inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases, where theabove mechanisms have been described as playing a pathological role.

]57[

__________________

176102]21][11[

ע י הדמיה ספקטלית"אימות חפ" אותנטי ואנליזה

AUTHENTICATING ANAUTHENTIC ARTICLE USING

]54[


SPECTRAL IMAGING ANDANALYSIS

01.12.2004]22[US]33[01.12.2003]32[60/525886]31[

Int. Cl.(2009.01) G06K 09/00, G08B 01/00]51[בע'ויז-גרין GREEN תל אביב,מ"ן מערכות VISION SYSTEMS LTD.]71[

DANNY דני משה S. MOSHE]72[WO/2005/055155]87[

ג ,ונס'פישר וילר26הברזל רמת החיל

תל אביב

FISHER WEILER JONES,26 HABARZEL STREETRAMAT HACHAYAL,TEL-AVIV 69710

]74[

Authenticating an authentic article having an authentication mark. Acquiring a set ofspectral images of the authentication mark, for forming a set of single-authenticationmark spectral fingerprint data (FIG. 1). Identifying at least one spectral shift in the setof single-authentication mark spectral fingerprint data, for forming an intra-authentication mark physicochemical region group including sub-sets of intra-authentication mark spectral fingerprint pattern data, such that data elements in eachsub-set are shifted relative to corresponding data elements in remaining sub-sets in thesame intra-authentication mark physicochemical region group (FIG. 2). Forming a setof intra-authentication mark physicochemical properties and characteristics datarelating to the imaged authentication mark, by performing pattern recognition andclassification analysis on the intra-authentication mark physicochemical region group(FIG. 3). Comparing and matching elements in the set of intra-authentication markphysicochemical properties and characteristics data to corresponding referenceelements in reference set of data, thereby authenticating the authentic article.

]57[

__________________

176207]21][11[

ע CVDMETHODי"שיטה לשילוב סימ ביהלו המיוצר OF INCORPORATING AMARK IN CVD DIAMOND

]54[

10.12.2004]22[GB]33[12.12.2003]32[0328917.0]31[US17.12.2003 60/529746 GB07.09.20040419839.6US16.09.200460/610223

Int. Cl.(2010.01) C03B 29//04, C30B 25//00, 33//00]51[ELEMENT SIX LIMITED, UNITEDKINGDOM

]71[





]74[

A method of incorporating a mark of origin, such as a brand mark, or fingerprint in aCVD single crystal diamond material, includes the steps of providing a diamondsubstrate, providing a source gas, dissociating the source gas thereby allowinghomoepitaxial diamond growth, and introducing in a controlled manner a dopant intothe source gas in order to produce the mark of origin or fingerprint in the syntheticdiamond material. The dopant is selected such that the mark of origin or fingerprint isnot readily detectable or does not affect the perceived quality of the diamond materialunder normal viewing conditions, but which mark of origin or fingerprint is detectableor rendered detectable under specialised conditions, such as when exposed to light orradiation of a specified wavelength, for example. Detection of the mark of origin orfingerprint may be visual detection or detection using specific optical instrumentation,for example.

]57[

__________________

176232]21][11[

PRINTING מצע הדפסה נע MOVINGSUBSTRATES

]54[

10.12.2004]22[GB]33[12.12.2003]32[0328861.0]31[

Int. Cl.(2009.01) B41J 11/00, 13/12, 13/14]51[INCA DIGITAL PRINTERSLIMITED, UNITED KINGDOM

]71[



PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,P.O.B. 12704,

]74[


HERZLIYA 46733

An ink jet printing apparatus for printing on a moving substrate (16) is described. Theapparatus comprises ink jet printheads (4) for printing on a surface of the substrate, aplurality of rollers (12, 14) arranged to move the substrate (16) relative to theprintheads (4), and a pressure source (22). The pressure source (22) is arranged toapply a negative gauge pressure (32) to the substrate (16). The application of thepressure can hold the substrate flat and can reduce undesired movement of thesubstrate relative to the rollers (12, 14). The apparatus allows for high quality fullcolour images to be printed onto substrates in a single pass using an ink jet printer.

]57[

__________________

176354]21][11[

חמכשיר למדידת פלואורס FLUORESCENCE נציה באבני MEASURINGDEVICE FOR GEMSTONES

]54[

12.01.2005]22[US]33[12.01.2004]32[10/756164]31[

Int. Cl.(2009.01) G01N 21/87]51[GEMOLOGICAL INSTITUTE OFAMERICA, INC., U.S.A.

]71[

WO/2005/067566]87[,וריינהולד כהן ושותפי



]74[

A gemstone fluorescence measuring device according to the invention generallyincludes an ultraviolet ('UV') emission chamber, a UV radiation source, and a lightmeter assembly. The UV radiation source includes an upper light emitting diode('LED') and a lower LED that radiate a gemstone under test from both above andbelow the gemstone. The UV radiation source provides both trans-radiation and directradiation to the gemstone, and the UV radiation source has an adjustable intensity, thusfacilitating calibration of the fluorescence measuring device. The light meter assembly

]57[


includes a light detector that detects the visible light emitted from the gemstone undertest in response to the UV radiation. The light detector is configured to simulate thespectral characteristics of the human eye. The fluorescence measuring device convertsthe measured visible light into a numerical lux reading, which can then be convertedinto a fluorescence grade for the gemstone under test.

__________________

176392]21][11[

PROTECTIVE שכבת הגנה כנגד מטעני חלולי LAYER AGAINSTSHAPED CHARGES

]54[

29.12.2003]22[Int. Cl.(2009.01) F41H 05/02]51[RUAG LAND SYSTEMS,SWITZERLAND

]71[



]74[

The rupture disks of reactive armor that may be provided are initiated or light armor isdestroyed directly when bomblets with frontal hollow charges are dropped ontovehicles. Previously known disrupting elements that prevent a shaped-charge jet fromforming are mostly composed of pointed parts protruding from the surface of thevehicle or layers which are covered by a sensitive film. The disadvantages associatedwith said disrupting elements can be overcome in an economic manner by using asingle protective layer (1) which consists of a high-density elastomer, is placed as aprotective roof cover in the vertical projection of a vehicle (100), and can be retrofittedonto existing vehicles and installations. Also disclosed is a method for producingprotective layers (1), which is based on the use of a PUR high pressure system andpreviously known high-density starting materials.

]57[


__________________

176414]21][11[

סיבי מפוליאתיל בעל–תהלי להכנת חוט רב ביצועי גבוהי

PROCESS FOR MAKING HIGH-PERFORMANCE POLYETHYLENEMULTIFILAMENT YARN

]54[

23.12.2004]22[WO]33[01.01.2004]32[PCT/NL04/00029]31[

Int. Cl.(2010.01) D01F 06//04]51[DSM IP ASSETS B.V., THENETHERLANDS

]71[




]74[

The invention relates to a process for making high-performance polyethylene multi-filament yarn comprising the steps of a) making a solution of ultra-high molar masspolyethylene in a solvent; b) spinning of the solution through a spinplate containing atleast 5 spinholes into an air-gap to form fluid filaments, while applying a draw ratioDRfluid; c) cooling the fluid filaments to form solvent-containing gel filaments; d)removing at least partly the solvent from the filaments; and e) drawing the filaments inat least one step before, during and/or after said solvent removing, while applying adraw ratio DRsolid of at least 4, wherein in step b) each spinhole comprises a contractionzone of specific dimension and a downstream zone of diameter Dn and length Dn withLn/Dn of from 0 to at most 25, to result in a draw ratio DRfluid = DRsp* DRag of at least150, wherein DRsp is the draw ratio in the spinholes and DRag is the draw ratio in theair-gap, with DRsp being greater than 1 and DRag at least 1. The invention furtherrelates to a high-performance polyethylene multifilament yarn, and to semi-finished orend-use products containing said yarn, especially to ropes and ballistic-resistantcomposites.

]57[


__________________

176476]21][11[

FOLDABLE שילדה מתקפלת עבור כרכרת תינוק CHASSIS FOR BABYCARRIAGES

]54[

21.06.2006]22[ES]33[07.07.2005]32[U200501565]31[ES13.12.2005 U200502696

Int. Cl.(2010.01) B62B 07//08, 07//10]51[JANE, S.A., SPAIN]71[

,פיור יצחק הס ושות"ד 279רחוב הירקון



]74[

This foldable chassis for baby carriages comprises two rear wheels (1) and (2), a frontrolling support (3), and a U-shaped handlebar (4) being at the end of each of itsbranches (5) and (6) fitted to a respective lateral member (7) and (8) each of saidlateral members being at its upper end (9) linked in a pin-jointed connection to arespective armrest (10) and (11), each of said armrests being in its turn linked in a pin-jointed connection (12) to the respective branch of the handlebar. This chassis ischaracterized in that each of the lateral members (7) and (8) inferiorly ends in arespective bush bearing (13) and (14), said bush bearing being both fitted on thecentral length of the shaft (15) being fitted to each of the wheels (1) and (2) through arespective inflected length (16) and (17), two connecting rods (18) and (19) beingsolidly secured to said central length of said shaft and articulately linked (20) to acentral support (21) making up an articulated connection with the middle length of aU-shaped member having the end of each of its branches (24) and (25) linked in a pin-jointed connection to the end region (26) of the respective branch of the handlebar andan intermediary point (27) of each of its aforementioned branches linked in a pin-jointed connection to the respective one of said lateral members (7) and (8).

]57[


__________________

177035]21][11[

PIPE אביזר צנרת מורכב ושיטה לייצורו FITTING ASSEMBLY ANDA METHOD FOR FORMING IT

]54[

23.07.2006]22[Int. Cl.(2010.01) F16L 21//02, 21//035, 37//24, 37//26, 47//06, 47//12, 47//24]51[

קבוץ,מ"שגיב אגודה שיתופית חקלאית בע משאבי שדה

SAGIV AGUDAH SHITUFITCHAKLAIT BE'AM

]71[

',גדור ושות, בלום מגדל הורד23קומה,53דרך השלום

גבעתיים

BLUM, GADOR & CO.,53 HASHALOM RD.,GIVATAYIM 53454

]74[

For use with a pipe fitting assembly (10), an adapter (12) comprising:a hollow, substantially cylindrical sleeve formed of a polymeric material;said sleeve defining a bore (16) on a first open end (13) for engaging a pipe fittingassembly having an annular seal (19) thereabout and a tapered second open end (15)for insertion into a pipe;said bore being sized and configured to permit said sleeve to slide over and cover theannular seal on the the pipe fitting assembly, and create thermal coupling and sealingengagement between said pipe fitting assembly and said pipe.

]57[


__________________

177063]21][11[

שיטה והתק לטיפול בתעלות הפטמה של בעל חיי

METHOD AND DEVICE FORTREATING A TEAT CANAL OFAN ANIMAL

]54[

02.02.2005]22[US]33[02.02.2004]32[60/540336]31[IE24.05.2004 2004/0364

Int. Cl.(2009.01) A61D 01/02, 07/00, A61M 05/19]51[BIMEDA RESEARCH &DEVELOPMENT LIMITED,IRELAND

]71[




]74[

The invention relates to a method and device for treating or preventing or suppressinga disease or condition in a non-human animal. The method comprises the steps ofproviding a single delivery device containing two components for sequential deliveryfrom the delivery device. A first component is delivered from the single deliverydevice into a teat canal of a non-human animal and subsequently the secondcomponent is delivered from the single delivery device into the teat canal. The

]57[


components are delivered without substantial mixing of the components.

__________________

177077]21][11[

PLATE מחלי, לוח חו ומסה ע הארכה לקצה HEAT AND MASSEXCHANGER WITH EDGEEXTENSION

]54[

18.02.2005]22[US]33[18.02.2004]32[60/545672]31[

Int. Cl.(2009.01) F24F 05/00, 06/02, F28C 03/04, F28D 03/00, 05/00, 07/00]51[IDALEX TECHNOLOGIES, INC.,U.S.A.

]71[

ALAN D. GILLAN, LELAND E.GILLAN, TIMOTHY L. HEATON,VALERIY MAISOTSENKO, RICK J.GILLAN

]72[


ז,54.ק, מגדל משה אביב 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

Heat exchanger plates (6) for indirect evaporative coolers, of the type having a dry side(9) having low permeability to an evaporative liquid (22) and formed to allow aproduct fluid (1) to flow over a heat transfer area of its surface, a wet side (10)designed to have its surface wet by an evaporative liquid (22), and formed to allow aworking gas (2) to flow over its surface to evaporate the evaporative liquid, furtherinclude edge extensions (20) formed beyond the heat exchange area of the plates tofacilitate removal of excess evaporative liquid. The edge extensions may slant or curveaway from the wet side of the plates to assist in liquid removal. The plates may be usedin a variety of configurations.

]57[


__________________

177163]21][11[

AUDIO קידוד אודיו CODING]54[

10.02.2005]22[DE]33[13.02.2004]32[102004007191.8]31[

Int. Cl.(2010.01) G10L 19//00]51[FRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V., GERMANY

]71[




]74[

The aim of the invention is to encode an audio signal of a sequence of audio valuesinto an encoded signal. To this end, a first monitoring threshold is determined for afirst block of audio values of the sequence of audio values, and a second monitoringthreshold is determined for a second block of audio values of the sequence of audiovalues; a version of a first parameterisation of a parameterisable filter is calculatedsuch that the transmission function thereof corresponds approximately to the inverse ofthe quantity of the first monitoring threshold; a pre-determined block of audio valuesof the sequence of audio values is filtered by means of the parameterisable filter, usinga pre-determined parameterisation that depends, in a pre-determined manner, on theversion of the second parameterisation, in order to obtain a block of filtered audiovalues that corresponds to the pre-determined block; the filtered audio values arequantised in order to obtain a block of quantised filtered audio values; a combinationof the version of the first parameterisation and the version of the secondparameterisation, containing at least one difference between the version of the firstparameterisation and the version of the second parameterisation, is formed; andinformation containing said combination and from which the quantified filtered audiovalues and a version of the first parameterisation can be derived is integrated into theencoded signal.

]57[


__________________

177264]21][11[

שיטה ומתק להדמייה מגנטית תהודתית במצב מוצק

METHOD AND APPARATUS FORSOLID-STATE MAGNETICRESONANCE IMAGING

]54[

12.03.1999]22[US]33[13.03.1998]32[09/041981]31[

Int. Cl.(2010.01) A61B 05/055, G01N 24//08, G01R 33//54]51[DIVISION FROM 138425]62[SKELSCAN, INC., U.S.A.]71[WO/1999/045842]87[




]74[

A method for generating a magnetic resonance image of in vivo solid-state tissue, themethod comprising:positioning the tissue in a substantially static magnetic field;subjecting the tissue to magnetic gradients in at least two dimensions;exciting first isotopes in the solid-state tissue using an RF excitation pluse while thetissue is subjected to the magnetic gradients;acquiring RF signals emitted by excited first isotopes after the first isotopes have beenexcited, nd while the tissue is subjected to the magnetic gradients;processing the RF signals to generate data representative of the distribution of the firstisotope within the solid-state tissue.

]57[


__________________

177514]21][11[

תצורת התק רפואי המבוסס על הכרה של מידע מזוהה

MEDICAL DEVICECONFIGURATION BASED ONRECOGNITION OFIDENTIFICATION INFORMATION

]54[

19.04.2005]22[US ]33[27.05.2004]32[10/855855]31[

Int. Cl.(2009.01) A61M 05/172, 39/00]51[BAXTER INTERNATIONAL INC.,U.S.A.

]71[




]74[

A medical delivery system (10) is provided for delivering a medicament (17) or fluid(17) to a patient. The system comprises a disposable element such as a line set (14)associated with a container (16) containing the fluid (17), an identifier (18) associatedwith the line set (14) and having identification information associated therewith, and adelivery device (12) configured to engage the line set (14) and deliver the fluid (17) tothe patient. The delivery device (12) includes a recognition system (20) that is capableof obtaining the identification information associated with the identifier (18). Theidentification information may include information regarding the identification of thefluid (17), a type of line set (14), or a type of administration associated with the line set(14). The device (12) can be capable of configuration based on the identificationinformation.

]57[




__________________

177829]21][11[

מכשיר לחלוקת תרופה ע תכונת נעילה בעזרתידי מת מנה–הנעת קפי" המאופשרת על

אחרונה

MEDICATION DISPENSINGAPPARATUS WITH SPRING-DRIVEN LOCKING FEATUREENABLED BY ADMINISTRATIONOF FINAL DOSE

]54[

25.03.2005]22[US]33[30.03.2004]32[60/557545]31[US21.12.2004 60/638027

Int. Cl.(2009.01) A61M 05/00, 05/315]51[ELI LILLY AND COMPANY, U.S.A.]71[WO/2005/097233]87[




]74[

A medication dispensing apparatus with a spring-driven locking feature includes adrive member movable in a distal direction within a housing, and a fluid container witha piston that is advanceable by the drive member (60) when such drive member ismoved distally by a driving means. The apparatus includes a latching element (180)having a skid (190) that is slidable along a surface of the drive member as the drivemember passes distally during advancement. The drive member is arranged with theskid so as to maintain a latching lip of the latching element against a spring force in afirst position free of the driving means during dose preparing and injecting prior to afinal dose administration. The skid-engaging surface shifts distally of the skid suchthat the skid passes beyond a proximal end of that surface upon administration of afinal dose, whereby the latching lip is urged by the spring force from the first positionto a second position to physically lock the driving means to prevent further dosepreparing and injecting.

]57[


__________________

177835]21][11[

LIQUID מכשיר לדגימת נוזלי ושיטה לשימוש בו SAMPLING APPARATUSAND METHOD OF USING SAME

]54[

07.03.2005]22[US]33[05.03.2004]32[60/550743]31[

Int. Cl.(2009.01) A61B 10/00, B01L 03/14, B65D 81/00]51[BRIAN H. RUTLEDGE, U.S.A.PETER E. RISING, U.S.A.

]71[

WO/2005/086816]87[עורכי דין ועורכי, קבוצת איתן מהולל

,פטנטים10שדרות אבא אבן



]74[

A sampling apparatus (100) includes an ampoule barrel (101) for receiving an ampoule(102) through a first opening, the ampoule barrel (101) comprising a second opening(301) adapted to flow a liquid into the ampoule barrel (101) and a structure (304)adapted break a frangible tip (104) of the ampoule (102).

]57[

__________________

178421]21][11[


SPRAY התק למניעת השפריצה PREVENTION DEVICE]54[

04.04.2005]22[GB]33[03.04.2004]32[0407653.5]31[

Int. Cl.(2009.01) B62D 25/18]51[SPRAYDOWN LIMITED, UNITEDKINGDOM

]71[




]74[

A device for preventing spray from emerging from the wheels of vehicles comprises apanel (4) that is adapted to be mounted substantially vertically behind a vehicle wheel(3) for receiving on a first side water released by the wheel (3) as it rotates. The panel(4) includes at least one passage (6) which leads from the first side to a rear secondside of the panel (4). The or each passage (6) is other than normal to the plane of thepanel (4). There is at least one water-collecting pocket (7A, 7B, 7C) along the side ofthe or each passage (6). In use, air and water enter the or each passage (6) and areseparated so that air passes through the or each passage (6) and mixes with ambient airand water collects in the at least one water-collecting pocket (7A, 7B, 7C).

]57[

__________________

178825]21][11[

FLUID תא המודד לח" של נוזל PRESSURE SENSINGCHAMBER

]54[

23.10.2006]22[US]33[27.10.2005]32[11/260596]31[

Int. Cl.(2009.01) G01L 19/14]51[ALCON, INC., SWITZERLAND]71[




]74[

A surgical cassette (200), adapted to be received in a cassette receiving portion (25) ofa surgical console (110), comprising:(a) a body (220);(b) a pressure sensing chamber (210) formed in the body; and(c) a tubing extension (240) extending through the pressure sensing chaber, the tubingextension defining at least one hole (260) that fluidly communicate(s) with thepressure sensing chamber, the at least one hole being adapted to allow the purging of

]57[


air from the chamber during initial priming of the cassette,characterized in that the tubing extension has a reduced diameter portion (241) in orderto create a flow restriction (242) within the tubing extension.

__________________

179100]21][11[

SCANNING מערכת סריקה ע גלאי בעל הסתכלות נעולה SYSTEM WITH ASTARING DETECTOR

]54[

13.06.2001]22[Int. Cl.(2009.01) G02B 26/10, 26/12, H04N 03/08]51[DIVISION FROM 143731]62[

ISRAEL לוד,מ"התעשיה האוירית לישראל בע AEROSPACEINDUSTRIES LTD.

]71[

זאב, יצחק זובלסקי, טל מזור, אשר לוטן ליסאק

ASHER LOTTAN, TAL MAZOR,IZHACK ZUBALSKY, ZEEVLISSAK

]72[



]74[

A scanning system for scanning a field of regard (FOR) by dividing it into a pluralityof fields of view (FOVs) having different space orientations, said system having acentral axis (7) and a reference plane (x,y) perpendicular thereto and comprising:a fixed optical system (12) having a line of sight directed along said axis;a panoramic polygonal member (30) comprising a plurality of flat mirrors (32) havingdifferent orientations relative to said reference plane and facing in different directionsof sight from one another and away from said reference axis to define said FOVs;wherein said flat mirrors are fixed being spaced from said central axis;

]57[


each mirror having an operative state when its FOV is viewed by said optical systemand a corresponding inoperative state, and being radially spaced from said central axisat least in the inoperative state;a switching mechanism (40) for switching between said mirrors to successively bringthem into their operative state while keeping unchanged their said orientation and saidspace orientation of the FOV, said switching mechanism comprising a folding member(20) to perform said switching by the movement of the folding member tosuccessively establish a folded optical path between each flat mirror and said opticalsystem wherein the folding member is facing each respective mirror in turn when therespective mirror is in its said operative state.

__________________

179247]21][11[

PLASTIC שקית פלסטיק בעלת פריקת לח" יתר BAG FEATURINGOVERPRESSURE RELIEF

]54[

27.05.2005]22[EP]33[27.05.2004]32[04012528.8]31[

Int. Cl.(2009.01) B65D 33/01]51[JURGEN HEINEMEIER, GERMANYBURKHARD LUCKMANN,GERMANYGUNTER REIMANN, GERMANY

]71[




]74[


The invention relates to a flexible packaging container (1) which is made of plastic andin which a zone (4) having an inner (5) and an outer (6) wall is embodied by means ofwelded or glued seams. The inner wall is provided with holes (12) which allow gas tobe discharged from the interior (14) of the container into the zone (4) located betweenthe inner and the outer wall while at least one subsection of the welded or glued seams(7) that enclose said zone is configured such that gas can be discharged.

]57[

__________________

179416]21][11[

שיטה ומערכת עבור מת ריענו שקע זיכרו של זכרו נדי,

METHOD AND SYSTEM FORPROVIDING DIRECTED BANKREFRESH FOR VOLATILEMEMORIES

]54[

26.05.2005]22[US]33[27.05.2004]32[60/575334]31[US05.11.2004 10/982038

Int. Cl.(2009.01) G11C 11/406]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A memory system is provided. The memory system includes a volatile memory havinga number of banks and a memory controller configured to control the volatile memoryto engage in an auto-refresh mode or a self-refresh mode. The memory controller isfurther configured to direct the volatile memory to perform an auto-refresh operationon a target bank. The remaining banks are available for access while the auto-refreshoperation is being performed on the target bank.

]57[


בקשות חלוקה מבקשה זו.ר פורסמושט


__________________

179856]21][11[

טי שיב–שימוש בנוגד חד"ALEMTUZUMAB"ל HIV–בהכנת תרופה

USE OF ALEMTUZUMABMONOCLONAL ANTIBODY INFORMULATING AN HIVMEDICAMENT

]54[

28.07.2005]22[US]33[30.08.2004]32[60/605173]31[

Int. Cl.(2010.01) A61K 08//00, 38//00, 39//395, A61P 01//18]51[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[




]74[

A method of treating HIV infection comprises administering to a patient a regimen thatis able to shut down the immune system in a controlled manner by using T-celldepletion or T-cell modification such that T-cells no longer can be attacked by HIVcells. The T-cell depletor or T-cell modifiers ate administered either alone or incombination with 'conventional' anti-HIV drugs.

]57[

__________________


180225]21][11[

משושה קומפקטית משדרת וקולטת תדר רדיוב הוהתק בקרה המשתמש

COMPACT RADIO FREQUENCYTRANSMITTING ANDRECEIVING ANTENNA ANDCONTROL DEVICE EMPLOYINGSAME

]54[

20.06.2005]22[US]33[21.06.2004]32[10/873033]31[

Int. Cl.(2010.01) H01Q 07//00]51[LUTRON ELECTRONICS CO. INC.,U.S.A.

]71[



]74[

A compact antenna for use in a device for controlling the power delivered to anelectric load and operable to transmit or receive radio frequency signals at a specifiedfrequency is presented. The antenna comprises a first loop of conductive materialhaving a capacitance and an inductance forming a circuit being resonant at thespecified frequency, and a second loop of conductive material having two endsadapted to be electrically coupled to an electronic circuit. The second loop issubstantially only magnetically coupled to the first loop and is electrically isolatedfrom the first loop. In a first embodiment of the antenna, the first and second loops areformed on respective first and second printed circuit boards, which allow for a small,low-cost antenna that is easy to manufacture and maximizes efficiency. When theantenna is installed in a load control device, such as a dimmer, the first loop of theantenna is mounted on an outer surface of the device. The second loop of the antennamay be at a high-voltage potential such as line voltage.

]57[




__________________

180244]21][11[

FIBROUS-COMPOSITE המבוסס על חומר סיביMEMSסורק אופטיMATERIAL-BASED MEMSOPTICAL SCANNER

]54[

24.06.2005]22[US]33[24.06.2004]32[60/582405]31[US08.03.2005 60/659736

Int. Cl.(2009.01) G02B 26/08]51[CORNELL RESEARCHFOUNDATION, INC., U.S.A.

]71[




]74[

Mems can be fabricated from fibers without the use of a matrix material. Devices canbe built where fibers are attached only at a substrate edge (e.g. cantilevers, bridges).Motions can be controlled by adjusting the linkage between multiple fibers with weakcoupling (e.g. base, tip, in-between). Driving mechanisms include base forcing(magnetics, piezo, electrostatics) or tip forcing (magnetics). Mirrors may be formed onfree ends of cantilevers to form optical scanners.

]57[

__________________

180964]21][11[

DRIVE מנוע הנעה עבור מעלית ושיטת הצבה של המנוע ENGINE FOR A LIFTINSTALLATION AND METHOD

]54[


OF MOUNTING A DRIVE ENGINE

06.08.2003]22[EP]33[05.09.2002]32[02405768.9]31[EP29.04.2003 03405297.7

Int. Cl.(2009.01) B66B 11/04, B66D 01/12]51[DIVISION FROM 157278]62[INVENTIO AG, SWITZERLAND]71[

,פיוריינהולד כהן ושות'א26רחוב הברזל רמת החייל


]74[

Lif t insallation with cage and counterweight in a shaft, wherein the cage and thecounterweight are guided by means of cage guide rails and counterweight guide railsrespectively, and with a drive engine (20), which drives the cage and thecounterweight by way of at least two drive means, wherein the drive engine comprisesa drive shaft (4), at least two mutually spaced-apart drive zones (3;3') and componentssuch as a motor (1) a brake (2), wherein either the motor is arranged to the left or rightof the two drive zones and the brake is arranged on a side of the two drive zones whichis cpposite to that of the motor, or the motor as well as the brake are arranged to theleft or right of the two drive zones, and the support and drive means are arranged incorrespondence with a spacing (D) of the drive zone, characterized in that the spacing(D) of the two drive zones, relative to one another allows an arrangement of the cageguide rail between the two drive zones and the spacing (D) of the two drive zones or ofthe support and drive means from one another corresponds with at least the width of arail foot of the cage guide rail and at most three times the width of the rail foot of thecage guide rail, or the spacing (D) of the two drive zones or of the support and drivemeans from one another amounts to 100 to 250 mm.

]57[

__________________


181215]21][11[

SYSTEMS מערכות ושיטות ליחידות הדמיה אוניברסליות AND METHODS FORUNIVERSAL IMAGINGCOMPONENTS

]54[

19.07.2005]22[US]33[13.08.2004]32[10/918166]31[

Int. Cl.(2009.01) G03G 15/00]51[STATIC CONTROL COMPONENTS,INC., U.S.A.

]71[



]74[

A cartridge chip 106 for use with an imaging cartridge installed in an imaging device,the cartridge chip comprising a memory element 106 storing imaging cartridge data,and a controller 104 for controlling the operation of the cartridge chip and determiningif the imaging device is a first type of imaging device or a second type of imagingdevice, the controller for operating the cartridge chip in a first mode of operation if theimaging device is the first type of imaging device, the controller for operating thecartridge chip in a second mode of operation if the imaging device is the second typeof imaging device.

]57[

__________________

181227]21][11[

SEAL מכשיר להתקנת אט INSTALLATION TOOL]54[

08.02.2007]22[US]33[16.02.2006]32[11/355420]31[

Int. Cl.(2009.01) B23P 19/02]51[AIR PRODUCTS AND CHEMICALS,]71[


INC., U.S.A.,ריינהולד כהן ושותפיו



]74[

A tool for installing a seal in a fitting, said tool comprising:a sleeve having a first socket sized to receive said seal, and a second socket positionedadjacent to said first socket, said second socket defining an open end of said sleeve andbeing sized to receive said fitting:a pusher element movable within said sleeve, said pusher element having a contactsurface engageable with said seal for moving said seal out of said first socket and intosaid fitting when said pusher element is moved relatively to said sleeve, and saidpusher element comprises a shaft having said contact surface at one end thereof,wherein said shaft has a conduit therein, and said conduit having an inlet positioned atsaid one end providing filuid communication with said fitting, and an outlet providingfluid communication with the atmosphere to allow gas to escape from said fitting tothe atmosphere when said second socket is engaged with said fitting.

]57[

__________________

181671]21][11[

שיטה ומערכת לקבלת תמונה בעלת עומק שדה רחב באמצעות עדשות אור מולטיפוקל בעלות טווח נשלט של סטייה ספרית וצמצ ממורכז

מוסתר

EXTENDED DEPTH OF FIELDUSING A MULTI-FOCAL LENGTHLENS WITH A CONTROLLEDRANGE OF SPHERICALABERRATION AND CENTRALLYOBSCURED APERTURE

]54[

11.05.2005]22[US]33[03.09.2004]32[60/607076]31[US30.11.2004 60/522990 US05.05.200510/908287

Int. Cl.(2010.01) G02B 13//18]51[AUTOMATIC RECOGNITION &CONTROL INC., U.S.A.

]71[




]74[

An extended depth of field is achieved by a computational imaging system thatcombines a multifocal imaging subsystem for producing a purposefully blurred

]57[


intermediate image with a digital processing subsystem for producing a recoveredimage having an extended depth of field. The multifocal imaging system preferablyexhibits spherical aberration as the dominant feature of the purposeful blur. A centralobscuration of the multifocal imaging subsystem renders point-spread functions ofobject points more uniform over a range of object distances. An iterative digitaldeconvolution algorithm for converting the intermediate image into the recoveredimage contains a metric parameter that speeds convergence, avoids stagnations, andenhances image quality.

__________________

182100]21][11[

CUTTING שימת חיתו לכלי כרסו INSERT FOR AMILLING CUTTER

]54[

21.03.2007]22[Int. Cl.(2010.01) B23B 27//16, B23C 05//02, 05//20]51[TAEGUTEC INDIA LTD., INDIA]71[KEDAR SURESH BHAGATH]72[

,מ"ישקר בע תפן11.ד.ת,

ISCAR LTD.,P.O.B. 11,TEFEN 24959

]74[

A double-ended indexable cutting insert comprising:first (102) and second (104) substantially square end surfaces facing oppositedirections, each end surface having an associated abutment surface (108) and fourassociated insert corners (106);four side surfaces (112A, 112B, 112C, 112 D) connecting the first and second endsurfaces to form a total of eight edges, each edge comprising a primary cutting edge(120), a wiper (122) and a transitive edge (124) connecting the primary cutting edge tothe wiper, at least the primary cutting edge and the wiper occupying a common plane;a median plane (M) located mid-way between the first and second end surfaces andpassing through the four side surfaces;wherein:each insert corner has associated therewith:a primary cutting edge extending from said each insert corner in a downward directiontowards the median plane; anda wiper extending from said each insert corner in an upward direction away from themedian plane, said wiper rising above an associated abutment surface.

]57[


__________________

182290]21][11[

מערכות,)AIOL(עדשה מסתגלת תו עינית)AIOL(הכוללת אות

ACCOMMODATINGINTRAOCULAR LENS (AIOL),AND AIOL ASSEMBLIESINCLUDING SAME

]54[

09.10.2005]22[US]33[13.10.2004]32[60/617738]31[

Int. Cl.(2010.01) A61F 02//16]51[NULENS הרצליה פיתוח,מ"ניולנס בע LTD.]71[

WO/2006/040759]87[,מ"ניולנס בע

15משכית הרצליה פיתוח2225.ד.ת,

NULENS LTD.,P.O.BOX 2225MASKIT 15 ST.HERZLIYA PITUACH 46121

]74[

An accommodating intraocular lens (AIOL) including a biasing mechanism (79) forelastically deforming an elastically deformable shape memory disk-like opticalelement (66) for affording the AIOL a natural positive diopter strength for near vision.The AIOL is intended to be implanted in a human eye (10) such that relaxation of itsciliary body (19) causes its capsular diaphragm to apply an accommodation force forovercoming the biasing mechanism to reduce the AIOL's natural positive diopterstrength for distance vision.

]57[


__________________

182524]21][11[

AMORPHOUS אמורפית של תרכובת סינאמידצורה FORM OFCINNAMIDE COMPOUND

]54[

25.10.2005]22[JP]33[26.10.2004]32[2004-310909]31[

Int. Cl.(2010.01) A61K 31//454, A61P 05//28, C07D 40/1/06]51[EISAI R&D MANAGEMENT CO.,LTD., JAPAN

]71[




]74[

An amorphous form of (3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidine-2-one, which is represented by theformula (1) and has Abeta-production inhibitory activity. The amorphous object hassuch satisfactory properties that it has excellent solubility, is stable, does not readilybecome a crystalline form, and has low hygroscopicity. It is hence suitable for use inpharmaceutical preparations.

]57[

__________________


182549]21][11[

מוצקה המתאי תהלי לייצור צורת מינו דחוסהלשימוש ע תרופות בעלות מסיסות נמוכה במי וצורות מינו דחוסות מוצקות המוכנות בתהלי זה

COMPRESSED SOLID DOSAGEFORM MANUFACTURINGPROCESS WELL-SUITED FORUSE WITH DRUGS OF LOWAQUEOUS SOLUBILITY ANDCOMPRESSED SOLID DOSAGEFORMS MADE THEREBY

]54[

10.11.2004]22[Int. Cl.(2010.01) A61K 09//20]51[

TEVAפתח תקוה,מ"טבע תעשיות פרמצבטיות בע PHARMACEUTICALINDUSTRIES LTD.

]71[

MALI KADOSH, FANNY LESKA,DORIT MARKO, ILAN ZALIT,YONIT TRIGER-MESSER

]72[

WO/2006/052254]87[בעטבע תעשיות פרמצב ,מ"טיות

5בזל פתח תקוה3190.ד.ת,

TEVA PHARMACEUTICALINDUSTRIES LTD.,5 BASEL ST.,P.O.B. 3190,PETAH TIQVA 49131

]74[

A pharmaceutical formulation of compounds with low aqueous solubility and methodof manufacture thereof. The formulation may include a pharmacologically activecompound having low aqueous solubility and starch in the amount of greater thanabout (25) weight percent. A manufacturing method may include blending the activecompound and starch, compressing the blend into a solid, comminuting the solid intogranules, wetting the granules, drying the granules, and tabletting the dried granules tomake a solid pharmaceutical formulation.

]57[



__________________

182570]21][11[

שיטה אלקטרואקוסטית ומיכשור לזירוז שלהעברה המונית של תהליכי עבור התאוששות

ELECTROACOUSTIC METHODAND DEVICE FOR STIMULATION

]54[


OF טובה MASS TRANSFER PROCESSESFOR ENHANCED WELLRECOVERY

12.11.2004]22[US]33[11.11.2004]32[10/986677]31[

Int. Cl.(2009.01) E21B 43/00]51[KLAMATH FALLS, INC., BRITISHVIRGIN ISLANDS

]71[




]74[

An electro acoustic device and related method for increasing production capacity ofwells that contains oil, gas and/or water is disclosed. The electro acoustic deviceproduces vibrations stimulating occurrence of mass transfer processes within the well.The resultant acoustic flow generated in porous media, produced by superposition oflongitudinal and shear waves, is developed over a characteristic frequency thresholdvalue specific to water, normal oil and heavy oil, with an acoustic energy densitycapable of establishing higher fluidity zones in the porous media, promoting mobilityand recovery of desired fluid and formation damage reduction in a wellbore. The downhole electro acoustic device is a submerged unit placed in the well producing zone, andconsists of an electric generator, one or more electro acoustic transducers, and one ormore waveguide systems (sonotrodes) that include tubular type radiators whichprovide transmission of elastic vibrations into the medium under treatment.

]57[

__________________

182723]21][11[

COATED כלי חיתו מצופה ושיטה לייצורו CUTTING INSERT ANDMANUFACTURING METHODTHEREOF

]54[


20.10.2005]22[JP]33[29.10.2004]32[2004-316611]31[

Int. Cl.(2009.01) B23B 27/14]51[SUMITOMO ELECTRICHARDMETAL CORP., JAPAN

]71[




]74[

An edge replacement type cutting tip (1) and a method of manufacturing the cuttingtip. The cutting tip (1) comprises a body (8), a base layer formed on the body (8), and ause state indicating layer formed on the base layer. The body (8) is characterized inthat at least one face thereof is formed in a face (2) and the other at least one face isformed in a flank (3), ridges where the face (2) crosses the flank (3) are formed in edgeridge lines (4), the base layer presents a color different from that of the use stateindicating layer, and the use state indicating layer is formed on the base layer in theentire surfaces or parts of the surfaces of areas (A2) on the flank (3) excluding areas(A1) vertically extended by a distance of 0.2 to less than 3.0 mm from the edge ridgelines (4).

]57[

__________________

182795]21][11[

–3,2–דיאלקיל–4,1תהלי להכנת בוטאנדיאו–4,1–דיול

PROCESS FOR THE PREPARATIONOF 1,4-DIALKYL-2, 3-DIOL-1, 4-BUTANEDIONE

]54[

27.10.2005]22[WO]33[02.11.2004]32[PCT/IB2004/003631]31[

Int. Cl.(2010.01) C07C 45//72, 49//17]51[FIRMENICH SA, SWITZERLAND]71[FERDINAND NAEF, RENE DECORZANT]72[WO/2006/048795]87[

PEARL,פרל כהן צדק לצר COHEN ZEDEK LATZER,]74[



5 SHENKAR ST.,P.O.B. 12704,HERZLIYA 46733

The present invention relates to a process for the preparation of compounds of a 1,4-dialkyl-2,3-diol-1,4-butanedione by a catalytic aldol condensation between an alkylglyoxal and an a-hydroxy ketone.

]57[

__________________

182840]21][11[

מערכת ושיטה למת שירותי סלולרי ברשתות שונות

SYSTEM AND METHOD FORSHARING CELLULARCOMMUNICATION SERVICESAMONG MOBILE STATIONS OFDIFFERENT NETWORKS

]54[

27.03.2002]22[Int. Cl.(2010.01) H04W 08//10, 08//28]51[DIVISION FROM 148926]62[

CELLCOM נתניה,מ"סלקום ישראל בע ISRAEL LIMITED]71[,ריינהולד כהן ושותפיו



]74[

A Home Location Register (HLR) operative in a wireless network and configured tosupport, at least, Interim Standard 41 (IS-41), said HLR operatively coupled to a firstVisitor's Location Register (VLR) configured to support communication with a firstsingle-protocol mobile station over protocol IS-41 and to a second VLR configured tosupport communication with a second single-protocol mobile station over a protocolother than IS-41; wherein the first mobile station and the second mobile station arebearing different inherent telephone numbers, and said HLR is configured to receivean incoming call addressed to either the first or the second mobile stations; said HLRis further configured to accommodate a configuration comprising a Calling LineIdentity (CLI) common to the first and the second mobile stations, said CLI associatedwith the inherent telephone number of the first mobile station and the inherenttelephone number of the second mobile station.

]57[


__________________

183107]21][11[

TRIPEPTIDE פפטידיי–תיואתרי תלת פפטידיי וארבע ANDTETRAPEPTIDE THIOETHERS

]54[

04.01.2006]22[US]33[06.01.2005]32[60/641932]31[

Int. Cl.(2010.01) A61K 38//06, 38//07, A61P 31//00, C07K 05//08, 05//10]51[TELIK, INC., U.S.A.]71[WO/2006/074249]87[



]74[

Tripeptide and tetrapeptide thioethers, pharmaceutical compositions containing them,their pharmaceutical use, and their preparation. The compounds are useful inpotentiating the cytotoxic effects of chemotherapeutic agents in tumor cells, selectivelyexerting toxicity in tumor cells, elevating the production of GM progenitors in bonemarrow, stimulating the differentiation of bone marrow, mitigating themyelosuppressive effects of chemotherapeutic agents, and modulating hematopoiesisin bone marrow.

]57[

__________________

183145]21][11[


CONTROLLED-VOLUME התק אינפוזיה בעל נפח מבוקרINFUSION DEVICE

]54[

18.11.2005]22[US]33[19.11.2004]32[60/629795]31[

Int. Cl.(2009.01) A61M 05/178]51[CURLIN MEDICAL INC., U.S.A.]71[WO/2006/055834]87[



]74[

An infusion device capable of administering liquid medication at a continuous flowrate, and upon user demand delivers a controlled volume dosage of liquid medicationat a higher dosage flow rate. The dosage reservoir (200) remains empty until the useractuates it by selectively and temporarily removing the pressure source, such as aspring (230). During actuation, fluid rapidly flows from the medication reservoir (100)to fill the dosage reservoir (200). After actuation, the pressure source (230) exerts ahigher pressure on the dosage reservoir (200) than the medication reservoir pressure(100), which results in a temporary higher bolus flow rate. Thus, two distinct flowrates are achieved with one flow restrictor element (700).

]57[

__________________

183147]21][11[

TOROIDAL מנוע הטבעת הבוכנה שריפה פנימית PISTON INTERNALCOMBUSTION ENGINE

]54[

13.05.2007]22[Int. Cl.(2010.01) F01C 09//00, F02B 53//00]51[

גן, יפים לפטין רמתגן, לגה לפטיןאו רמת

EFIM LAPATINOLGA LAPATIN

]71[

,יפים לפטין1דירה42עוזיאל' רח

רמת גן

EFIM LAPATIN,42/1 UZIEL ST.,RAMAT GAN 52382

]74[

A toroidal piston internal combustion engine comprising:a stator,

]57[


a piston assembly and its stopping device,a reversible mechanism,a driveshaft rotatably set in bearings disposed in the stator,a fly wheel attached to the driveshaft,at least two pairs of toroidal cylinders connected with combustion chambers andsymmetrically disposed in the stator on both sides of the driveshaft,feed channels disposed in the stator and connected with the combustion chambers bycontrolled admission valves,exhaust channels disposed in the stator and connected with the combustion chambersby controlled exhaust valves,the piston assembly having at least two pairs of toroidal pistons, slidably set in thetoroidal cylinders and connected by a connecting rod,split seal rings, fitted to the toroidal cylinders, disposed in external ring grooves of thetoroidal pistons,the stopping device including stopping toroidal cylinders, disposed in the stator onboth sides of the driveshaft, and stopping toroidal pistons fitted to the said cylindersand connected to the piston assembly,the stopping toroidal cylinder, having a buffer, set on its bottom, and formed on itswall a hole and a chamel, connected with a throttle and set between the said buffer andthe said hole,the reversible mechanism, disposed in the stator including: two conical gear wheelsrotatably put on the driveshaft, opposite set to each other and engaged with drivenconical gear wheels, rotatably set in the stator on an axisperpendicular to the driveshaft; circular profile surfaces formed on the conical gearwheels, disposed opposite to each other; projections and hollows evenly disposed onthe circular profile surfaces, the projection set after the near hollow in the direction ofthe driveshaft rotation and displaced from the said hollow on an arc conforming tocalculated angleα0 of the piston assembly turn; a spline slider slidably set on thedriveshaft between the circular profile surfaces and having two cams, adjoining to thecircular profile surfaces and rotatably set on axles, attached to the spline slider andperpendicular to the driveshaft, the projections, formed on one of the circular profilesurfaces, disposed opposite the hollows formed on other of the circular profile surfacesor, on the contrary, the hollows formed on one of the circular profile surfaces,disposed opposite of the projections, formed on other of the circular profile surfaces,a lever, connecting one of the conical gear wheel with the connecting rod.

__________________

183924]21][11[

בשילוב חומרי פעילי להכנת תכשירי שימוש רוקחות

USE OF A COMBINATION OFACTIVE AGENTS IN THEPREPARATION OFPHARMACEUTICAL

]54[


COMPOSITIONS

20.12.2005]22[US]33[22.12.2004]32[60/638674]31[EP22.12.2004 04106910.5

Int. Cl.(2009.01) A61K 31/7076, 39/395, A61P 37/02, C07K 16/18, 16/28]51[MERCK SERONO S.A.,SWITZERLAND

]71[

GIAMPIERO DELUCA]72[WO/2006/067134]87[

,מ"אינטרפארם מעבדות בע18רחוב הקישון

יבנה151.ד.ת,

INTERPHARM LABORATORIESLTD.,18 HAKISHON ST.,P.O.B. 151,YAVNE 81101

]74[

This invention is directed towards treatments for multiple sclerosis comprisingadministering to a patient in need thereof a first agent, such as 2-chloro-2'-deoxyadenosine (2-CdA), that reduces the number of lymphocytes in combination witha second agent, such as an anti-alpha-4 integrin antibody, that blocks the adhesion ofmonocytes and leukocytes to endothelial cells. The use of 2-CdA combined with ananti-alpha-4 integrin antibody may be more effective than either treatment alone forMS. Furthermore, the combination treatment may allow for a lowering or altering thedose of one or more of the agents in order to limit any adverse effects associated withthe individual agents, but maintaining the same therapeutic efficacy.

]57[

__________________

184284]21][11[

MODIFIED תימוסי שעברו שינוי–פפטידי של בטה BETA THYMOSINPEPTIDES

]54[

17.01.2006]22[US]33[14.01.2005]32[60/643684]31[US14.01.2005 60/643686 US14.01.200560/643687US14.01.200560/643688

Int. Cl.(2010.01) A61K 38//00, C07K 14//575]51[REGENERXBIOPHARMACEUTICALS, INC.,U.S.A.FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-

]71[


NURNBERG, GERMANYEWALD HANNAPPEL, THOMASHUFF, ALLAN L. GOLDSTEIN,DAVID CROCKFORD

]72[

WO/2006/076523]87[',ר וב ושות"ד

2פקריס' רח רחובות2189.ד.ת,


]74[

A composition including an oxidized or superoxidized methionine-containing betathymosin peptide, isoform thereof, fragment thereof, isolated R-enantiomer thereof orisolated S-enantiomer thereof, other than racemic thymosin beta 4 sulfoxide, or amodified beta thymosin peptide, isoform or fragment thereof with an amino acidsubstituent substituted for at least one methionine of an amino acid sequence of anormally methionine-containing beta thymosin peptide, isoform or fragment thereof,and method for forming same.

]57[

__________________

187278]21][11[

INHALATOR משא, לכמוסות CAPSULES]54[

17.05.2006]22[DE]33[18.05.2005]32[102005022862.3]31[

Int. Cl.(2009.01) A61K 09/48]51[BOEHRINGER INGELHEIM PHARMAGMBH & CO. KG, GERMANY

]71[




]74[

The invention relates to a capsule, which is used, in particular, in the form of a packagefor inhalation formulations and comprises at least one cavity encased by a wall. Saidinvention is characterised in that at least one part of the wall comprises a polymercomposition containing at least one type of absorber. The preferred use thereof, aninhalator and a secondary packing means containing said capsule are also disclosed.

]57[


__________________

188164]21][11[

רמולציה רוקחית של אינדיבולי מעכב טובולי פולמת דר הפה ע תכונות פארמאקוקינטיות

ושיטה להכנתה, משופרות

PHARMACEUTICALFORMULATION OF THETUBULIN INHIBITOR INDIBULINFOR ORAL ADMINISTRATIONWITH IMPROVEDPHARMACOKINETICPROPERTIES AND PROCESS FORTHE MANUFACTURE THEREOF

]54[

07.06.2006]22[US]33[14.06.2005]32[11/151459]31[

Int. Cl.(2010.01) A61K 09//16, 31//4439]51[ZIOPHARM ONCOLOGY, INC.,U.S.A.

]71[




]74[

The present invention relates to a pharmaceutical formulation for oral administrationof the poorly soluble and therefore hardly bioavailable tubulin inhibitor Indibulin and aprocess for its manufacture. In particular, there is provided a pharmaceuticalformulation of lndibulin for oral administration comprising a granulate containingmicronized lndibulin having a particle size of less than 20 µm for at least 99 vol.-% ofthe particles, at least one hydrophilic surfactant, and one or more capsulationexcipients.

]57[

__________________


188457]21][11[

שימוש באנטיהיסטמיני להפחתה משמעותית לגולתי מוגברגו–של לח" תו

USE OF ANTI-HISTAMINICS FORACUTE REDUCTION OFELEVATED INTRACRANIALPRESSURE

]54[

22.11.2002]22[EP]33[23.11.2001]32[01204574.6]31[

Int. Cl.(2010.01) A61K 45//06, A61P 07//02, 07//08, 09//10, C07D 51/9/00]51[DIVISION FROM 162109]62[JANSSEN PHARMACEUTICA, N.V.,BELGIUM

]71[




]74[

The invention concerns a novel histamine receptor antagonist and the use of anhistamine receptor antagonist for the reduction of intracranial pressure (ICP), inparticular for the prevention and treatment of elevated intracranial pressure and/orsecondary ischaemia, in particular caused by brain injury, more in particular caused bytraumatic (TBI) and non-traumatic brain injury. The novel compounds comprisecompounds according to the general Formula (I) the pharmaceutically acceptable acidor base addition salts thereof, the stereochemically isomeric forms thereof and theN-oxide form thereof. In particular, the preferred compound is 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenylmethyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2-a]benzimidazol-4(10H)-one, the pharmaceuticallyacceptable acid or base addition salts thereof, the stereochemically isomeric formsthereof and theN-oxide form thereof. Also claimed is the novel use of commerciallyavailable histamine H1-and H2-receptor antagonists for the reduction of intracranialpressure (ICP).

]57[


__________________

188706]21][11[

שימושה ופורמולציות, תמצית סאליקס המכילות אותה

SALIX EXTRACT, ITS USE ANDFORMULATIONS CONTAINING IT

]54[

14.06.2006]22[IT]33[14.07.2005]32[MI2005A001349]31[

Int. Cl.(2009.01) A61K 36/185, 36/76]51[INDENA S.P.A., ITALY]71[WO/2007/006384]87[



]74[

The present invention relates to an extract of Salix spp obtainable by fractioning on aresin and to the process for its preparation. The extract of the invention is characterizedby an high content in salicin derivatives, reduced content in high molecular tannins anda content in proanthocyanidins sufficient to inhibit some tissue metal proteases. Theproduct is formulated in oils rich in &ohgr;-3 and &ohgr;-6 acids which provide abetter absorption of the extract active principles, also increasing synergetically theiraction.

]57[

__________________

189071]21][11[

תמיכה בגילוי משתמשי רבי בערו" הבא מלוויי

SUPPORT OF MULTIUSERDETECTION IN THE DOWNLINK

]54[

02.02.2001]22[US]33[04.02.2000]32[60/180402]31[

Int. Cl.(2010.01) H04B 01//707, H04J 03//00, 11//00, 13//00, H04W 16//14]51[DIVISION FROM 150991]62[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[




]74[


A wireless time division duplex base station, the base station comprising:means for assigning at least one channelization code to a user equipment;a mapping between midamble codes and channelization codes, where at least onemidamble code is mapped to a plurality of channelization codes having a samespreading factor; andmeans for selecting the midamble code mapped to the at least one channelization codeto the user equipment; andmeans for forming a communication burst with the assigned at least one channelizationcode and the selected midamble code.

]57[

__________________

189470]21][11[

DETACHABLE גיליו הנית להפרדה SHEET]54[

02.11.2006]22[US]33[15.11.2005]32[60/736333]31[

Int. Cl.(2010.01) B26F 01//18, B42D 05//00, 13//00, B42F 03//00]51[א DAVID מודיעין, גליק. דיויד A. GLUCK]71[א DAVID גליק. דיויד A. GLUCK]72[

WO/2007/057882]87[א ,גליק. דיויד

20קומה93דירה18חטיבת הראל מודיעין

DAVID A. GLUCK,18 HATIVAT HARELAP. 93, 20TH FLOORMODI'IN 71721

]74[

In one aspect, the present invention is directed to a sheet comprising: a first section onone side of the sheet; and a second section on the other side of the sheet and parallel tothe first section; wherein the distance between the tip of the first section and the tip ofthe second section being substantially greater than zero, thereby upon applying a forcealong the tips, detaching the sheet between the tips. In another aspect, the presentinvention is directed to a sheet comprising: a section on one side of the sheet in whichthe shortest distance between the tip of the section and the un-sectioned edge of thesheet is substantially greater than zero, thereby upon applying a force along thesection, detaching the sheet between the tip and the edge.

]57[


לתקנות35 לתקנה פירוט זה נבח5 בהתא 1968–ח"תשכ, הפטנטי

This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________________

192371]21][11[

aveCרצפי פולינוקלאוטידי של אללשל סטרפטומיצס אוורמיטיליס המייצרי

מופחת 2:1אוורמקטיני של סוג יחס

POLYNUCLEOTIDE SEQUENCESTO A STREPTOMYCESAVERMITILIS AVEC ALLELEPRODUCING A REDUCED CLASS2:1 RATIO OF AVERMECTINS

]54[

31.01.2003]22[US]33[12.02.2002]32[60/356222]31[

Int. Cl.(2010.01) C12N 15//00]51[DIVISION FROM 162866]62[PFIZER PRODUCTS, INC., U.S.A.]71[WO/2003/068955]87[




]74[

A polynucleotide molecule comprising a nucleotide sequence that is otherwise thesame as theStreptomyces avermetiils aveC allele, the S. avermetilis AveC geneproduct-encoding sequence of plasmid pSE 186 (ATCC 209604) or the nucleotidesequence of the aveC ORF of S. avermetilis as presented in SEQ ID IN: 1, or a variantthereof which includes one or more silent changes to the nucleotide sequenceaccording to the degeneracy of the genetic code, but which nucleotide sequence furthercomprises mutations encoding a combination of amino acid substitutions at amino acidresidues to the amino acid positions of SED ID IN: 2, such that cells of S. avermetilisstrain ATCC 53692 in which the wild-type aveC allel has been inactivated and thatSexpress the polynucleotide molecule comprising the mutated nucleotide sequence arecapable of producing a class 2:1 ratio of avermectins that is reduced compared to the

]57[


ratio produced by cells of S. avermetilis strain ATCC 53692 that instead express onlythe wild-type aveC allele, wherein when the class 2:1 avermectins are cyclohexyl132:cyclohexyl B1 avermectins the ratio of class 2:1 avermectins is 0.2:1 or less, andwherein the combinations of amino acid substitutions comprise substitutions at bothD48 and G179, and wherein the combination of amino acid substitutions comprises acombination selected from the group as set forth in the specification.

__________________

193631]21][11[

HUMANIZED נוגדני מואנשי לסילוק פפטיד עמילויד בטא ANTIBODIES THATSEQUESTER AMYLOID BETAPEPTIDE

]54[

26.02.2001]22[US]33[24.02.2000]32[60/184601]31[US08.12.2000 60/254465 US08.12.200060/254498

Int. Cl.(2009.01) A61K 39/395, A61P 25/28, C07K 16/18, C12N 05/10, 15/13, C12R01/91

]51[

DIVISION FROM 151378]62[ELI LILLY AND COMPANY, U.S.A.WASHINGTON UNIVERSITY,U.S.A.

]71[

WO/2001/062801]87[,טו את לוצאטולוצא



]74[

A method to treat conditions characterized by formation of amyloid plaques bothprophylactically and therapeutically is described. The method employs humanizedantibodies which sequester soluble Aβ peptide from human biological fluids or which

]57[


preferably specifically bind an epitope contained within position 13-28 of the amyloidbeta peptide Aβ.

__________________

194204]21][11[

מערכות פרבוליות באמצעות סולרית ע אמצעי מעקב סיבוביי

PARABOLIC SOLAR TROUGHSYSTEMS WITH ROTARYTRACKING MEANS

]54[

28.03.2006]22[Int. Cl.(2010.01) F24J 02//14, 02//18, 02//38, 02//54]51[CAPAN, RAHMI, OGUZ, TURKEY]71[WO/2007/110713]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

The inventive solar trough field system (A) comprises multiple parabolic reflectors(1), support circles (3) of which the center coincides with the focus of the parabolicreflector (1 ) and which are used in order to support the reflector (1 ), coremechanisms (2) which are located on the center of the circles (3), guy wires (4) whichconnect the circle (3) and the core mechanism (2) to each other, side support units(5,5J) which bear the support circles (3) from their outer surfaces, lightweight fillingmaterials (6) which support the reflectors (1 ) from their lower parts, thermal receivertubes (11) which pass through the center axis of the circles (3). The parabolicreflectors (1) are rotated around the center axis of the circles (3), which is the focusthereof, and directed towards the sun. Thus, the parallel beams coming from the sunare concentrated in the thermal receiver tubes (11) which are located in the focus ofthe reflectors (1).

]57[


__________________

195435]21][11[

PROCESSES תהליכי להכנת מגיבי מסומני FOR PREPARINGLABELING REAGENTS

]54[

02.03.2003]22[US]33[12.03.2002]32[10/096075]31[

Int. Cl.(2010.01) C07D 41/3/00, 41/7/00]51[DIVISION FROM 154700]62[ENZO LIFE SCIENCES, INC., U.S.A.]71[




]74[

A process for preparing a cyanine dye labeling reagent, said process comprising thesteps of:(a) providing:(i) a first intermediate compound of formula I as set forth in the specificationwherein, X1 comprises carbon, oxygen, nitrogen or sulfur; and(ii) a second intermediate compound of formula II as set forth in the specificationwherein X2 comprises carbon, oxygen, nitrogen or sulfur,wherein at least one of R1 through R10 comprises a reactive group capable of forming acarbon-carbon linkage with a target, and(iii) linking reagents suitable for link said first intermediate compound and said secondintermediate compound;(b) forming a reaction mixture comprising said first intermediate compound (I), saidsecond intermediate compound (II), and said linking reagents under conditions to link(I) and (II) to form a compound of formula III as set forth in the specificationwherein at least one of R1 through R10 comprises a reactive group capable forming acarbon-carbon linkage with a target, wherein said reactive group comprises an alkenegroup, an alkyne group or a metallo-organic compound, and wherein n is an infeger of1,2 or 3, and wherein X1 and X2 independently comprises carbon, oxygen, nitrogen orsulfur.

]57[

__________________

195436]21][11[

LABELING מגיבי מסומני REAGENTS]54[

02.03.2003]22[


US]33[12.03.2002]32[10/096075]31[Int. Cl.(2010.01) C07D 31/1/26]51[DIVISION FROM 154700]62[ENZO LIFE SCIENCES, INC., U.S.A.]71[




]74[

A labeling reagent comprising an aphemylic analog of a rhodamine dye, said analogcomprising at least one reactive group for attaching said labeling reagent to a target,said at least one reactive group being attached directly to sid analog or indirectiythrough a linker arm.

]57[

__________________

195437]21][11[

LABELING מגיבי מסומני ומטרות מסומנות REAGENTS ANDLABELED TARGETS

]54[

02.03.2003]22[US]33[12.03.2002]32[10/096075]31[

Int. Cl.(2010.01) C07D 48/7/22]51[DIVISION FROM 154700]62[ENZO LIFE SCIENCES, INC., U.S.A.]71[




]74[

A labeling reagent comprising a nometallic porphyrin, said reagent comprising acompound of formula I as set forth in the specificationwherein R0 is a reactive group and is attached directly or indirectly to any one of thefour non-pyrrole positions of said nonmetallic porphyrin, and R1 through R8

independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, beterocyclic,aromatic, heteroaromatic, charged or polar groups, or any combinations of theforegoing, wherein said reactive group R0 comprises sulfhydryl, hydroxyl, amine,isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogensubstituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine,sulfonylhalide, acid halide, hydroxysuccinimide ester,hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyldithio)-propionamide, glyoxal, an alkene group, an alkyne group or ahalogenated compound.

]57[


__________________

195440]21][11[

פלואורסצנטי ומטרה מסומנת על תרכובת צבע ידה

FLUORESCENT DYECOMPOSITION AND TARGETLABELED THEREWITH

]54[

02.03.2003]22[US]33[12.03.2002]32[10/096075]31[

Int. Cl.(2010.01) C09B 62//00, C12Q 01//68, G01N 33//00]51[DIVISION FROM 154700]62[ENZO LIFE SCIENCES, INC., U.S.A.]71[




]74[

A dye composition of the formulaR-Fluorescent Dyewherein R comprises a reactive group covalently linked to said Fluorescent Dyewherein said Fluorescent Dye comprises a combination of two or more membersselected from:

(a) unsaturated aliphatic groups comprising an alkene or alkyne;(b) unsaturated heterocyclic goups;(c) aromatic groups;(d) and wherein R provides a conjugated system or an electron delocalized

system with said Fluorescent Dye and said composition optionally comprisesa charged or polar R' group and wherein said composition further comprises areactive group Rx attached to either said fluorescent dye, said R group or saidpolar R' group, wherein sid reactive group Rx comprises sulfhydryl, hydroxyl,amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine,mono- or di-halogen substituted pyridine, mono- or di-hlogen substituteddiazine, maleimide, aziridine, sulfonylhalide, acid halide,hydroxysuccinimide ester, hydroxysulosuccinimide ester, imidoester,hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide,glyoxal or aldehyde.

]57[

__________________

195538]21][11[

DYNAMICהקצאת רוחב פס דינמית עבור תקשורת רבת BANDWIDTH]54[


ALLOCATION כניסות FOR MULTIPLEACCESS COMMUNICATIONUSING SESSION QUEUES

17.01.2002]22[US]33[31.01.2001]32[09/773252]31[

Int. Cl.(2009.01) H04J 03/16, 13/00, H04W 72/04]51[DIVISION FROM 156935]62[TANTIVY COMMUNICATIONS,INC., U.S.A.

]71[


'א26רחוב הברזל מת החיילר


]74[

A code division multiple acess (CDMA) user device comprising:a transceiver configured to receive data traffic from at least one data buffer over a datatraffic channel and to receive control data indicative of a data rate associated with thedata traffic channel over a control channel wherein the transceiver is dynamicallyassigned additional data traffic channels for receiving data traffic based on an urgencyfactor indicative of the urgency of the data traffic; and wherein the urgency factor isused to determine channel allocation based on a data type of the data traffic.

]57[



__________________

195688]21][11[

MOISTURE איטו מעבר לחות של סלילי סיבי אופטי BARRIER SEALINGOF FIBER OPTIC COILS

]54[

15.08.2003]22[


US]33[15.08.2002]32[10/219412]31[Int. Cl.(2010.01) B21J 05//06]51[DIVISION FROM 166806]62[NORTHROP GRUMMANCORPORATION, U.S.A.

]71[

WO/2004/066009]87[,הנרי סיני4המייסדים

רעננה669.ד.ת,

HENRY SINAI,IP-PARTNERSHIPP.O.B 669RAANANA 43350

]74[

A system for applying a moisture barrier seal to a fiber optic coil, comprising:mounting means for mounting a fiber optic coil in a vacuum deposition chamber, so asto expose a large exterior surface area of the fiber optic coil to an interior portion ofthe deposition chamber; means for reducing air pressure within the chamber to a valueless than ambient pressure outside of the chamber; and means for introducing a vaporform of a non-porous material into the chamber wherein the vapor form of the non-porous material changes into a solid state upon contact with the fiber optic coil, so asto form a conformal coat on the fiber optic coil.

]57[

The 166806בקשת הורה לבקשה זו שטר פורסמה parent application from whichthis application has been divided hasnot yet been published

__________________

195808]21][11[

GENES גני המקודדי חלבוני מסנתזי פלוו ENCODING FLAVONESYNTHASE PROTEINS

]54[

28.01.2000]22[JP]33[29.01.1999]32[11-22427]31[


JP19.07.1999 11-205229 Int. Cl.(2009.01) A01H 05/00, C12N 09/02, 15/53, 15/82]51[DIVISION FROM 138716]62[SUNTORY LIQUORS LIMITED,JAPAN

]71[



]74[

A DNA encoding an enzyme capable of converting flavanone directly into flavonewhich is obtained from, for example, antirrhinum and torenia, and utilization thereof.The amino acid sequences of this DNA and the enzyme encoded thereby arerepresented by, for example, SEQ ID NOS: 1, 2, 3 and 4. Transfer of this gene into aplant makes it possible to, for example, change the flower color of the plant.

]57[

__________________

197482]21][11[

שיטה ומערכת לתיקו, הקצב המזוהה של מסגרות דיבור נכנסות בעלות קצב משתנה

METHOD AND SYSTEM FORVALIDATING DETECTEDRATES OF RECEIVED VARIABLERATE SPEECH FRAMES

]54[

29.11.2001]22[US]33[04.12.2000]32[09/730147]31[

Int. Cl.(2009.01) H04B 01/707, 07/26, H04L 01/00, 01/08, 29/08]51[DIVISION FROM 156249]62[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A method for detecting rate errors in a variable rate receiver, comprising:receiving an encoded speech signal;performing a rate determination algorithm on the speech signal to provide a rate for acurrent frame;providing a set of illegal rate transitions which are based upon knowledge of speechclassification and phonetic character of conversational speech; and detecting errors inthe provided rate by determining whether a rate transition from a rate for a previousframe to the rate for the current frame is within the set of illegal rate transitions.

]57[


__________________

197704]21][11[

מערכת לשיחרור יעיל של מידע בעקבות שינויHS–DSCH–ב

SYSTEM FOR EFFICIENTRECOVERY OF NODE BBUFFERED DATA FOLLOWINGSERVING HIGH SPEEDDOWNLINK SHARED CHANNELCELL CHANGE

]54[

02.04.2003]22[US]33[05.04.2002]32[60/370740]31[US30.12.2002 10/334489

Int. Cl.(2009.01) H04B 01/69, 07/26, H04L 12/56]51[DIVISION FROM 164415]62[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[

WO/2003/087978]87[,כהן ושותפיוריינהולד



]74[

A user equipment (UE) comprising:a reordering buffer of a medium access control (MAC-hs) circuity, wherein thereordering buffer is flushed in response to receiving a radio resource control RRC)requested message associated with a high speed-downlink shared channel (HS-DSCH)cell change; andat least one acknowledge mode (AM) radio link control (RLC) instance mapped to theHS-DSCH which generates a status report, the status report indicating HS-DSCHpacket data units (PDUs) missed by the (UE) in response to the reordering bufferhaving been flushed.

]57[




__________________

199377]21][11[

EXPANDABLE מתקני מתנפחי להזזת ממברנת שניידר DEVICES FORDISPLACING THESCHNEIDERIAN MEMBRANE

]54[

09.05.2001]22[US]33[09.05.2000]32[09/567471]31[

Int. Cl.(2010.01) A61C 08//00]51[DIVISION FROM 152732]62[

BEN פתח תקוה, בן ציון כרמון ZION KARMON]71[BEN-ZION ציון כרמון-בן KARMON]72[

WO/2001/085062]87[לתקנות35זה נבח5 בהתא לתקנה פירוט

1968–ח"תשכ, הפטנטיThis specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________________

202910]21][11[

SELF-OBSERVATION מערכת ושיטה לצפייה עצמית SYSTEMAND METHOD

]54[

23.12.2009]22[Int. Cl.(2010.01) G02B 27//02]51[

מבשרת ציון, אלי זקן ציון- מבשרת, כפיר ששון

ELI ZAKENKFIR SASSON

]71[

,אלי זקן 109/3הראשונים

שרת ציוןמב

ELI ZAKEN,109/3 HARISHONIM STREETMEVASERET ZION 90805

]74[

A self-observation system (10), comprising:]57[


a semi-transparent mirror (44) disposed in front of a user (48);a display device (46) disposed behind said semi-transparent mirror;at least one video camera (12), for providing a video of the body of said user to saiddisplay device; anda user interface (58) for turning said display device to ON, for transmitting said videofrom said display device through transparency of said said semi-transparent mirror tothe eyes of said user, andfor turning said display device off, thereby reflecting the body of said user throughreflectance of said semi-transparent mirror to said user's eyes,thereby providing selection of the viewed picture through said semi-transparentmirror.



__________________


PATENTS פטנטים

יתנופטנטים שנPATENTS GRANTED

148836 148679 148317 147536 146703 146491 132533 131481 161124 161107 150692 150622 150295 150124 149698 148880 161702 161636 161498 161360 161347 161318 161185 161179 162424 162286 162205 162132 162126 162058 162041 161794 163243 163237 163042 163011 162920 162884 162782 162508 164296 164275 164246 164073 163873 163867 163492 163367 165167 165119 165117 165073 164966 164801 164322 164307 165766 165695 165559 165500 165469 165382 165292 165178 166743 166563 166528 166358 166353 166285 166169 166154 156641 156553 156438 156250 142155 138665 192393 190634 157880 157757 157380 156994 156820 156720 156715 156678 158912 158854 158827 158763 158646 158514 158179 157884 159834 159827 159619 159525 159507 159485 159362 159258 160695 160335 160286 160084 160038 160015 159998 159913 143832 143767 185118 183364 181042 160953 160914 160711 152054 151940 151807 151585 151441 145615 144755 144361 153078 152732 152615 152605 152302 152268 152231 152112 173388 155315 155124 154933 154271 154266 154150 153700 174686 174662 174559 174058 174017 173708 173668 173469 177908 177241 177018 176516 176456 175558 174905 174725 167824 167019 166929 166781 136684 136055 180016 179989 170197 169673 169583 169094 168381 168261 167893 167872 171703 171431 171132 170948 170898 170872 170263 170206

173038 172841 172784 172608 172432 172079 171953

פטנטים שחודשוPATENTS RENEWED

102297 102289 102215 102200 102189 101850 100696 100385 102399 102398 102395 102394 102382 102379 102354 102310 102464 102460 102457 102456 102451 102417 102413 102407 102567 102531 102525 102519 102491 102486 102468 102465 102643 102609 102599 102594 102593 102590 102585 102579 102915 102758 102712 102695 102687 102673 102665 102659 118709 118682 118546 118403 117389 117388 116847 106199 118801 118797 118792 118791 118778 118777 118753 118747 118872 118860 118857 118844 118837 118836 118825 118805 118931 118919 118917 118914 118898 118890 118883 118876


118986 118977 118974 118973 118968 118966 118959 118955 122312 122290 122243 122162 122161 122120 122118 120558 122517 122463 122437 122434 122408 122405 122402 122325 122704 122665 122618 122617 122607 122606 122594 122584 122837 122757 122756 122755 122754 122747 122733 122705 122910 122907 122905 122894 122889 122880 122870 122853 123131 123120 123077 122992 122991 122960 122942 122940 126993 126433 123822 123617 123616 123333 123278 123189 137078 137046 136915 136849 136725 136702 134966 127776 137269 137268 137224 137151 137139 137133 137123 137099 137455 137447 137381 137364 137342 137316 137296 137292 137728 137676 137615 137594 137586 137522 137521 137507 141620 141619 141585 141461 141194 139824 138659 137762 141934 141932 141787 141761 141752 141743 141643 141636 143481 143172 142409 142408 142319 142070 142025 141935 145795 145676 145145 144323 144182 143952 143889 143768 146848 146812 146791 146783 146746 146636 146450 146386 146955 146938 146931 146928 146916 146903 146889 146851 147163 147142 147119 147089 147069 147052 147027 147015 147242 147227 147215 147214 147198 147195 147194 147181 147346 147302 147293 147282 147268 147267 147261 147254 147409 147403 147401 147388 147387 147371 147355 147347 147482 147467 147461 147445 147440 147425 147418 147413 147527 147522 147514 147513 147511 147499 147495 147494 147620 147616 147604 147582 147577 147563 147537 147533 147675 147669 147663 147655 147639 147632 147628 147625 147736 147732 147724 147706 147705 147704 147699 147682 147809 147801 147785 147761 147759 147756 147755 147744 147916 147894 147876 147855 147840 147830 147826 147810 149169 148700 148470 148406 148305 148058 147962 147931 151141 150972 150873 150768 149804 149616 149325 149261 152604 152576 152372 152239 151858 151772 151671 151225 153527 153526 153434 153433 153432 153430 152955 152686 153724 153723 153722 153714 153664 153625 153620 153528 154560 154538 154078 153804 153801 153728 153727 153725 156764 156579 156556 155801 155656 155568 155476 154574 157902 157651 157592 157591 157588 157269 157176 156858 160951 160643 160407 160015 159815 159017 158162 158161 162152 162092 161994 161657 161643 161611 161045 161034 162718 162676 162626 162575 162522 162512 162511 162450 162970 162969 162935 162916 162905 162882 162830 162799 163287 163209 163136 163135 163104 163015 163010 162980 164592 164363 164323 164199 164093 163950 163373 163288 166422 166421 166420 166283 165895 165380 165314 164709 166781 166769 166725 166724 166722 166721 166720 166687 167968 167673 167495 167337 167269 166897 166890 166875 169328 169252 168472 168187 168186 168177 168175 168041


171598 170424 170387 169612 169585 169515 169478 169351 172929 172839 172597 171953 171947 171883 171664 171613 177349 177348 175538 175454 173304 173202 173158 173018

187652 187551 186993 179865 179576

פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידושPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

160801 160757 159905 159276 159105 140934 139796 138888 115892 115890 115879 115875 168109 167357 143276 142337 115967 115951 115930 115920 115915 115902 115896 115895 116011 115994 115992 115991 115990 115988 115981 115971 116100 116099 116092 116073 116035 116034 116020 116019 116236 116218 116215 116167 116123 116110 116108 116105 152987 152880 151933 116531 116305 116277 116275 116268 165960 165668 164963 161924 155355 154637 153852 153805

פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS

161337 126626

צווי הארכה שחודשוEXTENSION ORDERS RENEWED

88363 84863 79336


NOTICEהודעהלחוק60לפי סעיף 1967-ז"תשכ, הפטנטים

Under section 60 of thePatent Law, 5727-1967

הוגשה בקשה להחזר תוקפו, של הפטנט המפורט מטהשתוקפו פקע מחמת אי

תשלום אגרות החידוש :הקבועות

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 118049 הפטנט' מס of PatentAcceptance 11/2000:'קיבול פורסם ביומן מס published in

journal no::Proprietors:שם בעל הפטנט

DOMETIC GMBHTitle:שם האמצאה of invention:

עלת יחידת קירור ספיגהיחידת קירור ספיגה ושיטה להפMETHOD FOR OPERATING AN ABSORPTION REFRIGERATION UNIT AS WELL

AS AN ABSORPTION REFRIGERATION UNITכל אדם רשאי להתנגדלבקשה האמורה תוך

שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה

92לחוק ובתקנה61בסעיף -ח"תשכ, לתקנות הפטנטים

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968





תשלום אגרות החידוש :הקבועות




דרור בכרDROR BACHAR

Title:שם האמצאה of invention: תפס מטלית עבור מגבי שטיפת רצפה

RAG CLAMPING DEVICE FOR FLOOR-WASHING WIPERSכל אדם רשאי להתנגדלבקשה האמורה תוך

שלושה חודשים מתאריך כפי שנקבע, יומן פטנטים זה


1968





הוגשה בקשה להחזר תוקפו, מטה של הפטנט המפורט

שתוקפו פקע מחמת איתשלום אגרות החידוש

:הקבועות




מ"אימארד מערכות הדמייה בעORBOTECH MEDICAL SOLUTIONS LTD.

Title:שם האמצאה of invention: זמני של קרינה גאמא4גלאי לגילוי בו

GAMMA-RAY DETECTOR FOR COINCIDENCE DETECTIONר שאי להתנגד כל אדם

לבקשה האמורה תוך שלושה חודשים מתאריך

כפי שנקבע, יומן פטנטים זה92לחוק ובתקנה61בסעיף

-ח"תשכ, לתקנות הפטנטים1968






תשלום אגרות החידוש :קבועותה



journal no::Proprietors:ם בעל הפטנטש

מ"יד כוננה בעYAD KONENA LTD.

Title:שם האמצאה of invention: מערכת ושיטה לייצור אנרגיה על ידי אמצעי הידרותרמיי

SYSTEM AND METHOD FOR POWER GENERATION BY HYDROTHERMALMEANS

כל אדם רשאי להתנגדלבקשה האמורה תוך

מתאריך שלושה חודשיםכפי שנקבע, יומן פטנטים זה


1968



NOTICE הודעה, לחוק הפטנטים66לפי סעיף

1967-ז"תשכUnder section 66 of the PatentsLaw, 5727-1967

מודע בזאת כי ניתנה רשות'לבעלת בקשת הפטנט מס

141912 This is to notify that permissionhas been granted to the owner ofPatent Application No.

Acceptance 9/2006 דבר הקיבול פורסם ביומן published in journalלתקן את הפירוט של בקשת

הפטנט האמורהTo amend the specification of thesaid Patent Application.

כל אדם רשאי להתנגד למתןהרשות תוך שלושה חודשים

ז כפי,המתאריך יומן פטנטיםלחוק ובתקנה67שנקבע בסעיף

-ח"התשכ, לתקנות הפטנטים 991968.

Any person may oppose suchgrant of permission within threemonths from the date of thisPatents Journal, as prescribed bysection 67 of the Law and byregulation 99 of the PatentRegulations, 5728-1968.









כפי, מתאריך יומן פטנטים זהלחוק ובתקנה67שנקבע בסעיף




NOTICEעההוד, לחוק הפטנטים66לפי סעיף




Acceptance 8/2008ם ביומןדבר הקיבול פורס published in journalלתקן את הפירוט של בקשת




-ח"התשכ, הפטנטיםלתקנות 991968.














שינויים בפרטים רשומים בפנקסCHANGES IN PARTICULARS ENTERED IN REGISTER


תיקונים ביומןGournal Corrections

173309Patent'בקשת פטנט מס application No

.112009No:מספר יומן בו נפלה טעות of Patent:

DELETEמחק די5 קדימה PRIORITY NUMBER

10/891953 15.07.2004 USUS 15.7.2004 10/891953


DESIGNSמדגמים

שנרשמו מדגמיםDESIGNS REGISTERED

47225 ,47226 ,47227 25Class)02( פרסום סוג

08.02.2009 RESHAFIM דלתות פלדה רשפים SECURITY DOORSDoor דלת

46890 13Class)03( פרסום סוג

27.11.2008 DAVID זילברברג דוד ZILBERBERG

Socket's לשקע מכסה cover


09.04.2008 בע.בי.איי .A.Bמ"דנטל דיוייסס DENTAL DEVICES LTD.

Dental דנטלי שתל implant


23.07.2008 MOSHE סלס משה SELES

Profile פרופיל



05.08.2008 NOMS DE CODE

Flask בקבוקConvention 07.02.2008)איחוד אירופי(האמנה תאריך date (OHIM)


05.11.2008 LABORATOIRES LA PRAIRIE SA

Container מיכל


12.11.2008 LABORATOIRES LA PRAIRIE SA

Container מארז


18.11.2008 OTSUKA PHARMACEUTICAL CO.LTD.

Inhaler משאףConvention 23.05.2008)יפן(האמנה תאריך date (JAPAN)


20.11.2008 בע כתר KETERמ"פלסטיק PLASTIC LTD.Storage אחסון ארון cabinet



07.12.2008 ARMAND SERFATY

Dispenser לנייר יבש ורטוב מושיט for wet and dry paperConvention 06.06.2008)ארצות הברית(האמנה תאריך date (U.S.A.)


07.12.2008 SULZER MIXPAC AG

Coupling מחברConvention 12.06.2008)איחוד אירופי(האמנה תאריך date (OHIM)


29.12.2008 בע כתר KETERמ"פלסטיק PLASTIC LTD.Storage אחסון ארון cabinet

Convention 04.12.2008)איחוד אירופי(האמנה תאריך date (OHIM)


31.12.2008 STRAUSS COFFEE B.V.

Cupסכו

47181 ,47182 25Class)01( פרסום סוג


02.02.2009 DOMAמ"בע) 1996(שיווק לבניין וסחר דומא MARKETING FOR

BUILDING AND TRADE (1996)LTD.

Building בניה יחידת unit



08.02.2009 DAVID שיש דוד SHISHRAFI גבע רפי GEVA

Shopping קניות עגלת cart


15.03.2009 בע הדר HADARמ"רוזן ROSEN LTD.Bag תיק

47428 ,47429 ,47430 26Class)05( פרסום סוג

15.03.2009 LSI INDUSTRIES, INC.

Lighting תאורהConvention 29.09.2008)ארצות הברית(האמנה תאריך date (U.S.A.)


30.04.2009 בע.אי.סי C.I.Qמ"קיו LTD.

EHUD עמיר אהוד AMIRConnector לציוד משרדי מחבר for office equipment


13.05.2009 YA'ACOV משה יעקב MOSHEH


Massage עיסוי מכשיר appliance



05.04.2009 AMISHAYמ"בע) 1980(חברה לשיווק עמישי MARKETING

COMPANY (1980) LTD.Door לדלת מתקן apparatus

47849 ,47850 6Class)01( פרסום סוג

15.06.2009 KEREN שטיימברג קרן SHTEIMBERG

Seating ישיבה מערכת system


17.01.2010 ARNON ברק ארנון BARAK



03.06.2009 בע'ג GERALDOמ"ראלדו LTD.

Ring טבעת


03.06.2009 בע'ג GERALDOמ"ראלדו LTD.

חן ספירת Gemstone אבני sphere



07.07.2009 BEAUTE PRESTIGE INTERNATIONAL

Bottle בקבוקConvention 07.01.2009)איחוד אירופי(האמנה תאריך date (OHIM)


27.07.2009 BENELLI ARMI S.P.A

A לרובה ציד תיבה case for a shotgun


05.08.2009 בעפל כתר KETERמ"סטיק PLASTIC LTD.

Furniture ריהוט מערכת setConvention 16.02.2009)איחוד אירופי(האמנה תאריך date (OHIM)


06.08.2009 H. STERN COMERCIO E INDUSTRIA S.A.

Jewel תכשיט


16.08.2009 ISRAEL חי גורמן ישראל HAY GURMAN


Napkins מפיות אריזת packaging



30.08.2009 HENIAL פלד הניה PELEDLabel תווית


09.09.2009 AYELET פיינברג אילת FEINBERGOrnament קישוט


15.09.2009 ADITAL אלה עדיטל ELAODED דוידוביץ עודד DAVIDOVITCHDew מי טל ומי גשם קולט and rain collector


14.09.2009 בע.בי.איי .A.Bמ"דנטל דיוייסס DENTAL DEVICES LTD.

Implant שתל


01.10.2009 EFRAIM ECKHAUS

Sink כיורConvention 08.04.2009)ארצות הברית(האמנה תאריך date (U.S.A.)


48382 ,48383 ,48384 48385 ,48386

11Class)01( פרסום סוג11.10.2009

H. STERN COMERCIO E INDUSTRIA S.A.Jewel תכשיט


13.10.2009 בע כתר KETERמ"פלסטיק PLASTIC LTD.Bath אמבטיה מתקן device

48418 ,48419 24Class)02( פרסום סוג

14.10.2009 MORIS טופז מוריס TOPAZWound סגירת פצע התקן closure devices

48467 ,48469 ,48471 11Class)01( פרסום סוג

25.10.2009 H. STERN COMERCIO E INDUSTRIA S.A.

Jewel תכשיט


01.11.2009 LARS HAMMAR

Sign לשלט תומך supportConvention 04.05.2009)איחוד אירופי(האמנה תאריך date (OHIM)



11.11.2009 בע מוראל MORELמ"אקוסטיקה ACOUSTIC LTD.Loudspeaker רמקול


17.11.2009 בע רותם ROTHEMמ"קולקשיין COLLECTION LTD.Gemstoneחן אבן


22.11.2009 EYA זיגלשטיין אייל SIEGELSTEIN

ALBERT פולטוב אלברט PULATOVEar אוזן מגן protector


13.01.2010 YAIR וינר יאיר VIENER

TZAFRIR מילר צפריר MILLERCasual פנאי משחק game


19.01.2010 בע סאן SUNWAYמ"וואי בגדי הגנה משמש SUN PROTECTIVE

SWIMWEAR LTD.


Swimsuitים בגד



19.01.2010 בע סאן SUNWAYמ"וואי בגדי הגנה משמש SUN PROTECTIVE

SWIMWEAR LTD.Hat כובע


20.08.2009 בע קליל KLILמ"תעשיות INDUSTRIES LTD.


48306 ,48307 ,48308 48309

11Class)01( פרסום סוג13.09.2009

H. STERN COMERCIO E INDUSTRIA S.A.Jewel תכשיט


12.11.2009 בע.י רטרו RETROמ"עמרני J. AMRANI LTD.

Belt חגורה


04.06.2009 VICTAULIC COMPANY

Flexible לצינור גמיש מחבר pipe coupling


Convention 04.12.2008)ארצות הברית(האמנה תאריך date (U.S.A.)



21.05.2009 בע איידיאס IDEASמ"יצור ויבוא מוצרי נייר MANUFACTURING &

IMPORT OF PAPER PRODUCTSLTD.

Chair כסא


שחודשומדגמיםDESIGNS RENEWED

33784 33698 33693 33687 33546 33544 33543 33542 40791 34046 33937 33936 33934 33932 33884 33788 41031 40992 40991 40956 40954 40953 40906 40866 41285 41283 41281 41277 41098 41034 41033 41032

41365 41340 41289


שבוטלומדגמיםDESIGNS VOID

24588 24582 24573 24568 24566 24565 24562 24561 32621 32613 32579 24662 24634 24616 24590 24589

39863 32696 32695


שהוזנחומדגמיםWITHDRAWN DESIGNS

46855 46844 46280 45697 45696 45695 45212 44795 46913 46898 46897 46896 46889 46879 46859 46857 46990 46986 46944 46938 46937 46921 46919 46916 47010 47009 47008 47006 47004 46995 46994 46992 48626 48493 47939 47823 47071 47013 47012 47011

ר מאיר נועם"ד המדגמים, רשם הפטנטים וסימני מסחר

Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks


מפתחות לבקשות שקובלוINDICES OF APPLICATIONS ACCEPTED

NAMEמפתח שמי INDEX

בע"אג 163263-מ"מ מערכות אנרגיהבע-אהבה 157786-מ"מעבדות ים המלח

183147-אולגה לפטיןבע.טי.איי.אמ. אי 172034-מ"טכנולוגיות172034-מ"בע.טי.איי.אם.אי

152630-מ"אינובנשינס בע202910-אלי זקן

171027-מ"אלמדיקל בע168149-מ"אלתא מערכות בע

מינימלי אינוסיב מסטופקסי-אם איי אם150151-מ"בע

חברה אוניברסיטאית למחקר-אריאל172078-מ"ופיתוח בע

147102-אריה סנסולו174280-מ''ארפל אלומיניום בע

161926-בוריס גלינר199377-בן ציון כרמון

בע'גיוון אימג 152128,154421-מ"ינגבע'ויז-גרין 176102-מ"ן מערכות

172308- דוד פרץאדי 189470-גליק. ויד

150518-דן יוסף

בע'הוק מדיקל טכנולוג 173906-מ"יסע ש"המכון למחקר במדעי הרפואה

155783-משפחת רפפורטבעהתעשיה הא -מ"וירית לישראל

179100

182549-מ"טבע תעשיות פרמצבטיות בע

158003-מ"ידע חברה למחקר ופיתוח בע

183147-יפים לפטין

202910- כפיר ששון

169190-מ"מדיגייד בע-מ"מוסד הטכניון למחקר ופיתוח בע

155783160988-מ"מור ישום מחקרים בע

157419-מישל כהן

182290-מ"ניולנס בע

169884-מ"סביון דיאגנוסטיקה בע182840-מ"סלקום ישראל בע

150151-עדי שפרעם-מ"עמינח תעשית רהיטים ומזרונים בע

162012157419-עמרם אוחיון

160939-קבוץ סאסא-פלסאןמ"פלסן סאסא אגודה שיתופית חקלאית בע

-171040

160988-מ"קיורטק בע131245-מ"קרדיוסנס בע

בע'רג 199377-מ"ין אקס166978- רון יעקב דוידסון

-מ"רפאל רשות פתוח אמצעי לחימה בע170271

-מ"שגיב אגודה שיתופית חקלאית בע177035

-מ"תצפית כפר נחום שוק שמן זית בע


174320

A.D. INTEGRITY APPLICATIONS, LTD.- 173695ABBOTT GMBH & CO. KG - 145134ADCOCK INGRAM LIMITED - 163637ADI SHFARAM - 150151AGAM ENERGY SYSTEMS LTD. -163263AGENCE SPATIALE EUROPEENNE(ESA) -173417AHAVA- DEAD SEA LABORATORIESLTD. - 157786AIR PRODUCTS AND CHEMICALS,INC. - 181227AIRBUS ESPANA, S.L. -172470AIRSEC S.A.S. -187278ALBEMARLE CORPORATION -173166ALBIREO AB - 170913ALCON, INC. - 178825ALZA CORPORATION -154838AMINACH BEDDING & FURNITUREMANUFACTURING LTD. - 162012AMRAM OHAYON - 157419ARIE SANSOLO -147102ARIEL-UNIVERSITY RESEARCH ANDDEVELOPMENT COMPANY LTD -172078ARPAL ALUMINUM LTD. - 174280ASK S.A. -170974ASTRAZENECA AB -170913ATLAS COPCO ROCK DRILLS AB -171671AUGUSTO LARRAIN ORREGO -168851AUTOMATIC RECOGNITION &CONTROL INC. -181671AVENTIS PHARMACEUTICALS INC. -145526AVENTIS PHARMACEUTICALS INC. -157341AZIENDE CHIMICHE RIUNITEANGELINI FRANCESCO A.C.R.A.F.S.p.A. -162272

BASF SE -165879BAXTER INTERNATIONAL INC. -

177514BAYERBETEILIGUNGSVERWALTUNGGOSLAR GMBH -168350BAYER SCHERING PHARMA AG -174194BAYER SCHERING PHARMAAKTIENGESELLSCHAFT -148417BAYER SCHERING PHARMAAKTIENGESELLSCHAFT -179856BEN ZION KARMON - 199377BIMEDA RESEARCH &DEVELOPMENT LIMITED - 177063BIOFORM MEDICAL, INC. - 161545BIO-KEY INTERNATIONAL, INC. -162003BIOSENSE WEBSTER INC. -153438BIOSENSE WEBSTER, INC. -165105BK GIULINI GMBH - 171255BOEHRINGER INGELHEIM PHARMAGMBH & CO. KG - 163698, 187278BORIS GLINER -161926BRIAN H. RUTLEDGE -177835BRISTOL-MYERS SQUIBB COMPANY -171356BURKHARD LUCKMANN - 179247

C.D.C. S.R.L. -164731C2CURE INC. -152128C2CURE INC. -152128CALIFORNIA PACIFIC MEDICALCENTER -157669CAPAN, RAHMI, OGUZ -194204CAPER NAUM VISTA OLIVE OILMARKET LTD - 174320CARDIOSENSE LTD. -131245CAREFUSION 303, INC. -152717CATHOLIC HEALTHCARE WEST -157669CELLCOM ISRAEL LIMITED - 182840CENTELION -152860CERNIUM CORPORATION -151004CHAI-TECH CORPORATION -103992CHRISTOS C. ZOUBOULIS -158559


CHUGAI SEIYAKU KABUSHIKIKAISHA - 174909CIBA SPECIALTY CHEMICALSHOLDING INC. - 160909COLEY PHARMACEUTICAL GMBH -160157COLEY PHARMACEUTICAL GROUP,INC. - 160157COMBINED RESOURCE ENGINEERINGPTY LTD. - 166496CONLY L. HANSEN - 170191CORCEPT THERAPEUTICS, INC. -157770CORNELL RESEARCH FOUNDATION,INC. - 158969CORNELL RESEARCH FOUNDATION,INC. - 180244COSMEDICAL APS -174545CSL BEHRING GMBH -152332CURETECH LTD. -160988CURLIN MEDICAL INC. - 183145CUTANIX CORPORATION -161545

DAN YOSEF -150518DAVID A. GLUCK - 189470DAVID PERETZ -172308DEERE & COMPANY -173718DELAVAU L.L.C. - 173443DENTSU INC. -162670DEVTEK PTY LTD. - 166496DOMPE S.P.A. -161447DORMINA UK LIMITED - 169890DSM IP ASSETS B.V. -176414

E.M.A.T TECHNOLOGIES LTD -172034E.M.A.T. LTD, - 172034EASYNET ACCESS INC. -125432EDWARD D. WATTS -170191EFIM LAPATIN - 183147EISAI R&D MANAGEMENT CO., LTD. -182524ELAN PHARMA INTERNATIONALLTD. - 136252ELECTRONIC NAVIGATIONRESEARCH INSTITUTE -161562ELEMENT SIX LIMITED - 176207ELI LILLY AND COMPANY - 177829,

193631ELI ZAKEN - 202910ELMEDICAL LTD. - 171027ELTA SYSTEMS LTD. -168149ENSCHEDE/SDU B.V. -165832ENZO LIFE SCIENCES, INC. -154700,195435, 195436, 195437, 195440EVONIK ROHM GMBH - 161145

F. HOFFMANN-LA ROCHE AG -158589, 166038, 168266, 169600FABIO PERINI S.P.A. -168816FAES FARMA ,S.A. -164645FANGLU LOU - 171802FIBROGEN, INC. -149459FIRMENICH SA -167832, 182795FLAMEL TECHNOLOGIES -160795FRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V. -174318, 177163FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG -184284

GEFA S.R.L. -164731GEMOLOGICAL INSTITUTE OFAMERICA, INC. - 176354GENENTECH, INC. -138585, 171733GENERAL ELECTRIC COMPANY -159065GENETICS INSTITUTE, LLC. -145134GERON CORPORATION -159578GIVEN IMAGING LTD. - 152128, 154421GLAXO GROUP LIMITED - 161114GOOD BIOTECH CORPORATION -150194GREEN VISION SYSTEMS LTD. -176102GUNTER REIMANN -179247

H.C. STARCK INC. -162966H.C. STARCK GMBH -168350H.E.F. -175505HAWK MEDICAL TECHNOLOGIESLTD - 173906HEALTHSTATS INTERNATIONAL PTELTD. - 155300


HONEYWELL INTERNATIONAL INC. -165600, 173055

IBM CORPORATION -173731IDALEX TECHNOLOGIES, INC. -177077IMMUNEX CORPORATION -146482IMMUNOMEDICS, INC. - 163851INCA DIGITAL PRINTERS LIMITED -176232INDENA S.P.A. -172973, 188706INNOVENTIONS LTD. - 152630INTERDIGITAL TECHNOLOGYCORPORATION -168896, 172753,189071, 197704INVENTIO AG - 180964IPR LICENSING, INC. -168053ISOTECHNIKA INC. - 160762ISRAEL AEROSPACE INDUSTRIESLTD. - 179100ISTITUTO SUPERIORE DI SANITA -162680ITT MANUFACTURING ENTERPRISES,INC. - 169589

JACKEL INTERNATIONAL LIMITED -154846JANE, S.A. -176476JANSSEN PHARMACEUTICA N.V. -166795JANSSEN PHARMACEUTICA, N.V. -173372, 188457JAPAN TOBACCO INC. -164569JENAPHARM GMBH & CO.KG -148417JENS BIRGER NILSSON -166681JHRG, LLC -173055JOHN ANTHONY DOWNES -178421JOHNS HOPKINS SCHOOL OFMEDICINE - 140621JOSEPH J. MAZZILLI -167079JURGEN HEINEMEIER -179247

KAKUICHI SHIOMI - 161562KENT STATE UNIVERSITY -158165KFIR SASSON -202910KIA SILVERBROOK - 146625KISSEI PHARMACEUTICAL CO., LTD. -

167038, 167168KLAMATH FALLS, INC. - 182570KONINKLIJKE PHILIPS ELECTRONICSN.V. - 167306

L-3 COMMUNICATIONS SECURITY &DETECTION SYSTEMS -162409LG ELECTRONICS INC. -174613LIGHTWAVES SYSTEMS, INC. -164572LONZA AG - 174453LUCA TONCELLI - 172945LUTRON ELECTRONICS CO. INC. -180225

MALLINCKRODT BAKER, INC. -173664MARUISHI PHARMACEUTICAL CO.,LTD. - 168477McKESSON AUTOMATION, INC. -152717MEDIGUIDE LTD. - 169190MEGADYNE MEDICAL PRODUCTS,INC. - 161926MERCK PATENT GESELLSCHAFT MITBESCHRANKTER HAFTUNG -165879MERCK SERONO S.A. -163413, 183924MERCKLE GMBH - 160047MICHEL COHEN -157419MICHIKO TAKAOKA - 161562MICROSOFT CORPORATION -168620,169885MIM - MINIMALLY INVASIVEMASTOPEXY LTD. - 150151MITSUBISHI SPACE SOFTWARE CO.,LTD. - 161562MOR RESEARCH APPLICATIONS LTD.- 160988

NAGRAVISION S.A. -171933, 171934NERVIANO MEDICAL SCIENCES S.R.L.- 164356NESTEC S.A. -174583NEURALAB LIMITED - 136252NEWRON PHARMACEUTICALS S.P.A. -175754NEXMED HOLDINGS, INC. -169425NICOX S.A. -172703


NOKIA CORPORATION -170283NORTHROP GRUMMANCORPORATION -173327, 173331NORTHROP GRUMMANCORPORATION -195688NOVARTIS AG - 149147, 154465,167426, 170518, 174145NULENS LTD. - 182290NYCOMED GMBH - 165065

OLGA LAPATIN - 183147ORTHO-MCNEIL PHARMACEUTICAL,INC. - 161830ORTHOVITA, INC. - 173865

PETER E. RISING -177835PFIZER ITALIA S.R.L. -164356PFIZER PRODUCTS, INC. -192371PHARMACIA & UPJOHN COMPANYLLC - 142207PHILIP MORRIS PRODUCTS S.A. -172083PLASAN -KIBBUTZ SASA - 160939PLASAN SASA AGRICULTURALCOOPERATIVE SOCIETY LTED. -171040POLYMETERS RESPONSEINTERNATIONAL LTD. - 166819

QUALCOMM INCORPORATED -151016, 161680, 161883, 163187, 167378,168512, 168932, 170145, 170231,172262, 173154, 173266, 197482QUALCOMM INCORPORATED -164827QUALCOMM INCORPORATED -165573QUALCOMM INCORPORATED -179416

RAFAEL - ARMAMENTDEVELOPMENT AUTHORITY LTD -170271RAPPAPORT FAMILY INSTITUTE FORRESEARCH IN THE MEDICALSCIENCES -155783RAYTHEON COMPANY -166030,169149, 172996REGENE EX LTD. -199377REGENERX BIOPHARMACEUTICALS,

INC. - 184284RESPONSE GENETICS, INC. -157694RKW SE -179247RON YAACOV DAVIDSON - 166978RUAG LAND SYSTEMS -176392

SAGEM DEFENSE SECURITE -173495SAGIV AGUDAH SHITUFIT CHAKLAITBE'AM - 177035SAMSUNG ELECTRONICS CO., LTD. -141800SANOFI PASTEUR -132669SANOFI PASTEUR -169689SANOFI-AVENTIS -161114, 164400SANOFI-AVENTIS DEUTSCHLANDGMBH - 152288SANOFI-AVENTIS DEUTSCHLANDGMBH - 160555, 160938, 166438,170313, 170314, 170316SAVYON DIAGNOSTICS LTD. -169884SCHERING CORPORATION -134068SCIENTIFIC GAMES HOLDINGSLIMITED - 156597SCIENTIFIC GAMES INTERNATIONAL,INC. - 156597SEEREAL TECHNOLOGIES GMBH -168538SEMINIS VEGETABLE SEEDS, INC. -116114SHERWOOD SERVICES AG -157152SHOTSPOTTER, INC. -169836SILVERBROOK RESEARCH PTY. LTD.- 149959SKELSCAN, INC. -177264SNECMA -164499SOLARGENIX ENERGY LLC -171542SOLVAY PHARMACEUTICALS B.V. -147889SPINE WAVE, INC. -157768SPRAYDOWN LIMITED - 178421STATIC CONTROL COMPONENTS,INC. - 181215SUMITOMO CHEMICAL COMPANY,LIMITED - 167829SUMITOMO CHEMICAL COMPANY,LIMITED. - 170056, 175720SUMITOMO ELECTRIC HARDMETAL


CORP. -182723SUNTORY FLOWERS LIMITED -195808SUNTORY LIMITED - 195808SUNTORY LIQUORS LIMITED -195808SYNGENTA PARTICIPATIONS AG -151886SYNTONIX PHARMACEUTICALS, INC- 171779

TAEGUTEC INDIA LTD. - 182100TAKEDA PHARMACEUTICALCOMPANY LIMITED - 167835TANTIVY COMMUNICATIONS, INC. -195538TASER INTERNATIONAL, INC. -169842, 174777TECHNION RESEARCH ANDDEVELOPMENT FOUNDATION LTD. -155783TELECOM PRODUCTIONS INC. -156597TELIK, INC. - 183107TEVA PHARMACEUTICALINDUSTRIES LTD. -182549THE REGENTS OF THE UNIVERSITYOF CALIFORNIA - 157159THE RESEARCH FOUNDATION OFTHE STATE UNIVERSITY OF NEWYORK - 142824THE SCRIPPS RESEARCH INSTITUTE -169200THE TRUSTEES OF THE UNIVERSITYOF PENNSYLVANIA - 145526TIMOTHY R. WILLIS - 157177T-MOBILE DEUTSCHLAND GMBH -

165957TREK 2000 INTERNATIONAL LTD. -172644TRUSTEES OF BOSTON UNIVERSITY -164314

ULTRA PROIZVODNJAELEKTRONSKIH NAPRAV D.O.O. -164383UNILEVER PLC -169197UNIVERSITY OF IOWA RESEARCHFOUNDATION - 160157UNIVERSITY OF ZURICH -174145URU TECHNOLOGY, INCORPORATED- 172568

VERENIUM CORPORATION -146937VERNALIS (R&D) LIMITED - 163413VIFOR (INTERNATIONAL) AG. - 166747

WASHINGTON UNIVERSITY -193631WEIR MINERALS NETHERLANDS B.V.- 166496WELCH ALLYN, INC. - 173279

YEDA RESEARCH ANDDEVELOPMENT CO. LTD. -158003

ZIOPHARM ONCOLOGY, INC. -188164ZYMOGENETICS INC. -145288

SUBJECTמפתח ענייני MATTER INDEX

A01D - 173718A01H - 140621

A01M - 157419A21D - 174583


A23L - 169197A23N - 150518A24D - 172083A47D - 162012A61B - 150151, 157768, 157786,

169190, 173279, 173695,173865, 173906

A61B - 152128, 153438, 155300,161562, 161926, 165105

A61C -199377A61F -157177A61F -171027, 182290A61J -154846A61K - 136252, 148417, 157770,

161114, 161145, 162680,164356, 164400, 167835,168851, 169425, 170518,170913, 171356, 174545,183924, 187278, 188706

A61K - 157341, 158559, 160795,163637, 174909, 179856,182549, 184284, 188164,188457

A61L - 157152A61M - 152630, 177063, 177514,

177829, 183145A61N - 131245A61N - 154838

B01J -174453B21J -195688B23B -182723B23C -182100B23P -181227B29C -172945B41J -176232B42F -189470B60N -160939B60R -166978, 167079B60V - 173055B62B -176476B62D -171040B62D -172078, 178421B65D -177835, 179247B65H -168816B66B -180964B67D -170191

C01F -173443C03C -175505C07C -142824, 160938, 161545,

163698C07C -164569, 175720, 182795C07D -149147, 166795, 167426,

167829, 168477, 170056,172703, 172973, 175754,182524, 195435, 195436,195437

C07D -157669, 158589, 160047,161830, 163413, 164645,165065, 167168, 169600,170313, 170314, 170316,173372, 174194

C07F -103992C07H -162272, 167038C07H -164314, 168266C07K -132669, 145134, 147889,

154465, 160762C07K -150194, 152332, 158969,

163851, 166038, 166438,169200, 183107

C08B -166747, 169689C08J -172034C08K -160909, 173166C09J -171255C09K -166681C12J -174320C12N -116114, 138585, 149459,

151886, 152288, 159578,160988, 171733, 174145,192371

C12N -134068, 142207, 145288,146482, 152860, 155783,160157, 161447, 171779,193631, 195808

C12P -167832C12Q -154700, 157694, 160555C12Q -195440C30B -176207C40B -146937

D01F -176414D03D -165600


E06B -174280E21B -182570E21D -171671

F01C -183147F02C -163263F04B -166496F16K -170271F16L -177035F24J -171542F24J -194204F25B -173495F25D -172308F28C -177077F41H -176392F42C -147102

G01L -178825G01N -145526, 158003, 158165,

162409, 169884, 176354G01N -177264G01R -166819G01S -166030, 169836G02B -164499, 169589, 172470,

179100, 180244G02B -181671, 202910G03F -173664G03G -181215G03H -168538G06F -125432, 152717, 163187,

172644G06F -149959, 168620, 172568,

172996, 173327, 173331G06K -146625G06K -162003, 170974G06Q -169885G06T -169149

G06T -174318G07C -165832G07F -156597G07F -164383G08B -176102G10L -165957, 177163G11B -167306G11C -179416

H01G -162966, 169842H01G -168350H01L - 159065, 165879H01Q -168053, 180225H01R -169890H01T -174777H04B -151016, 168149, 168896H04B -165573, 172753, 173266,

189071H04J -161680, 161883H04L - 141800, 164572, 164731,

164827, 168932, 170145,173417, 197482, 197704

H04L - 167378, 170283, 171933,171934, 173731, 174613

H04N -151004, 162670H04N -154421H04W -168512, 170231, 172262,

173154, 195538H04W -182840H05B -171802H05H -157159


קודים למדינת המופיעים ביומןCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization Code Country or OrganizationAR Argentina MX MexicoAT Austria MY MalaysiaAU Australia NL The NetherlandsBA Herzegovina NO NorwayBE Belgium NZ New ZealandBR Brazil PL PolandCA Canada PT PortugalCH Switzerland RU Russian FederationCN China SE SwedenCU Cuba SG SingaporeCZ Czech Republic SI SloveniaDE Germany SK SlovakiaDK Denmark TH ThailandEC Ecuador TR TurkeyEP European Patent Office TW TaiwanES Spain UA UkraineFI Finland US United States of AmericaFR France UY UruguayGB United Kingdom UZ UzbekistanGE Georgia WO World Intellectual PropertyGR Greece Organization (W.I.P.O.)GT Guatemala ZA South AfricaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV Latvia


ע ירושלים,יםמשרד המשפט,י רשות הפטנטים"נערך ירושלים, הודפס במדפיס הממשלתי

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

PRINTED BY THE GOVERNMENT PRINTER

Documents

PATENTS AND DESIGNS JOURNAL · The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem. Fees to the Patent Office can be accepted only by payment to the Postal